ID,Description,GeneRatio,BgRatio,RichFactor,FoldEnrichment,zScore,pvalue,p.adjust,qvalue,geneID,Count,fold_enrichment,ci_lower,ci_upper
R-HSA-112316,Neuronal System,77/1194,400/9872,0.1925,1.5915912897822446,4.48026640289365,1.771512093897418e-5,0.02789311917713886,0.02686379052026925,HCN2/CACNB4/NRXN1/KCNMB4/GABRB1/PTPRF/GABRG2/GNB3/KCNH5/GRIN1/GNAI1/TSPAN7/PRKAR2A/ARHGEF7/FLOT2/KCNMA1/CAMK2D/GLUL/GABRA2/PPFIA2/KCNMB2/DLGAP1/KCNB2/KCNF1/LRRTM2/PRKCG/GRIK4/GABRA3/GLS2/KCNJ16/SLC1A2/SYN2/FLOT1/KCNK10/PLCB1/SLC32A1/CACNG3/PRKAG3/ALDH5A1/ADCY3/NRG1/SLITRK5/NRXN3/GNG3/KCNB1/IL1RAPL2/GABRA4/NAAA/GABRG3/LRRTM1/TUBB2A/CACNG2/CAMK4/GRIN2B/GRIK2/GIT1/IL1RAP/KCNQ2/TUBB4A/KCNH2/NLGN4X/GRIA1/CHRNB2/GAD2/CAMK2G/NSF/PPFIA4/GRIK1/KCND2/GABRB3/CACNG4/GNAL/SLC1A6/GABRA1/KCNS2/NCALD/RPS6KA3,77,3.144650335008375,2.4470555125489275,4.0411121360985325
R-HSA-9702518,STAT5 activation downstream of FLT3 ITD mutants,7/1194,10/9872,0.7,5.787604690117252,5.618348844158576,3.2061056525446965e-5,0.02789311917713886,0.02686379052026925,PIM1/CDKN1A/BCL2L1/STAT5B/PTPN11/GRB2/STAT5A,7,11.435092127303182,4.344985807433834,30.094766186851917
R-HSA-9013026,RHOB GTPase cycle,20/1194,70/9872,0.2857142857142857,2.3622876286192867,4.242612820914982,1.5911812691883585e-4,0.08862277636182789,0.08535236537690866,ERBIN/ARHGAP21/ARHGAP26/ARHGEF10/RTKN/TJP2/TFRC/FLOT2/PCDH7/ARHGAP5/CAVIN1/ARHGEF3/MYO9B/FLOT1/PREX1/ARHGAP1/RHOB/ABR/SLK/OPHN1,20,4.667384541756401,2.8298525971393675,7.698096530769141
R-HSA-112315,Transmission across Chemical Synapses,52/1194,263/9872,0.19771863117870722,1.6347389673334989,3.8699633754426515,2.0373052037201813e-4,0.08862277636182789,0.08535236537690866,CACNB4/GABRB1/GABRG2/GNB3/GRIN1/GNAI1/TSPAN7/PRKAR2A/ARHGEF7/CAMK2D/GLUL/GABRA2/PPFIA2/PRKCG/GRIK4/GABRA3/GLS2/KCNJ16/SLC1A2/SYN2/PLCB1/SLC32A1/CACNG3/PRKAG3/ALDH5A1/ADCY3/NRG1/GNG3/GABRA4/NAAA/GABRG3/TUBB2A/CACNG2/CAMK4/GRIN2B/GRIK2/GIT1/TUBB4A/GRIA1/CHRNB2/GAD2/CAMK2G/NSF/PPFIA4/GRIK1/GABRB3/CACNG4/GNAL/SLC1A6/GABRA1/NCALD/RPS6KA3,52,3.2299010897325666,2.3852512165152335,4.373652962515529
R-HSA-186763,Downstream signal transduction,11/1194,29/9872,0.3793103448275862,3.136140472477329,4.273050065866917,3.3594438826384856e-4,0.11404982179470738,0.10984108668915556,STAT3/NCK2/BCAR1/PDGFRA/PDGFRB/STAT5B/PTPN11/PDGFA/GRB2/STAT5A/STAT1,11,6.1963553399179805,3.087790910761891,12.434397473194334
R-HSA-6785807,Interleukin-4 and Interleukin-13 signaling,24/1194,98/9872,0.24489795918367346,2.0248179673879605,3.781782239528958,4.891880860434809e-4,0.11404982179470738,0.10984108668915556,STAT3/PIM1/IL1B/VEGFA/BCL6/HMOX1/BATF/HIF1A/CDKN1A/BCL2L1/FOS/OPRM1/JAK3/MCL1/CEBPD/IL4R/SOCS3/JUNB/RORA/IL13RA2/ZEB1/IL1A/CCL2/STAT1,24,4.000615321505487,2.55039198541941,6.275475708112552
R-HSA-9006934,Signaling by Receptor Tyrosine Kinases,87/1194,513/9872,0.1695906432748538,1.4021765748822081,3.4700333321242867,5.582572606822256e-4,0.11404982179470738,0.10984108668915556,ERBIN/STAT3/SGK1/FGF20/DOCK1/PTPN2/ELMO1/SHB/PTPRJ/PAK2/GABRB1/PTPRF/RALGDS/VGF/CTNNA1/VEGFA/GABRG2/FGFR3/PXN/CXCL12/PCSK6/HNRNPF/COL9A1/ID4/SPRED1/NCK2/HIF1A/PTPRO/SHC2/ARHGEF7/ADAM12/BCAR1/IGF1/ITGB3/GRB10/MXD4/SPP1/FOS/RAP1A/WWP1/PDGFRA/FGFR2/COL5A3/PDGFRB/DNM3/STAT5B/VEGFD/PTPN1/JAK3/SPRY1/DUSP3/BDNF/PTPN11/PRKCZ/LAMA1/COL4A2/PTK2/PDGFA/FGFBP2/GAB1/COL5A2/EGR1/ADORA2A/NRG1/HPN/FLRT2/JUNB/GRB2/GABRG3/HSPB1/GRIN2B/LAMA2/PTPRZ1/MST1/PAK3/ITGA2/PAG1/AXL/SH2B2/STAT5A/STAT1/PRR5/GABRB3/GABRA1/ALKAL2/RPS6KA3/DNM1,87,2.770406613966519,2.190976075873188,3.5030746758157036
R-HSA-418990,Adherens junctions interactions,16/1194,55/9872,0.2909090909090909,2.405238312776001,3.876277387275789,5.658074374090065e-4,0.11404982179470738,0.10984108668915556,CDH19/CTNNA1/ADAM19/TNRC6C/CDH18/AGO2/CDH10/NECTIN2/CDH6/CDH4/AFDN/NECTIN3/CDH8/CDH24/SOX10/CADM3,16,4.752246078879245,2.7151038956327826,8.31785583989955
R-HSA-418038,Nucleotide-like (purinergic) receptors,7/1194,14/9872,0.5,4.134003350083752,4.352532110262033,5.899128713519347e-4,0.11404982179470738,0.10984108668915556,P2RY14/P2RY13/P2RY12/LPAR4/ADORA1/ADORA2A/GPR17,7,8.1679229480737,3.290472894239262,20.275190657996013
R-HSA-8986944,Transcriptional Regulation by MECP2,17/1194,61/9872,0.2786885245901639,2.3041985885712712,3.7898753136095547,6.654965112942766e-4,0.11579639296520412,0.11152320484005142,SLC2A3/SGK1/CRH/FKBP5/TNRC6C/CAMK2D/AGO2/LBR/PTPN1/OPRM1/BDNF/PPARG/FOXG1/CAMK4/GRIN2B/GAD2/CAMK2G,17,4.552612790729604,2.6511427185960073,7.817867773369448
R-HSA-1500931,Cell-Cell communication,31/1194,143/9872,0.21678321678321677,1.7923650888475007,3.5402356086022717,7.932500039576953e-4,0.1166626351271422,0.11235748041283146,CDH19/CTNNA1/PXN/ITGB4/CLDN11/NCK2/ADAM19/IQGAP1/CD47/TNRC6C/CDH18/AGO2/PTPN11/CDH10/PTK2/NECTIN2/CDH6/CDH4/CLDN10/AFDN/GRB2/NECTIN3/FERMT2/CDH8/SFTPD/FLNA/CDH24/CLDN15/SOX10/CLDN20/CADM3,31,3.5413372222417445,2.3912582207255686,5.244548335658036
R-HSA-112314,Neurotransmitter receptors and postsynaptic signal transmission,40/1194,200/9872,0.2,1.653601340033501,3.463719417765357,8.405370579577961e-4,0.1166626351271422,0.11235748041283146,GABRB1/GABRG2/GNB3/GRIN1/GNAI1/TSPAN7/PRKAR2A/ARHGEF7/CAMK2D/GABRA2/PRKCG/GRIK4/GABRA3/KCNJ16/PLCB1/CACNG3/PRKAG3/ADCY3/NRG1/GNG3/GABRA4/GABRG3/TUBB2A/CACNG2/CAMK4/GRIN2B/GRIK2/GIT1/TUBB4A/GRIA1/CHRNB2/CAMK2G/NSF/GRIK1/GABRB3/CACNG4/GNAL/GABRA1/NCALD/RPS6KA3,40,3.2671691792294806,2.315093000738614,4.6107842934609735
R-HSA-186797,Signaling by PDGF,16/1194,57/9872,0.2807017543859649,2.3208439860119308,3.709511445838786,8.716173888809475e-4,0.1166626351271422,0.11235748041283146,STAT3/COL9A1/NCK2/BCAR1/SPP1/PDGFRA/COL5A3/PDGFRB/STAT5B/PTPN11/COL4A2/PDGFA/COL5A2/GRB2/STAT5A/STAT1,16,4.5855006024273415,2.6255895571279555,8.008416897369914
R-HSA-9013106,RHOC GTPase cycle,19/1194,74/9872,0.25675675675675674,2.122866585178143,3.596236270145898,9.9585544273482e-4,0.12162301745074447,0.11713481172509692,ERBIN/ARHGAP21/ARHGAP26/ARHGEF10/IQGAP1/RTKN/TJP2/TFRC/FLOT2/LBR/ARHGAP5/CAVIN1/MYO9B/FLOT1/PREX1/ARHGAP1/ABR/SLK/OPHN1,19,4.194338811172982,2.5250832397987306,6.967088365892543
R-HSA-8985947,Interleukin-9 signaling,5/1194,8/9872,0.625,5.16750418760469,4.373885632924149,0.0010484742883684868,0.12162301745074447,0.11713481172509692,STAT3/STAT5B/JAK3/STAT5A/STAT1,5,10.209903685092126,3.3349559323245392,31.257424498019873
R-HSA-982772,Growth hormone receptor signaling,8/1194,20/9872,0.4,3.307202680067002,3.8309938978437637,0.001472963992724999,0.13835123935841484,0.13324571872873348,STAT3/STAT5B/PTPN1/SOCS3/CISH/PRLR/STAT5A/STAT1,8,6.534338358458962,2.872161221622884,14.866010118576265
R-HSA-421270,Cell-cell junction organization,20/1194,82/9872,0.24390243902439024,2.0165870000408543,3.4287281139181665,0.0014765821359361032,0.13835123935841484,0.13324571872873348,CDH19/CTNNA1/CLDN11/ADAM19/TNRC6C/CDH18/AGO2/CDH10/NECTIN2/CDH6/CDH4/CLDN10/AFDN/NECTIN3/CDH8/CDH24/CLDN15/SOX10/CLDN20/CADM3,20,3.9843526575969275,2.4353518459606582,6.518592426975395
R-HSA-5576892,Phase 0 - rapid depolarisation,11/1194,34/9872,0.3235294117647059,2.6749433441718398,3.6287670319763756,0.0015693299038518898,0.13835123935841484,0.13324571872873348,FGF11/SCN1A/FGF14/CAMK2D/SCN2A/SCN11A/SCN1B/SCN4B/CAMK2G/FGF12/CACNG4,11,5.285126613459455,2.6711768249090255,10.457025180745466
R-HSA-9703648,Signaling by FLT3 ITD and TKD mutants,7/1194,16/9872,0.4375,3.617252931323283,3.886227809834046,0.0015794218772853673,0.13835123935841484,0.13324571872873348,PIM1/CDKN1A/BCL2L1/STAT5B/PTPN11/GRB2/STAT5A,7,7.146932579564489,2.934575554096544,17.40580344763545
R-HSA-5362517,Signaling by Retinoic Acid,12/1194,39/9872,0.3076923076923077,2.5440020615900014,3.583522010130128,0.0015902441305564925,0.13835123935841484,0.13324571872873348,PDK1/RARA/PPARD/RXRG/CYP26C1/AKR1C3/DHRS4/PDK3/PDHX/ADH1A/ADH4/RDH10,12,5.026414121891509,2.624926427382824,9.62497030819284
R-HSA-446728,Cell junction organization,24/1194,107/9872,0.22429906542056074,1.8545061757385055,3.296430223295359,0.0018303011919684274,0.15165352733452683,0.146057117674874,CDH19/CTNNA1/PXN/ITGB4/CLDN11/ADAM19/TNRC6C/CDH18/AGO2/CDH10/NECTIN2/CDH6/CDH4/CLDN10/AFDN/NECTIN3/FERMT2/CDH8/FLNA/CDH24/CLDN15/SOX10/CLDN20/CADM3,24,3.6641149673601654,2.3444776849846978,5.726537121687476
R-HSA-6802957,Oncogenic MAPK signaling,19/1194,80/9872,0.2375,1.963651591289782,3.2099794377742445,0.002662058915118054,0.2105446596502461,0.2027750140128202,LMNA/MARK3/SPRED3/SPRED1/QKI/IQGAP1/ITGB3/KDM7A/RAP1A/CAMK2D/MPRIP/FXR1/CNKSR2/SND1/KIAA1549/PPP1CB/KSR2/ARRB1/CAMK2G,19,3.8797634003350088,2.344713833170685,6.419787280490406
R-HSA-75876,Synthesis of very long-chain fatty acyl-CoAs,8/1194,22/9872,0.36363636363636365,3.0065478909700016,3.4947464409041653,0.0029966891325062654,0.2267060474156914,0.218340004528603,ELOVL5/ACSL1/TECR/ACSL4/ACSL6/HACD2/HACD4/ELOVL2,8,5.940307598599055,2.639120165914433,13.370840336005292
R-HSA-6802952,Signaling by BRAF and RAF1 fusions,16/1194,64/9872,0.25,2.067001675041876,3.176418933746365,0.0032526562377333357,0.23581757723566685,0.22711529519611715,LMNA/MARK3/QKI/IQGAP1/ITGB3/KDM7A/RAP1A/CAMK2D/MPRIP/FXR1/CNKSR2/SND1/KIAA1549/KSR2/ARRB1/CAMK2G,16,4.083961474036851,2.3540173769722825,7.085224384736406
R-HSA-9020958,Interleukin-21 signaling,5/1194,10/9872,0.5,4.134003350083752,3.6778149490660894,0.003827672628758267,0.26640601496157534,0.25657493999929104,STAT3/STAT5B/JAK3/STAT5A/STAT1,5,8.1679229480737,2.7873445376991004,23.93495471526492
R-HSA-8854691,Interleukin-20 family signaling,7/1194,19/9872,0.3684210526315789,3.0461077316406593,3.3112652540631013,0.005017148305088181,0.32364834691092215,0.3117048809934592,STAT3/STAT5B/JAK3/PTPN11/IL10RB/STAT5A/STAT1,7,6.018469540685885,2.525069917063618,14.344939665783984
R-HSA-70171,Glycolysis,16/1194,67/9872,0.23880597014925373,1.9744493612340308,2.9685597459058886,0.0052820441955478605,0.32364834691092215,0.3117048809934592,PGK1/PFKFB3/HK2/NUP205/ENO1/PFKFB4/NUP58/NUP98/NUP188/NUP153/ENO2/ENO4/PFKL/HK1/GAPDHS/TPI1,16,3.901097527438186,2.2541172720763445,6.751450826054845
R-HSA-2046105,Linoleic acid (LA) metabolism,4/1194,7/9872,0.5714285714285714,4.724575257238573,3.6563700722531367,0.005507808595926721,0.32364834691092215,0.3117048809934592,ELOVL5/ACSL1/FADS1/ELOVL2,4,9.334769083512802,2.7288005487869613,31.932679682742673
R-HSA-9645135,STAT5 Activation,4/1194,7/9872,0.5714285714285714,4.724575257238573,3.6563700722531367,0.005507808595926721,0.32364834691092215,0.3117048809934592,STAT5B/PTPN11/GRB2/STAT5A,4,9.334769083512802,2.7288005487869613,31.932679682742673
R-HSA-9860927,"Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells",9/1194,29/9872,0.3103448275862069,2.5659331138450874,3.1324300444993103,0.005640379040507658,0.32364834691092215,0.3117048809934592,PPP2R2A/ITGB3/PDE4D/PTPN1/PTK2/NFKBIA/RELA/STAT1/IKBKE,9,5.069745278114711,2.3944145016540426,10.734280621509537
R-HSA-1474244,Extracellular matrix organization,51/1194,298/9872,0.17114093959731544,1.4149944352635662,2.6982153593183273,0.00614967662860936,0.32364834691092215,0.3117048809934592,TLL2/SGCZ/P4HA1/NRXN1/A2M/ITGB8/MUSK/ITGB4/P4HA2/JAM2/COL10A1/CAST/COL9A1/BMP1/ADAM19/CD47/ADAM12/ADAM9/ITGB3/SPP1/P3H2/JAM3/ADAMTS2/COL5A3/PLOD1/ACAN/BMP2/LAMA1/TGFB3/COL4A2/MADCAM1/PDGFA/PLOD3/COL5A2/SSPN/BCAN/ITGA4/LOXL2/HAPLN1/NTN4/SNTB2/NID1/MMP19/LAMA2/ADAM8/ITGA2/COL12A1/ASPN/ADAMTS18/ITGB7/PECAM1,51,2.795732015783616,2.065531574059207,3.784070697460797
R-HSA-1170546,Prolactin receptor signaling,5/1194,11/9872,0.45454545454545453,3.7581848637125015,3.394940369149316,0.006324163100558248,0.32364834691092215,0.3117048809934592,CUL1/STAT5B/PTPN11/PRLR/STAT5A,5,7.425384498248818,2.575761997262226,21.40583446973679
R-HSA-2586552,Signaling by Leptin,5/1194,11/9872,0.45454545454545453,3.7581848637125015,3.394940369149316,0.006324163100558248,0.32364834691092215,0.3117048809934592,STAT3/STAT5B/PTPN11/SOCS3/STAT5A,5,7.425384498248818,2.575761997262226,21.40583446973679
R-HSA-417957,P2Y receptors,5/1194,11/9872,0.45454545454545453,3.7581848637125015,3.394940369149316,0.006324163100558248,0.32364834691092215,0.3117048809934592,P2RY14/P2RY13/P2RY12/LPAR4/GPR17,5,7.425384498248818,2.575761997262226,21.40583446973679
R-HSA-2022870,Chondroitin sulfate biosynthesis,7/1194,20/9872,0.35,2.893802345058626,3.1445634535372147,0.006925555242514512,0.3347351700548681,0.3223825715228978,CSPG5/CHSY1/CSGALNACT1/CHST3/CHST9/BCAN/CHST7,7,5.717546063651591,2.4128647458521186,13.548348719576904
R-HSA-9008059,Interleukin-37 signaling,7/1194,20/9872,0.35,2.893802345058626,3.1445634535372147,0.006925555242514512,0.3347351700548681,0.3223825715228978,PTPN14/STAT3/PTPN2/PTPN13/PTPN11/CASP1/PTPN20,7,5.717546063651591,2.4128647458521186,13.548348719576904
R-HSA-977443,GABA receptor activation,14/1194,58/9872,0.2413793103448276,1.995725755212846,2.8210035134177613,0.007954258220875253,0.3608573064141538,0.3475407330982051,GABRB1/GABRG2/GNB3/GNAI1/GABRA2/GABRA3/KCNJ16/ADCY3/GNG3/GABRA4/GABRG3/GABRB3/GNAL/GABRA1,14,3.943135216311442,2.193326553696296,7.088919480737028
R-HSA-8980692,RHOA GTPase cycle,28/1194,146/9872,0.1917808219178082,1.5856451205800692,2.6443366297461224,0.008567042474437722,0.3608573064141538,0.3475407330982051,ERBIN/ARHGAP21/ARHGAP26/ARHGEF10/IQGAP1/RTKN/ARHGEF7/TJP2/TFRC/ARHGAP31/FLOT2/LBR/PCDH7/ARHGAP5/ARHGAP42/TEX2/CAVIN1/ARHGEF3/ARHGAP23/MYO9B/FLOT1/PREX1/ARHGAP1/ABR/ARAP3/SLK/NGEF/OPHN1,28,3.132901952685803,2.082133462027548,4.713950774118367
R-HSA-8848021,Signaling by PTK6,13/1194,53/9872,0.24528301886792453,2.0280016434373125,2.7833705654222793,0.009006909254420553,0.3608573064141538,0.3475407330982051,STAT3/DOCK1/ELMO1/LRRK2/PXN/HIF1A/BCAR1/PTPN1/SOCS3/NRG1/GPNMB/CDK2/KHDRBS1,13,4.006905597168231,2.1783966826307815,7.370233618437495
R-HSA-9006927,Signaling by Non-Receptor Tyrosine Kinases,13/1194,53/9872,0.24528301886792453,2.0280016434373125,2.7833705654222793,0.009006909254420553,0.3608573064141538,0.3475407330982051,STAT3/DOCK1/ELMO1/LRRK2/PXN/HIF1A/BCAR1/PTPN1/SOCS3/NRG1/GPNMB/CDK2/KHDRBS1,13,4.006905597168231,2.1783966826307815,7.370233618437495
R-HSA-399719,Trafficking of AMPA receptors,9/1194,31/9872,0.2903225806451613,2.4003890419841145,2.8965621491115434,0.009093393317065872,0.3608573064141538,0.3475407330982051,TSPAN7/CAMK2D/PRKCG/CACNG3/CACNG2/GRIA1/CAMK2G/NSF/CACNG4,9,4.742664937591182,2.2527813098404423,9.984489223168257
R-HSA-399721,"Glutamate binding, activation of AMPA receptors and synaptic plasticity",9/1194,31/9872,0.2903225806451613,2.4003890419841145,2.8965621491115434,0.009093393317065872,0.3608573064141538,0.3475407330982051,TSPAN7/CAMK2D/PRKCG/CACNG3/CACNG2/GRIA1/CAMK2G/NSF/CACNG4,9,4.742664937591182,2.2527813098404423,9.984489223168257
R-HSA-9013406,RHOQ GTPase cycle,14/1194,59/9872,0.23728813559322035,1.9618998949550008,2.7487035298591196,0.009299145584965333,0.3608573064141538,0.3475407330982051,ARHGAP21/PAK2/ARHGAP26/RHOQ/IQGAP1/ARHGEF7/TFRC/GJA1/ARHGAP5/PREX1/ARHGAP1/OPHN1/GIT1/CFTR,14,3.8763024160349766,2.158217545132974,6.9620972429045915
R-HSA-70326,Glucose metabolism,17/1194,77/9872,0.22077922077922077,1.8254040766603579,2.6970106934157467,0.009407338537597185,0.3608573064141538,0.3475407330982051,PGK1/PFKFB3/HK2/NUP205/ENO1/PFKFB4/NUP58/PCK1/NUP98/NUP188/NUP153/ENO2/ENO4/PFKL/HK1/GAPDHS/TPI1,17,3.6066153277208555,2.126119743568275,6.118034584599729
R-HSA-196836,Vitamin C (ascorbate) metabolism,4/1194,8/9872,0.5,4.134003350083752,3.289204187781785,0.009967142903484974,0.3608573064141538,0.3475407330982051,SLC2A3/SLC23A2/GSTO2/SLC2A1,4,8.167922948073702,2.4560224601895273,27.163825399430877
R-HSA-448706,Interleukin-1 processing,4/1194,8/9872,0.5,4.134003350083752,3.289204187781785,0.009967142903484974,0.3608573064141538,0.3475407330982051,IL1B/RELA/CASP1/IL1A,4,8.167922948073702,2.4560224601895273,27.163825399430877
R-HSA-8939242,RUNX1 regulates transcription of genes involved in differentiation of keratinocytes,4/1194,8/9872,0.5,4.134003350083752,3.289204187781785,0.009967142903484974,0.3608573064141538,0.3475407330982051,CBFB/RUNX1/SOCS4/SOCS3,4,8.167922948073702,2.4560224601895273,27.163825399430877
R-HSA-9700206,Signaling by ALK in cancer,19/1194,90/9872,0.2111111111111111,1.7454680811464731,2.635174594482905,0.010241316690809792,0.3608573064141538,0.3475407330982051,STAT3/TPM4/RRBP1/TNRC6C/CDKN1A/PPM1B/MSN/BCL2A1/AGO2/CUL1/SEC31A/MCL1/JUN/TFG/JUNB/GRB2/STAT5A/STAT1/EIF2AK3,19,3.448678578075563,2.095318946697625,5.676168753984747
R-HSA-9725370,Signaling by ALK fusions and activated point mutants,19/1194,90/9872,0.2111111111111111,1.7454680811464731,2.635174594482905,0.010241316690809792,0.3608573064141538,0.3475407330982051,STAT3/TPM4/RRBP1/TNRC6C/CDKN1A/PPM1B/MSN/BCL2A1/AGO2/CUL1/SEC31A/MCL1/JUN/TFG/JUNB/GRB2/STAT5A/STAT1/EIF2AK3,19,3.448678578075563,2.095318946697625,5.676168753984747
R-HSA-71387,Metabolism of carbohydrates and carbohydrate derivatives,47/1194,278/9872,0.16906474820143885,1.3978284708916284,2.495693901989316,0.010369462827992927,0.3608573064141538,0.3475407330982051,PGK1/SLC35D2/PFKFB3/B3GAT1/CSPG5/HK2/CHSY1/CSGALNACT1/OMD/CHST3/NUP205/HS3ST4/GYS1/B3GALT5/AKR1E2/GPC5/CHST9/ACAN/ENO1/ST3GAL4/PFKFB4/NUP58/PYGL/GLCE/GLB1L3/PCK1/B4GALT5/NUP98/HAS2/NUP188/NUP153/HS6ST3/BCAN/SLC2A1/HS3ST1/GPC2/GBE1/OGN/ENO2/ENO4/PFKL/B3GALT1/HK1/CHST7/GAPDHS/HPSE2/TPI1,47,2.761815673089669,2.0163612584487485,3.7828666763771865
R-HSA-192105,Synthesis of bile acids and bile salts,9/1194,32/9872,0.28125,2.3253768844221105,2.7854139627207406,0.01132582677109798,0.38641056042569577,0.3721510055642515,OSBPL1A/OSBPL6/NCOA1/CYP8B1/CYP27A1/OSBPL3/CYP39A1/AKR1C3/OSBPL9,9,4.594456658291457,2.188075689490131,9.647304289477098
R-HSA-1839117,Signaling by cytosolic FGFR1 fusion mutants,6/1194,17/9872,0.35294117647058826,2.918120011823825,2.935924203232236,0.011742019796214963,0.39290604702719295,0.3784067918132434,STAT3/FGFR1OP2/STAT5B/GRB2/STAT5A/STAT1,6,5.765592669228496,2.2690327936270878,14.650321018200602
R-HSA-70263,Gluconeogenesis,7/1194,22/9872,0.3181818181818182,2.630729404598751,2.840194250257472,0.012275833070260459,0.3985624866129796,0.3838544940640433,PGK1/ENO1/PCK1/ENO2/ENO4/GAPDHS/TPI1,7,5.1977691487741735,2.2159578990727318,12.191930241659275
R-HSA-9013409,RHOJ GTPase cycle,13/1194,55/9872,0.23636363636363636,1.9542561291305012,2.632266300589764,0.012369180619023505,0.3985624866129796,0.3838544940640433,ARHGAP21/PAK2/RHOJ/ARHGAP26/ARHGEF7/TFRC/GJA1/ARHGAP5/PREX1/ARHGAP1/OPHN1/GIT1/PAK3,13,3.8611999390893863,2.103734683586843,7.086856097368914
R-HSA-8865999,MET activates PTPN11,3/1194,5/9872,0.6,4.960804020100502,3.285857374974679,0.014612214482213573,0.44459990040558545,0.42819300752915435,PTPN11/GAB1/GRB2,3,9.801507537688442,2.339558879712689,41.06310417934906
R-HSA-9707587,Regulation of HMOX1 expression and activity,3/1194,5/9872,0.6,4.960804020100502,3.285857374974679,0.014612214482213573,0.44459990040558545,0.42819300752915435,HMOX1/NFE2L2/BACH1,3,9.801507537688442,2.339558879712689,41.06310417934906
R-HSA-9658195,Leishmania infection,29/1194,159/9872,0.18238993710691823,1.5080012220431296,2.3952979415434683,0.014950612704746027,0.44459990040558545,0.42819300752915435,DOCK1/ELMO1/WIPF3/IL1B/NT5E/GNB3/HMOX1/GNAI1/WIPF1/PRKAR2A/FGR/CYSLTR1/JUN/ENTPD1/MYO9B/DPEP2/PTK2/MYO10/ADCY3/FCGR2A/ACTR3/GRB2/GNG3/GNAZ/RELA/CASP1/IL1A/FCGR3A/FCGR1A,29,2.9794939055866334,1.9971037899323063,4.445128980366511
R-HSA-9824443,Parasitic Infection Pathways,29/1194,159/9872,0.18238993710691823,1.5080012220431296,2.3952979415434683,0.014950612704746027,0.44459990040558545,0.42819300752915435,DOCK1/ELMO1/WIPF3/IL1B/NT5E/GNB3/HMOX1/GNAI1/WIPF1/PRKAR2A/FGR/CYSLTR1/JUN/ENTPD1/MYO9B/DPEP2/PTK2/MYO10/ADCY3/FCGR2A/ACTR3/GRB2/GNG3/GNAZ/RELA/CASP1/IL1A/FCGR3A/FCGR1A,29,2.9794939055866334,1.9971037899323063,4.445128980366511
R-HSA-9682385,FLT3 signaling in disease,8/1194,28/9872,0.2857142857142857,2.3622876286192867,2.677533679149845,0.015075513864327322,0.44459990040558545,0.42819300752915435,PIM1/ETV6/CDKN1A/BCL2L1/STAT5B/PTPN11/GRB2/STAT5A,8,4.667384541756401,2.1226835488061577,10.262706597447679
R-HSA-9855142,Cellular responses to mechanical stimuli,20/1194,101/9872,0.19801980198019803,1.6372290495381197,2.3875895125222923,0.017148188877321602,0.4972974774423265,0.47894590688940336,CALCRL/GNB3/PPP2R2A/PRKAR2A/ITGB3/SPP1/GJA1/PDE4D/PTPN1/ADM/PTK2/NFKBIA/ADCY3/GNG3/RELA/TRPV4/STAT1/IKBKE/PRR5/PECAM1,20,3.2348209695341392,1.9951598000819006,5.2447261139224235
R-HSA-9013420,RHOU GTPase cycle,10/1194,40/9872,0.25,2.067001675041876,2.508112879717427,0.018191273576474105,0.4992622434545414,0.4808381679247611,PAK2/NCK2/IQGAP1/ARHGEF7/DLG5/ARHGAP31/ITSN2/GRB2/GIT1/PAK3,10,4.08396147403685,2.0373370455594797,8.186540051274157
R-HSA-354192,Integrin signaling,7/1194,24/9872,0.2916666666666667,2.411501954215522,2.567946675073789,0.020094619375363037,0.4992622434545414,0.4808381679247611,BCAR1/ITGB3/RAP1A/PTPN1/RASGRP1/PTK2/GRB2,7,4.76462171970966,2.048792726030649,11.080486495045
R-HSA-391160,Signal regulatory protein family interactions,5/1194,14/9872,0.35714285714285715,2.9528595357741088,2.7121489311940485,0.02010606208406269,0.4992622434545414,0.4808381679247611,CD47/PTPN11/PTK2/GRB2/SFTPD,5,5.8342306771955,2.0978967711469383,16.22493921668036
R-HSA-5654710,PI-3K cascade:FGFR3,5/1194,14/9872,0.35714285714285715,2.9528595357741088,2.7121489311940485,0.02010606208406269,0.4992622434545414,0.4808381679247611,FGF20/FGFR3/PTPN11/GAB1/GRB2,5,5.8342306771955,2.0978967711469383,16.22493921668036
R-HSA-877312,Regulation of IFNG signaling,5/1194,14/9872,0.35714285714285715,2.9528595357741088,2.7121489311940485,0.02010606208406269,0.4992622434545414,0.4808381679247611,PTPN2/PTPN1/PTPN11/SOCS3/STAT1,5,5.8342306771955,2.0978967711469383,16.22493921668036
R-HSA-8983432,Interleukin-15 signaling,5/1194,14/9872,0.35714285714285715,2.9528595357741088,2.7121489311940485,0.02010606208406269,0.4992622434545414,0.4808381679247611,STAT3/STAT5B/JAK3/GRB2/STAT5A,5,5.8342306771955,2.0978967711469383,16.22493921668036
R-HSA-9703465,Signaling by FLT3 fusion proteins,6/1194,19/9872,0.3157894736842105,2.6109494842634224,2.607038217393901,0.020845038502446452,0.4992622434545414,0.4808381679247611,PIM1/ETV6/CDKN1A/STAT5B/GRB2/STAT5A,6,5.15868817773076,2.0564272376737955,12.94092162733768
R-HSA-425407,SLC-mediated transmembrane transport,39/1194,234/9872,0.16666666666666666,1.378001116694584,2.1706033403531646,0.022678606642933866,0.4992622434545414,0.4808381679247611,SLC11A1/SLC2A3/SLC38A4/SLC35D2/SLCO1C1/SLC9A7/SLC8A1/SLC24A3/SLC16A7/SLC6A6/SLC7A3/RUNX1/SLC31A1/SLC12A5/SLC40A1/SLC28A2/SLC24A5/SLC7A1/SLC6A15/SLC1A2/SLC11A2/SLC4A10/SLC45A3/SLC32A1/SLC30A10/SLC39A14/SLC2A1/SLC4A4/AHCYL2/SLC22A3/LCN12/SLC27A4/SLC1A4/SLC24A1/SLC4A5/SLC7A11/MFSD4B/SLC1A6/SLC14A1,39,2.722640982691234,1.9301644711895483,3.8404882232970765
R-HSA-445095,Interaction between L1 and Ankyrins,8/1194,30/9872,0.26666666666666666,2.2048017867113345,2.451362094921892,0.022836952183572796,0.4992622434545414,0.4808381679247611,NFASC/SCN1A/SCN2A/SCN11A/SCN1B/SCN4B/ANK1/KCNQ2,8,4.356225572305974,1.99274703860438,9.522885177690613
R-HSA-9674555,Signaling by CSF3 (G-CSF),8/1194,30/9872,0.26666666666666666,2.2048017867113345,2.451362094921892,0.022836952183572796,0.4992622434545414,0.4808381679247611,STAT3/STAT5B/PTPN11/SOCS3/GRB2/UBE2D1/STAT5A/STAT1,8,4.356225572305974,1.99274703860438,9.522885177690613
R-HSA-9759476,Regulation of Homotypic Cell-Cell Adhesion,8/1194,30/9872,0.26666666666666666,2.2048017867113345,2.451362094921892,0.022836952183572796,0.4992622434545414,0.4808381679247611,CDH19/CTNNA1/ADAM19/TNRC6C/AGO2/CDH8/CDH24/SOX10,8,4.356225572305974,1.99274703860438,9.522885177690613
R-HSA-9764260,Regulation of Expression and Function of Type II Classical Cadherins,8/1194,30/9872,0.26666666666666666,2.2048017867113345,2.451362094921892,0.022836952183572796,0.4992622434545414,0.4808381679247611,CDH19/CTNNA1/ADAM19/TNRC6C/AGO2/CDH8/CDH24/SOX10,8,4.356225572305974,1.99274703860438,9.522885177690613
R-HSA-9860931,Response of endothelial cells to shear stress,18/1194,91/9872,0.1978021978021978,1.6354298967364294,2.258757603591114,0.023190003551941004,0.4992622434545414,0.4808381679247611,CALCRL/GNB3/PPP2R2A/PRKAR2A/ITGB3/PDE4D/PTPN1/ADM/PTK2/NFKBIA/ADCY3/GNG3/RELA/TRPV4/STAT1/IKBKE/PRR5/PECAM1,18,3.2312662212159697,1.9423577790780011,5.375467642901251
R-HSA-5576891,Cardiac conduction,24/1194,131/9872,0.183206106870229,1.5147493191146573,2.1998981446287824,0.023974742879934997,0.4992622434545414,0.4808381679247611,ATP1A2/TRDN/KAT2B/FGF11/SCN1A/SLC8A1/FGF14/CAMK2D/SCN2A/RYR1/SCN11A/SCN1B/ATP1B3/KCNK10/SCN4B/NPPC/KCNH2/ATP1A3/CAMK2G/KCNK12/FXYD1/KCND2/FGF12/CACNG4,24,2.992826729065173,1.9292305989642489,4.642789635938657
R-HSA-1650814,Collagen biosynthesis and modifying enzymes,14/1194,66/9872,0.21212121212121213,1.7538196030658342,2.2791156686165874,0.024346973533907197,0.4992622434545414,0.4808381679247611,TLL2/P4HA1/P4HA2/COL10A1/COL9A1/BMP1/P3H2/ADAMTS2/COL5A3/PLOD1/COL4A2/PLOD3/COL5A2/COL12A1,14,3.465179432516116,1.940783424379185,6.186918307679612
R-HSA-425381,Bicarbonate transporters,4/1194,10/9872,0.4,3.307202680067002,2.7075480015198456,0.02451707517740659,0.4992622434545414,0.4808381679247611,SLC4A10/SLC4A4/AHCYL2/SLC4A5,4,6.534338358458962,2.0463303372743127,20.86543751274333
R-HSA-5663202,Diseases of signal transduction by growth factor receptors and second messengers,67/1194,439/9872,0.15261958997722094,1.26185979250848,2.081848293242383,0.024950467275436636,0.4992622434545414,0.4808381679247611,ERBIN/STAT3/FGF20/NEURL1B/HES5/PIM1/LMNA/FGFR3/MARK3/TPM4/RRBP1/KAT2B/HDAC4/ETV6/FZD5/SPRED3/SPRED1/KREMEN2/FGFR1OP2/QKI/TNKS/IQGAP1/ITGB3/TNRC6C/CDKN1A/KDM7A/BCL2L1/PPM1B/MSN/RAP1A/CAMK2D/MPRIP/PDGFRA/BCL2A1/FGFR2/AGO2/FXR1/CUL1/PDGFRB/STAT5B/SEC31A/MCL1/BDNF/JUN/PTPN11/CNKSR2/SND1/KIAA1549/PDGFA/TFG/PPP1CB/GAB1/RNF43/DHH/NRG1/JUNB/HES1/GRB2/TGFBR1/KSR2/ARRB1/CAMK2G/HHAT/STAT5A/STAT1/PRR5/EIF2AK3,67,2.493170102601084,1.9153910267462257,3.2452366507444528
R-HSA-9660826,Purinergic signaling in leishmaniasis infection,7/1194,25/9872,0.28,2.3150418760469016,2.4419149543206498,0.025076367255436955,0.4992622434545414,0.4808381679247611,IL1B/NT5E/HMOX1/ENTPD1/RELA/CASP1/IL1A,7,4.5740368509212725,1.9743327024281836,10.596903494458946
R-HSA-9664424,Cell recruitment (pro-inflammatory response),7/1194,25/9872,0.28,2.3150418760469016,2.4419149543206498,0.025076367255436955,0.4992622434545414,0.4808381679247611,IL1B/NT5E/HMOX1/ENTPD1/RELA/CASP1/IL1A,7,4.5740368509212725,1.9743327024281836,10.596903494458946
R-HSA-194068,Bile acid and bile salt metabolism,10/1194,42/9872,0.23809523809523808,1.9685730238494057,2.3332064690803436,0.025294745018457503,0.4992622434545414,0.4808381679247611,OSBPL1A/OSBPL6/NCOA1/CYP8B1/CYP27A1/OSBPL3/CYP39A1/AKR1C3/OSBPL9/FABP6,10,3.889487118130334,1.9467267923876543,7.771049384668524
R-HSA-216083,Integrin cell surface interactions,16/1194,79/9872,0.20253164556962025,1.6745330025655705,2.2327072771827208,0.025412912899145393,0.4992622434545414,0.4808381679247611,ITGB8/JAM2/COL10A1/COL9A1/CD47/ITGB3/SPP1/JAM3/COL5A3/COL4A2/MADCAM1/COL5A2/ITGA4/ITGA2/ITGB7/PECAM1,16,3.3085257511184616,1.9270703040589254,5.680302697186528
R-HSA-425393,Transport of inorganic cations/anions and amino acids/oligopeptides,20/1194,105/9872,0.19047619047619047,1.5748584190795245,2.1965842653655248,0.0254293753690542,0.4992622434545414,0.4808381679247611,SLC38A4/SLC9A7/SLC8A1/SLC24A3/SLC6A6/SLC7A3/SLC12A5/SLC24A5/SLC7A1/SLC6A15/SLC1A2/SLC4A10/SLC32A1/SLC4A4/AHCYL2/SLC1A4/SLC24A1/SLC4A5/SLC7A11/SLC1A6,20,3.111589694504267,1.9220375527185205,5.03735757568888
R-HSA-1630316,Glycosaminoglycan metabolism,23/1194,125/9872,0.184,1.5213132328308208,2.175660810354787,0.02549175611101937,0.4992622434545414,0.4808381679247611,SLC35D2/B3GAT1/CSPG5/CHSY1/CSGALNACT1/OMD/CHST3/HS3ST4/GPC5/CHST9/ACAN/ST3GAL4/GLCE/GLB1L3/B4GALT5/HAS2/HS6ST3/BCAN/HS3ST1/GPC2/OGN/CHST7/HPSE2,23,3.0057956448911223,1.9194119871798037,4.707070456573162
R-HSA-3656225,Defective CHST6 causes MCDC1,3/1194,6/9872,0.5,4.134003350083752,2.8482456479019764,0.026614361525787316,0.4992622434545414,0.4808381679247611,OMD/ACAN/OGN,3,8.167922948073702,2.040212773891943,32.70000371500588
R-HSA-3656243,Defective ST3GAL3 causes MCT12 and EIEE15,3/1194,6/9872,0.5,4.134003350083752,2.8482456479019764,0.026614361525787316,0.4992622434545414,0.4808381679247611,OMD/ACAN/OGN,3,8.167922948073702,2.040212773891943,32.70000371500588
R-HSA-3656244,Defective B4GALT1 causes B4GALT1-CDG (CDG-2d),3/1194,6/9872,0.5,4.134003350083752,2.8482456479019764,0.026614361525787316,0.4992622434545414,0.4808381679247611,OMD/ACAN/OGN,3,8.167922948073702,2.040212773891943,32.70000371500588
R-HSA-8857538,PTK6 promotes HIF1A stabilization,3/1194,6/9872,0.5,4.134003350083752,2.8482456479019764,0.026614361525787316,0.4992622434545414,0.4808381679247611,LRRK2/HIF1A/GPNMB,3,8.167922948073702,2.040212773891943,32.70000371500588
R-HSA-8939245,RUNX1 regulates transcription of genes involved in BCR signaling,3/1194,6/9872,0.5,4.134003350083752,2.8482456479019764,0.026614361525787316,0.4992622434545414,0.4808381679247611,ELF2/CBFB/RUNX1,3,8.167922948073702,2.040212773891943,32.70000371500588
R-HSA-8949275,RUNX3 Regulates Immune Response and Cell Migration,3/1194,6/9872,0.5,4.134003350083752,2.8482456479019764,0.026614361525787316,0.4992622434545414,0.4808381679247611,CBFB/SPP1/ITGA4,3,8.167922948073702,2.040212773891943,32.70000371500588
R-HSA-9028335,Activated NTRK2 signals through PI3K,3/1194,6/9872,0.5,4.134003350083752,2.8482456479019764,0.026614361525787316,0.4992622434545414,0.4808381679247611,BDNF/GAB1/GRB2,3,8.167922948073702,2.040212773891943,32.70000371500588
R-HSA-5683057,MAPK family signaling cascades,47/1194,294/9872,0.1598639455782313,1.3217561731560297,2.0774761815467686,0.026692285703712564,0.4992622434545414,0.4808381679247611,FGF20/PAK2/RALGDS/RASA3/DUSP1/FGFR3/DNAJB1/MARK3/SPRED3/GRIN1/SPRED1/CSF2RA/IQGAP1/SHC2/ITGB3/TNRC6C/BCL2L1/CDC14B/RGL1/RAP1A/CAMK2D/PDGFRA/FGFR2/AGO2/PDGFRB/JAK3/RASGRP1/JUN/ABHD17C/PTPN11/MAPK6/CNKSR2/PTK2/PDGFA/PPP1CB/ABHD17B/CDC14A/NRG1/GRB2/HSPB1/GRIN2B/KSR2/FNTB/ARRB1/PAK3/CAMK2G/RASAL1,47,2.6115127793160813,1.9089119279160023,3.572715376123577
R-HSA-388844,Receptor-type tyrosine-protein phosphatases,6/1194,20/9872,0.3,2.480402010050251,2.4581330092306657,0.02681053132813153,0.4992622434545414,0.4808381679247611,PTPRF/PPFIA2/SLITRK5/IL1RAPL2/IL1RAP/PPFIA4,6,4.900753768844221,1.9644049025383774,12.2262917750846
R-HSA-6794362,Protein-protein interactions at synapses,17/1194,86/9872,0.19767441860465115,1.6343734174749718,2.1916162532953414,0.027005772237317833,0.4992622434545414,0.4808381679247611,NRXN1/PTPRF/GRIN1/FLOT2/PPFIA2/DLGAP1/LRRTM2/FLOT1/SLITRK5/NRXN3/IL1RAPL2/LRRTM1/GRIN2B/IL1RAP/NLGN4X/GRIA1/PPFIA4,17,3.2291788399361145,1.9130902913723693,5.45065542766977
R-HSA-912694,Regulation of IFNA/IFNB signaling,5/1194,15/9872,0.3333333333333333,2.756002233389168,2.524475915075814,0.027223139620919296,0.4992622434545414,0.4808381679247611,IFNAR2/PTPN1/PTPN11/SOCS3/STAT1,5,5.445281965382467,1.9757035902940372,15.007866477636286
R-HSA-9013148,CDC42 GTPase cycle,27/1194,153/9872,0.17647058823529413,1.4590600059119125,2.122644666284328,0.027258570763322665,0.4992622434545414,0.4808381679247611,ARHGAP21/WIPF3/PAK2/ARHGAP26/ARHGEF10/WIPF1/IQGAP1/ARHGEF7/DOCK9/TFRC/ARHGAP31/KCTD3/ARFGAP3/LBR/ARHGAP5/ARHGAP42/SPATA13/MYO9B/PREX1/ARHGAP1/ABR/ARAP3/CHN1/NGEF/OPHN1/GIT1/PAK3,27,2.882796334614248,1.906894379677876,4.358141067188631
R-HSA-373752,Netrin-1 signaling,10/1194,43/9872,0.23255813953488372,1.922792255852908,2.24934679299263,0.0295079603541735,0.5348317814193947,0.5150950974105726,DOCK1/ROBO1/PTPN11/DSCAML1/PTK2/MYO10/TRPC5/DSCAM/NTN1/NTN4,10,3.799033929336605,1.904381468346724,7.5786595470183515
R-HSA-372790,Signaling by GPCR,85/1194,580/9872,0.14655172413793102,1.2116906370935134,1.9490992870200723,0.0321649581648182,0.5658866240148946,0.5450039355303764,EDNRB/P2RY14/CX3CR1/CD55/RGS16/RGS18/CRH/CALCRL/CXCL12/TACR1/GNB3/FZD5/P2RY13/ARHGEF10/GNAI1/P2RY12/PRKAR2A/ARHGEF7/ADGRE2/CHRM5/PENK/PDE8B/MGLL/CAMK2D/C5AR1/NPFFR1/PDE4D/PDE7B/CYSLTR1/LPAR4/PRKCG/CX3CL1/OPRM1/ADORA1/ARHGEF3/RASGRP1/ADM/PROK2/RGS2/PTH2R/QRFP/GNRHR/RGS17/PREX1/PLCB1/ADORA2A/ADCY3/DHH/GPR27/RHOB/ABR/GPR17/GRB2/GNG3/HTR2B/LPAR5/GNAZ/TSHR/NGEF/CCRL2/CAMK4/GNA12/ARRB1/HCRTR2/WNT2B/ADRB1/RGS22/HRH2/ACKR3/OXGR1/RGS9/CAMK2G/WNT6/PTAFR/CHRM1/CCL2/PDYN/FFAR4/KEL/RGS14/NTSR2/CCL3/GNAL/RGS1/RPS6KA3,85,2.394046381331947,1.8926305946895712,3.0283025604944642
R-HSA-382551,Transport of small molecules,99/1194,687/9872,0.14410480349344978,1.1914594808101644,1.9296946000592592,0.03294543761676483,0.5658866240148946,0.5450039355303764,SLC11A1/SLC2A3/SLC38A4/SGK1/ATP1A2/TRPM1/A2M/MLKL/SLC35D2/TRDN/TRPC4AP/LRRC8B/ATP11A/CLCA4/PCSK6/GNB3/MCUB/HMOX1/SLCO1C1/BMP1/SLC9A7/SLC8A1/PRKAR2A/ADD1/ANO3/TFRC/SLC24A3/CAMK2D/WWP1/LRRC8D/SLC16A7/SLC6A6/SLC7A3/CUL1/RYR1/RUNX1/SLC31A1/SLC12A5/SLC40A1/RAB11FIP2/SLC28A2/TSC22D3/SLC24A5/SLC7A1/CLCN2/SLC6A15/NIPAL2/ATP13A4/SLC1A2/ATP1B3/ATP11C/SLC11A2/ABCA9/SLC4A10/ATP2C2/SLC45A3/SLC32A1/SLC30A10/SLC39A14/TRPC5/MAIP1/ADCY3/UNC80/BEST1/SLC2A1/ABCC2/TRPM6/SLC4A4/GNG3/ANGPTL3/PLEKHA8/NCEH1/CUBN/TUSC3/AHCYL2/SLC22A3/TRPV5/AQP4/LCN12/ABCB6/CFTR/TRPV4/SLC27A4/ATP1A3/LPA/SLC9B2/SLC1A4/EIF2S1/LPL/SGK2/SLC24A1/CAMK2G/SLC4A5/FXYD1/SLC7A11/TFR2/MFSD4B/SLC1A6/SLC14A1,99,2.3540738627635998,1.8917300914488675,2.9294156583946926
R-HSA-163560,Triglyceride catabolism,6/1194,21/9872,0.2857142857142857,2.3622876286192867,2.3179881794483603,0.033805392586994214,0.5658866240148946,0.5450039355303764,PLIN3/PNPLA4/MGLL/PPP1CB/FABP6/FABP7,6,4.667384541756401,1.8802702252795782,11.585823233140578
R-HSA-5365859,RA biosynthesis pathway,6/1194,21/9872,0.2857142857142857,2.3622876286192867,2.3179881794483603,0.033805392586994214,0.5658866240148946,0.5450039355303764,CYP26C1/AKR1C3/DHRS4/ADH1A/ADH4/RDH10,6,4.667384541756401,1.8802702252795782,11.585823233140578
R-HSA-8849932,Synaptic adhesion-like molecules,6/1194,21/9872,0.2857142857142857,2.3622876286192867,2.3179881794483603,0.033805392586994214,0.5658866240148946,0.5450039355303764,PTPRF/GRIN1/FLOT2/FLOT1/GRIN2B/GRIA1,6,4.667384541756401,1.8802702252795782,11.585823233140578
R-HSA-9692916,SARS-CoV-1 activates/modulates innate immune responses,9/1194,38/9872,0.23684210526315788,1.9582121131975667,2.1951351774431545,0.03403169093729768,0.5658866240148946,0.5450039355303764,RUNX1/IRAK2/NFKBIA/RELA/CASP1/TRAF6/SFTPD/RCAN3/IKBKE,9,3.8690161332980693,1.8664910478433299,8.02001480640224
R-HSA-204005,COPII-mediated vesicle transport,14/1194,69/9872,0.2028985507246377,1.6775665768455805,2.094932022857513,0.03459519799979021,0.5658866240148946,0.5450039355303764,TMED10/GOSR2/SERPINA1/SEC31A/ANKRD28/SEC24D/RAB1A/TFG/SEC22A/CD59/SEC23A/GRIA1/NSF/SEC24A,14,3.314519457189328,1.8604659178464327,5.904993543124639
R-HSA-1059683,Interleukin-6 signaling,4/1194,11/9872,0.36363636363636365,3.0065478909700016,2.4697802265930844,0.034913024935605684,0.5658866240148946,0.5450039355303764,STAT3/PTPN11/SOCS3/STAT1,4,5.940307598599055,1.8886771355107745,18.683582123437194
R-HSA-9762292,Regulation of CDH11 function,4/1194,11/9872,0.36363636363636365,3.0065478909700016,2.4697802265930844,0.034913024935605684,0.5658866240148946,0.5450039355303764,CTNNA1/ADAM19/CDH8/CDH24,4,5.940307598599055,1.8886771355107745,18.683582123437194
R-HSA-9006931,Signaling by Nuclear Receptors,37/1194,227/9872,0.16299559471365638,1.3476486691902978,1.965510192592138,0.0351186169244535,0.5658866240148946,0.5450039355303764,PDK1/KDM3A/CXXC5/CBFB/CXCL12/KAT2B/GNB3/FKBP5/GNAI1/TNRC6C/FOS/KDM4B/RARA/AGO2/RUNX1/PTGES3/JUN/EEPD1/NCOA1/PRKCZ/PCK1/PTK2/PPARD/RXRG/GNG3/CYP26C1/ANGPTL3/HSPB1/AKR1C3/DHRS4/GREB1/PDK3/PDHX/ADH1A/ADH4/RDH10/FABP6,37,2.6626709169931893,1.8719104383235607,3.7874762953674352
R-HSA-399954,Sema3A PAK dependent Axon repulsion,5/1194,16/9872,0.3125,2.583752093802345,2.351634172286778,0.03575756758943352,0.5658866240148946,0.5450039355303764,PAK2/SEMA3A/PLXNA3/PLXNA2/PAK3,5,5.104951842546063,1.8669596168835223,13.958809327765088
R-HSA-5686938,Regulation of TLR by endogenous ligand,5/1194,16/9872,0.3125,2.583752093802345,2.351634172286778,0.03575756758943352,0.5658866240148946,0.5450039355303764,TLR2/CD14/TLR4/GSDME/SFTPD,5,5.104951842546063,1.8669596168835223,13.958809327765088
R-HSA-8873719,RAB geranylgeranylation,13/1194,63/9872,0.20634920634920634,1.706096620669485,2.0854268312747526,0.03607278925551077,0.5658866240148946,0.5450039355303764,RAB40B/PTP4A2/RAB27B/RAB8B/RAB10/RAB1A/RAB7B/RAB37/RAB20/RAB21/RAB42/RAB40C/RAB3C,13,3.3708888357129565,1.8501374381832436,6.141647268049518
R-HSA-166166,MyD88-independent TLR4 cascade,20/1194,109/9872,0.1834862385321101,1.5170654495720193,2.0134462475747554,0.03644878156992286,0.5658866240148946,0.5450039355303764,MAP2K4/NLRC5/FOS/TIFA/NOD2/CUL1/IRAK2/DUSP3/JUN/MAP2K3/PTPN11/NFKBIA/TNIP2/CD14/UBE2D1/RELA/TLR4/TRAF6/IKBKE/RPS6KA3,20,2.997402916724294,1.8540896787902934,4.845733379546787
R-HSA-937061,TRIF (TICAM1)-mediated TLR4 signaling,20/1194,109/9872,0.1834862385321101,1.5170654495720193,2.0134462475747554,0.03644878156992286,0.5658866240148946,0.5450039355303764,MAP2K4/NLRC5/FOS/TIFA/NOD2/CUL1/IRAK2/DUSP3/JUN/MAP2K3/PTPN11/NFKBIA/TNIP2/CD14/UBE2D1/RELA/TLR4/TRAF6/IKBKE/RPS6KA3,20,2.997402916724294,1.8540896787902934,4.845733379546787
R-HSA-1839124,FGFR1 mutant receptor activation,7/1194,27/9872,0.25925925925925924,2.14355729263602,2.2070128719153916,0.03743186654351401,0.5658866240148946,0.5450039355303764,STAT3/FGF20/FGFR1OP2/STAT5B/GRB2/STAT5A/STAT1,7,4.2352193064085855,1.8405619470824364,9.745438126550946
R-HSA-1280215,Cytokine Signaling in Immune system,101/1194,707/9872,0.14285714285714285,1.1811438143096433,1.8541287882507371,0.03852357695215474,0.5658866240148946,0.5450039355303764,PTPN14/STAT3/PTPN2/IFNAR2/PTPRJ/PAK2/PIM1/PTPN13/IL1B/VEGFA/BCL6/IL7/FKBP5/HMOX1/HNRNPF/HSPA1A/HSPA1B/GBP2/CSF2RA/MAP2K4/BATF/HIF1A/NLRC5/CDKN1A/GRB10/TNFRSF13C/BCL2L1/FOS/NUP205/PPM1B/MSN/CAMK2D/TIFA/NOD2/CUL1/STAT5B/PTPN1/OPRM1/JAK3/IRAK2/UBA7/KPNA3/MCL1/DUSP3/CEBPD/NUP58/JUN/MAP2K3/PTPN11/TRIM34/IRF1/NUP98/IL4R/NUP188/NUP153/NFKBIA/ATF6/GBP7/TNIP2/EGR1/SOCS3/HSPA9/LMNB1/CISH/TXLNA/IL10RB/JUNB/PRLR/GRB2/SAMHD1/CSF1/UBE2D1/RORA/RELA/TUBB2A/CASP1/ABCE1/IL13RA2/PTPRZ1/ISG20/IL1RAP/ZEB1/IL1A/TUBB4A/TRAF6/TRIM3/FLNA/PTPN20/EDA/EIF2S1/CAMK2G/PTAFR/CCL2/STAT5A/STAT1/FCGR1A/EIF4G1/OAS1/CCL3/EIF2AK3/RPS6KA3,101,2.333692270878201,1.8793486963575137,2.8978760704238264
R-HSA-449147,Signaling by Interleukins,62/1194,412/9872,0.15048543689320387,1.2442146005106438,1.8782248456091133,0.0387397619158879,0.5658866240148946,0.5450039355303764,PTPN14/STAT3/PTPN2/PAK2/PIM1/PTPN13/IL1B/VEGFA/BCL6/IL7/HMOX1/HNRNPF/CSF2RA/MAP2K4/BATF/HIF1A/NLRC5/CDKN1A/BCL2L1/FOS/MSN/TIFA/NOD2/CUL1/STAT5B/OPRM1/JAK3/IRAK2/MCL1/DUSP3/CEBPD/JUN/MAP2K3/PTPN11/IL4R/NFKBIA/TNIP2/SOCS3/HSPA9/LMNB1/CISH/TXLNA/IL10RB/JUNB/GRB2/CSF1/RORA/RELA/CASP1/IL13RA2/PTPRZ1/IL1RAP/ZEB1/IL1A/TRAF6/PTPN20/PTAFR/CCL2/STAT5A/STAT1/CCL3/RPS6KA3,62,2.4583069067017935,1.8704143262077217,3.230980838235194
R-HSA-5694530,Cargo concentration in the ER,8/1194,33/9872,0.24242424242424243,2.0043652606466678,2.143611552322878,0.0391610579169528,0.5658866240148946,0.5450039355303764,TMED10/GOSR2/SERPINA1/SEC24D/CD59/SEC23A/GRIA1/SEC24A,8,3.960205065732704,1.8251862486409982,8.592670569555533
R-HSA-3560782,Diseases associated with glycosaminoglycan metabolism,9/1194,39/9872,0.23076923076923078,1.908001546192501,2.107408796243596,0.0396666197491992,0.5658866240148946,0.5450039355303764,CSPG5/CHSY1/OMD/CHST3/GPC5/ACAN/BCAN/GPC2/OGN,9,3.7698105914186315,1.8218727454977355,7.800474500917746
R-HSA-1638091,Heparan sulfate/heparin (HS-GAG) metabolism,12/1194,58/9872,0.20689655172413793,1.710622075896725,2.0132725927013584,0.04219824848157609,0.5658866240148946,0.5450039355303764,SLC35D2/B3GAT1/CSPG5/HS3ST4/GPC5/GLCE/GLB1L3/HS6ST3/BCAN/HS3ST1/GPC2/HPSE2,12,3.3798301854098076,1.8103135790869929,6.310095783498711
R-HSA-420597,Nectin/Necl  trans heterodimerization,3/1194,7/9872,0.42857142857142855,3.54343144292893,2.4968556053953477,0.042444276223182746,0.5658866240148946,0.5450039355303764,NECTIN2/NECTIN3/CADM3,3,7.001076812634602,1.8080950643747715,27.10868333317363
R-HSA-447043,Neurofascin interactions,3/1194,7/9872,0.42857142857142855,3.54343144292893,2.4968556053953477,0.042444276223182746,0.5658866240148946,0.5450039355303764,NFASC/DCX/ANK1,3,7.001076812634602,1.8080950643747715,27.10868333317363
R-HSA-9764302,Regulation of CDH19 Expression and Function,3/1194,7/9872,0.42857142857142855,3.54343144292893,2.4968556053953477,0.042444276223182746,0.5658866240148946,0.5450039355303764,CDH19/CTNNA1/SOX10,3,7.001076812634602,1.8080950643747715,27.10868333317363
R-HSA-9833576,CDH11 homotypic and heterotypic interactions,3/1194,7/9872,0.42857142857142855,3.54343144292893,2.4968556053953477,0.042444276223182746,0.5658866240148946,0.5450039355303764,CTNNA1/CDH8/CDH24,3,7.001076812634602,1.8080950643747715,27.10868333317363
R-HSA-166016,Toll Like Receptor 4 (TLR4) Cascade,24/1194,139/9872,0.17266187050359713,1.427569502187195,1.8830579051722385,0.044805308598227,0.5658866240148946,0.5450039355303764,TLR2/MAP2K4/NLRC5/FOS/TIFA/NOD2/CUL1/DNM3/IRAK2/DUSP3/JUN/MAP2K3/PTPN11/NFKBIA/TNIP2/CD14/UBE2D1/RELA/TLR4/TRAF6/SFTPD/IKBKE/RPS6KA3/DNM1,24,2.8205777086873214,1.8217011478701626,4.3671590260812865
R-HSA-3295583,TRP channels,7/1194,28/9872,0.25,2.067001675041876,2.0971583831598735,0.044883984103242826,0.5658866240148946,0.5450039355303764,TRPM1/MLKL/TRPC4AP/TRPC5/TRPM6/TRPV5/TRPV4,7,4.08396147403685,1.7802568652128627,9.368727427669821
R-HSA-6806834,Signaling by MET,15/1194,78/9872,0.19230769230769232,1.5900012884937509,1.9404083197423965,0.04502869389846343,0.5658866240148946,0.5450039355303764,STAT3/PTPN2/PTPRJ/RAP1A/COL5A3/PTPN1/PTPN11/LAMA1/PTK2/GAB1/COL5A2/HPN/GRB2/LAMA2/ITGA2,15,3.1415088261821933,1.802240017908618,5.476006307102781
R-HSA-180292,GAB1 signalosome,5/1194,17/9872,0.29411764705882354,2.431766676519854,2.191499183087667,0.04576404583660785,0.5658866240148946,0.5450039355303764,PXN/PTPN11/GAB1/GRB2/PAG1,5,4.804660557690412,1.7695612408298262,13.04547282229151
R-HSA-8934593,Regulation of RUNX1 Expression and Activity,5/1194,17/9872,0.29411764705882354,2.431766676519854,2.191499183087667,0.04576404583660785,0.5658866240148946,0.5450039355303764,CBFB/TNRC6C/AGO2/RUNX1/PTPN11,5,4.804660557690412,1.7695612408298262,13.04547282229151
R-HSA-9022699,MECP2 regulates neuronal receptors and channels,5/1194,17/9872,0.29411764705882354,2.431766676519854,2.191499183087667,0.04576404583660785,0.5658866240148946,0.5450039355303764,SLC2A3/FKBP5/PTPN1/OPRM1/GRIN2B,5,4.804660557690412,1.7695612408298262,13.04547282229151
R-HSA-9818027,NFE2L2 regulating anti-oxidant/detoxification enzymes,5/1194,17/9872,0.29411764705882354,2.431766676519854,2.191499183087667,0.04576404583660785,0.5658866240148946,0.5450039355303764,HMOX1/NFE2L2/BACH1/GCLC/SLC7A11,5,4.804660557690412,1.7695612408298262,13.04547282229151
R-HSA-9841251,Mitochondrial unfolded protein response (UPRmt),5/1194,17/9872,0.29411764705882354,2.431766676519854,2.191499183087667,0.04576404583660785,0.5658866240148946,0.5450039355303764,HSPA1A/HSPA1B/HSPD1/HSPA9/DNAJA1,5,4.804660557690412,1.7695612408298262,13.04547282229151
R-HSA-388396,GPCR downstream signalling,75/1194,514/9872,0.14591439688715954,1.2064212111139356,1.7828601478735657,0.04589408661967495,0.5658866240148946,0.5450039355303764,EDNRB/P2RY14/CX3CR1/RGS16/RGS18/CRH/CALCRL/CXCL12/TACR1/GNB3/P2RY13/ARHGEF10/GNAI1/P2RY12/PRKAR2A/ARHGEF7/CHRM5/PENK/PDE8B/MGLL/CAMK2D/C5AR1/NPFFR1/PDE4D/PDE7B/CYSLTR1/LPAR4/PRKCG/CX3CL1/OPRM1/ADORA1/ARHGEF3/RASGRP1/ADM/PROK2/RGS2/PTH2R/QRFP/GNRHR/RGS17/PREX1/PLCB1/ADORA2A/ADCY3/GPR27/RHOB/ABR/GPR17/GRB2/GNG3/HTR2B/LPAR5/GNAZ/TSHR/NGEF/CAMK4/GNA12/ARRB1/HCRTR2/ADRB1/RGS22/HRH2/ACKR3/OXGR1/RGS9/CAMK2G/PTAFR/CHRM1/PDYN/FFAR4/RGS14/NTSR2/GNAL/RGS1/RPS6KA3,75,2.3836351015779282,1.857829038130984,3.0582557279814884
R-HSA-8875878,MET promotes cell motility,9/1194,40/9872,0.225,1.8603015075376887,2.0222398352007387,0.04590139767031299,0.5658866240148946,0.5450039355303764,RAP1A/COL5A3/LAMA1/PTK2/GAB1/COL5A2/GRB2/LAMA2/ITGA2,9,3.6755653266331656,1.7793398005508703,7.592580386368832
R-HSA-9656223,Signaling by RAF1 mutants,9/1194,40/9872,0.225,1.8603015075376887,2.0222398352007387,0.04590139767031299,0.5658866240148946,0.5450039355303764,MARK3/IQGAP1/ITGB3/RAP1A/CAMK2D/CNKSR2/KSR2/ARRB1/CAMK2G,9,3.6755653266331656,1.7793398005508703,7.592580386368832
R-HSA-5655302,Signaling by FGFR1 in disease,8/1194,34/9872,0.23529411764705882,1.9454133412158834,2.0482392888883654,0.04598488082656331,0.5658866240148946,0.5450039355303764,STAT3/FGF20/FGFR1OP2/STAT5B/GAB1/GRB2/STAT5A/STAT1,8,3.8437284461523302,1.7754293741225278,8.321507226984174
R-HSA-75105,Fatty acyl-CoA biosynthesis,8/1194,34/9872,0.23529411764705882,1.9454133412158834,2.0482392888883654,0.04598488082656331,0.5658866240148946,0.5450039355303764,ELOVL5/ACSL1/TECR/ACSL4/ACSL6/HACD2/HACD4/ELOVL2,8,3.8437284461523302,1.7754293741225278,8.321507226984174
R-HSA-2672351,Stimuli-sensing channels,19/1194,105/9872,0.18095238095238095,1.4961154981255484,1.8957006817983197,0.04604660385226402,0.5658866240148946,0.5450039355303764,SGK1/TRPM1/MLKL/TRDN/TRPC4AP/CLCA4/ANO3/WWP1/RYR1/TSC22D3/CLCN2/TRPC5/UNC80/BEST1/TRPM6/TRPV5/TRPV4/SLC9B2/SGK2,19,2.956010209779054,1.8070793102616367,4.8354249371893285
R-HSA-1474290,Collagen formation,16/1194,85/9872,0.18823529411764706,1.5563306729727067,1.9106915824694117,0.04671708790909934,0.5658866240148946,0.5450039355303764,TLL2/P4HA1/ITGB4/P4HA2/COL10A1/COL9A1/BMP1/P3H2/ADAMTS2/COL5A3/PLOD1/COL4A2/PLOD3/COL5A2/LOXL2/COL12A1,16,3.074982756921864,1.7967548752499638,5.262553665842337
R-HSA-193775,Synthesis of bile acids and bile salts via 24-hydroxycholesterol,4/1194,12/9872,0.3333333333333333,2.756002233389168,2.2576163723080946,0.04748244086561759,0.5658866240148946,0.5450039355303764,CYP8B1/CYP27A1/CYP39A1/AKR1C3,4,5.445281965382469,1.7535378494208995,16.909298930908022
R-HSA-2029481,FCGR activation,4/1194,12/9872,0.3333333333333333,2.756002233389168,2.2576163723080946,0.04748244086561759,0.5658866240148946,0.5450039355303764,FGR/FCGR2A/FCGR3A/FCGR1A,4,5.445281965382469,1.7535378494208995,16.909298930908022
R-HSA-2046104,alpha-linolenic (omega3) and linoleic (omega6) acid metabolism,4/1194,12/9872,0.3333333333333333,2.756002233389168,2.2576163723080946,0.04748244086561759,0.5658866240148946,0.5450039355303764,ELOVL5/ACSL1/FADS1/ELOVL2,4,5.445281965382469,1.7535378494208995,16.909298930908022
R-HSA-2046106,alpha-linolenic acid (ALA) metabolism,4/1194,12/9872,0.3333333333333333,2.756002233389168,2.2576163723080946,0.04748244086561759,0.5658866240148946,0.5450039355303764,ELOVL5/ACSL1/FADS1/ELOVL2,4,5.445281965382469,1.7535378494208995,16.909298930908022
R-HSA-354194,GRB2:SOS provides linkage to MAPK signaling for Integrins,4/1194,12/9872,0.3333333333333333,2.756002233389168,2.2576163723080946,0.04748244086561759,0.5658866240148946,0.5450039355303764,ITGB3/RAP1A/PTK2/GRB2,4,5.445281965382469,1.7535378494208995,16.909298930908022
R-HSA-372708,p130Cas linkage to MAPK signaling for integrins,4/1194,12/9872,0.3333333333333333,2.756002233389168,2.2576163723080946,0.04748244086561759,0.5658866240148946,0.5450039355303764,BCAR1/ITGB3/RAP1A/PTK2,4,5.445281965382469,1.7535378494208995,16.909298930908022
R-HSA-451306,Ionotropic activity of kainate receptors,4/1194,12/9872,0.3333333333333333,2.756002233389168,2.2576163723080946,0.04748244086561759,0.5658866240148946,0.5450039355303764,GRIK4/GRIK2/GRIK1/NCALD,4,5.445281965382469,1.7535378494208995,16.909298930908022
R-HSA-451308,Activation of Ca-permeable Kainate Receptor,4/1194,12/9872,0.3333333333333333,2.756002233389168,2.2576163723080946,0.04748244086561759,0.5658866240148946,0.5450039355303764,GRIK4/GRIK2/GRIK1/NCALD,4,5.445281965382469,1.7535378494208995,16.909298930908022
R-HSA-9673767,"Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants",4/1194,12/9872,0.3333333333333333,2.756002233389168,2.2576163723080946,0.04748244086561759,0.5658866240148946,0.5450039355303764,STAT3/PDGFRA/GRB2/STAT1,4,5.445281965382469,1.7535378494208995,16.909298930908022
R-HSA-9673770,Signaling by PDGFRA extracellular domain mutants,4/1194,12/9872,0.3333333333333333,2.756002233389168,2.2576163723080946,0.04748244086561759,0.5658866240148946,0.5450039355303764,STAT3/PDGFRA/GRB2/STAT1,4,5.445281965382469,1.7535378494208995,16.909298930908022
R-HSA-3371497,HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand,11/1194,53/9872,0.20754716981132076,1.716001390600803,1.9386128496215984,0.04945338159025762,0.5834424869737203,0.5619119414774124,DNAJB1/FKBP5/HSPA1A/HSPA1B/STIP1/PTGES3/DNAJA4/DYNC1I1/TUBB2A/TUBB4A/DNAJA1,11,3.3904585822192725,1.7663978632105477,6.507712467932336
R-HSA-3000171,Non-integrin membrane-ECM interactions,15/1194,79/9872,0.189873417721519,1.5698746899052225,1.886287790803759,0.04962614257017851,0.5834424869737203,0.5619119414774124,SGCZ/NRXN1/ITGB4/COL10A1/ITGB3/COL5A3/LAMA1/COL4A2/PDGFA/COL5A2/SSPN/NTN4/SNTB2/LAMA2/ITGA2,15,3.101742891673558,1.7804258466541703,5.4036560883044675
R-HSA-1266695,Interleukin-7 signaling,6/1194,23/9872,0.2608695652173913,2.156871313087175,2.0602779652121783,0.05106700139743885,0.5884541882883683,0.5667386979764564,STAT3/IL7/STAT5B/JAK3/CISH/STAT5A,6,4.261525016386279,1.7319264046901435,10.485777811404839
R-HSA-3371571,HSF1-dependent transactivation,6/1194,23/9872,0.2608695652173913,2.156871313087175,2.0602779652121783,0.05106700139743885,0.5884541882883683,0.5667386979764564,DNAJB1/HSPA1A/HSPA1B/CAMK2D/PTGES3/CAMK2G,6,4.261525016386279,1.7319264046901435,10.485777811404839
R-HSA-425410,Metal ion SLC transporters,6/1194,23/9872,0.2608695652173913,2.156871313087175,2.0602779652121783,0.05106700139743885,0.5884541882883683,0.5667386979764564,SLC11A1/SLC31A1/SLC40A1/SLC11A2/SLC30A10/SLC39A14,6,4.261525016386279,1.7319264046901435,10.485777811404839
R-HSA-2029482,Regulation of actin dynamics for phagocytic cup formation,12/1194,60/9872,0.2,1.653601340033501,1.8835740815354385,0.05297916701373571,0.6064720434467114,0.5840916474090531,DOCK1/ELMO1/WIPF3/WIPF1/MYO9B/PTK2/MYO10/FCGR2A/ACTR3/GRB2/FCGR3A/FCGR1A,12,3.2671691792294806,1.7530711611381367,6.088968139078255
R-HSA-3371556,Cellular response to heat stress,16/1194,87/9872,0.1839080459770115,1.5205529563526443,1.8089103558047406,0.05602290140529988,0.624733336682544,0.6016790514208168,DNAJB1/HSPA12A/HSPH1/HSPA1A/HSPA1B/NUP205/CAMK2D/PTGES3/NUP58/NUP98/RPA3/NUP188/NUP153/HSPA9/ST13/CAMK2G,16,3.0042934981420513,1.7571497125619902,5.13660239560275
R-HSA-5654695,PI-3K cascade:FGFR2,5/1194,18/9872,0.2777777777777778,2.296668527824307,2.0423579489657717,0.05727069524011435,0.624733336682544,0.6016790514208168,FGF20/FGFR2/PTPN11/GAB1/GRB2,5,4.537734971152056,1.6818214979285075,12.243296148716285
R-HSA-9824594,Regulation of MITF-M-dependent genes involved in apoptosis,5/1194,18/9872,0.2777777777777778,2.296668527824307,2.0423579489657717,0.05727069524011435,0.624733336682544,0.6016790514208168,DICER1/TRPM1/TNRC6C/BCL2A1/AGO2,5,4.537734971152056,1.6818214979285075,12.243296148716285
R-HSA-3000178,ECM proteoglycans,14/1194,74/9872,0.1891891891891892,1.5642174838154739,1.8070351423145716,0.05803268225187756,0.624733336682544,0.6016790514208168,MUSK/COL9A1/ITGB3/COL5A3/ACAN/LAMA1/TGFB3/COL4A2/COL5A2/BCAN/HAPLN1/LAMA2/ITGA2/ASPN,14,3.0905654398116704,1.7404343198418197,5.4880523952356945
R-HSA-9705671,SARS-CoV-2 activates/modulates innate and adaptive immune responses,19/1194,108/9872,0.17592592592592593,1.4545567342887278,1.761809733762637,0.058643394674165086,0.624733336682544,0.6016790514208168,IFNAR2/TLR2/NUP205/NOD2/G3BP1/IRAK2/SEC24D/NUP58/PTPN11/NUP98/NUP188/NUP153/SEC23A/RNF135/TRAF6/SFTPD/SEC24A/STAT1/IKBKE,19,2.873898815062969,1.7586995807736496,4.696250848929575
R-HSA-8957322,Metabolism of steroids,24/1194,143/9872,0.16783216783216784,1.3876374881400009,1.7319390493824374,0.05916955654012331,0.624733336682544,0.6016790514208168,MVK/TM7SF2/OSBPL1A/HELZ2/LBR/HSD17B1/OSBPL6/DHCR7/SEC24D/NCOA1/STS/CYP8B1/CYP27A1/LSS/SEC23A/OSBPL3/CYP39A1/AKR1C3/CUBN/OSBPL9/GC/SEC24A/INSIG2/FABP6,24,2.741680430122641,1.7723124069908043,4.241245251834697
R-HSA-983712,Ion channel transport,29/1194,179/9872,0.16201117318435754,1.3395094653902662,1.7002869138792962,0.0607079544398549,0.624733336682544,0.6016790514208168,SGK1/ATP1A2/TRPM1/MLKL/TRDN/TRPC4AP/ATP11A/CLCA4/ANO3/CAMK2D/WWP1/RYR1/TSC22D3/CLCN2/ATP13A4/ATP1B3/ATP11C/ATP2C2/TRPC5/UNC80/BEST1/TRPM6/TRPV5/TRPV4/ATP1A3/SLC9B2/SGK2/CAMK2G/FXYD1,29,2.646589558593713,1.7799846594736153,3.9351104822041827
R-HSA-2187338,Visual phototransduction,16/1194,88/9872,0.18181818181818182,1.5032739454850008,1.7589782851050038,0.061125042146501954,0.624733336682544,0.6016790514208168,RBP4/GUCA1B/BCO1/HSD17B1/GPC5/RLBP1/GRK7/RBP2/GPC2/AKR1C3/FNTB/GRK4/LPL/RGS9/SLC24A1/RDH10,16,2.9701537992995277,1.7379952488570376,5.075855988268629
R-HSA-9620244,Long-term potentiation,6/1194,24/9872,0.25,2.067001675041876,1.9411970316716816,0.061391128738130865,0.624733336682544,0.6016790514208168,GRIN1/CAMK2D/NRG1/GRIN2B/GRIA1/CAMK2G,6,4.083961474036851,1.6662035098743635,10.010026519914653
R-HSA-3371453,Regulation of HSF1-mediated heat shock response,13/1194,68/9872,0.19117647058823528,1.5806483397379052,1.782128067337787,0.061687061888712535,0.624733336682544,0.6016790514208168,DNAJB1/HSPA12A/HSPH1/HSPA1A/HSPA1B/NUP205/NUP58/NUP98/RPA3/NUP188/NUP153/HSPA9/ST13,13,3.123029362498768,1.7205354722959605,5.668765658178614
R-HSA-9013424,RHOV GTPase cycle,8/1194,36/9872,0.2222222222222222,1.8373348222594454,1.8668699252622836,0.06184935751015106,0.624733336682544,0.6016790514208168,PAK2/SH3RF1/TPM4/NCK2/IQGAP1/ARHGEF7/DLG5/GIT1,8,3.630187976921645,1.6836398248024178,7.827246988133577
R-HSA-2161522,Abacavir ADME,3/1194,8/9872,0.375,3.100502512562814,2.204522742639422,0.06193055621500147,0.624733336682544,0.6016790514208168,PCK1/SLC22A3/ADH1A,3,6.125942211055277,1.6230715171139602,23.12108097363274
R-HSA-3595172,Defective CHST3 causes SEDCJD,3/1194,8/9872,0.375,3.100502512562814,2.204522742639422,0.06193055621500147,0.624733336682544,0.6016790514208168,CSPG5/CHST3/BCAN,3,6.125942211055277,1.6230715171139602,23.12108097363274
R-HSA-3595177,Defective CHSY1 causes TPBS,3/1194,8/9872,0.375,3.100502512562814,2.204522742639422,0.06193055621500147,0.624733336682544,0.6016790514208168,CSPG5/CHSY1/BCAN,3,6.125942211055277,1.6230715171139602,23.12108097363274
R-HSA-389397,Orexin and neuropeptides FF and QRFP bind to their respective receptors,3/1194,8/9872,0.375,3.100502512562814,2.204522742639422,0.06193055621500147,0.624733336682544,0.6016790514208168,NPFFR1/QRFP/HCRTR2,3,6.125942211055277,1.6230715171139602,23.12108097363274
R-HSA-8983711,OAS antiviral response,3/1194,8/9872,0.375,3.100502512562814,2.204522742639422,0.06193055621500147,0.624733336682544,0.6016790514208168,ABCE1/FLNA/OAS1,3,6.125942211055277,1.6230715171139602,23.12108097363274
R-HSA-193807,Synthesis of bile acids and bile salts via 27-hydroxycholesterol,4/1194,13/9872,0.3076923076923077,2.5440020615900014,2.0662174984005754,0.06221899747321782,0.624733336682544,0.6016790514208168,NCOA1/CYP8B1/CYP27A1/AKR1C3,4,5.026414121891509,1.6364211495680518,15.43908115060678
R-HSA-2022857,Keratan sulfate degradation,4/1194,13/9872,0.3076923076923077,2.5440020615900014,2.0662174984005754,0.06221899747321782,0.624733336682544,0.6016790514208168,OMD/ACAN/GLB1L3/OGN,4,5.026414121891509,1.6364211495680518,15.43908115060678
R-HSA-425561,Sodium/Calcium exchangers,4/1194,13/9872,0.3076923076923077,2.5440020615900014,2.0662174984005754,0.06221899747321782,0.624733336682544,0.6016790514208168,SLC8A1/SLC24A3/SLC24A5/SLC24A1,4,5.026414121891509,1.6364211495680518,15.43908115060678
R-HSA-428540,Activation of RAC1,4/1194,13/9872,0.3076923076923077,2.5440020615900014,2.0662174984005754,0.06221899747321782,0.624733336682544,0.6016790514208168,PAK2/NCK2/ROBO1/PAK3,4,5.026414121891509,1.6364211495680518,15.43908115060678
R-HSA-352230,Amino acid transport across the plasma membrane,7/1194,30/9872,0.23333333333333334,1.9292015633724178,1.8906093235559427,0.0624733336682544,0.624733336682544,0.6016790514208168,SLC38A4/SLC6A6/SLC7A3/SLC7A1/SLC6A15/SLC1A4/SLC7A11,7,3.8116973757677273,1.6707809705854129,8.695955448513308
R-HSA-9616222,Transcriptional regulation of granulopoiesis,7/1194,30/9872,0.23333333333333334,1.9292015633724178,1.8906093235559427,0.0624733336682544,0.624733336682544,0.6016790514208168,STAT3/CBFB/CDKN1A/RARA/RUNX1/CEBPA/CDK2,7,3.8116973757677273,1.6707809705854129,8.695955448513308
R-HSA-168179,Toll Like Receptor TLR1:TLR2 Cascade,19/1194,109/9872,0.1743119266055046,1.4412121770934183,1.718074574675864,0.06332892410728312,0.6260927724242763,0.602988320447337,TLR2/MAP2K4/NLRC5/FOS/TIFA/NOD2/CUL1/IRAK2/DUSP3/JUN/MAP2K3/NFKBIA/TNIP2/CD14/RELA/TLR4/TRAF6/SFTPD/RPS6KA3,19,2.8475327708880798,1.7431439835556604,4.651619692793229
R-HSA-181438,Toll Like Receptor 2 (TLR2) Cascade,19/1194,109/9872,0.1743119266055046,1.4412121770934183,1.718074574675864,0.06332892410728312,0.6260927724242763,0.602988320447337,TLR2/MAP2K4/NLRC5/FOS/TIFA/NOD2/CUL1/IRAK2/DUSP3/JUN/MAP2K3/NFKBIA/TNIP2/CD14/RELA/TLR4/TRAF6/SFTPD/RPS6KA3,19,2.8475327708880798,1.7431439835556604,4.651619692793229
R-HSA-9012999,RHO GTPase cycle,64/1194,441/9872,0.14512471655328799,1.199892128822495,1.5929752636154222,0.06703420043367561,0.6537535649993789,0.6296283578215435,ALDH3A2/ERBIN/ARHGAP21/DOCK1/WIPF3/PAK2/SH3RF1/RHOJ/PTPN13/TPM4/ARHGAP26/ARHGEF10/WIPF1/NCK2/RHOQ/IQGAP1/RTKN/ARHGEF7/DLG5/DOCK9/TJP2/PICALM/TFRC/ARHGAP31/FLOT2/LRRC1/TRA2B/GJA1/KCTD3/RBBP6/ARFGAP3/LBR/ITSN2/PCDH7/PDE5A/ARHGAP5/ARHGAP42/STIP1/TEX2/CAVIN1/ARHGEF3/SPATA13/ARHGAP23/MYO9B/STK38/FLOT1/PREX1/ARHGAP1/RHOB/LMNB1/ABR/ARAP3/SLITRK5/CHN1/GRB2/SLK/NGEF/OPHN1/PLXND1/FERMT2/RHOBTB2/GIT1/PAK3/CFTR,64,2.3707350053365848,1.8122906734057869,3.101259940253418
R-HSA-166520,Signaling by NTRKs,22/1194,131/9872,0.16793893129770993,1.3885202091884359,1.6604293694151466,0.06816685242227445,0.6537535649993789,0.6296283578215435,STAT3/SGK1/RALGDS/VGF/PCSK6/ID4/PTPRO/SHC2/FOS/RAP1A/DNM3/DUSP3/BDNF/PTPN11/GAB1/EGR1/ADORA2A/JUNB/GRB2/GRIN2B/RPS6KA3/DNM1,22,2.7434245016430756,1.7399240243740544,4.3256934732671475
R-HSA-6802946,Signaling by moderate kinase activity BRAF mutants,9/1194,43/9872,0.20930232558139536,1.730513030267617,1.7806577064878548,0.06838112001717642,0.6537535649993789,0.6296283578215435,MARK3/IQGAP1/ITGB3/RAP1A/CAMK2D/CNKSR2/KSR2/ARRB1/CAMK2G,9,3.4191305364029447,1.6628858876034445,7.030220000129656
R-HSA-6802949,Signaling by RAS mutants,9/1194,43/9872,0.20930232558139536,1.730513030267617,1.7806577064878548,0.06838112001717642,0.6537535649993789,0.6296283578215435,MARK3/IQGAP1/ITGB3/RAP1A/CAMK2D/CNKSR2/KSR2/ARRB1/CAMK2G,9,3.4191305364029447,1.6628858876034445,7.030220000129656
R-HSA-6802955,Paradoxical activation of RAF signaling by kinase inactive BRAF,9/1194,43/9872,0.20930232558139536,1.730513030267617,1.7806577064878548,0.06838112001717642,0.6537535649993789,0.6296283578215435,MARK3/IQGAP1/ITGB3/RAP1A/CAMK2D/CNKSR2/KSR2/ARRB1/CAMK2G,9,3.4191305364029447,1.6628858876034445,7.030220000129656
R-HSA-9649948,Signaling downstream of RAS mutants,9/1194,43/9872,0.20930232558139536,1.730513030267617,1.7806577064878548,0.06838112001717642,0.6537535649993789,0.6296283578215435,MARK3/IQGAP1/ITGB3/RAP1A/CAMK2D/CNKSR2/KSR2/ARRB1/CAMK2G,9,3.4191305364029447,1.6628858876034445,7.030220000129656
R-HSA-373076,Class A/1 (Rhodopsin-like receptors),38/1194,247/9872,0.15384615384615385,1.2720010307950007,1.6058004447549565,0.06929678212993035,0.6588874366452394,0.6345727762487727,EDNRB/P2RY14/CX3CR1/CXCL12/TACR1/P2RY13/P2RY12/CHRM5/PENK/C5AR1/NPFFR1/CYSLTR1/LPAR4/CX3CL1/OPRM1/ADORA1/PROK2/QRFP/GNRHR/ADORA2A/GPR17/HTR2B/LPAR5/TSHR/CCRL2/HCRTR2/ADRB1/HRH2/ACKR3/OXGR1/PTAFR/CHRM1/CCL2/PDYN/FFAR4/KEL/NTSR2/CCL3,38,2.5132070609457546,1.7772367985507316,3.5539494435059105
R-HSA-3928664,Ephrin signaling,5/1194,19/9872,0.2631578947368421,2.175791236886185,1.9028111807247006,0.07027985836071009,0.6637412030757586,0.6392474260717531,PAK2/NCK2/ARHGEF7/GIT1/PAK3,5,4.298906814775632,1.6023718842132917,11.533277626871055
R-HSA-913531,Interferon Signaling,39/1194,255/9872,0.15294117647058825,1.2645186717903243,1.5873749846130962,0.0713842551019038,0.6637412030757586,0.6392474260717531,STAT3/PTPN2/IFNAR2/FKBP5/HSPA1A/HSPA1B/GBP2/NUP205/PPM1B/CAMK2D/PTPN1/UBA7/KPNA3/NUP58/PTPN11/TRIM34/IRF1/NUP98/NUP188/NUP153/ATF6/GBP7/EGR1/SOCS3/SAMHD1/TUBB2A/ABCE1/ISG20/TUBB4A/TRIM3/FLNA/EIF2S1/CAMK2G/PTAFR/STAT1/FCGR1A/EIF4G1/OAS1/EIF2AK3,39,2.498423489999015,1.7747038426482717,3.517274141957207
R-HSA-9013149,RAC1 GTPase cycle,29/1194,182/9872,0.15934065934065933,1.3174296390376792,1.6032239690694994,0.07214715374180088,0.6637412030757586,0.6392474260717531,ERBIN/ARHGAP21/DOCK1/WIPF3/PAK2/ARHGAP26/ARHGEF10/WIPF1/IQGAP1/ARHGEF7/DOCK9/TFRC/ARHGAP31/LBR/ARHGAP5/ARHGAP42/SPATA13/ARHGAP23/MYO9B/PREX1/ARHGAP1/ABR/ARAP3/CHN1/NGEF/OPHN1/FERMT2/GIT1/PAK3,29,2.602964455979531,1.7514255063590316,3.8685196341453167
R-HSA-2022928,HS-GAG biosynthesis,7/1194,31/9872,0.22580645161290322,1.866969254876533,1.7932376309948956,0.07263967084671344,0.6637412030757586,0.6392474260717531,SLC35D2/HS3ST4/GPC5/GLCE/HS6ST3/HS3ST1/GPC2,7,3.6887393959042525,1.6209449768358506,8.394361638022461
R-HSA-451326,Activation of kainate receptors upon glutamate binding,7/1194,31/9872,0.22580645161290322,1.866969254876533,1.7932376309948956,0.07263967084671344,0.6637412030757586,0.6392474260717531,GNB3/GRIK4/PLCB1/GNG3/GRIK2/GRIK1/NCALD,7,3.6887393959042525,1.6209449768358506,8.394361638022461
R-HSA-8941326,RUNX2 regulates bone development,7/1194,31/9872,0.22580645161290322,1.866969254876533,1.7932376309948956,0.07263967084671344,0.6637412030757586,0.6392474260717531,CBFB/HDAC4/GLI3/MAF/HES1/ZNF521/SMAD6,7,3.6887393959042525,1.6209449768358506,8.394361638022461
R-HSA-9013508,NOTCH3 Intracellular Domain Regulates Transcription,6/1194,25/9872,0.24,1.9843216080402009,1.8277970445776055,0.07285894815371834,0.6637412030757586,0.6392474260717531,HES5/KAT2B/HES1/PLXND1/STAT1/FABP7,6,3.9206030150753772,1.6052888055765433,9.575303801048785
R-HSA-9705462,Inactivation of CSF3 (G-CSF) signaling,6/1194,25/9872,0.24,1.9843216080402009,1.8277970445776055,0.07285894815371834,0.6637412030757586,0.6392474260717531,STAT3/STAT5B/SOCS3/UBE2D1/STAT5A/STAT1,6,3.9206030150753772,1.6052888055765433,9.575303801048785
R-HSA-112310,Neurotransmitter release cycle,10/1194,50/9872,0.2,1.653601340033501,1.7185844885363026,0.07331594843285726,0.6644257826727689,0.6399067429008156,PPFIA2/GLS2/SLC1A2/SYN2/SLC32A1/ALDH5A1/NAAA/GAD2/PPFIA4/SLC1A6,10,3.2671691792294806,1.652765981180196,6.458503240782301
R-HSA-1236394,Signaling by ERBB4,11/1194,57/9872,0.19298245614035087,1.5955802403832025,1.6726515334241367,0.07702330209838927,0.6852897061409543,0.6600007333190558,GABRB1/GABRG2/CXCL12/MXD4/WWP1/NRG1/GRB2/GABRG3/STAT5A/GABRB3/GABRA1,11,3.1525316641687975,1.6488784432979735,6.027403617278584
R-HSA-2682334,EPH-Ephrin signaling,16/1194,91/9872,0.17582417582417584,1.4537154637657153,1.6128187529595714,0.07829889263008835,0.6852897061409543,0.6600007333190558,PAK2/EFNA5/EFNA1/GRIN1/NCK2/ARHGEF7/EPHA6/LIMK2/PTK2/ACTR3/NGEF/GRIN2B/GIT1/PAK3/EPHA4/DNM1,16,2.872236641080862,1.682959895102879,4.901925082334282
R-HSA-4420097,VEGFA-VEGFR2 Pathway,17/1194,98/9872,0.17346938775510204,1.4342460602331384,1.6024543776889273,0.07875515466482391,0.6852897061409543,0.6600007333190558,DOCK1/ELMO1/SHB/PAK2/CTNNA1/VEGFA/PXN/NCK2/SHC2/BCAR1/ITGB3/PRKCZ/PTK2/HSPB1/PAK3/AXL/PRR5,17,2.8337691860663865,1.6876722022880128,4.758179810636552
R-HSA-3371568,Attenuation phase,4/1194,14/9872,0.2857142857142857,2.3622876286192867,1.8919573416600561,0.07906417162887995,0.6852897061409543,0.6600007333190558,DNAJB1/HSPA1A/HSPA1B/PTGES3,4,4.667384541756401,1.533952971496554,14.201529554959729
R-HSA-5682910,LGI-ADAM interactions,4/1194,14/9872,0.2857142857142857,2.3622876286192867,1.8919573416600561,0.07906417162887995,0.6852897061409543,0.6600007333190558,LGI1/CACNG3/CACNG2/CACNG4,4,4.667384541756401,1.533952971496554,14.201529554959729
R-HSA-8849471,"PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases",4/1194,14/9872,0.2857142857142857,2.3622876286192867,1.8919573416600561,0.07906417162887995,0.6852897061409543,0.6600007333190558,DOCK1/ELMO1/PXN/BCAR1,4,4.667384541756401,1.533952971496554,14.201529554959729
R-HSA-9648895,Response of EIF2AK1 (HRI) to heme deficiency,4/1194,14/9872,0.2857142857142857,2.3622876286192867,1.8919573416600561,0.07906417162887995,0.6852897061409543,0.6600007333190558,ATF3/PPP1R15A/GRB10/EIF2S1,4,4.667384541756401,1.533952971496554,14.201529554959729
R-HSA-1793185,Chondroitin sulfate/dermatan sulfate metabolism,10/1194,51/9872,0.19607843137254902,1.6211777843465696,1.649666154707927,0.08179100961907484,0.6852897061409543,0.6600007333190558,B3GAT1/CSPG5/CHSY1/CSGALNACT1/CHST3/GPC5/CHST9/BCAN/GPC2/CHST7,10,3.203107038460275,1.6221522867674707,6.324865293799921
R-HSA-2559582,Senescence-Associated Secretory Phenotype (SASP),10/1194,51/9872,0.19607843137254902,1.6211777843465696,1.649666154707927,0.08179100961907484,0.6852897061409543,0.6600007333190558,STAT3/CDKN1A/FOS/JUN/CDK2/UBE2D1/RELA/CCNA2/IL1A/RPS6KA3,10,3.203107038460275,1.6221522867674707,6.324865293799921
R-HSA-438064,Post NMDA receptor activation events,14/1194,78/9872,0.1794871794871795,1.4840012025941673,1.5917930665485234,0.08318751787369923,0.6852897061409543,0.6600007333190558,GRIN1/PRKAR2A/ARHGEF7/CAMK2D/PRKAG3/NRG1/TUBB2A/CAMK4/GRIN2B/GIT1/TUBB4A/GRIA1/CAMK2G/RPS6KA3,14,2.9320749044367136,1.6550211477575003,5.194533771895485
R-HSA-168274,Export of Viral Ribonucleoproteins from Nucleus,7/1194,32/9872,0.21875,1.8086264656616415,1.6994105409206162,0.0837253895347081,0.6852897061409543,0.6600007333190558,HSPA1A/HSPA1B/NUP205/NUP58/NUP98/NUP188/NUP153,7,3.5734662897822447,1.5739978381938915,8.112883648469827
R-HSA-168898,Toll-like Receptor Cascades,26/1194,163/9872,0.15950920245398773,1.3188231546279454,1.5224019191356344,0.08415015915392628,0.6852897061409543,0.6600007333190558,TLR2/MAP2K4/NLRC5/FOS/TIFA/NOD2/CUL1/DNM3/IRAK2/EEA1/DUSP3/JUN/MAP2K3/PTPN11/NFKBIA/TNIP2/CD14/UBE2D1/RELA/TLR4/GSDME/TRAF6/SFTPD/IKBKE/RPS6KA3/DNM1,26,2.605717750305721,1.7154808655067717,3.9579368856746404
R-HSA-9669938,Signaling by KIT in disease,5/1194,20/9872,0.25,2.067001675041876,1.7717025649241163,0.08476963403823622,0.6852897061409543,0.6600007333190558,STAT3/STAT5B/GRB2/STAT5A/STAT1,5,4.08396147403685,1.5300906535355874,10.900492257029086
R-HSA-9670439,"Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants",5/1194,20/9872,0.25,2.067001675041876,1.7717025649241163,0.08476963403823622,0.6852897061409543,0.6600007333190558,STAT3/STAT5B/GRB2/STAT5A/STAT1,5,4.08396147403685,1.5300906535355874,10.900492257029086
R-HSA-9671555,Signaling by PDGFR in disease,5/1194,20/9872,0.25,2.067001675041876,1.7717025649241163,0.08476963403823622,0.6852897061409543,0.6600007333190558,STAT3/ETV6/PDGFRA/GRB2/STAT1,5,4.08396147403685,1.5300906535355874,10.900492257029086
R-HSA-111453,BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members,3/1194,9/9872,0.3333333333333333,2.756002233389168,1.954855761186041,0.08477517724352857,0.6852897061409543,0.6600007333190558,STAT3/BCL2L1/PMAIP1,3,5.445281965382468,1.4722281538513962,20.140285732854203
R-HSA-1296052,Ca2+ activated K+ channels,3/1194,9/9872,0.3333333333333333,2.756002233389168,1.954855761186041,0.08477517724352857,0.6852897061409543,0.6600007333190558,KCNMB4/KCNMA1/KCNMB2,3,5.445281965382468,1.4722281538513962,20.140285732854203
R-HSA-447041,CHL1 interactions,3/1194,9/9872,0.3333333333333333,2.756002233389168,1.954855761186041,0.08477517724352857,0.6852897061409543,0.6600007333190558,ANK1/ITGA2/CHL1,3,5.445281965382468,1.4722281538513962,20.140285732854203
R-HSA-8877330,RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs),3/1194,9/9872,0.3333333333333333,2.756002233389168,1.954855761186041,0.08477517724352857,0.6852897061409543,0.6600007333190558,CBFB/RUNX1/CTLA4,3,5.445281965382468,1.4722281538513962,20.140285732854203
R-HSA-8951936,RUNX3 regulates p14-ARF,3/1194,9/9872,0.3333333333333333,2.756002233389168,1.954855761186041,0.08477517724352857,0.6852897061409543,0.6600007333190558,CBFB/HDAC4/RUNX1,3,5.445281965382468,1.4722281538513962,20.140285732854203
R-HSA-9758881,Uptake of dietary cobalamins into enterocytes,3/1194,9/9872,0.3333333333333333,2.756002233389168,1.954855761186041,0.08477517724352857,0.6852897061409543,0.6600007333190558,ABCD4/PRSS3/CUBN,3,5.445281965382468,1.4722281538513962,20.140285732854203
R-HSA-9664407,Parasite infection,11/1194,58/9872,0.1896551724137931,1.5680702362386645,1.609407132343157,0.08517384656189896,0.6852897061409543,0.6600007333190558,DOCK1/ELMO1/WIPF3/WIPF1/FGR/MYO9B/PTK2/MYO10/ACTR3/GRB2/FCGR3A,11,3.0981776699589902,1.6219038287775984,5.918171413324118
R-HSA-9664417,Leishmania phagocytosis,11/1194,58/9872,0.1896551724137931,1.5680702362386645,1.609407132343157,0.08517384656189896,0.6852897061409543,0.6600007333190558,DOCK1/ELMO1/WIPF3/WIPF1/FGR/MYO9B/PTK2/MYO10/ACTR3/GRB2/FCGR3A,11,3.0981776699589902,1.6219038287775984,5.918171413324118
R-HSA-9664422,FCGR3A-mediated phagocytosis,11/1194,58/9872,0.1896551724137931,1.5680702362386645,1.609407132343157,0.08517384656189896,0.6852897061409543,0.6600007333190558,DOCK1/ELMO1/WIPF3/WIPF1/FGR/MYO9B/PTK2/MYO10/ACTR3/GRB2/FCGR3A,11,3.0981776699589902,1.6219038287775984,5.918171413324118
R-HSA-2022854,Keratan sulfate biosynthesis,6/1194,26/9872,0.23076923076923078,1.908001546192501,1.719555758168347,0.08546429093826845,0.6852897061409543,0.6600007333190558,SLC35D2/OMD/ACAN/ST3GAL4/B4GALT5/OGN,6,3.769810591418632,1.54867309438829,9.176547295015467
R-HSA-909733,Interferon alpha/beta signaling,12/1194,65/9872,0.18461538461538463,1.5264012369540008,1.579350085493099,0.08760758653242959,0.6992532136074655,0.6734489510363492,IFNAR2/GBP2/PTPN1/PTPN11/IRF1/EGR1/SOCS3/SAMHD1/ABCE1/ISG20/STAT1/OAS1,12,3.0158484731349056,1.6246537511668502,5.598326416553518
R-HSA-194138,Signaling by VEGF,18/1194,107/9872,0.16822429906542055,1.3908796318038792,1.5078971557288965,0.09106226470319198,0.7224664449306282,0.6958055537383908,DOCK1/ELMO1/SHB/PAK2/CTNNA1/VEGFA/PXN/NCK2/SHC2/BCAR1/ITGB3/VEGFD/PRKCZ/PTK2/HSPB1/PAK3/AXL/PRR5,18,2.7480862255201237,1.6622511761780892,4.543223076705671
R-HSA-9013423,RAC3 GTPase cycle,16/1194,93/9872,0.17204301075268819,1.422452765620216,1.5182571158232152,0.09134633211766563,0.7224664449306282,0.6958055537383908,ERBIN/ARHGAP21/PAK2/ARHGAP26/TFRC/LBR/ARHGAP5/ARHGAP42/PREX1/ARHGAP1/ABR/ARAP3/SLITRK5/OPHN1/FERMT2/GIT1,16,2.8104681111651444,1.6481673516330113,4.792432634980954
R-HSA-109582,Hemostasis,78/1194,559/9872,0.13953488372093023,1.1536753535117448,1.387516766482233,0.09496791195603503,0.7274662786442309,0.7006208805817397,SRGN/DOCK1/KCNMB4/A2M/HABP4/KIF19/VEGFA/PROS1/PLAUR/JAM2/GNB3/ITPK1/SERPINB6/PSG9/GNAI1/TSPAN7/P2RY12/RAB27B/GUCY1A1/SELPLG/SLC8A1/PRKAR2A/JMJD1C/SERPINA1/CD47/BCAR1/DOCK9/TNFRSF10D/IGF1/FGR/ITGB3/MAFF/MGLL/JAM3/RAP1A/KCNMA1/PCDH7/KCNMB2/PDE5A/VEGFD/PRKCG/PTPN1/CD84/KIF26B/RASGRP1/PSG8/PTPN11/IRF1/SELL/ANGPT2/PRKCZ/TGFB3/CARMIL1/ATP1B3/PTK2/PDGFA/PDPN/ITGA4/PSG4/RHOB/CALU/GRB2/GNG3/SERPINE2/KIF21B/CDK2/TUBB2A/GNA12/ARRB1/TUBB4A/CABLES1/FLNA/AK3/ITGA2/SH2B2/TAGLN2/SLC7A11/PECAM1,78,2.2794203576019636,1.785890604017794,2.9093367505048455
R-HSA-6802948,Signaling by high-kinase activity BRAF mutants,7/1194,33/9872,0.21212121212121213,1.7538196030658342,1.6088732583790903,0.09572347881641145,0.7274662786442309,0.7006208805817397,MARK3/IQGAP1/ITGB3/RAP1A/CNKSR2/KSR2/ARRB1,7,3.465179432516116,1.5296953068996868,7.849581838535462
R-HSA-8979227,Triglyceride metabolism,7/1194,33/9872,0.21212121212121213,1.7538196030658342,1.6088732583790903,0.09572347881641145,0.7274662786442309,0.7006208805817397,PLIN3/PNPLA4/MGLL/GK/PPP1CB/FABP6/FABP7,7,3.465179432516116,1.5296953068996868,7.849581838535462
R-HSA-9022692,Regulation of MECP2 expression and activity,7/1194,33/9872,0.21212121212121213,1.7538196030658342,1.6088732583790903,0.09572347881641145,0.7274662786442309,0.7006208805817397,TNRC6C/CAMK2D/AGO2/LBR/FOXG1/CAMK4/CAMK2G,7,3.465179432516116,1.5296953068996868,7.849581838535462
R-HSA-9725371,Nuclear events stimulated by ALK signaling in cancer,7/1194,33/9872,0.21212121212121213,1.7538196030658342,1.6088732583790903,0.09572347881641145,0.7274662786442309,0.7006208805817397,STAT3/TNRC6C/BCL2A1/AGO2/CUL1/JUNB/STAT5A,7,3.465179432516116,1.5296953068996868,7.849581838535462
R-HSA-166058,MyD88:MAL(TIRAP) cascade initiated on plasma membrane,18/1194,108/9872,0.16666666666666666,1.378001116694584,1.465088946064658,0.0975460387089976,0.7274662786442309,0.7006208805817397,TLR2/MAP2K4/NLRC5/FOS/TIFA/NOD2/CUL1/IRAK2/DUSP3/JUN/MAP2K3/NFKBIA/TNIP2/CD14/RELA/TLR4/TRAF6/RPS6KA3,18,2.722640982691234,1.647404726974815,4.499667749674494
R-HSA-168138,Toll Like Receptor 9 (TLR9) Cascade,18/1194,108/9872,0.16666666666666666,1.378001116694584,1.465088946064658,0.0975460387089976,0.7274662786442309,0.7006208805817397,MAP2K4/NLRC5/FOS/TIFA/NOD2/CUL1/IRAK2/EEA1/DUSP3/JUN/MAP2K3/NFKBIA/TNIP2/CD14/RELA/TLR4/TRAF6/RPS6KA3,18,2.722640982691234,1.647404726974815,4.499667749674494
R-HSA-168188,Toll Like Receptor TLR6:TLR2 Cascade,18/1194,108/9872,0.16666666666666666,1.378001116694584,1.465088946064658,0.0975460387089976,0.7274662786442309,0.7006208805817397,TLR2/MAP2K4/NLRC5/FOS/TIFA/NOD2/CUL1/IRAK2/DUSP3/JUN/MAP2K3/NFKBIA/TNIP2/CD14/RELA/TLR4/TRAF6/RPS6KA3,18,2.722640982691234,1.647404726974815,4.499667749674494
R-HSA-418457,cGMP effects,4/1194,15/9872,0.26666666666666666,2.2048017867113345,1.7320553671067065,0.09791545599541097,0.7274662786442309,0.7006208805817397,KCNMB4/KCNMA1/KCNMB2/PDE5A,4,4.356225572305974,1.4435503927059024,13.145852983518722
R-HSA-975163,IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation,4/1194,15/9872,0.26666666666666666,2.2048017867113345,1.7320553671067065,0.09791545599541097,0.7274662786442309,0.7006208805817397,IRAK2/CD14/TLR4/TRAF6,4,4.356225572305974,1.4435503927059024,13.145852983518722
R-HSA-975577,N-Glycan antennae elongation,4/1194,15/9872,0.26666666666666666,2.2048017867113345,1.7320553671067065,0.09791545599541097,0.7274662786442309,0.7006208805817397,MGAT4C/ST3GAL4/B4GALT5/ST8SIA3,4,4.356225572305974,1.4435503927059024,13.145852983518722
R-HSA-975138,TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation,17/1194,101/9872,0.16831683168316833,1.3916446921074017,1.4674264460925472,0.09806520473662379,0.7274662786442309,0.7006208805817397,MAP2K4/NLRC5/FOS/TIFA/NOD2/CUL1/IRAK2/DUSP3/JUN/MAP2K3/NFKBIA/TNIP2/CD14/RELA/TLR4/TRAF6/RPS6KA3,17,2.7495978241040184,1.6393858729707547,4.611658743049581
R-HSA-9013404,RAC2 GTPase cycle,15/1194,87/9872,0.1724137931034483,1.4255183965806042,1.4786672993912258,0.09836764029644533,0.7274662786442309,0.7006208805817397,ERBIN/ARHGAP21/DOCK1/PAK2/ARHGAP26/IQGAP1/TFRC/LBR/ARHGAP42/PREX1/ARHGAP1/ABR/SLITRK5/OPHN1/GIT1,15,2.816525154508173,1.6232569912752515,4.886973528292132
R-HSA-5620971,Pyroptosis,6/1194,27/9872,0.2222222222222222,1.8373348222594454,1.6160176168958955,0.09918784076534122,0.7274662786442309,0.7006208805817397,IL1B/IRF1/CASP1/IL1A/GSDME/CASP4,6,3.630187976921645,1.495916641398486,8.80949137344078
R-HSA-9759475,Regulation of CDH11 Expression and Function,6/1194,27/9872,0.2222222222222222,1.8373348222594454,1.6160176168958955,0.09918784076534122,0.7274662786442309,0.7006208805817397,CTNNA1/ADAM19/TNRC6C/AGO2/CDH8/CDH24,6,3.630187976921645,1.495916641398486,8.80949137344078
R-HSA-416476,G alpha (q) signalling events,29/1194,188/9872,0.15425531914893617,1.275384012259881,1.414044815670722,0.09932550924037373,0.7274662786442309,0.7006208805817397,EDNRB/RGS16/RGS18/TACR1/GNB3/CHRM5/MGLL/NPFFR1/CYSLTR1/LPAR4/RASGRP1/PROK2/RGS2/QRFP/GNRHR/RGS17/PLCB1/GPR17/GRB2/GNG3/HTR2B/LPAR5/HCRTR2/PTAFR/CHRM1/FFAR4/NTSR2/RGS1/RPS6KA3,29,2.519891122278057,1.6969724696030992,3.7418705264092567
R-HSA-392154,Nitric oxide stimulates guanylate cyclase,5/1194,21/9872,0.23809523809523808,1.9685730238494057,1.648066658647546,0.10069595949174935,0.7274662786442309,0.7006208805817397,KCNMB4/GUCY1A1/KCNMA1/KCNMB2/PDE5A,5,3.889487118130334,1.4640496346019307,10.333058172727238
R-HSA-5654708,Downstream signaling of activated FGFR3,5/1194,21/9872,0.23809523809523808,1.9685730238494057,1.648066658647546,0.10069595949174935,0.7274662786442309,0.7006208805817397,FGF20/FGFR3/PTPN11/GAB1/GRB2,5,3.889487118130334,1.4640496346019307,10.333058172727238
R-HSA-622312,Inflammasomes,5/1194,21/9872,0.23809523809523808,1.9685730238494057,1.648066658647546,0.10069595949174935,0.7274662786442309,0.7006208805817397,HMOX1/BCL2L1/RELA/NLRP1/CASP1,5,3.889487118130334,1.4640496346019307,10.333058172727238
R-HSA-9609523,Insertion of tail-anchored proteins into the endoplasmic reticulum membrane,5/1194,21/9872,0.23809523809523808,1.9685730238494057,1.648066658647546,0.10069595949174935,0.7274662786442309,0.7006208805817397,ALDH3A2/HMOX1/SGTA/VAPA/GET1,5,3.889487118130334,1.4640496346019307,10.333058172727238
R-HSA-556833,Metabolism of lipids,97/1194,709/9872,0.1368124118476728,1.1311659378226346,1.344615952836579,0.10075826043290784,0.7274662786442309,0.7006208805817397,ALDH3A2/PIP4K2A/ETNPPL/ELOVL5/AHR/OSBPL5/ACSL1/PTPN13/SYNJ2/LTC4S/MVK/PLIN3/ACSF2/PIK3C2B/INPP5F/PNPLA4/SGMS1/MTMR10/HILPDA/TECR/MBOAT2/ACSM6/PLEKHA1/PIP5K1B/MED28/MGLL/RGL1/TM7SF2/NEU4/OSBPL1A/GLIPR1/HELZ2/LBR/GK/HSD17B1/SPTLC3/OSBPL6/ACSL4/DHCR7/PTGES3/ALOX15B/ACSM3/SEC24D/FAM120B/PGS1/CHPT1/NCOA1/MED15/PLD4/DPEP2/GLB1L3/PLAAT1/B4GALT5/STS/CYP8B1/FADS1/PPARD/ACSL6/HACD2/PPP1CB/CYP27A1/HACD4/PLAAT3/UGCG/LSS/ELOVL2/SMPD3/SEC23A/AGPS/PPM1L/OSBPL3/MED29/GPAT4/PPARG/ALAS1/PLEKHA8/CYP39A1/RORA/ARSG/AKR1C3/AGPAT5/CUBN/OSBPL9/MBOAT7/VAPA/PCTP/GC/CERS5/SEC24A/INSIG2/ALOX5AP/TPTE2/SBF1/PLA2G12A/FABP6/CHKA/FABP7,97,2.2349464766238336,1.7934364452498583,2.785147902287329
R-HSA-1296072,Voltage gated Potassium channels,8/1194,40/9872,0.2,1.653601340033501,1.5363667906840501,0.10272277697456111,0.7355458104351289,0.7084022566320178,KCNH5/KCNB2/KCNF1/KCNB1/KCNQ2/KCNH2/KCND2/KCNS2,8,3.267169179229481,1.5258834482790193,6.995550320534802
R-HSA-1433557,Signaling by SCF-KIT,8/1194,40/9872,0.2,1.653601340033501,1.5363667906840501,0.10272277697456111,0.7355458104351289,0.7084022566320178,STAT3/GRB10/STAT5B/PTPN11/GRB2/SH2B2/STAT5A/STAT1,8,3.267169179229481,1.5258834482790193,6.995550320534802
R-HSA-198933,Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell,18/1194,109/9872,0.1651376146788991,1.3653589046148173,1.4227029017769728,0.10431425917966619,0.7438803728386032,0.716429252001849,SIGLEC9/CD22/PIANP/SIGLEC5/SELL/NCR3/MADCAM1/NECTIN2/ITGA4/SIGLEC7/RAET1E/KLRD1/SFTPD/FCGR3A/ITGB7/FCGR1A/CD300LF/LILRB4,18,2.6976626250518647,1.6328213053646627,4.456938193231402
R-HSA-975155,MyD88 dependent cascade initiated on endosome,17/1194,102/9872,0.16666666666666666,1.378001116694584,1.4233732618220873,0.10510833069929708,0.7457010950187228,0.7181827847972213,MAP2K4/NLRC5/FOS/TIFA/NOD2/CUL1/IRAK2/DUSP3/JUN/MAP2K3/NFKBIA/TNIP2/CD14/RELA/TLR4/TRAF6/RPS6KA3,17,2.722640982691234,1.6238990483029443,4.564799719771133
R-HSA-1638074,Keratan sulfate/keratin metabolism,7/1194,34/9872,0.20588235294117646,1.7022366735638979,1.5213967078590287,0.10861867088785375,0.7457010950187228,0.7181827847972213,SLC35D2/OMD/ACAN/ST3GAL4/GLB1L3/B4GALT5/OGN,7,3.3632623903832886,1.4878199265631116,7.602757366408271
R-HSA-76009,Platelet Aggregation (Plug Formation),7/1194,34/9872,0.20588235294117646,1.7022366735638979,1.5213967078590287,0.10861867088785375,0.7457010950187228,0.7181827847972213,BCAR1/ITGB3/RAP1A/PTPN1/RASGRP1/PTK2/GRB2,7,3.3632623903832886,1.4878199265631116,7.602757366408271
R-HSA-500792,GPCR ligand binding,50/1194,348/9872,0.14367816091954022,1.1879319971505036,1.3238950979466055,0.10913664574964946,0.7457010950187228,0.7181827847972213,EDNRB/P2RY14/CX3CR1/CD55/CRH/CALCRL/CXCL12/TACR1/GNB3/FZD5/P2RY13/P2RY12/ADGRE2/CHRM5/PENK/C5AR1/NPFFR1/CYSLTR1/LPAR4/CX3CL1/OPRM1/ADORA1/ADM/PROK2/PTH2R/QRFP/GNRHR/ADORA2A/DHH/GPR17/GNG3/HTR2B/LPAR5/TSHR/CCRL2/HCRTR2/WNT2B/ADRB1/HRH2/ACKR3/OXGR1/WNT6/PTAFR/CHRM1/CCL2/PDYN/FFAR4/KEL/NTSR2/CCL3,50,2.3471042954234775,1.7350695926008555,3.1750303256352637
R-HSA-373760,L1CAM interactions,19/1194,117/9872,0.1623931623931624,1.3426677547280563,1.3830104110280372,0.1101325461008186,0.7457010950187228,0.7181827847972213,NFASC/SCN1A/ITGB3/MSN/SCN2A/DNM3/SCN11A/SCN1B/LAMA1/SCN4B/DCX/TUBB2A/ANK1/KCNQ2/TUBB4A/ITGA2/CHL1/RPS6KA3/DNM1,19,2.652829675442741,1.6279567454601758,4.322906801138836
R-HSA-428542,Regulation of commissural axon pathfinding by SLIT and ROBO,3/1194,10/9872,0.3,2.480402010050251,1.7372810539736023,0.11060007812900949,0.7457010950187228,0.7181827847972213,ROBO1/NELL2/NTN1,3,4.900753768844221,1.3469416559908005,17.831052589411392
R-HSA-9028731,Activated NTRK2 signals through FRS2 and FRS3,3/1194,10/9872,0.3,2.480402010050251,1.7372810539736023,0.11060007812900949,0.7457010950187228,0.7181827847972213,BDNF/PTPN11/GRB2,3,4.900753768844221,1.3469416559908005,17.831052589411392
R-HSA-1655829,Regulation of cholesterol biosynthesis by SREBP (SREBF),10/1194,54/9872,0.18518518518518517,1.531112351882871,1.4515923950410472,0.1106625060903571,0.7457010950187228,0.7181827847972213,MVK/TM7SF2/HELZ2/DHCR7/SEC24D/NCOA1/LSS/SEC23A/SEC24A/INSIG2,10,3.025156647434704,1.5367622492975916,5.955099915879174
R-HSA-211859,Biological oxidations,28/1194,183/9872,0.15300546448087432,1.26505020549011,1.3424160273354098,0.11187963493054547,0.7457010950187228,0.7181827847972213,AHR/ACSM5/SLC35D2/ACY3/MAT2A/NNMT/TPST1/PTGES3/GSTO2/NAT2/NCOA1/ALDH3A1/DPEP2/GCLC/CYP8B1/GSTA4/CYP27A1/AOC2/CBR3/CYP26C1/UGT3A2/CHAC2/CYP39A1/FMO3/SULT4A1/ADH1A/ADH4/TPST2,28,2.499473689028018,1.6720941055374596,3.7362542583303004
R-HSA-390648,Muscarinic acetylcholine receptors,2/1194,5/9872,0.4,3.307202680067002,1.91404040780264,0.11396220179676249,0.7457010950187228,0.7181827847972213,CHRM5/CHRM1,2,6.534338358458962,1.2663980799669403,33.7157632013646
R-HSA-391906,Leukotriene receptors,2/1194,5/9872,0.4,3.307202680067002,1.91404040780264,0.11396220179676249,0.7457010950187228,0.7181827847972213,CYSLTR1/GPR17,2,6.534338358458962,1.2663980799669403,33.7157632013646
R-HSA-5660668,CLEC7A/inflammasome pathway,2/1194,5/9872,0.4,3.307202680067002,1.91404040780264,0.11396220179676249,0.7457010950187228,0.7181827847972213,IL1B/RELA,2,6.534338358458962,1.2663980799669403,33.7157632013646
R-HSA-5688849,Defective CSF2RB causes SMDP5,2/1194,5/9872,0.4,3.307202680067002,1.91404040780264,0.11396220179676249,0.7457010950187228,0.7181827847972213,CSF2RA/SFTPD,2,6.534338358458962,1.2663980799669403,33.7157632013646
R-HSA-5688890,Defective CSF2RA causes SMDP4,2/1194,5/9872,0.4,3.307202680067002,1.91404040780264,0.11396220179676249,0.7457010950187228,0.7181827847972213,CSF2RA/SFTPD,2,6.534338358458962,1.2663980799669403,33.7157632013646
R-HSA-68911,G2 Phase,2/1194,5/9872,0.4,3.307202680067002,1.91404040780264,0.11396220179676249,0.7457010950187228,0.7181827847972213,CDK2/CCNA2,2,6.534338358458962,1.2663980799669403,33.7157632013646
R-HSA-77352,Beta oxidation of butanoyl-CoA to acetyl-CoA,2/1194,5/9872,0.4,3.307202680067002,1.91404040780264,0.11396220179676249,0.7457010950187228,0.7181827847972213,ACSM6/ACSM3,2,6.534338358458962,1.2663980799669403,33.7157632013646
R-HSA-8852405,Signaling by MST1,2/1194,5/9872,0.4,3.307202680067002,1.91404040780264,0.11396220179676249,0.7457010950187228,0.7181827847972213,HPN/MST1,2,6.534338358458962,1.2663980799669403,33.7157632013646
R-HSA-8935964,RUNX1 regulates expression of components of tight junctions,2/1194,5/9872,0.4,3.307202680067002,1.91404040780264,0.11396220179676249,0.7457010950187228,0.7181827847972213,CBFB/RUNX1,2,6.534338358458962,1.2663980799669403,33.7157632013646
R-HSA-8941284,RUNX2 regulates chondrocyte maturation,2/1194,5/9872,0.4,3.307202680067002,1.91404040780264,0.11396220179676249,0.7457010950187228,0.7181827847972213,CBFB/HDAC4,2,6.534338358458962,1.2663980799669403,33.7157632013646
R-HSA-9818026,NFE2L2 regulating inflammation associated genes,2/1194,5/9872,0.4,3.307202680067002,1.91404040780264,0.11396220179676249,0.7457010950187228,0.7181827847972213,NFE2L2/CCL2,2,6.534338358458962,1.2663980799669403,33.7157632013646
R-HSA-9927353,Co-inhibition by BTLA,2/1194,5/9872,0.4,3.307202680067002,1.91404040780264,0.11396220179676249,0.7457010950187228,0.7181827847972213,PTPN11/GRB2,2,6.534338358458962,1.2663980799669403,33.7157632013646
R-HSA-1855204,Synthesis of IP3 and IP4 in the cytosol,6/1194,28/9872,0.21428571428571427,1.771715721464465,1.5167830871699017,0.11399798349136797,0.7457010950187228,0.7181827847972213,ITPK1/ITPKC/PLD4/PLCZ1/PLCB1/PLCH2,6,3.500538406317301,1.4466377192689814,8.470516820406546
R-HSA-6783783,Interleukin-10 signaling,8/1194,41/9872,0.1951219512195122,1.6132696000326838,1.4595448130679554,0.11483604091086125,0.7483697048123542,0.7207529159475305,STAT3/IL1B/IL10RB/CSF1/IL1A/PTAFR/CCL2/CCL3,8,3.1874821260775423,1.4909609461230164,6.814425508919748
R-HSA-438066,"Unblocking of NMDA receptors, glutamate binding and activation",5/1194,22/9872,0.22727272727272727,1.8790924318562507,1.5310898689640848,0.11799507186997867,0.7533739733849717,0.7255725139920599,GRIN1/CAMK2D/GRIN2B/GRIA1/CAMK2G,5,3.712692249124409,1.4034742236124866,9.821401422841083
R-HSA-9617324,Negative regulation of NMDA receptor-mediated neuronal transmission,5/1194,22/9872,0.22727272727272727,1.8790924318562507,1.5310898689640848,0.11799507186997867,0.7533739733849717,0.7255725139920599,GRIN1/CAMK2D/CAMK4/GRIN2B/CAMK2G,5,3.712692249124409,1.4034742236124866,9.821401422841083
R-HSA-381771,"Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)",4/1194,16/9872,0.25,2.067001675041876,1.5843373535131438,0.11863475213073693,0.7533739733849717,0.7255725139920599,DPP4/GNB3/PAX6/FFAR4,4,4.083961474036851,1.3632030942015805,12.234964395518693
R-HSA-399956,CRMPs in Sema3A signaling,4/1194,16/9872,0.25,2.067001675041876,1.5843373535131438,0.11863475213073693,0.7533739733849717,0.7255725139920599,SEMA3A/PLXNA3/PLXNA2/CRMP1,4,4.083961474036851,1.3632030942015805,12.234964395518693
R-HSA-5654706,FRS-mediated FGFR3 signaling,4/1194,16/9872,0.25,2.067001675041876,1.5843373535131438,0.11863475213073693,0.7533739733849717,0.7255725139920599,FGF20/FGFR3/PTPN11/GRB2,4,4.083961474036851,1.3632030942015805,12.234964395518693
R-HSA-5654720,PI-3K cascade:FGFR4,4/1194,16/9872,0.25,2.067001675041876,1.5843373535131438,0.11863475213073693,0.7533739733849717,0.7255725139920599,FGF20/PTPN11/GAB1/GRB2,4,4.083961474036851,1.3632030942015805,12.234964395518693
R-HSA-937072,TRAF6-mediated induction of TAK1 complex within TLR4 complex,4/1194,16/9872,0.25,2.067001675041876,1.5843373535131438,0.11863475213073693,0.7533739733849717,0.7255725139920599,IRAK2/CD14/TLR4/TRAF6,4,4.083961474036851,1.3632030942015805,12.234964395518693
R-HSA-397014,Muscle contraction,30/1194,200/9872,0.15,1.2402010050251255,1.2729302011982373,0.12383154417666817,0.7835159522451004,0.7546021754229885,ATP1A2/PAK2/PXN/TRDN/TPM4/MYBPC1/KAT2B/FGF11/GUCY1A1/SCN1A/SLC8A1/FGF14/CAMK2D/SCN2A/RYR1/PDE5A/SCN11A/SCN1B/ATP1B3/KCNK10/SCN4B/NPPC/KCNH2/ATP1A3/CAMK2G/KCNK12/FXYD1/KCND2/FGF12/CACNG4,30,2.450376884422111,1.6620838607546096,3.612541471273389
R-HSA-6806667,Metabolism of fat-soluble vitamins,8/1194,42/9872,0.19047619047619047,1.5748584190795245,1.3847829220672023,0.12768102058470776,0.7957866810831528,0.7664200824466905,RBP4/TTPA/BCO1/GPC5/RBP2/GPC2/AKR1C3/LPL,8,3.1115896945042674,1.4576022213913273,6.642409214842849
R-HSA-9696270,RND2 GTPase cycle,8/1194,42/9872,0.19047619047619047,1.5748584190795245,1.3847829220672023,0.12768102058470776,0.7957866810831528,0.7664200824466905,ALDH3A2/PTPN13/DLG5/TFRC/LRRC1/ARHGAP5/ARHGAP1/PLXND1,8,3.1115896945042674,1.4576022213913273,6.642409214842849
R-HSA-9925563,Developmental Lineage of Pancreatic Ductal Cells,8/1194,42/9872,0.19047619047619047,1.5748584190795245,1.3847829220672023,0.12768102058470776,0.7957866810831528,0.7664200824466905,PROM1/COL5A3/LAMA1/COL5A2/CLDN10/SLC4A4/LAMA2/CFTR,8,3.1115896945042674,1.4576022213913273,6.642409214842849
R-HSA-168164,Toll Like Receptor 3 (TLR3) Cascade,17/1194,105/9872,0.1619047619047619,1.3386296562175959,1.2939335146639097,0.1280576268409671,0.7957866810831528,0.7664200824466905,MAP2K4/NLRC5/FOS/TIFA/NOD2/CUL1/IRAK2/DUSP3/JUN/MAP2K3/NFKBIA/TNIP2/UBE2D1/RELA/TRAF6/IKBKE/RPS6KA3,17,2.6448512403286273,1.5791468690172095,4.429757751298586
R-HSA-168181,Toll Like Receptor 7/8 (TLR7/8) Cascade,17/1194,105/9872,0.1619047619047619,1.3386296562175959,1.2939335146639097,0.1280576268409671,0.7957866810831528,0.7664200824466905,MAP2K4/NLRC5/FOS/TIFA/NOD2/CUL1/IRAK2/DUSP3/JUN/MAP2K3/NFKBIA/TNIP2/CD14/RELA/TLR4/TRAF6/RPS6KA3,17,2.6448512403286273,1.5791468690172095,4.429757751298586
R-HSA-196807,Nicotinate metabolism,6/1194,29/9872,0.20689655172413793,1.710622075896725,1.4215000124479,0.12985184579646555,0.8012135166164897,0.771646653631852,NAMPT/NT5E/PARP9/NNMT/NMRK1/BST1,6,3.3798301854098076,1.4005033476569961,8.156533221657828
R-HSA-8874081,MET activates PTK2 signaling,6/1194,29/9872,0.20689655172413793,1.710622075896725,1.4215000124479,0.12985184579646555,0.8012135166164897,0.771646653631852,COL5A3/LAMA1/PTK2/COL5A2/LAMA2/ITGA2,6,3.3798301854098076,1.4005033476569961,8.156533221657828
R-HSA-877300,Interferon gamma signaling,15/1194,91/9872,0.16483516483516483,1.3628582472803579,1.2898493276438001,0.13107679911250755,0.8059138885362656,0.7761735696005656,PTPN2/GBP2/CAMK2D/PTPN1/PTPN11/TRIM34/IRF1/GBP7/SOCS3/TRIM3/CAMK2G/PTAFR/STAT1/FCGR1A/OAS1,15,2.6927218510133084,1.5546448372258794,4.663927601536847
R-HSA-168643,"Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways",10/1194,56/9872,0.17857142857142858,1.4764297678870544,1.3261679989704525,0.13273523479367205,0.8075500298635993,0.7777493330567756,HMOX1/BCL2L1/NOD2/IRAK2/RELA/NLRP1/CASP1/CASP2/CASP4/TRAF6,10,2.91711533859775,1.484663887647742,5.731642002934797
R-HSA-2022090,Assembly of collagen fibrils and other multimeric structures,10/1194,56/9872,0.17857142857142858,1.4764297678870544,1.3261679989704525,0.13273523479367205,0.8075500298635993,0.7777493330567756,TLL2/ITGB4/COL10A1/COL9A1/BMP1/COL5A3/COL4A2/COL5A2/LOXL2/COL12A1,10,2.91711533859775,1.484663887647742,5.731642002934797
R-HSA-936837,Ion transport by P-type ATPases,10/1194,56/9872,0.17857142857142858,1.4764297678870544,1.3261679989704525,0.13273523479367205,0.8075500298635993,0.7777493330567756,ATP1A2/ATP11A/CAMK2D/ATP13A4/ATP1B3/ATP11C/ATP2C2/ATP1A3/CAMK2G/FXYD1,10,2.91711533859775,1.484663887647742,5.731642002934797
R-HSA-450294,MAP kinase activation,11/1194,63/9872,0.1746031746031746,1.443620217489564,1.310213754558845,0.13354240084402222,0.8096298866501696,0.7797524377175258,MAP2K4/FOS/NOD2/CUL1/IRAK2/DUSP3/JUN/MAP2K3/TNIP2/TRAF6/RPS6KA3,11,2.8522905532955787,1.4992767072359547,5.426324147607017
R-HSA-3214842,HDMs demethylate histones,5/1194,23/9872,0.21739130434782608,1.797392760905979,1.420080795788992,0.13658620255679538,0.8195172153407723,0.7892748982592315,KDM3A/KDM4C/KDM7A/KDM4B/KDM6A,5,3.551270846988565,1.3477128988932048,9.357723472876133
R-HSA-9820841,M-decay: degradation of maternal mRNAs by maternally stored factors,5/1194,23/9872,0.21739130434782608,1.797392760905979,1.420080795788992,0.13658620255679538,0.8195172153407723,0.7892748982592315,DICER1/CNOT2/AGO2/ZFP36L2/EIF4G1,5,3.551270846988565,1.3477128988932048,9.357723472876133
R-HSA-9820960,Respiratory syncytial virus (RSV) attachment and entry,5/1194,23/9872,0.21739130434782608,1.797392760905979,1.420080795788992,0.13658620255679538,0.8195172153407723,0.7892748982592315,CX3CR1/GPC5/CD14/GPC2/TLR4,5,3.551270846988565,1.3477128988932048,9.357723472876133
R-HSA-1296071,Potassium Channels,16/1194,99/9872,0.16161616161616163,1.3362435070977785,1.247183829088745,0.1382856022082547,0.8197625022141439,0.7895111334089033,HCN2/KCNMB4/GNB3/KCNH5/KCNMA1/KCNMB2/KCNB2/KCNF1/KCNJ16/KCNK10/GNG3/KCNB1/KCNQ2/KCNH2/KCND2/KCNS2,16,2.6401367104884694,1.5519221466709379,4.491412062790048
R-HSA-8875555,MET activates RAP1 and RAC1,3/1194,11/9872,0.2727272727272727,2.254910918227501,1.5446200840368527,0.1389827230765359,0.8197625022141439,0.7895111334089033,RAP1A/GAB1/GRB2,3,4.455230698949292,1.2412487631294473,15.991218819680043
R-HSA-9020558,Interleukin-2 signaling,3/1194,11/9872,0.2727272727272727,2.254910918227501,1.5446200840368527,0.1389827230765359,0.8197625022141439,0.7895111334089033,STAT5B/JAK3/STAT5A,3,4.455230698949292,1.2412487631294473,15.991218819680043
R-HSA-9818030,NFE2L2 regulating tumorigenic genes,3/1194,11/9872,0.2727272727272727,2.254910918227501,1.5446200840368527,0.1389827230765359,0.8197625022141439,0.7895111334089033,NFE2L2/BCL2L1/PDGFA,3,4.455230698949292,1.2412487631294473,15.991218819680043
R-HSA-9926550,"Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition",3/1194,11/9872,0.2727272727272727,2.254910918227501,1.5446200840368527,0.1389827230765359,0.8197625022141439,0.7895111334089033,PXN/ZEB1/ITGA2,3,4.455230698949292,1.2412487631294473,15.991218819680043
R-HSA-416993,Trafficking of GluR2-containing AMPA receptors,4/1194,17/9872,0.23529411764705882,1.9454133412158834,1.4470741629430988,0.14105650791354585,0.8221939235155653,0.7918528289393709,TSPAN7/PRKCG/GRIA1/NSF,4,3.8437284461523302,1.291323296126468,11.441169234751934
R-HSA-5654689,PI-3K cascade:FGFR1,4/1194,17/9872,0.23529411764705882,1.9454133412158834,1.4470741629430988,0.14105650791354585,0.8221939235155653,0.7918528289393709,FGF20/PTPN11/GAB1/GRB2,4,3.8437284461523302,1.291323296126468,11.441169234751934
R-HSA-8963743,Digestion and absorption,4/1194,17/9872,0.23529411764705882,1.9454133412158834,1.4470741629430988,0.14105650791354585,0.8221939235155653,0.7918528289393709,GUCY2C/PIR/MGAM/SLC2A5,4,3.8437284461523302,1.291323296126468,11.441169234751934
R-HSA-5684996,MAPK1/MAPK3 signaling,37/1194,256/9872,0.14453125,1.1949853433835846,1.172458931727531,0.1416611019728689,0.8221939235155653,0.7918528289393709,FGF20/RALGDS/RASA3/DUSP1/FGFR3/MARK3/SPRED3/GRIN1/SPRED1/CSF2RA/IQGAP1/SHC2/ITGB3/BCL2L1/RGL1/RAP1A/CAMK2D/PDGFRA/FGFR2/PDGFRB/JAK3/RASGRP1/ABHD17C/PTPN11/CNKSR2/PTK2/PDGFA/PPP1CB/ABHD17B/NRG1/GRB2/GRIN2B/KSR2/FNTB/ARRB1/CAMK2G/RASAL1,37,2.3610402271775546,1.664397138710842,3.349267326107261
R-HSA-2029480,Fcgamma receptor (FCGR) dependent phagocytosis,14/1194,85/9872,0.16470588235294117,1.3617893388511184,1.2425485020918823,0.14175757301992506,0.8221939235155653,0.7918528289393709,DOCK1/ELMO1/WIPF3/WIPF1/FGR/MYO9B/PLD4/PTK2/MYO10/FCGR2A/ACTR3/GRB2/FCGR3A/FCGR1A,14,2.690609912306631,1.524137238919975,4.749822729436507
R-HSA-1226099,Signaling by FGFR in disease,10/1194,57/9872,0.17543859649122806,1.4505274912574568,1.265279550941207,0.14458883749479645,0.833698638790623,0.8029329902932076,STAT3/FGF20/FGFR3/FGFR1OP2/FGFR2/STAT5B/GAB1/GRB2/STAT5A/STAT1,10,2.865937876517088,1.4599181473270213,5.626068781385887
R-HSA-202733,Cell surface interactions at the vascular wall,20/1194,129/9872,0.15503875968992248,1.2818615039019385,1.195245686770839,0.14515888297429022,0.833698638790623,0.8029329902932076,PROS1/JAM2/PSG9/TSPAN7/SELPLG/CD47/TNFRSF10D/ITGB3/JAM3/CD84/PSG8/PTPN11/SELL/ANGPT2/ATP1B3/ITGA4/PSG4/GRB2/SLC7A11/PECAM1,20,2.5326892862244037,1.5756235251020596,4.07109624752549
R-HSA-3000157,Laminin interactions,6/1194,30/9872,0.2,1.653601340033501,1.329856552189993,0.14669647382851791,0.833698638790623,0.8029329902932076,ITGB4/LAMA1/COL4A2/NID1/LAMA2/ITGA2,6,3.2671691792294806,1.357221751808103,7.864886067060532
R-HSA-418555,G alpha (s) signalling events,19/1194,122/9872,0.1557377049180328,1.2876403877310048,1.1857698114697348,0.14801101784173026,0.833698638790623,0.8029329902932076,CRH/CALCRL/GNB3/GNAI1/PRKAR2A/PDE8B/PDE4D/PDE7B/ADM/PTH2R/ADORA2A/ADCY3/GPR27/GNG3/GNAZ/TSHR/ARRB1/ADRB1/HRH2,19,2.5441071477606614,1.5633929711438017,4.140021925870323
R-HSA-5673001,RAF/MAP kinase cascade,36/1194,250/9872,0.144,1.1905929648241207,1.1321842535425448,0.15072222961649834,0.833698638790623,0.8029329902932076,FGF20/RALGDS/RASA3/DUSP1/FGFR3/MARK3/SPRED3/GRIN1/SPRED1/CSF2RA/IQGAP1/SHC2/ITGB3/BCL2L1/RGL1/RAP1A/CAMK2D/PDGFRA/FGFR2/PDGFRB/JAK3/RASGRP1/ABHD17C/CNKSR2/PTK2/PDGFA/PPP1CB/ABHD17B/NRG1/GRB2/GRIN2B/KSR2/FNTB/ARRB1/CAMK2G/RASAL1,36,2.352361809045226,1.6506538941498399,3.3523721116016154
R-HSA-5674135,MAP2K and MAPK activation,7/1194,37/9872,0.1891891891891892,1.5642174838154739,1.2753610113719465,0.15241974056753033,0.833698638790623,0.8029329902932076,MARK3/IQGAP1/ITGB3/RAP1A/CNKSR2/KSR2/ARRB1,7,3.0905654398116704,1.3749126980240065,6.947055439582193
R-HSA-76002,"Platelet activation, signaling and aggregation",35/1194,243/9872,0.1440329218106996,1.1908651625755664,1.1174089008777859,0.15435679625361257,0.833698638790623,0.8029329902932076,SRGN/A2M/HABP4/VEGFA/PROS1/GNB3/GNAI1/P2RY12/RAB27B/SERPINA1/BCAR1/IGF1/ITGB3/MGLL/RAP1A/PCDH7/VEGFD/PRKCG/PTPN1/RASGRP1/PTPN11/PRKCZ/TGFB3/PTK2/PDGFA/PDPN/RHOB/CALU/GRB2/GNG3/GNA12/ARRB1/FLNA/TAGLN2/PECAM1,35,2.352899614671437,1.642970388893466,3.369590002440375
R-HSA-196854,Metabolism of vitamins and cofactors,28/1194,190/9872,0.14736842105263157,1.2184430926562637,1.127730936283486,0.1548648372525865,0.833698638790623,0.8029329902932076,SLC2A3/NAMPT/SHMT1/NT5E/RBP4/PARP9/NNMT/MMAB/TTPA/SLC23A2/BCO1/GPC5/ABCD4/PRSS3/GSTO2/RBP2/NMRK1/MOCOS/SLC2A1/GCH1/GPC2/AKR1C3/CUBN/LPL/FOLR2/SLC25A32/BST1/PDXK,28,2.4073878162743543,1.6120424310752899,3.5951386801155034
R-HSA-5633008,TP53 Regulates Transcription of Cell Death Genes,8/1194,44/9872,0.18181818181818182,1.5032739454850008,1.2409981335585119,0.15547158059739485,0.833698638790623,0.8029329902932076,BCL2L14/BCL6/BNIP3L/TNFRSF10D/NDRG1/PMAIP1/CASP1/CASP2,8,2.9701537992995277,1.3951737499459116,6.323093157275519
R-HSA-196849,Metabolism of water-soluble vitamins and cofactors,19/1194,123/9872,0.15447154471544716,1.2771717666925413,1.1473460557750566,0.1563691135853563,0.833698638790623,0.8029329902932076,SLC2A3/NAMPT/SHMT1/NT5E/PARP9/NNMT/MMAB/SLC23A2/ABCD4/PRSS3/GSTO2/NMRK1/MOCOS/SLC2A1/CUBN/FOLR2/SLC25A32/BST1/PDXK,19,2.5234233498113876,1.5510902671158229,4.105283578507452
R-HSA-210500,Glutamate Neurotransmitter Release Cycle,5/1194,24/9872,0.20833333333333334,1.7225013958682303,1.314447388269574,0.15637437987749672,0.833698638790623,0.8029329902932076,PPFIA2/GLS2/SLC1A2/PPFIA4/SLC1A6,5,3.4033012283640423,1.2962137164457355,8.935609231742832
R-HSA-211976,Endogenous sterols,5/1194,24/9872,0.20833333333333334,1.7225013958682303,1.314447388269574,0.15637437987749672,0.833698638790623,0.8029329902932076,AHR/NCOA1/CYP8B1/CYP27A1/CYP39A1,5,3.4033012283640423,1.2962137164457355,8.935609231742832
R-HSA-5223345,Miscellaneous transport and binding events,5/1194,24/9872,0.20833333333333334,1.7225013958682303,1.314447388269574,0.15637437987749672,0.833698638790623,0.8029329902932076,LRRC8B/ADD1/LRRC8D/NIPAL2/TUSC3,5,3.4033012283640423,1.2962137164457355,8.935609231742832
R-HSA-5683826,Surfactant metabolism,5/1194,24/9872,0.20833333333333334,1.7225013958682303,1.314447388269574,0.15637437987749672,0.833698638790623,0.8029329902932076,CSF2RA/ZDHHC2/ADORA2A/ADA2/SFTPD,5,3.4033012283640423,1.2962137164457355,8.935609231742832
R-HSA-8940973,RUNX2 regulates osteoblast differentiation,5/1194,24/9872,0.20833333333333334,1.7225013958682303,1.314447388269574,0.15637437987749672,0.833698638790623,0.8029329902932076,CBFB/GLI3/MAF/HES1/ZNF521,5,3.4033012283640423,1.2962137164457355,8.935609231742832
R-HSA-9006115,Signaling by NTRK2 (TRKB),5/1194,24/9872,0.20833333333333334,1.7225013958682303,1.314447388269574,0.15637437987749672,0.833698638790623,0.8029329902932076,BDNF/PTPN11/GAB1/GRB2/GRIN2B,5,3.4033012283640423,1.2962137164457355,8.935609231742832
R-HSA-162791,Attachment of GPI anchor to uPAR,2/1194,6/9872,0.3333333333333333,2.756002233389168,1.595890355006541,0.15763612193225,0.833698638790623,0.8029329902932076,PLAUR/PGAP1,2,5.445281965382469,1.0978457231093355,27.008435755928694
R-HSA-190371,FGFR3b ligand binding and activation,2/1194,6/9872,0.3333333333333333,2.756002233389168,1.595890355006541,0.15763612193225,0.833698638790623,0.8029329902932076,FGF20/FGFR3,2,5.445281965382469,1.0978457231093355,27.008435755928694
R-HSA-2142700,Biosynthesis of Lipoxins (LX),2/1194,6/9872,0.3333333333333333,2.756002233389168,1.595890355006541,0.15763612193225,0.833698638790623,0.8029329902932076,LTC4S/ALOX5AP,2,5.445281965382469,1.0978457231093355,27.008435755928694
R-HSA-375281,Hormone ligand-binding receptors,2/1194,6/9872,0.3333333333333333,2.756002233389168,1.595890355006541,0.15763612193225,0.833698638790623,0.8029329902932076,GNRHR/TSHR,2,5.445281965382469,1.0978457231093355,27.008435755928694
R-HSA-446205,Synthesis of GDP-mannose,2/1194,6/9872,0.3333333333333333,2.756002233389168,1.595890355006541,0.15763612193225,0.833698638790623,0.8029329902932076,PMM2/HK1,2,5.445281965382469,1.0978457231093355,27.008435755928694
R-HSA-6798163,Choline catabolism,2/1194,6/9872,0.3333333333333333,2.756002233389168,1.595890355006541,0.15763612193225,0.833698638790623,0.8029329902932076,DMGDH/BHMT,2,5.445281965382469,1.0978457231093355,27.008435755928694
R-HSA-804914,Transport of fatty acids,2/1194,6/9872,0.3333333333333333,2.756002233389168,1.595890355006541,0.15763612193225,0.833698638790623,0.8029329902932076,LCN12/SLC27A4,2,5.445281965382469,1.0978457231093355,27.008435755928694
R-HSA-8851907,MET activates PI3K/AKT signaling,2/1194,6/9872,0.3333333333333333,2.756002233389168,1.595890355006541,0.15763612193225,0.833698638790623,0.8029329902932076,GAB1/GRB2,2,5.445281965382469,1.0978457231093355,27.008435755928694
R-HSA-8931987,RUNX1 regulates estrogen receptor mediated transcription,2/1194,6/9872,0.3333333333333333,2.756002233389168,1.595890355006541,0.15763612193225,0.833698638790623,0.8029329902932076,CBFB/RUNX1,2,5.445281965382469,1.0978457231093355,27.008435755928694
R-HSA-8939246,RUNX1 regulates transcription of genes involved in differentiation of myeloid cells,2/1194,6/9872,0.3333333333333333,2.756002233389168,1.595890355006541,0.15763612193225,0.833698638790623,0.8029329902932076,CBFB/RUNX1,2,5.445281965382469,1.0978457231093355,27.008435755928694
R-HSA-8939256,RUNX1 regulates transcription of genes involved in WNT signaling,2/1194,6/9872,0.3333333333333333,2.756002233389168,1.595890355006541,0.15763612193225,0.833698638790623,0.8029329902932076,CBFB/RUNX1,2,5.445281965382469,1.0978457231093355,27.008435755928694
R-HSA-9027283,Erythropoietin activates STAT5,2/1194,6/9872,0.3333333333333333,2.756002233389168,1.595890355006541,0.15763612193225,0.833698638790623,0.8029329902932076,STAT5B/STAT5A,2,5.445281965382469,1.0978457231093355,27.008435755928694
R-HSA-9664535,LTC4-CYSLTR mediated IL4 production,2/1194,6/9872,0.3333333333333333,2.756002233389168,1.595890355006541,0.15763612193225,0.833698638790623,0.8029329902932076,CYSLTR1/DPEP2,2,5.445281965382469,1.0978457231093355,27.008435755928694
R-HSA-446652,Interleukin-1 family signaling,20/1194,131/9872,0.15267175572519084,1.2622910992622143,1.1209605942015108,0.16143459540798746,0.8512005939693884,0.8197890777974994,PTPN14/STAT3/PTPN2/PTPN13/IL1B/MAP2K4/NLRC5/TIFA/NOD2/CUL1/IRAK2/PTPN11/NFKBIA/TNIP2/RELA/CASP1/IL1RAP/IL1A/TRAF6/PTPN20,20,2.4940222742209777,1.5523118901206285,4.007021490911222
R-HSA-2243919,Crosslinking of collagen fibrils,4/1194,18/9872,0.2222222222222222,1.8373348222594454,1.3188701611019102,0.1649953115345261,0.8595564133834593,0.8278365457389397,TLL2/BMP1/COL4A2/LOXL2,4,3.630187976921645,1.2266404449125252,10.743380264724793
R-HSA-5655332,Signaling by FGFR3 in disease,4/1194,18/9872,0.2222222222222222,1.8373348222594454,1.3188701611019102,0.1649953115345261,0.8595564133834593,0.8278365457389397,FGF20/FGFR3/GAB1/GRB2,4,3.630187976921645,1.2266404449125252,10.743380264724793
R-HSA-936964,"Activation of IRF3, IRF7 mediated by TBK1, IKK (IKBKE)",4/1194,18/9872,0.2222222222222222,1.8373348222594454,1.3188701611019102,0.1649953115345261,0.8595564133834593,0.8278365457389397,PTPN11/CD14/TLR4/IKBKE,4,3.630187976921645,1.2266404449125252,10.743380264724793
R-HSA-9909505,Modulation of host responses by IFN-stimulated genes,4/1194,18/9872,0.2222222222222222,1.8373348222594454,1.3188701611019102,0.1649953115345261,0.8595564133834593,0.8278365457389397,FKBP5/UBA7/ATF6/EIF2AK3,4,3.630187976921645,1.2266404449125252,10.743380264724793
R-HSA-425366,"Transport of bile salts and organic acids, metal ions and amine compounds",12/1194,73/9872,0.1643835616438356,1.3591243890686306,1.1423215447283526,0.16651566085365302,0.8597670607449122,0.8280394196647914,SLC11A1/SLC16A7/SLC6A6/RUNX1/SLC31A1/SLC40A1/SLC6A15/SLC11A2/SLC30A10/SLC39A14/SLC22A3/SLC14A1,12,2.6853445308735457,1.4542351832078897,4.958671976004315
R-HSA-975634,Retinoid metabolism and transport,7/1194,38/9872,0.18421052631578946,1.5230538658203296,1.1982461135127642,0.16860209269929669,0.8597670607449122,0.8280394196647914,RBP4/BCO1/GPC5/RBP2/GPC2/AKR1C3/LPL,7,3.0092347703429425,1.3409930528525111,6.752826857513114
R-HSA-111932,CaMK IV-mediated phosphorylation of CREB,3/1194,12/9872,0.25,2.067001675041876,1.3717980564326768,0.16948281714684188,0.8597670607449122,0.8280394196647914,CAMK2D/CAMK4/CAMK2G,3,4.083961474036851,1.1509000135497451,14.49191165614349
R-HSA-112308,Presynaptic depolarization and calcium channel opening,3/1194,12/9872,0.25,2.067001675041876,1.3717980564326768,0.16948281714684188,0.8597670607449122,0.8280394196647914,CACNB4/CACNG2/CACNG4,3,4.083961474036851,1.1509000135497451,14.49191165614349
R-HSA-1482922,Acyl chain remodelling of PI,3/1194,12/9872,0.25,2.067001675041876,1.3717980564326768,0.16948281714684188,0.8597670607449122,0.8280394196647914,PLAAT3/MBOAT7/PLA2G12A,3,4.083961474036851,1.1509000135497451,14.49191165614349
R-HSA-210990,PECAM1 interactions,3/1194,12/9872,0.25,2.067001675041876,1.3717980564326768,0.16948281714684188,0.8597670607449122,0.8280394196647914,ITGB3/PTPN11/PECAM1,3,4.083961474036851,1.1509000135497451,14.49191165614349
R-HSA-389359,CD28 dependent Vav1 pathway,3/1194,12/9872,0.25,2.067001675041876,1.3717980564326768,0.16948281714684188,0.8597670607449122,0.8280394196647914,PAK2/GRB2/PAK3,3,4.083961474036851,1.1509000135497451,14.49191165614349
R-HSA-4755510,SUMOylation of immune response proteins,3/1194,12/9872,0.25,2.067001675041876,1.3717980564326768,0.16948281714684188,0.8597670607449122,0.8280394196647914,NFKBIA/RELA/IKBKE,3,4.083961474036851,1.1509000135497451,14.49191165614349
R-HSA-75205,Dissolution of Fibrin Clot,3/1194,12/9872,0.25,2.067001675041876,1.3717980564326768,0.16948281714684188,0.8597670607449122,0.8280394196647914,PLAUR/SERPINB6/SERPINE2,3,4.083961474036851,1.1509000135497451,14.49191165614349
R-HSA-5654696,Downstream signaling of activated FGFR2,5/1194,25/9872,0.2,1.653601340033501,1.2136791348345615,0.17725323780844116,0.8965716098450222,0.8634857851622961,FGF20/FGFR2/PTPN11/GAB1/GRB2,5,3.2671691792294806,1.2485059911834127,8.549734259255876
R-HSA-422356,Regulation of insulin secretion,12/1194,74/9872,0.16216216216216217,1.3407578432704061,1.091354691182041,0.178306145295547,0.8979568342418337,0.8648198911754382,GNB3/GNAI1/PRKAR2A/MARCKS/IQGAP1/RAP1A/ACSL4/PLCB1/SLC2A1/GNG3/KCNB1/CACNA1D,12,2.6490560912671466,1.435415678202476,4.888826478102396
R-HSA-168142,Toll Like Receptor 10 (TLR10) Cascade,15/1194,96/9872,0.15625,1.2918760469011725,1.0659243716231213,0.17959136684836674,0.8979568342418337,0.8648198911754382,MAP2K4/NLRC5/FOS/TIFA/NOD2/CUL1/IRAK2/DUSP3/JUN/MAP2K3/NFKBIA/TNIP2/RELA/TRAF6/RPS6KA3,15,2.5524759212730324,1.4766314633492288,4.412159357556477
R-HSA-168176,Toll Like Receptor 5 (TLR5) Cascade,15/1194,96/9872,0.15625,1.2918760469011725,1.0659243716231213,0.17959136684836674,0.8979568342418337,0.8648198911754382,MAP2K4/NLRC5/FOS/TIFA/NOD2/CUL1/IRAK2/DUSP3/JUN/MAP2K3/NFKBIA/TNIP2/RELA/TRAF6/RPS6KA3,15,2.5524759212730324,1.4766314633492288,4.412159357556477
R-HSA-975871,MyD88 cascade initiated on plasma membrane,15/1194,96/9872,0.15625,1.2918760469011725,1.0659243716231213,0.17959136684836674,0.8979568342418337,0.8648198911754382,MAP2K4/NLRC5/FOS/TIFA/NOD2/CUL1/IRAK2/DUSP3/JUN/MAP2K3/NFKBIA/TNIP2/RELA/TRAF6/RPS6KA3,15,2.5524759212730324,1.4766314633492288,4.412159357556477
R-HSA-2514856,The phototransduction cascade,6/1194,32/9872,0.1875,1.550251256281407,1.156408830020554,0.1831035027770994,0.9025498437171472,0.869243406653175,GUCA1B/GRK7/FNTB/GRK4/RGS9/SLC24A1,6,3.0629711055276383,1.2782197971573304,7.339732974064115
R-HSA-68962,Activation of the pre-replicative complex,6/1194,32/9872,0.1875,1.550251256281407,1.156408830020554,0.1831035027770994,0.9025498437171472,0.869243406653175,ORC4/RPA3/CDK2/POLE/MCM7/CDC7,6,3.0629711055276383,1.2782197971573304,7.339732974064115
R-HSA-69273,Cyclin A/B1/B2 associated events during G2/M transition,6/1194,32/9872,0.1875,1.550251256281407,1.156408830020554,0.1831035027770994,0.9025498437171472,0.869243406653175,PPP2R2A/MIS18BP1/PPME1/CCNH/CDK2/CCNA2,6,3.0629711055276383,1.2782197971573304,7.339732974064115
R-HSA-8864260,Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors,6/1194,32/9872,0.1875,1.550251256281407,1.156408830020554,0.1831035027770994,0.9025498437171472,0.869243406653175,VEGFA/CDKN1A/HSPD1/TFAP2E/ATAD2/KCTD15,6,3.0629711055276383,1.2782197971573304,7.339732974064115
R-HSA-9634815,Transcriptional Regulation by NPAS4,6/1194,32/9872,0.1875,1.550251256281407,1.156408830020554,0.1831035027770994,0.9025498437171472,0.869243406653175,NAMPT/TNRC6C/FOS/AGO2/BDNF/IQSEC3,6,3.0629711055276383,1.2782197971573304,7.339732974064115
R-HSA-418597,G alpha (z) signalling events,8/1194,46/9872,0.17391304347826086,1.4379142087247834,1.1042120675765974,0.1858595690113183,0.9109736621963207,0.8773563643173277,RGS16/GNB3/GNAI1/PRKCG/RGS17/ADCY3/GNG3/GNAZ,8,2.8410166775908525,1.3378760860772256,6.032977079376142
R-HSA-9024446,NR1H2 and NR1H3-mediated signaling,8/1194,46/9872,0.17391304347826086,1.4379142087247834,1.1042120675765974,0.1858595690113183,0.9109736621963207,0.8773563643173277,KDM3A/TNRC6C/AGO2/EEPD1/NCOA1/PCK1/ANGPTL3/FABP6,8,2.8410166775908525,1.3378760860772256,6.032977079376142
R-HSA-76005,Response to elevated platelet cytosolic Ca2+,18/1194,119/9872,0.15126050420168066,1.2506228622102105,1.0202297196514536,0.1873367393198986,0.9156346247657966,0.881845325243284,SRGN/A2M/HABP4/VEGFA/PROS1/RAB27B/SERPINA1/IGF1/ITGB3/PCDH7/VEGFD/PRKCG/TGFB3/PDGFA/CALU/FLNA/TAGLN2/PECAM1,18,2.4709682868122123,1.5000402186266262,4.070347047109036
R-HSA-2995383,Initiation of Nuclear Envelope (NE) Reformation,4/1194,19/9872,0.21052631578947367,1.7406329895089483,1.1985841440555005,0.19025276571421063,0.9246922132478392,0.8905686651485543,LMNA/PPP2R2A/LBR/LMNB1,4,3.439125451820506,1.1681258523194393,10.125265055879607
R-HSA-400508,"Incretin synthesis, secretion, and inactivation",4/1194,19/9872,0.21052631578947367,1.7406329895089483,1.1985841440555005,0.19025276571421063,0.9246922132478392,0.8905686651485543,DPP4/GNB3/PAX6/FFAR4,4,3.439125451820506,1.1681258523194393,10.125265055879607
R-HSA-2559583,Cellular Senescence,19/1194,127/9872,0.14960629921259844,1.2369458842770282,0.996857371388355,0.19227878404370743,0.9303421962614848,0.896010149091521,STAT3/PHC2/MAP3K5/MAP2K4/CABIN1/TNRC6C/CDKN1A/FOS/JUN/MAP2K3/LMNB1/ETS2/ERF/CDK2/UBE2D1/RELA/CCNA2/IL1A/RPS6KA3,19,2.443945449029927,1.5037576442288816,3.9719627566029394
R-HSA-448424,Interleukin-17 signaling,11/1194,68/9872,0.16176470588235295,1.3374716720859199,1.0357693247296658,0.19389264392497918,0.9303421962614848,0.896010149091521,MAP2K4/FOS/NOD2/CUL1/IRAK2/DUSP3/JUN/MAP2K3/TNIP2/TRAF6/RPS6KA3,11,2.6425633067297274,1.3938993053793403,5.009788585965279
R-HSA-111885,Opioid Signalling,14/1194,90/9872,0.15555555555555556,1.2861343755816117,1.0114638791526485,0.19449580892277543,0.9303421962614848,0.896010149091521,GNB3/GNAI1/PRKAR2A/CAMK2D/PDE4D/PRKCG/OPRM1/PLCB1/ADCY3/GNG3/CAMK4/CAMK2G/PDYN/GNAL,14,2.5411315838451514,1.4426523595431169,4.476026177547297
R-HSA-156580,Phase II - Conjugation of compounds,13/1194,83/9872,0.1566265060240964,1.294989001231055,1.0010335236916483,0.19876955033868565,0.9303421962614848,0.896010149091521,ACSM5/SLC35D2/MAT2A/NNMT/TPST1/GSTO2/NAT2/GCLC/GSTA4/UGT3A2/CHAC2/SULT4A1/TPST2,13,2.5586264656616415,1.4218059997565244,4.6044041113240795
R-HSA-191273,Cholesterol biosynthesis,5/1194,26/9872,0.19230769230769232,1.5900012884937509,1.1173330235068626,0.19910774896800634,0.9303421962614848,0.896010149091521,MVK/TM7SF2/LBR/DHCR7/LSS,5,3.141508826182193,1.2041858771469418,8.195643124766805
R-HSA-9615933,Postmitotic nuclear pore complex (NPC) reformation,5/1194,26/9872,0.19230769230769232,1.5900012884937509,1.1173330235068626,0.19910774896800634,0.9303421962614848,0.896010149091521,NUP205/NUP58/NUP98/NUP188/AHCTF1,5,3.141508826182193,1.2041858771469418,8.195643124766805
R-HSA-209560,NF-kB is activated and signals survival,3/1194,13/9872,0.23076923076923078,1.908001546192501,1.2151076284093176,0.20166196304892903,0.9303421962614848,0.896010149091521,NFKBIA/RELA/TRAF6,3,3.769810591418632,1.0727880338954843,13.247231928536442
R-HSA-5602498,MyD88 deficiency (TLR2/4),3/1194,13/9872,0.23076923076923078,1.908001546192501,1.2151076284093176,0.20166196304892903,0.9303421962614848,0.896010149091521,TLR2/CD14/TLR4,3,3.769810591418632,1.0727880338954843,13.247231928536442
R-HSA-8935690,Digestion,3/1194,13/9872,0.23076923076923078,1.908001546192501,1.2151076284093176,0.20166196304892903,0.9303421962614848,0.896010149091521,GUCY2C/PIR/MGAM,3,3.769810591418632,1.0727880338954843,13.247231928536442
R-HSA-9707616,Heme signaling,8/1194,47/9872,0.1702127659574468,1.4073202893902135,1.038225304228556,0.20193635685647707,0.9303421962614848,0.896010149091521,HMOX1/NFE2L2/HELZ2/BACH1/NCOA1/RAI1/RORA/TLR4,8,2.7805695142378557,1.3109575258168031,5.897648605122983
R-HSA-9662851,Anti-inflammatory response favouring Leishmania parasite infection,12/1194,76/9872,0.15789473684210525,1.3054747421317112,0.9915865589523716,0.20303430337064704,0.9303421962614848,0.896010149091521,GNB3/GNAI1/PRKAR2A/FGR/CYSLTR1/DPEP2/ADCY3/FCGR2A/GNG3/GNAZ/FCGR3A/FCGR1A,12,2.57934408886538,1.3992019169620002,4.754864789786777
R-HSA-9664433,Leishmania parasite growth and survival,12/1194,76/9872,0.15789473684210525,1.3054747421317112,0.9915865589523716,0.20303430337064704,0.9303421962614848,0.896010149091521,GNB3/GNAI1/PRKAR2A/FGR/CYSLTR1/DPEP2/ADCY3/FCGR2A/GNG3/GNAZ/FCGR3A/FCGR1A,12,2.57934408886538,1.3992019169620002,4.754864789786777
R-HSA-380108,Chemokine receptors bind chemokines,7/1194,40/9872,0.175,1.446901172529313,1.0504937461673618,0.20305774834920617,0.9303421962614848,0.896010149091521,CX3CR1/CXCL12/CX3CL1/CCRL2/ACKR3/CCL2/CCL3,7,2.8587730318257956,1.277940843511066,6.395118591750123
R-HSA-451927,Interleukin-2 family signaling,7/1194,40/9872,0.175,1.446901172529313,1.0504937461673618,0.20305774834920617,0.9303421962614848,0.896010149091521,STAT3/CSF2RA/STAT5B/JAK3/GRB2/STAT5A/STAT1,7,2.8587730318257956,1.277940843511066,6.395118591750123
R-HSA-1483148,Synthesis of PG,2/1194,7/9872,0.2857142857142857,2.3622876286192867,1.3373411385375589,0.20371286021587687,0.9303421962614848,0.896010149091521,PGS1/PLD4,2,4.667384541756401,0.9685228404319879,22.492477772553233
R-HSA-426496,Post-transcriptional silencing by small RNAs,2/1194,7/9872,0.2857142857142857,2.3622876286192867,1.3373411385375589,0.20371286021587687,0.9303421962614848,0.896010149091521,TNRC6C/AGO2,2,4.667384541756401,0.9685228404319879,22.492477772553233
R-HSA-5603029,IkBA variant leads to EDA-ID,2/1194,7/9872,0.2857142857142857,2.3622876286192867,1.3373411385375589,0.20371286021587687,0.9303421962614848,0.896010149091521,NFKBIA/RELA,2,4.667384541756401,0.9685228404319879,22.492477772553233
R-HSA-5687613,Diseases associated with surfactant metabolism,2/1194,7/9872,0.2857142857142857,2.3622876286192867,1.3373411385375589,0.20371286021587687,0.9303421962614848,0.896010149091521,CSF2RA/SFTPD,2,4.667384541756401,0.9685228404319879,22.492477772553233
R-HSA-6802953,RAS signaling downstream of NF1 loss-of-function variants,2/1194,7/9872,0.2857142857142857,2.3622876286192867,1.3373411385375589,0.20371286021587687,0.9303421962614848,0.896010149091521,SPRED3/SPRED1,2,4.667384541756401,0.9685228404319879,22.492477772553233
R-HSA-8937144,Aryl hydrocarbon receptor signalling,2/1194,7/9872,0.2857142857142857,2.3622876286192867,1.3373411385375589,0.20371286021587687,0.9303421962614848,0.896010149091521,AHR/PTGES3,2,4.667384541756401,0.9685228404319879,22.492477772553233
R-HSA-8963896,HDL assembly,2/1194,7/9872,0.2857142857142857,2.3622876286192867,1.3373411385375589,0.20371286021587687,0.9303421962614848,0.896010149091521,A2M/BMP1,2,4.667384541756401,0.9685228404319879,22.492477772553233
R-HSA-9032500,Activated NTRK2 signals through FYN,2/1194,7/9872,0.2857142857142857,2.3622876286192867,1.3373411385375589,0.20371286021587687,0.9303421962614848,0.896010149091521,BDNF/GRIN2B,2,4.667384541756401,0.9685228404319879,22.492477772553233
R-HSA-9662001,Defective factor VIII causes hemophilia A,2/1194,7/9872,0.2857142857142857,2.3622876286192867,1.3373411385375589,0.20371286021587687,0.9303421962614848,0.896010149091521,TPST1/TPST2,2,4.667384541756401,0.9685228404319879,22.492477772553233
R-HSA-418594,G alpha (i) signalling events,35/1194,251/9872,0.1394422310756972,1.1529093008201698,0.910193170181442,0.2059794845953984,0.9359952378166743,0.901454578707892,P2RY14/CX3CR1/RGS16/RGS18/CXCL12/GNB3/P2RY13/GNAI1/P2RY12/PRKAR2A/PENK/CAMK2D/C5AR1/PDE4D/PRKCG/CX3CL1/OPRM1/ADORA1/RGS17/PLCB1/ADCY3/GPR17/GNG3/LPAR5/GNAZ/CAMK4/RGS22/ACKR3/OXGR1/RGS9/CAMK2G/PDYN/RGS14/GNAL/RGS1,35,2.2779067982675665,1.5917220857450531,3.2599028612239147
R-HSA-442755,Activation of NMDA receptors and postsynaptic events,14/1194,91/9872,0.15384615384615385,1.2720010307950007,0.9668799023280289,0.2060265379791875,0.9359952378166743,0.901454578707892,GRIN1/PRKAR2A/ARHGEF7/CAMK2D/PRKAG3/NRG1/TUBB2A/CAMK4/GRIN2B/GIT1/TUBB4A/GRIA1/CAMK2G/RPS6KA3,14,2.513207060945754,1.4273904580149277,4.425004872157791
R-HSA-114608,Platelet degranulation,17/1194,114/9872,0.14912280701754385,1.2329483675688384,0.9279073325252929,0.2125024604147268,0.9542404420804439,0.9190264874725147,SRGN/A2M/HABP4/VEGFA/PROS1/RAB27B/SERPINA1/IGF1/ITGB3/PCDH7/VEGFD/TGFB3/PDGFA/CALU/FLNA/TAGLN2/PECAM1,17,2.436047195039525,1.4585672427680336,4.068599487534025
R-HSA-112040,G-protein mediated events,9/1194,55/9872,0.16363636363636364,1.3529465509365008,0.9735848516750638,0.2151445674243074,0.9542404420804439,0.9190264874725147,GNAI1/PRKAR2A/CAMK2D/PRKCG/PLCB1/ADCY3/CAMK4/CAMK2G/GNAL,9,2.673138419369575,1.3179419938108732,5.421838777932653
R-HSA-189200,Cellular hexose transport,4/1194,20/9872,0.2,1.653601340033501,1.085272120617567,0.2166235486332042,0.9542404420804439,0.9190264874725147,SLC2A3/SLC45A3/SLC2A1/MFSD4B,4,3.267169179229481,1.1149378150796403,9.573981886105967
R-HSA-3560783,"Defective B4GALT7 causes EDS, progeroid type",4/1194,20/9872,0.2,1.653601340033501,1.085272120617567,0.2166235486332042,0.9542404420804439,0.9190264874725147,CSPG5/GPC5/BCAN/GPC2,4,3.267169179229481,1.1149378150796403,9.573981886105967
R-HSA-3560801,Defective B3GAT3 causes JDSSDHD,4/1194,20/9872,0.2,1.653601340033501,1.085272120617567,0.2166235486332042,0.9542404420804439,0.9190264874725147,CSPG5/GPC5/BCAN/GPC2,4,3.267169179229481,1.1149378150796403,9.573981886105967
R-HSA-4420332,Defective B3GALT6 causes EDSP2 and SEMDJL1,4/1194,20/9872,0.2,1.653601340033501,1.085272120617567,0.2166235486332042,0.9542404420804439,0.9190264874725147,CSPG5/GPC5/BCAN/GPC2,4,3.267169179229481,1.1149378150796403,9.573981886105967
R-HSA-5654700,FRS-mediated FGFR2 signaling,4/1194,20/9872,0.2,1.653601340033501,1.085272120617567,0.2166235486332042,0.9542404420804439,0.9190264874725147,FGF20/FGFR2/PTPN11/GRB2,4,3.267169179229481,1.1149378150796403,9.573981886105967
R-HSA-8862803,Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models,4/1194,20/9872,0.2,1.653601340033501,1.085272120617567,0.2166235486332042,0.9542404420804439,0.9190264874725147,LMNA/CAST/JUN/LMNB1,4,3.267169179229481,1.1149378150796403,9.573981886105967
R-HSA-8863678,Neurodegenerative Diseases,4/1194,20/9872,0.2,1.653601340033501,1.085272120617567,0.2166235486332042,0.9542404420804439,0.9190264874725147,LMNA/CAST/JUN/LMNB1,4,3.267169179229481,1.1149378150796403,9.573981886105967
R-HSA-9717207,"Sensory perception of sweet, bitter, and umami (glutamate) taste",4/1194,20/9872,0.2,1.653601340033501,1.085272120617567,0.2166235486332042,0.9542404420804439,0.9190264874725147,GNB3/SCN2A/SCN1B/SCN4B,4,3.267169179229481,1.1149378150796403,9.573981886105967
R-HSA-9768919,NPAS4 regulates expression of target genes,4/1194,20/9872,0.2,1.653601340033501,1.085272120617567,0.2166235486332042,0.9542404420804439,0.9190264874725147,NAMPT/FOS/BDNF/IQSEC3,4,3.267169179229481,1.1149378150796403,9.573981886105967
R-HSA-9931510,Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes,4/1194,20/9872,0.2,1.653601340033501,1.085272120617567,0.2166235486332042,0.9542404420804439,0.9190264874725147,CRY1/PER1/TFEB/RORA,4,3.267169179229481,1.1149378150796403,9.573981886105967
R-HSA-8955332,Carboxyterminal post-translational modifications of tubulin,7/1194,41/9872,0.17073170731707318,1.4116109000285983,0.979609219349787,0.22122104105710078,0.9555669870812552,0.9203040795120135,AGTPBP1/VASH1/TTLL9/AGBL1/TUBB2A/TUBB4A/TTL,7,2.7890468603178493,1.248588163878443,6.230062573143343
R-HSA-1971475,A tetrasaccharide linker sequence is required for GAG synthesis,5/1194,27/9872,0.18518518518518517,1.531112351882871,1.0250223618763992,0.22181681901406636,0.9555669870812552,0.9203040795120135,B3GAT1/CSPG5/GPC5/BCAN/GPC2,5,3.025156647434704,1.16290491214477,7.869579572623818
R-HSA-3000170,Syndecan interactions,5/1194,27/9872,0.18518518518518517,1.531112351882871,1.0250223618763992,0.22181681901406636,0.9555669870812552,0.9203040795120135,ITGB4/ITGB3/COL5A3/COL5A2/ITGA2,5,3.025156647434704,1.16290491214477,7.869579572623818
R-HSA-5654687,Downstream signaling of activated FGFR1,5/1194,27/9872,0.18518518518518517,1.531112351882871,1.0250223618763992,0.22181681901406636,0.9555669870812552,0.9203040795120135,FGF20/PTPN11/GAB1/FLRT2/GRB2,5,3.025156647434704,1.16290491214477,7.869579572623818
R-HSA-3301854,Nuclear Pore Complex (NPC) Disassembly,6/1194,34/9872,0.17647058823529413,1.4590600059119125,0.994554126829692,0.2226432748062506,0.9555669870812552,0.9203040795120135,NUP205/NEK9/NUP58/NUP98/NUP188/NUP153,6,2.882796334614248,1.2079121605816368,6.880065436930151
R-HSA-936440,Negative regulators of DDX58/IFIH1 signaling,6/1194,34/9872,0.17647058823529413,1.4590600059119125,0.994554126829692,0.2226432748062506,0.9555669870812552,0.9203040795120135,NLRC5/UBA7/RNF125/UBE2D1/RNF135/IKBKE,6,2.882796334614248,1.2079121605816368,6.880065436930151
R-HSA-9675108,Nervous system development,72/1194,546/9872,0.13186813186813187,1.0902865978242862,0.8050907196340695,0.22826992398525672,0.9555669870812552,0.9203040795120135,DOCK1/CACNB4/PAK2/EFNA5/NFASC/DAB1/CXCL12/SEMA3A/EFNA1/COL9A1/GRIN1/SCN1A/NCK2/PRKAR2A/ARHGEF7/ITGB3/GRB10/MSN/ROBO1/DOK6/COL5A3/SCN2A/DNM3/SCN11A/EPHA6/ENAH/SCN1B/PTPN11/MYO9B/LAMA1/ADGRV1/COL4A2/LIMK2/DSCAML1/PTK2/LHX2/MYO10/GAB1/NELL2/TRPC5/COL5A2/DSCAM/RHOB/NTN1/ACTR3/NTN4/SCN4B/GRB2/PLXNA3/PLXNA2/DCX/NGEF/TUBB2A/MPZ/PLXND1/MSI1/GRIN2B/LAMA2/CRMP1/GIT1/ANK1/PAK3/EPHA4/KCNQ2/TUBB4A/ITGA2/CACNA1D/CHL1/SOX10/EIF4G1/RPS6KA3/DNM1,72,2.1541774808106466,1.6733219060746845,2.773214527333504
R-HSA-5578775,Ion homeostasis,9/1194,56/9872,0.16071428571428573,1.328786791098349,0.9151957963763947,0.23092507792804648,0.9555669870812552,0.9203040795120135,ATP1A2/TRDN/SLC8A1/CAMK2D/RYR1/ATP1B3/ATP1A3/CAMK2G/FXYD1,9,2.6254038047379753,1.2955500199668903,5.320323439236094
R-HSA-170670,Adenylate cyclase inhibitory pathway,3/1194,14/9872,0.21428571428571427,1.771715721464465,1.0717657521260637,0.23509772434530612,0.9555669870812552,0.9203040795120135,GNAI1/ADCY3/GNAL,3,3.500538406317301,1.0045893073709558,12.197789727795328
R-HSA-190241,FGFR2 ligand binding and activation,3/1194,14/9872,0.21428571428571427,1.771715721464465,1.0717657521260637,0.23509772434530612,0.9555669870812552,0.9203040795120135,FGF20/FGFR2/FGFBP2,3,3.500538406317301,1.0045893073709558,12.197789727795328
R-HSA-2032785,YAP1- and WWTR1 (TAZ)-stimulated gene expression,3/1194,14/9872,0.21428571428571427,1.771715721464465,1.0717657521260637,0.23509772434530612,0.9555669870812552,0.9203040795120135,KAT2B/TEAD3/TEAD4,3,3.500538406317301,1.0045893073709558,12.197789727795328
R-HSA-204174,Regulation of pyruvate dehydrogenase (PDH) complex,3/1194,14/9872,0.21428571428571427,1.771715721464465,1.0717657521260637,0.23509772434530612,0.9555669870812552,0.9203040795120135,PDK1/PDK3/PDHX,3,3.500538406317301,1.0045893073709558,12.197789727795328
R-HSA-3296469,Defects in cobalamin (B12) metabolism,3/1194,14/9872,0.21428571428571427,1.771715721464465,1.0717657521260637,0.23509772434530612,0.9555669870812552,0.9203040795120135,MMAB/ABCD4/CUBN,3,3.500538406317301,1.0045893073709558,12.197789727795328
R-HSA-399955,SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion,3/1194,14/9872,0.21428571428571427,1.771715721464465,1.0717657521260637,0.23509772434530612,0.9555669870812552,0.9203040795120135,SEMA3A/PLXNA3/PLXNA2,3,3.500538406317301,1.0045893073709558,12.197789727795328
R-HSA-418885,DCC mediated attractive signaling,3/1194,14/9872,0.21428571428571427,1.771715721464465,1.0717657521260637,0.23509772434530612,0.9555669870812552,0.9203040795120135,DOCK1/PTK2/NTN1,3,3.500538406317301,1.0045893073709558,12.197789727795328
R-HSA-5603041,IRAK4 deficiency (TLR2/4),3/1194,14/9872,0.21428571428571427,1.771715721464465,1.0717657521260637,0.23509772434530612,0.9555669870812552,0.9203040795120135,TLR2/CD14/TLR4,3,3.500538406317301,1.0045893073709558,12.197789727795328
R-HSA-5654704,SHC-mediated cascade:FGFR3,3/1194,14/9872,0.21428571428571427,1.771715721464465,1.0717657521260637,0.23509772434530612,0.9555669870812552,0.9203040795120135,FGF20/FGFR3/GRB2,3,3.500538406317301,1.0045893073709558,12.197789727795328
R-HSA-6803205,TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain,3/1194,14/9872,0.21428571428571427,1.771715721464465,1.0717657521260637,0.23509772434530612,0.9555669870812552,0.9203040795120135,BCL2L14/BCL6/NDRG1,3,3.500538406317301,1.0045893073709558,12.197789727795328
R-HSA-6804116,TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest,3/1194,14/9872,0.21428571428571427,1.771715721464465,1.0717657521260637,0.23509772434530612,0.9555669870812552,0.9203040795120135,CDKN1A/CDK2/CCNA2,3,3.500538406317301,1.0045893073709558,12.197789727795328
R-HSA-9824878,"Regulation of TBK1, IKK (IKBKE)-mediated activation of IRF3, IRF7",3/1194,14/9872,0.21428571428571427,1.771715721464465,1.0717657521260637,0.23509772434530612,0.9555669870812552,0.9203040795120135,CD14/TLR4/IKBKE,3,3.500538406317301,1.0045893073709558,12.197789727795328
R-HSA-9931530,Phosphorylation and nuclear translocation of the CRY:PER:kinase complex,3/1194,14/9872,0.21428571428571427,1.771715721464465,1.0717657521260637,0.23509772434530612,0.9555669870812552,0.9203040795120135,CRY1/PER1/PPP1CB,3,3.500538406317301,1.0045893073709558,12.197789727795328
R-HSA-9816359,Maternal to zygotic transition (MZT),8/1194,49/9872,0.16326530612244897,1.3498786449253066,0.9106810933579869,0.2356444927112255,0.9555669870812552,0.9203040795120135,DICER1/CNOT2/AGO2/UHRF1/ZFP36L2/KDM6A/TEAD4/EIF4G1,8,2.667076881003658,1.2602459387769829,5.644373745086109
R-HSA-5619102,SLC transporter disorders,13/1194,86/9872,0.1511627906976744,1.24981496630439,0.8630540394463017,0.23622987353277988,0.9555669870812552,0.9203040795120135,NUP205/SLC40A1/SLC24A5/NUP58/SLC11A2/NUP98/NUP188/NUP153/SLC2A1/SLC4A4/SLC27A4/SLC24A1/HK1,13,2.4693720540687933,1.3740970417133604,4.437676638771154
R-HSA-1474228,Degradation of the extracellular matrix,18/1194,124/9872,0.14516129032258066,1.2001945209920573,0.8321051044201332,0.23841240170807843,0.9555669870812552,0.9203040795120135,TLL2/A2M/COL10A1/CAST/COL9A1/BMP1/ADAM9/SPP1/COL5A3/ACAN/COL4A2/COL5A2/BCAN/NID1/MMP19/ADAM8/COL12A1/ADAMTS18,18,2.371332468795591,1.4414356025426116,3.9011230662300505
R-HSA-9696273,RND1 GTPase cycle,7/1194,42/9872,0.16666666666666666,1.378001116694584,0.9105711485606316,0.2399290451515796,0.9555669870812552,0.9203040795120135,ALDH3A2/PTPN13/DLG5/TFRC/FLOT2/ARHGAP5/STIP1,7,2.722640982691234,1.2205541858753575,6.073285402985688
R-HSA-977606,Regulation of Complement cascade,7/1194,42/9872,0.16666666666666666,1.378001116694584,0.9105711485606316,0.2399290451515796,0.9555669870812552,0.9203040795120135,CD55/PROS1/C5AR1/C4BPA/CFB/CD59/CPB2,7,2.722640982691234,1.2205541858753575,6.073285402985688
R-HSA-948021,Transport to the Golgi and subsequent modification,25/1194,178/9872,0.1404494382022472,1.1612368960909416,0.8051853028227652,0.24067592574950272,0.9555669870812552,0.9203040795120135,MGAT4C/CD55/TMED10/COPA/GOSR2/SERPINA1/ARFGAP3/SEC31A/ANKRD28/ST3GAL4/SEC24D/RAB1A/B4GALT5/ST8SIA3/TFG/DYNC1I1/SEC22A/CD59/SEC23A/TUBB2A/ANK1/TUBB4A/GRIA1/NSF/SEC24A,25,2.2943603786723883,1.5034639094654736,3.5013075565566765
R-HSA-196741,"Cobalamin (Cbl, vitamin B12) transport and metabolism",4/1194,21/9872,0.19047619047619047,1.5748584190795245,0.9781451378467318,0.24390062843119317,0.9555669870812552,0.9203040795120135,MMAB/ABCD4/PRSS3/CUBN,4,3.1115896945042674,1.0663810123209778,9.079297469740494
R-HSA-2453902,The canonical retinoid cycle in rods (twilight vision),4/1194,21/9872,0.19047619047619047,1.5748584190795245,0.9781451378467318,0.24390062843119317,0.9555669870812552,0.9203040795120135,RBP4/HSD17B1/RLBP1/RDH10,4,3.1115896945042674,1.0663810123209778,9.079297469740494
R-HSA-389977,Post-chaperonin tubulin folding pathway,4/1194,21/9872,0.19047619047619047,1.5748584190795245,0.9781451378467318,0.24390062843119317,0.9555669870812552,0.9203040795120135,TBCD/TBCE/TUBB2A/TUBB4A,4,3.1115896945042674,1.0663810123209778,9.079297469740494
R-HSA-392170,ADP signalling through P2Y purinoceptor 12,4/1194,21/9872,0.19047619047619047,1.5748584190795245,0.9781451378467318,0.24390062843119317,0.9555669870812552,0.9203040795120135,GNB3/GNAI1/P2RY12/GNG3,4,3.1115896945042674,1.0663810123209778,9.079297469740494
R-HSA-442982,Ras activation upon Ca2+ influx through NMDA receptor,4/1194,21/9872,0.19047619047619047,1.5748584190795245,0.9781451378467318,0.24390062843119317,0.9555669870812552,0.9203040795120135,GRIN1/CAMK2D/GRIN2B/CAMK2G,4,3.1115896945042674,1.0663810123209778,9.079297469740494
R-HSA-6807004,Negative regulation of MET activity,4/1194,21/9872,0.19047619047619047,1.5748584190795245,0.9781451378467318,0.24390062843119317,0.9555669870812552,0.9203040795120135,PTPN2/PTPRJ/PTPN1/GRB2,4,3.1115896945042674,1.0663810123209778,9.079297469740494
R-HSA-190861,Gap junction assembly,5/1194,28/9872,0.17857142857142858,1.4764297678870544,0.93640779117993,0.24525569630160945,0.9555669870812552,0.9203040795120135,GJA1/GJB6/GJB7/TUBB2A/TUBB4A,5,2.91711533859775,1.1243608396539213,7.568354925364987
R-HSA-2559586,DNA Damage/Telomere Stress Induced Senescence,5/1194,28/9872,0.17857142857142858,1.4764297678870544,0.93640779117993,0.24525569630160945,0.9555669870812552,0.9203040795120135,CABIN1/CDKN1A/LMNB1/CDK2/CCNA2,5,2.91711533859775,1.1243608396539213,7.568354925364987
R-HSA-5260271,Diseases of Immune System,5/1194,28/9872,0.17857142857142858,1.4764297678870544,0.93640779117993,0.24525569630160945,0.9555669870812552,0.9203040795120135,TLR2/NFKBIA/CD14/RELA/TLR4,5,2.91711533859775,1.1243608396539213,7.568354925364987
R-HSA-5602358,Diseases associated with the TLR signaling cascade,5/1194,28/9872,0.17857142857142858,1.4764297678870544,0.93640779117993,0.24525569630160945,0.9555669870812552,0.9203040795120135,TLR2/NFKBIA/CD14/RELA/TLR4,5,2.91711533859775,1.1243608396539213,7.568354925364987
R-HSA-9018519,Estrogen-dependent gene expression,13/1194,87/9872,0.14942528735632185,1.2354492770365237,0.81818118656419625,0.2493008666297739,0.9555669870812552,0.9203040795120135,CXXC5/CBFB/CXCL12/KAT2B/TNRC6C/FOS/KDM4B/AGO2/RUNX1/PTGES3/JUN/NCOA1/GREB1,13,2.4409884672404165,1.3588980696981994,4.384747340559574
R-HSA-2995410,Nuclear Envelope (NE) Reassembly,11/1194,72/9872,0.1527777777777778,1.2631676903033688,0.8313017518481832,0.24946205134982874,0.9555669870812552,0.9203040795120135,LMNA/PPP2R2A/NUP205/LBR/NUP58/NUP98/NUP188/LMNB1/AHCTF1/TUBB2A/TUBB4A,11,2.495754234133631,1.3197004113857476,4.71985091726646
R-HSA-164944,Nef and signal transduction,2/1194,8/9872,0.25,2.067001675041876,1.1198412974970589,0.25097362821616875,0.9555669870812552,0.9203040795120135,ELMO1/PAK2,2,4.083961474036851,0.8662775281062364,19.253346393364883
R-HSA-1839130,Signaling by activated point mutants of FGFR3,2/1194,8/9872,0.25,2.067001675041876,1.1198412974970589,0.25097362821616875,0.9555669870812552,0.9203040795120135,FGF20/FGFR3,2,4.083961474036851,0.8662775281062364,19.253346393364883
R-HSA-190377,FGFR2b ligand binding and activation,2/1194,8/9872,0.25,2.067001675041876,1.1198412974970589,0.25097362821616875,0.9555669870812552,0.9203040795120135,FGFR2/FGFBP2,2,4.083961474036851,0.8662775281062364,19.253346393364883
R-HSA-194313,VEGF ligand-receptor interactions,2/1194,8/9872,0.25,2.067001675041876,1.1198412974970589,0.25097362821616875,0.9555669870812552,0.9203040795120135,VEGFA/VEGFD,2,4.083961474036851,0.8662775281062364,19.253346393364883
R-HSA-195399,VEGF binds to VEGFR leading to receptor dimerization,2/1194,8/9872,0.25,2.067001675041876,1.1198412974970589,0.25097362821616875,0.9555669870812552,0.9203040795120135,VEGFA/VEGFD,2,4.083961474036851,0.8662775281062364,19.253346393364883
R-HSA-2033514,FGFR3 mutant receptor activation,2/1194,8/9872,0.25,2.067001675041876,1.1198412974970589,0.25097362821616875,0.9555669870812552,0.9203040795120135,FGF20/FGFR3,2,4.083961474036851,0.8662775281062364,19.253346393364883
R-HSA-2142688,Synthesis of 5-eicosatetraenoic acids,2/1194,8/9872,0.25,2.067001675041876,1.1198412974970589,0.25097362821616875,0.9555669870812552,0.9203040795120135,LTC4S/ALOX5AP,2,4.083961474036851,0.8662775281062364,19.253346393364883
R-HSA-2428933,SHC-related events triggered by IGF1R,2/1194,8/9872,0.25,2.067001675041876,1.1198412974970589,0.25097362821616875,0.9555669870812552,0.9203040795120135,IGF1/GRB2,2,4.083961474036851,0.8662775281062364,19.253346393364883
R-HSA-3595174,"Defective CHST14 causes EDS, musculocontractural type",2/1194,8/9872,0.25,2.067001675041876,1.1198412974970589,0.25097362821616875,0.9555669870812552,0.9203040795120135,CSPG5/BCAN,2,4.083961474036851,0.8662775281062364,19.253346393364883
R-HSA-418886,Netrin mediated repulsion signals,2/1194,8/9872,0.25,2.067001675041876,1.1198412974970589,0.25097362821616875,0.9555669870812552,0.9203040795120135,PTPN11/NTN1,2,4.083961474036851,0.8662775281062364,19.253346393364883
R-HSA-446210,Synthesis of UDP-N-acetyl-glucosamine,2/1194,8/9872,0.25,2.067001675041876,1.1198412974970589,0.25097362821616875,0.9555669870812552,0.9203040795120135,PGM3/GFPT2,2,4.083961474036851,0.8662775281062364,19.253346393364883
R-HSA-5340588,Signaling by RNF43 mutants,2/1194,8/9872,0.25,2.067001675041876,1.1198412974970589,0.25097362821616875,0.9555669870812552,0.9203040795120135,FZD5/RNF43,2,4.083961474036851,0.8662775281062364,19.253346393364883
R-HSA-5362798,Release of Hh-Np from the secreting cell,2/1194,8/9872,0.25,2.067001675041876,1.1198412974970589,0.25097362821616875,0.9555669870812552,0.9203040795120135,GPC5/DHH,2,4.083961474036851,0.8662775281062364,19.253346393364883
R-HSA-549127,Organic cation transport,2/1194,8/9872,0.25,2.067001675041876,1.1198412974970589,0.25097362821616875,0.9555669870812552,0.9203040795120135,RUNX1/SLC22A3,2,4.083961474036851,0.8662775281062364,19.253346393364883
R-HSA-5632681,Ligand-receptor interactions,2/1194,8/9872,0.25,2.067001675041876,1.1198412974970589,0.25097362821616875,0.9555669870812552,0.9203040795120135,DHH/CDON,2,4.083961474036851,0.8662775281062364,19.253346393364883
R-HSA-5666185,RHO GTPases Activate Rhotekin and Rhophilins,2/1194,8/9872,0.25,2.067001675041876,1.1198412974970589,0.25097362821616875,0.9555669870812552,0.9203040795120135,RTKN/RHOB,2,4.083961474036851,0.8662775281062364,19.253346393364883
R-HSA-8948700,Competing endogenous RNAs (ceRNAs) regulate PTEN translation,2/1194,8/9872,0.25,2.067001675041876,1.1198412974970589,0.25097362821616875,0.9555669870812552,0.9203040795120135,TNRC6C/AGO2,2,4.083961474036851,0.8662775281062364,19.253346393364883
R-HSA-8951671,RUNX3 regulates YAP1-mediated transcription,2/1194,8/9872,0.25,2.067001675041876,1.1198412974970589,0.25097362821616875,0.9555669870812552,0.9203040795120135,TEAD3/TEAD4,2,4.083961474036851,0.8662775281062364,19.253346393364883
R-HSA-9022702,MECP2 regulates transcription of neuronal ligands,2/1194,8/9872,0.25,2.067001675041876,1.1198412974970589,0.25097362821616875,0.9555669870812552,0.9203040795120135,CRH/BDNF,2,4.083961474036851,0.8662775281062364,19.253346393364883
R-HSA-9026519,Activated NTRK2 signals through RAS,2/1194,8/9872,0.25,2.067001675041876,1.1198412974970589,0.25097362821616875,0.9555669870812552,0.9203040795120135,BDNF/GRB2,2,4.083961474036851,0.8662775281062364,19.253346393364883
R-HSA-9623433,NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis,2/1194,8/9872,0.25,2.067001675041876,1.1198412974970589,0.25097362821616875,0.9555669870812552,0.9203040795120135,NCOA1/FABP6,2,4.083961474036851,0.8662775281062364,19.253346393364883
R-HSA-9818749,Regulation of NFE2L2 gene expression,2/1194,8/9872,0.25,2.067001675041876,1.1198412974970589,0.25097362821616875,0.9555669870812552,0.9203040795120135,NFE2L2/RELA,2,4.083961474036851,0.8662775281062364,19.253346393364883
R-HSA-9839389,TGFBR3 regulates TGF-beta signaling,2/1194,8/9872,0.25,2.067001675041876,1.1198412974970589,0.25097362821616875,0.9555669870812552,0.9203040795120135,TGFBR1/ARRB1,2,4.083961474036851,0.8662775281062364,19.253346393364883
R-HSA-383280,Nuclear Receptor transcription pathway,8/1194,50/9872,0.16,1.3228810720268007,0.8489860225788255,0.2531839379993648,0.9618778430543553,0.9263820484830816,HNF4G/RARA/ESRRB/PPARD/RXRG/PPARG/RORA/NR2F1,8,2.613735343383585,1.2363341858734738,5.525700513106778
R-HSA-199977,ER to Golgi Anterograde Transport,21/1194,149/9872,0.14093959731543623,1.1652895349229369,0.75406930957432206,0.2590466614858612,0.9820069520379051,0.945768340982665,CD55/TMED10/COPA/GOSR2/SERPINA1/ARFGAP3/SEC31A/ANKRD28/SEC24D/RAB1A/TFG/DYNC1I1/SEC22A/CD59/SEC23A/TUBB2A/ANK1/TUBB4A/GRIA1/NSF/SEC24A,21,2.3023675424100367,1.4526100201063192,3.6492219019356966
R-HSA-8876198,RAB GEFs exchange GTP for GDP on RABs,13/1194,88/9872,0.14772727272727273,1.2214100807065633,0.7738440019796294,0.262633199439543,0.9884137074474679,0.9519386704515239,RIN2/RAB3IP/RAB27B/DENND1B/RAB8B/RAB10/DENND4A/DENND3/RAB1A/GDI2/RAB7B/RAB21/SBF1,13,2.413249961930866,1.3440318293088207,4.333063586562717
R-HSA-9013408,RHOG GTPase cycle,11/1194,73/9872,0.1506849315068493,1.2458640233129117,0.7820570795325728,0.2641783464378598,0.9884137074474679,0.9519386704515239,ERBIN/ARHGAP21/DOCK1/PAK2/TFRC/ARFGAP3/LBR/ARHGAP5/PREX1/ARHGAP1/OPHN1,11,2.461565819967417,1.3023694009387947,4.652525068282543
R-HSA-111465,Apoptotic cleavage of cellular proteins,6/1194,36/9872,0.16666666666666666,1.378001116694584,0.8427679080257164,0.26466281158612914,0.9884137074474679,0.9519386704515239,LMNA/ADD1/TJP2/PTK2/CASP7/LMNB1,6,2.722640982691234,1.1449381006941828,6.474388367489456
R-HSA-111933,Calmodulin induced events,6/1194,36/9872,0.16666666666666666,1.378001116694584,0.8427679080257164,0.26466281158612914,0.9884137074474679,0.9519386704515239,PRKAR2A/CAMK2D/PRKCG/ADCY3/CAMK4/CAMK2G,6,2.722640982691234,1.1449381006941828,6.474388367489456
R-HSA-111997,CaM pathway,6/1194,36/9872,0.16666666666666666,1.378001116694584,0.8427679080257164,0.26466281158612914,0.9884137074474679,0.9519386704515239,PRKAR2A/CAMK2D/PRKCG/ADCY3/CAMK4/CAMK2G,6,2.722640982691234,1.1449381006941828,6.474388367489456
R-HSA-168638,NOD1/2 Signaling Pathway,6/1194,36/9872,0.16666666666666666,1.378001116694584,0.8427679080257164,0.26466281158612914,0.9884137074474679,0.9519386704515239,NOD2/IRAK2/CASP1/CASP2/CASP4/TRAF6,6,2.722640982691234,1.1449381006941828,6.474388367489456
R-HSA-422475,Axon guidance,68/1194,521/9872,0.13051823416506717,1.0791256345708067,0.6883034645978185,0.26471309636236784,0.9884137074474679,0.9519386704515239,DOCK1/CACNB4/PAK2/EFNA5/NFASC/DAB1/CXCL12/SEMA3A/EFNA1/COL9A1/GRIN1/SCN1A/NCK2/PRKAR2A/ARHGEF7/ITGB3/GRB10/MSN/ROBO1/DOK6/COL5A3/SCN2A/DNM3/SCN11A/EPHA6/ENAH/SCN1B/PTPN11/MYO9B/LAMA1/COL4A2/LIMK2/DSCAML1/PTK2/LHX2/MYO10/GAB1/NELL2/TRPC5/COL5A2/DSCAM/RHOB/NTN1/ACTR3/NTN4/SCN4B/GRB2/PLXNA3/PLXNA2/DCX/NGEF/TUBB2A/PLXND1/MSI1/GRIN2B/CRMP1/GIT1/ANK1/PAK3/EPHA4/KCNQ2/TUBB4A/ITGA2/CACNA1D/CHL1/EIF4G1/RPS6KA3/DNM1,68,2.1321257599578187,1.6449857815809905,2.7635255618480774
R-HSA-442742,CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling,5/1194,29/9872,0.1724137931034483,1.4255183965806042,0.8511900017640965,0.2692981651568479,0.99521088554785,0.9584850149982924,GRIN1/CAMK2D/GRIN2B/CAMK2G/RPS6KA3,5,2.816525154508173,1.0882901969392467,7.289245063759525
R-HSA-983170,"Antigen Presentation: Folding, assembly and peptide loading of class I MHC",5/1194,29/9872,0.1724137931034483,1.4255183965806042,0.8511900017640965,0.2692981651568479,0.99521088554785,0.9584850149982924,SEC31A/SEC24D/TAP1/SEC23A/SEC24A,5,2.816525154508173,1.0882901969392467,7.289245063759525
R-HSA-2162123,Synthesis of Prostaglandins (PG) and Thromboxanes (TX),3/1194,15/9872,0.2,1.653601340033501,0.9396348191375987,0.26939329143278007,0.99521088554785,0.9584850149982924,PTGES3/CYP8B1/AKR1C3,3,3.2671691792294806,0.9445323353711638,11.301248296081278
R-HSA-2214320,Anchoring fibril formation,3/1194,15/9872,0.2,1.653601340033501,0.9396348191375987,0.26939329143278007,0.99521088554785,0.9584850149982924,TLL2/BMP1/COL4A2,3,3.2671691792294806,0.9445323353711638,11.301248296081278
R-HSA-9037629,Lewis blood group biosynthesis,3/1194,15/9872,0.2,1.653601340033501,0.9396348191375987,0.26939329143278007,0.99521088554785,0.9584850149982924,B3GALT5/ST3GAL4/B3GALT1,3,3.2671691792294806,0.9445323353711638,11.301248296081278
R-HSA-2980766,Nuclear Envelope Breakdown,8/1194,51/9872,0.1568627450980392,1.2969422274772555,0.7885915351723348,0.27111599483290527,0.9958094216021639,0.9590614635152119,LMNA/NUP205/NEK9/NUP58/NUP98/NUP188/NUP153/LMNB1,8,2.5624856307682204,1.213313355334284,5.411901697962017
R-HSA-193368,Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol,4/1194,22/9872,0.18181818181818182,1.5032739454850008,0.8765376783173914,0.27187964100035233,0.9958094216021639,0.9590614635152119,NCOA1/CYP8B1/CYP27A1/AKR1C3,4,2.9701537992995277,1.0218760325243257,8.632958706058526
R-HSA-450321,JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1,4/1194,22/9872,0.18181818181818182,1.5032739454850008,0.8765376783173914,0.27187964100035233,0.9958094216021639,0.9590614635152119,MAP2K4/NOD2/IRAK2/TRAF6,4,2.9701537992995277,1.0218760325243257,8.632958706058526
R-HSA-6783589,Interleukin-6 family signaling,4/1194,22/9872,0.18181818181818182,1.5032739454850008,0.8765376783173914,0.27187964100035233,0.9958094216021639,0.9590614635152119,STAT3/PTPN11/SOCS3/STAT1,4,2.9701537992995277,1.0218760325243257,8.632958706058526
R-HSA-445989,TAK1-dependent IKK and NF-kappa-B activation,7/1194,44/9872,0.1590909090909091,1.3153647022993755,0.7776420982147286,0.2787285643965472,0.9958094216021639,0.9590614635152119,NLRC5/TIFA/NOD2/IRAK2/NFKBIA/RELA/TRAF6,7,2.5988845743870868,1.1681020268593614,5.782201276670115
R-HSA-75153,Apoptotic execution phase,7/1194,44/9872,0.1590909090909091,1.3153647022993755,0.7776420982147286,0.2787285643965472,0.9958094216021639,0.9590614635152119,PAK2/LMNA/ADD1/TJP2/PTK2/CASP7/LMNB1,7,2.5988845743870868,1.1681020268593614,5.782201276670115
R-HSA-5218859,Regulated Necrosis,9/1194,59/9872,0.15254237288135594,1.2612213610425007,0.7464602927373384,0.2805581092176759,0.9958094216021639,0.9590614635152119,MLKL/IL1B/FLOT2/IRF1/FLOT1/CASP1/IL1A/GSDME/CASP4,9,2.491908696022485,1.2327201271763328,5.037322594493695
R-HSA-9679191,Potential therapeutics for SARS,14/1194,97/9872,0.14432989690721648,1.193320554663351,0.7097059284462598,0.2809548662605329,0.9958094216021639,0.9590614635152119,ATP1A2/IFNAR2/VEGFA/GATAD2A/NFE2L2/CYSLTR1/PTGES3/JAK3/ATP1B3/ITGA4/GRB2/FNTB/ATP1A3/FXYD1,14,2.3577509540831305,1.3421987412372425,4.1417037512310735
R-HSA-381340,Transcriptional regulation of white adipocyte differentiation,12/1194,82/9872,0.14634146341463414,1.2099522000245126,0.7081233684614179,0.28503658063684717,0.9958094216021639,0.9590614635152119,MED28/HELZ2/FAM120B/CEBPD/NCOA1/MED15/PCK1/CEBPA/MED29/PPARG/RELA/LPL,12,2.3906115945581567,1.3007579758377088,4.393610419613478
R-HSA-6811558,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling",15/1194,105/9872,0.14285714285714285,1.1811438143096433,0.6921663475294999,0.28506452855872183,0.9958094216021639,0.9590614635152119,PIP4K2A/FGF20/FGFR3/PIP5K1B/PDGFRA/FGFR2/PDGFRB/BDNF/PTPN11/PDGFA/GAB1/NRG1/GRB2/IL1RAP/TRAF6,15,2.333692270878201,1.3543124134663405,4.021317061709122
R-HSA-5083635,Defective B3GALTL causes PpS,6/1194,37/9872,0.16216216216216217,1.3407578432704061,0.7702513305461478,0.28638727694456717,0.9958094216021639,0.9590614635152119,ADAMTS2/SPON1/B3GLCT/ADAMTS10/ADAMTS18/THSD7B,6,2.6490560912671466,1.1158516165214318,6.288916976753591
R-HSA-187037,Signaling by NTRK1 (TRKA),16/1194,113/9872,0.1415929203539823,1.1706912141830095,0.6768939725091395,0.2886457140175324,0.9958094216021639,0.9590614635152119,STAT3/SGK1/RALGDS/VGF/ID4/SHC2/FOS/RAP1A/DNM3/DUSP3/EGR1/ADORA2A/JUNB/GRB2/RPS6KA3/DNM1,16,2.313040126888128,1.3658401852602744,3.917116135790896
R-HSA-381119,Unfolded Protein Response (UPR),13/1194,90/9872,0.14444444444444443,1.1942676344686394,0.6867217360865971,0.2900026604298244,0.9958094216021639,0.9590614635152119,SRPRB/LMNA/ATF3/GOSR2/ADD1/SEC31A/EDEM1/ATF6/CREB3L1/EIF2S1/DDX11/CCL2/EIF2AK3,13,2.3596221849990693,1.315254754540524,4.233261150905221
R-HSA-168271,Transport of Ribonucleoproteins into the Host Nucleus,5/1194,30/9872,0.16666666666666666,1.378001116694584,0.7691037808240434,0.2938185034225141,0.9958094216021639,0.9590614635152119,NUP205/NUP58/NUP98/NUP188/NUP153,5,2.7226409826912334,1.054462285291696,7.02990901052406
R-HSA-168333,NEP/NS2 Interacts with the Cellular Export Machinery,5/1194,30/9872,0.16666666666666666,1.378001116694584,0.7691037808240434,0.2938185034225141,0.9958094216021639,0.9590614635152119,NUP205/NUP58/NUP98/NUP188/NUP153,5,2.7226409826912334,1.054462285291696,7.02990901052406
R-HSA-170822,Regulation of Glucokinase by Glucokinase Regulatory Protein,5/1194,30/9872,0.16666666666666666,1.378001116694584,0.7691037808240434,0.2938185034225141,0.9958094216021639,0.9590614635152119,NUP205/NUP58/NUP98/NUP188/NUP153,5,2.7226409826912334,1.054462285291696,7.02990901052406
R-HSA-201556,Signaling by ALK,5/1194,30/9872,0.16666666666666666,1.378001116694584,0.7691037808240434,0.2938185034225141,0.9958094216021639,0.9590614635152119,STAT3/HIF1A/JAK3/PTPRZ1/ALKAL2,5,2.7226409826912334,1.054462285291696,7.02990901052406
R-HSA-381042,PERK regulates gene expression,5/1194,30/9872,0.16666666666666666,1.378001116694584,0.7691037808240434,0.2938185034225141,0.9958094216021639,0.9590614635152119,ATF3/ATF6/EIF2S1/CCL2/EIF2AK3,5,2.7226409826912334,1.054462285291696,7.02990901052406
R-HSA-3928663,EPHA-mediated growth cone collapse,5/1194,30/9872,0.16666666666666666,1.378001116694584,0.7691037808240434,0.2938185034225141,0.9958094216021639,0.9590614635152119,EFNA5/EFNA1/EPHA6/NGEF/EPHA4,5,2.7226409826912334,1.054462285291696,7.02990901052406
R-HSA-5619107,Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC),5/1194,30/9872,0.16666666666666666,1.378001116694584,0.7691037808240434,0.2938185034225141,0.9958094216021639,0.9590614635152119,NUP205/NUP58/NUP98/NUP188/NUP153,5,2.7226409826912334,1.054462285291696,7.02990901052406
R-HSA-190239,FGFR3 ligand binding and activation,2/1194,9/9872,0.2222222222222222,1.8373348222594454,0.9321564461659777,0.29845889992263763,0.9958094216021639,0.9590614635152119,FGF20/FGFR3,2,3.630187976921645,0.7834626802527572,16.820539229175477
R-HSA-190372,FGFR3c ligand binding and activation,2/1194,9/9872,0.2222222222222222,1.8373348222594454,0.9321564461659777,0.29845889992263763,0.9958094216021639,0.9590614635152119,FGF20/FGFR3,2,3.630187976921645,0.7834626802527572,16.820539229175477
R-HSA-190375,FGFR2c ligand binding and activation,2/1194,9/9872,0.2222222222222222,1.8373348222594454,0.9321564461659777,0.29845889992263763,0.9958094216021639,0.9590614635152119,FGF20/FGFR2,2,3.630187976921645,0.7834626802527572,16.820539229175477
R-HSA-2562578,TRIF-mediated programmed cell death,2/1194,9/9872,0.2222222222222222,1.8373348222594454,0.9321564461659777,0.29845889992263763,0.9958094216021639,0.9590614635152119,CD14/TLR4,2,3.630187976921645,0.7834626802527572,16.820539229175477
R-HSA-419812,Calcitonin-like ligand receptors,2/1194,9/9872,0.2222222222222222,1.8373348222594454,0.9321564461659777,0.29845889992263763,0.9958094216021639,0.9590614635152119,CALCRL/ADM,2,3.630187976921645,0.7834626802527572,16.820539229175477
R-HSA-426486,Small interfering RNA (siRNA) biogenesis,2/1194,9/9872,0.2222222222222222,1.8373348222594454,0.9321564461659777,0.29845889992263763,0.9958094216021639,0.9590614635152119,DICER1/AGO2,2,3.630187976921645,0.7834626802527572,16.820539229175477
R-HSA-5654227,Phospholipase C-mediated cascade; FGFR3,2/1194,9/9872,0.2222222222222222,1.8373348222594454,0.9321564461659777,0.29845889992263763,0.9958094216021639,0.9590614635152119,FGF20/FGFR3,2,3.630187976921645,0.7834626802527572,16.820539229175477
R-HSA-74749,Signal attenuation,2/1194,9/9872,0.2222222222222222,1.8373348222594454,0.9321564461659777,0.29845889992263763,0.9958094216021639,0.9590614635152119,GRB10/GRB2,2,3.630187976921645,0.7834626802527572,16.820539229175477
R-HSA-8866904,Negative regulation of activity of TFAP2 (AP-2) family transcription factors,2/1194,9/9872,0.2222222222222222,1.8373348222594454,0.9321564461659777,0.29845889992263763,0.9958094216021639,0.9590614635152119,TFAP2E/KCTD15,2,3.630187976921645,0.7834626802527572,16.820539229175477
R-HSA-8943723,Regulation of PTEN mRNA translation,2/1194,9/9872,0.2222222222222222,1.8373348222594454,0.9321564461659777,0.29845889992263763,0.9958094216021639,0.9590614635152119,TNRC6C/AGO2,2,3.630187976921645,0.7834626802527572,16.820539229175477
R-HSA-9613354,Lipophagy,2/1194,9/9872,0.2222222222222222,1.8373348222594454,0.9321564461659777,0.29845889992263763,0.9958094216021639,0.9590614635152119,PLIN3/PRKAG3,2,3.630187976921645,0.7834626802527572,16.820539229175477
R-HSA-9619229,Activation of RAC1 downstream of NMDARs,2/1194,9/9872,0.2222222222222222,1.8373348222594454,0.9321564461659777,0.29845889992263763,0.9958094216021639,0.9590614635152119,ARHGEF7/GIT1,2,3.630187976921645,0.7834626802527572,16.820539229175477
R-HSA-9759811,Regulation of CDH11 mRNA translation by microRNAs,2/1194,9/9872,0.2222222222222222,1.8373348222594454,0.9321564461659777,0.29845889992263763,0.9958094216021639,0.9590614635152119,TNRC6C/AGO2,2,3.630187976921645,0.7834626802527572,16.820539229175477
R-HSA-9768778,Regulation of NPAS4 mRNA translation,2/1194,9/9872,0.2222222222222222,1.8373348222594454,0.9321564461659777,0.29845889992263763,0.9958094216021639,0.9590614635152119,TNRC6C/AGO2,2,3.630187976921645,0.7834626802527572,16.820539229175477
R-HSA-9823739,Formation of the anterior neural plate,2/1194,9/9872,0.2222222222222222,1.8373348222594454,0.9321564461659777,0.29845889992263763,0.9958094216021639,0.9590614635152119,PAX6/ZNF521,2,3.630187976921645,0.7834626802527572,16.820539229175477
R-HSA-2428928,IRS-related events triggered by IGF1R,7/1194,45/9872,0.15555555555555556,1.2861343755816117,0.7135735299360738,0.29869151980606257,0.9958094216021639,0.9590614635152119,FGF20/FGFR3/IGF1/FGFR2/PTPN11/GAB1/GRB2,7,2.5411315838451514,1.1435316084377178,5.646848481291513
R-HSA-1169410,Antiviral mechanism by IFN-stimulated genes,20/1194,145/9872,0.13793103448275862,1.1404147172644832,0.6318006806592528,0.29915306345542264,0.9958094216021639,0.9590614635152119,STAT3/PTPN2/HSPA1A/HSPA1B/NUP205/PPM1B/UBA7/KPNA3/NUP58/NUP98/NUP188/NUP153/TUBB2A/ABCE1/TUBB4A/FLNA/EIF2S1/STAT1/EIF4G1/OAS1,20,2.253220123606538,1.4066403849886766,3.609309799154055
R-HSA-373080,Class B/2 (Secretin family receptors),12/1194,83/9872,0.14457831325301204,1.1953744626748197,0.6629955218484536,0.2996169237858324,0.9958094216021639,0.9590614635152119,CD55/CRH/CALCRL/GNB3/FZD5/ADGRE2/ADM/PTH2R/DHH/GNG3/WNT2B/WNT6,12,2.3618090452261304,1.2856824799618105,4.338662191521546
R-HSA-1368108,"BMAL1:CLOCK,NPAS2 activates circadian expression",4/1194,23/9872,0.17391304347826086,1.4379142087247834,0.779883626365806,0.30036247014636397,0.9958094216021639,0.9590614635152119,NAMPT/KLF15/HELZ2/NCOA1,4,2.8410166775908525,0.9809362024665603,8.228237210589151
R-HSA-1482839,Acyl chain remodelling of PE,4/1194,23/9872,0.17391304347826086,1.4379142087247834,0.779883626365806,0.30036247014636397,0.9958094216021639,0.9590614635152119,MBOAT2/PLAAT1/PLAAT3/PLA2G12A,4,2.8410166775908525,0.9809362024665603,8.228237210589151
R-HSA-166208,mTORC1-mediated signalling,4/1194,23/9872,0.17391304347826086,1.4379142087247834,0.779883626365806,0.30036247014636397,0.9958094216021639,0.9590614635152119,EIF4EBP1/RRAGD/EEF2K/EIF4G1,4,2.8410166775908525,0.9809362024665603,8.228237210589151
R-HSA-171319,Telomere Extension By Telomerase,4/1194,23/9872,0.17391304347826086,1.4379142087247834,0.779883626365806,0.30036247014636397,0.9958094216021639,0.9590614635152119,ANKRD28/SHQ1/CDK2/CCNA2,4,2.8410166775908525,0.9809362024665603,8.228237210589151
R-HSA-202040,G-protein activation,4/1194,23/9872,0.17391304347826086,1.4379142087247834,0.779883626365806,0.30036247014636397,0.9958094216021639,0.9590614635152119,GNB3/OPRM1/GNG3/PDYN,4,2.8410166775908525,0.9809362024665603,8.228237210589151
R-HSA-449836,Other interleukin signaling,4/1194,23/9872,0.17391304347826086,1.4379142087247834,0.779883626365806,0.30036247014636397,0.9958094216021639,0.9590614635152119,TXLNA/IL10RB/CSF1/PTPRZ1,4,2.8410166775908525,0.9809362024665603,8.228237210589151
R-HSA-450302,activated TAK1 mediates p38 MAPK activation,4/1194,23/9872,0.17391304347826086,1.4379142087247834,0.779883626365806,0.30036247014636397,0.9958094216021639,0.9590614635152119,NOD2/IRAK2/MAP2K3/TRAF6,4,2.8410166775908525,0.9809362024665603,8.228237210589151
R-HSA-5654716,Downstream signaling of activated FGFR4,4/1194,23/9872,0.17391304347826086,1.4379142087247834,0.779883626365806,0.30036247014636397,0.9958094216021639,0.9590614635152119,FGF20/PTPN11/GAB1/GRB2,4,2.8410166775908525,0.9809362024665603,8.228237210589151
R-HSA-9013422,RHOBTB1 GTPase cycle,4/1194,23/9872,0.17391304347826086,1.4379142087247834,0.779883626365806,0.30036247014636397,0.9958094216021639,0.9590614635152119,TRA2B/RBBP6/PDE5A/STK38,4,2.8410166775908525,0.9809362024665603,8.228237210589151
R-HSA-937041,IKK complex recruitment mediated by RIP1,4/1194,23/9872,0.17391304347826086,1.4379142087247834,0.779883626365806,0.30036247014636397,0.9958094216021639,0.9590614635152119,CD14/UBE2D1/TLR4/TRAF6,4,2.8410166775908525,0.9809362024665603,8.228237210589151
R-HSA-9734009,Defective Intrinsic Pathway for Apoptosis,4/1194,23/9872,0.17391304347826086,1.4379142087247834,0.779883626365806,0.30036247014636397,0.9958094216021639,0.9590614635152119,LMNA/CAST/JUN/LMNB1,4,2.8410166775908525,0.9809362024665603,8.228237210589151
R-HSA-1461973,Defensins,3/1194,16/9872,0.1875,1.550251256281407,0.8170405347395099,0.3041837235794053,0.9958094216021639,0.9590614635152119,TLR2/PRSS3/DEFB107B,3,3.0629711055276383,0.8912432532267074,10.526634517939778
R-HSA-193639,p75NTR signals via NF-kB,3/1194,16/9872,0.1875,1.550251256281407,0.8170405347395099,0.3041837235794053,0.9958094216021639,0.9590614635152119,NFKBIA/RELA/TRAF6,3,3.0629711055276383,0.8912432532267074,10.526634517939778
R-HSA-1963642,PI3K events in ERBB2 signaling,3/1194,16/9872,0.1875,1.550251256281407,0.8170405347395099,0.3041837235794053,0.9958094216021639,0.9590614635152119,GAB1/NRG1/GRB2,3,3.0629711055276383,0.8912432532267074,10.526634517939778
R-HSA-197264,Nicotinamide salvage,3/1194,16/9872,0.1875,1.550251256281407,0.8170405347395099,0.3041837235794053,0.9958094216021639,0.9590614635152119,NAMPT/PARP9/NNMT,3,3.0629711055276383,0.8912432532267074,10.526634517939778
R-HSA-2173791,TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition),3/1194,16/9872,0.1875,1.550251256281407,0.8170405347395099,0.3041837235794053,0.9958094216021639,0.9590614635152119,PRKCZ/TGFBR1/CGN,3,3.0629711055276383,0.8912432532267074,10.526634517939778
R-HSA-5684264,MAP3K8 (TPL2)-dependent MAPK1/3 activation,3/1194,16/9872,0.1875,1.550251256281407,0.8170405347395099,0.3041837235794053,0.9958094216021639,0.9590614635152119,MAP2K4/CUL1/TNIP2,3,3.0629711055276383,0.8912432532267074,10.526634517939778
R-HSA-844456,The NLRP3 inflammasome,3/1194,16/9872,0.1875,1.550251256281407,0.8170405347395099,0.3041837235794053,0.9958094216021639,0.9590614635152119,HMOX1/RELA/CASP1,3,3.0629711055276383,0.8912432532267074,10.526634517939778
R-HSA-8963889,Assembly of active LPL and LIPC lipase complexes,3/1194,16/9872,0.1875,1.550251256281407,0.8170405347395099,0.3041837235794053,0.9958094216021639,0.9590614635152119,PCSK6/ANGPTL3/LPL,3,3.0629711055276383,0.8912432532267074,10.526634517939778
R-HSA-9665348,Signaling by ERBB2 ECD mutants,3/1194,16/9872,0.1875,1.550251256281407,0.8170405347395099,0.3041837235794053,0.9958094216021639,0.9590614635152119,ERBIN/GAB1/GRB2,3,3.0629711055276383,0.8912432532267074,10.526634517939778
R-HSA-9716542,"Signaling by Rho GTPases, Miro GTPases and RHOBTB3",83/1194,649/9872,0.12788906009244994,1.0573876057225007,0.5610186081444224,0.3053866428459393,0.9958094216021639,0.9590614635152119,ALDH3A2/ERBIN/ARHGAP21/DOCK1/WIPF3/PAK2/SH3RF1/CTNNA1/RHOJ/PTPN13/KDM4C/TPM4/PLIN3/ARHGAP26/ARHGEF10/WIPF1/NCK2/RHOQ/IQGAP1/RTKN/ARHGEF7/DLG5/DOCK9/TJP2/PICALM/TFRC/ARHGAP31/FLOT2/LRRC1/TRA2B/GJA1/KCTD3/RBBP6/RHOBTB3/ARFGAP3/LBR/ITSN2/PCDH7/PDE5A/ARHGAP5/ARHGAP42/STIP1/TEX2/CAVIN1/ARHGEF3/SPATA13/YWHAG/ARHGAP23/MYO9B/PRKCZ/STK38/FLOT1/LIMK2/PTK2/NUP98/PREX1/PPP1CB/ARHGAP1/PAFAH1B1/DYNC1I1/NUF2/RHOB/LMNB1/ABR/ARAP3/ACTR3/SLITRK5/CHN1/AHCTF1/GRB2/SLK/NGEF/TUBB2A/OPHN1/PLXND1/FERMT2/SKA1/RHOBTB2/GIT1/PAK3/CFTR/TUBB4A/FLNA,83,2.0891759774733973,1.6502636926277963,2.644823542049736
R-HSA-194315,Signaling by Rho GTPases,81/1194,633/9872,0.12796208530805686,1.0579913786944197,0.5594041987452825,0.3061414853508815,0.9958094216021639,0.9590614635152119,ALDH3A2/ERBIN/ARHGAP21/DOCK1/WIPF3/PAK2/SH3RF1/CTNNA1/RHOJ/PTPN13/KDM4C/TPM4/ARHGAP26/ARHGEF10/WIPF1/NCK2/RHOQ/IQGAP1/RTKN/ARHGEF7/DLG5/DOCK9/TJP2/PICALM/TFRC/ARHGAP31/FLOT2/LRRC1/TRA2B/GJA1/KCTD3/RBBP6/ARFGAP3/LBR/ITSN2/PCDH7/PDE5A/ARHGAP5/ARHGAP42/STIP1/TEX2/CAVIN1/ARHGEF3/SPATA13/YWHAG/ARHGAP23/MYO9B/PRKCZ/STK38/FLOT1/LIMK2/PTK2/NUP98/PREX1/PPP1CB/ARHGAP1/PAFAH1B1/DYNC1I1/NUF2/RHOB/LMNB1/ABR/ARAP3/ACTR3/SLITRK5/CHN1/AHCTF1/GRB2/SLK/NGEF/TUBB2A/OPHN1/PLXND1/FERMT2/SKA1/RHOBTB2/GIT1/PAK3/CFTR/TUBB4A/FLNA,81,2.0903689061420847,1.646713566785443,2.653553266276693
R-HSA-9679506,SARS-CoV Infections,51/1194,392/9872,0.13010204081632654,1.075684545174854,0.567177490437618,0.30780903393559134,0.9958094216021639,0.9590614635152119,ZDHHC11/ATP1A2/IFNAR2/MGAT4C/VEGFA/TLR2/PARP9/GATAD2A/ANO3/NFE2L2/BCL2L1/NUP205/GJA1/NOD2/G3BP1/GPC5/RUNX1/CYSLTR1/ST3GAL4/PTGES3/JAK3/IRAK2/YWHAG/SEC24D/NUP58/ZDHHC2/PTPN11/ATP1B3/NUP98/NUP188/NUP153/NFKBIA/ITGA4/GEMIN8/SEC23A/EDEM2/GRB2/GPC2/RELA/CASP1/TUSC3/FNTB/RNF135/TRAF6/SFTPD/ATP1A3/RCAN3/SEC24A/FXYD1/STAT1/IKBKE,51,2.1253268895497897,1.5783328473370777,2.8618896166701298
R-HSA-177929,Signaling by EGFR,8/1194,53/9872,0.1509433962264151,1.2480010113460385,0.6714762759205776,0.30795802848404774,0.9958094216021639,0.9590614635152119,PXN/ARHGEF7/ADAM12/SPRY1/PTPN11/GAB1/GRB2/PAG1,8,2.4657880597958344,1.1697523689827918,5.197775971267258
R-HSA-109704,PI3K Cascade,6/1194,38/9872,0.15789473684210525,1.3054747421317112,0.6998015815475691,0.3084719989905554,0.9958094216021639,0.9590614635152119,FGF20/FGFR3/FGFR2/PTPN11/GAB1/GRB2,6,2.57934408886538,1.0882068068203343,6.113742247399125
R-HSA-111996,Ca-dependent events,6/1194,38/9872,0.15789473684210525,1.3054747421317112,0.6998015815475691,0.3084719989905554,0.9958094216021639,0.9590614635152119,PRKAR2A/CAMK2D/PRKCG/ADCY3/CAMK4/CAMK2G,6,2.57934408886538,1.0882068068203343,6.113742247399125
R-HSA-432040,Vasopressin regulates renal water homeostasis via Aquaporins,6/1194,38/9872,0.15789473684210525,1.3054747421317112,0.6998015815475691,0.3084719989905554,0.9958094216021639,0.9590614635152119,GNB3/PRKAR2A/RAB11FIP2/ADCY3/GNG3/AQP4,6,2.57934408886538,1.0882068068203343,6.113742247399125
R-HSA-5173214,O-glycosylation of TSR domain-containing proteins,6/1194,38/9872,0.15789473684210525,1.3054747421317112,0.6998015815475691,0.3084719989905554,0.9958094216021639,0.9590614635152119,ADAMTS2/SPON1/B3GLCT/ADAMTS10/ADAMTS18/THSD7B,6,2.57934408886538,1.0882068068203343,6.113742247399125
R-HSA-5689896,Ovarian tumor domain proteases,6/1194,38/9872,0.15789473684210525,1.3054747421317112,0.6998015815475691,0.3084719989905554,0.9958094216021639,0.9590614635152119,NOD2/TNIP2/YOD1/UBE2D1/RNF135/TRAF6,6,2.57934408886538,1.0882068068203343,6.113742247399125
R-HSA-9607240,FLT3 Signaling,6/1194,38/9872,0.15789473684210525,1.3054747421317112,0.6998015815475691,0.3084719989905554,0.9958094216021639,0.9590614635152119,PTPRJ/GRB10/STAT5B/PTPN11/GRB2/STAT5A,6,2.57934408886538,1.0882068068203343,6.113742247399125
R-HSA-2514859,"Inactivation, recovery and regulation of the phototransduction cascade",5/1194,31/9872,0.16129032258064516,1.3335494677689523,0.6899131128782481,0.31869319512989125,0.9999999999999981,0.963097398669085,GUCA1B/GRK7/FNTB/GRK4/RGS9,5,2.634813854217323,1.0226742308395538,6.788324020520573
R-HSA-2871796,FCERI mediated MAPK activation,5/1194,31/9872,0.16129032258064516,1.3335494677689523,0.6899131128782481,0.31869319512989125,0.9999999999999981,0.963097398669085,PAK2/MAP2K4/FOS/JUN/GRB2,5,2.634813854217323,1.0226742308395538,6.788324020520573
R-HSA-9680350,Signaling by CSF1 (M-CSF) in myeloid cells,5/1194,31/9872,0.16129032258064516,1.3335494677689523,0.6899131128782481,0.31869319512989125,0.9999999999999981,0.963097398669085,STAT3/PTPN11/GRB2/CSF1/STAT1,5,2.634813854217323,1.0226742308395538,6.788324020520573
R-HSA-2428924,IGF1R signaling cascade,7/1194,46/9872,0.15217391304347827,1.2581749326341856,0.6509948078428468,0.31894340841024765,0.9999999999999981,0.963097398669085,FGF20/FGFR3/IGF1/FGFR2/PTPN11/GAB1/GRB2,7,2.4858895928919957,1.1199739383218532,5.517670417677927
R-HSA-2024096,HS-GAG degradation,4/1194,24/9872,0.16666666666666666,1.378001116694584,0.6876977448674666,0.32916008820013753,0.9999999999999981,0.963097398669085,GPC5/GLB1L3/GPC2/HPSE2,4,2.7226409826912343,0.9431497570311378,7.85959373404701
R-HSA-5627123,RHO GTPases activate PAKs,4/1194,24/9872,0.16666666666666666,1.378001116694584,0.6876977448674666,0.32916008820013753,0.9999999999999981,0.963097398669085,PAK2/PPP1CB/PAK3/FLNA,4,2.7226409826912343,0.9431497570311378,7.85959373404701
R-HSA-9006335,Signaling by Erythropoietin,4/1194,24/9872,0.16666666666666666,1.378001116694584,0.6876977448674666,0.32916008820013753,0.9999999999999981,0.963097398669085,STAT5B/GAB1/GRB2/STAT5A,4,2.7226409826912343,0.9431497570311378,7.85959373404701
R-HSA-933542,TRAF6 mediated NF-kB activation,4/1194,24/9872,0.16666666666666666,1.378001116694584,0.6876977448674666,0.32916008820013753,0.9999999999999981,0.963097398669085,NFKBIA/RELA/RNF135/TRAF6,4,2.7226409826912343,0.9431497570311378,7.85959373404701
R-HSA-975576,N-glycan antennae elongation in the medial/trans-Golgi,4/1194,24/9872,0.16666666666666666,1.378001116694584,0.6876977448674666,0.32916008820013753,0.9999999999999981,0.963097398669085,MGAT4C/ST3GAL4/B4GALT5/ST8SIA3,4,2.7226409826912343,0.9431497570311378,7.85959373404701
R-HSA-168276,NS1 Mediated Effects on Host Pathways,6/1194,39/9872,0.15384615384615385,1.2720010307950007,0.6312955823570642,0.3308307027418125,0.9999999999999981,0.963097398669085,NUP205/KPNA3/NUP58/NUP98/NUP188/NUP153,6,2.5132070609457546,1.0618990525281529,5.948032175139495
R-HSA-190828,Gap junction trafficking,6/1194,39/9872,0.15384615384615385,1.2720010307950007,0.6312955823570642,0.3308307027418125,0.9999999999999981,0.963097398669085,GJA1/GJB6/GJB7/TUBB2A/TUBB4A/DNM1,6,2.5132070609457546,1.0618990525281529,5.948032175139495
R-HSA-381676,Glucagon-like Peptide-1 (GLP1) regulates insulin secretion,6/1194,39/9872,0.15384615384615385,1.2720010307950007,0.6312955823570642,0.3308307027418125,0.9999999999999981,0.963097398669085,GNB3/PRKAR2A/IQGAP1/RAP1A/GNG3/KCNB1,6,2.5132070609457546,1.0618990525281529,5.948032175139495
R-HSA-9031628,NGF-stimulated transcription,6/1194,39/9872,0.15384615384615385,1.2720010307950007,0.6312955823570642,0.3308307027418125,0.9999999999999981,0.963097398669085,SGK1/VGF/ID4/FOS/EGR1/JUNB,6,2.5132070609457546,1.0618990525281529,5.948032175139495
R-HSA-9664323,FCGR3A-mediated IL10 synthesis,6/1194,39/9872,0.15384615384615385,1.2720010307950007,0.6312955823570642,0.3308307027418125,0.9999999999999981,0.963097398669085,PRKAR2A/FGR/ADCY3/FCGR2A/FCGR3A/FCGR1A,6,2.5132070609457546,1.0618990525281529,5.948032175139495
R-HSA-1482801,Acyl chain remodelling of PS,3/1194,17/9872,0.17647058823529413,1.4590600059119125,0.7026491427985302,0.3391395555078043,0.9999999999999981,0.963097398669085,OSBPL5/PLAAT3/PLA2G12A,3,2.882796334614248,0.8436403940149837,9.850778561366209
R-HSA-190840,Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane,3/1194,17/9872,0.17647058823529413,1.4590600059119125,0.7026491427985302,0.3391395555078043,0.9999999999999981,0.963097398669085,GJA1/TUBB2A/TUBB4A,3,2.882796334614248,0.8436403940149837,9.850778561366209
R-HSA-190872,Transport of connexons to the plasma membrane,3/1194,17/9872,0.17647058823529413,1.4590600059119125,0.7026491427985302,0.3391395555078043,0.9999999999999981,0.963097398669085,GJA1/TUBB2A/TUBB4A,3,2.882796334614248,0.8436403940149837,9.850778561366209
R-HSA-196757,Metabolism of folate and pterines,3/1194,17/9872,0.17647058823529413,1.4590600059119125,0.7026491427985302,0.3391395555078043,0.9999999999999981,0.963097398669085,SHMT1/FOLR2/SLC25A32,3,2.882796334614248,0.8436403940149837,9.850778561366209
R-HSA-2142691,Synthesis of Leukotrienes (LT) and Eoxins (EX),3/1194,17/9872,0.17647058823529413,1.4590600059119125,0.7026491427985302,0.3391395555078043,0.9999999999999981,0.963097398669085,LTC4S/DPEP2/ALOX5AP,3,2.882796334614248,0.8436403940149837,9.850778561366209
R-HSA-432142,Platelet sensitization by LDL,3/1194,17/9872,0.17647058823529413,1.4590600059119125,0.7026491427985302,0.3391395555078043,0.9999999999999981,0.963097398669085,FGR/PTPN11/PECAM1,3,2.882796334614248,0.8436403940149837,9.850778561366209
R-HSA-9617828,FOXO-mediated transcription of cell cycle genes,3/1194,17/9872,0.17647058823529413,1.4590600059119125,0.7026491427985302,0.3391395555078043,0.9999999999999981,0.963097398669085,CDKN1A/FOXG1/CCNG2,3,2.882796334614248,0.8436403940149837,9.850778561366209
R-HSA-9856532,Mechanical load activates signaling by PIEZO1 and integrins in osteocytes,3/1194,17/9872,0.17647058823529413,1.4590600059119125,0.7026491427985302,0.3391395555078043,0.9999999999999981,0.963097398669085,ITGB3/SPP1/GJA1,3,2.882796334614248,0.8436403940149837,9.850778561366209
R-HSA-2404192,Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R),7/1194,47/9872,0.14893617021276595,1.2314052532164368,0.5898326100582741,0.33941964243215733,0.9999999999999981,0.963097398669085,FGF20/FGFR3/IGF1/FGFR2/PTPN11/GAB1/GRB2,7,2.4329983249581235,1.097367644644491,5.394254950141837
R-HSA-74751,Insulin receptor signalling cascade,7/1194,47/9872,0.14893617021276595,1.2314052532164368,0.5898326100582741,0.33941964243215733,0.9999999999999981,0.963097398669085,FGF20/FGFR3/GRB10/FGFR2/PTPN11/GAB1/GRB2,7,2.4329983249581235,1.097367644644491,5.394254950141837
R-HSA-180746,Nuclear import of Rev protein,5/1194,32/9872,0.15625,1.2918760469011725,0.6134071191204917,0.3438023974174456,0.9999999999999981,0.963097398669085,NUP205/NUP58/NUP98/NUP188/NUP153,5,2.5524759212730315,0.9927469125940794,6.56273340770646
R-HSA-180910,Vpr-mediated nuclear import of PICs,5/1194,32/9872,0.15625,1.2918760469011725,0.6134071191204917,0.3438023974174456,0.9999999999999981,0.963097398669085,NUP205/NUP58/NUP98/NUP188/NUP153,5,2.5524759212730315,0.9927469125940794,6.56273340770646
R-HSA-375280,Amine ligand-binding receptors,5/1194,32/9872,0.15625,1.2918760469011725,0.6134071191204917,0.3438023974174456,0.9999999999999981,0.963097398669085,CHRM5/HTR2B/ADRB1/HRH2/CHRM1,5,2.5524759212730315,0.9927469125940794,6.56273340770646
R-HSA-9861718,Regulation of pyruvate metabolism,5/1194,32/9872,0.15625,1.2918760469011725,0.6134071191204917,0.3438023974174456,0.9999999999999981,0.963097398669085,PDK1/MKLN1/LDHA/PDK3/PDHX,5,2.5524759212730315,0.9927469125940794,6.56273340770646
R-HSA-1234158,Regulation of gene expression by Hypoxia-inducible Factor,2/1194,10/9872,0.2,1.653601340033501,0.7670141064273587,0.3454236053710449,0.9999999999999981,0.963097398669085,VEGFA/HIF1A,2,3.267169179229481,0.7150451336168796,14.928280669100213
R-HSA-170660,Adenylate cyclase activating pathway,2/1194,10/9872,0.2,1.653601340033501,0.7670141064273587,0.3454236053710449,0.9999999999999981,0.963097398669085,ADCY3/GNAL,2,3.267169179229481,0.7150451336168796,14.928280669100213
R-HSA-1855167,Synthesis of pyrophosphates in the cytosol,2/1194,10/9872,0.2,1.653601340033501,0.7670141064273587,0.3454236053710449,0.9999999999999981,0.963097398669085,IP6K3/ITPK1,2,3.267169179229481,0.7150451336168796,14.928280669100213
R-HSA-2453864,Retinoid cycle disease events,2/1194,10/9872,0.2,1.653601340033501,0.7670141064273587,0.3454236053710449,0.9999999999999981,0.963097398669085,RBP4/RLBP1,2,3.267169179229481,0.7150451336168796,14.928280669100213
R-HSA-2474795,Diseases associated with visual transduction,2/1194,10/9872,0.2,1.653601340033501,0.7670141064273587,0.3454236053710449,0.9999999999999981,0.963097398669085,RBP4/RLBP1,2,3.267169179229481,0.7150451336168796,14.928280669100213
R-HSA-2559584,Formation of Senescence-Associated Heterochromatin Foci (SAHF),2/1194,10/9872,0.2,1.653601340033501,0.7670141064273587,0.3454236053710449,0.9999999999999981,0.963097398669085,CABIN1/LMNB1,2,3.267169179229481,0.7150451336168796,14.928280669100213
R-HSA-399997,Acetylcholine regulates insulin secretion,2/1194,10/9872,0.2,1.653601340033501,0.7670141064273587,0.3454236053710449,0.9999999999999981,0.963097398669085,MARCKS/PLCB1,2,3.267169179229481,0.7150451336168796,14.928280669100213
R-HSA-418890,Role of second messengers in netrin-1 signaling,2/1194,10/9872,0.2,1.653601340033501,0.7670141064273587,0.3454236053710449,0.9999999999999981,0.963097398669085,TRPC5/NTN1,2,3.267169179229481,0.7150451336168796,14.928280669100213
R-HSA-442729,CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde,2/1194,10/9872,0.2,1.653601340033501,0.7670141064273587,0.3454236053710449,0.9999999999999981,0.963097398669085,CAMK4/CAMK2G,2,3.267169179229481,0.7150451336168796,14.928280669100213
R-HSA-450341,Activation of the AP-1 family of transcription factors,2/1194,10/9872,0.2,1.653601340033501,0.7670141064273587,0.3454236053710449,0.9999999999999981,0.963097398669085,FOS/JUN,2,3.267169179229481,0.7150451336168796,14.928280669100213
R-HSA-5661231,Metallothioneins bind metals,2/1194,10/9872,0.2,1.653601340033501,0.7670141064273587,0.3454236053710449,0.9999999999999981,0.963097398669085,MT1M/MT1X,2,3.267169179229481,0.7150451336168796,14.928280669100213
R-HSA-8866910,TFAP2 (AP-2) family regulates transcription of growth factors and their receptors,2/1194,10/9872,0.2,1.653601340033501,0.7670141064273587,0.3454236053710449,0.9999999999999981,0.963097398669085,VEGFA/ATAD2,2,3.267169179229481,0.7150451336168796,14.928280669100213
R-HSA-8875656,MET receptor recycling,2/1194,10/9872,0.2,1.653601340033501,0.7670141064273587,0.3454236053710449,0.9999999999999981,0.963097398669085,GAB1/GRB2,2,3.267169179229481,0.7150451336168796,14.928280669100213
R-HSA-8963693,Aspartate and asparagine metabolism,2/1194,10/9872,0.2,1.653601340033501,0.7670141064273587,0.3454236053710449,0.9999999999999981,0.963097398669085,NAALAD2/ASPA,2,3.267169179229481,0.7150451336168796,14.928280669100213
R-HSA-937042,IRAK2 mediated activation of TAK1 complex,2/1194,10/9872,0.2,1.653601340033501,0.7670141064273587,0.3454236053710449,0.9999999999999981,0.963097398669085,IRAK2/TRAF6,2,3.267169179229481,0.7150451336168796,14.928280669100213
R-HSA-9675143,Diseases of the neuronal system,2/1194,10/9872,0.2,1.653601340033501,0.7670141064273587,0.3454236053710449,0.9999999999999981,0.963097398669085,RBP4/RLBP1,2,3.267169179229481,0.7150451336168796,14.928280669100213
R-HSA-9706019,RHOBTB3 ATPase cycle,2/1194,10/9872,0.2,1.653601340033501,0.7670141064273587,0.3454236053710449,0.9999999999999981,0.963097398669085,PLIN3/RHOBTB3,2,3.267169179229481,0.7150451336168796,14.928280669100213
R-HSA-9821002,Chromatin modifications during the maternal to zygotic transition (MZT),2/1194,10/9872,0.2,1.653601340033501,0.7670141064273587,0.3454236053710449,0.9999999999999981,0.963097398669085,UHRF1/KDM6A,2,3.267169179229481,0.7150451336168796,14.928280669100213
R-HSA-1442490,Collagen degradation,8/1194,55/9872,0.14545454545454545,1.2026191563880004,0.5589144894463888,0.34576621296832344,0.9999999999999981,0.963097398669085,COL10A1/COL9A1/ADAM9/COL5A3/COL4A2/COL5A2/MMP19/COL12A1,8,2.3761230394396224,1.1292121238333948,4.999911512984076
R-HSA-432722,Golgi Associated Vesicle Biogenesis,8/1194,55/9872,0.14545454545454545,1.2026191563880004,0.5589144894463888,0.34576621296832344,0.9999999999999981,0.963097398669085,SNX9/DTNBP1/PICALM/TFRC/IGF2R/SORT1/TPD52L1/ARRB1,8,2.3761230394396224,1.1292121238333948,4.999911512984076
R-HSA-6794361,Neurexins and neuroligins,8/1194,55/9872,0.14545454545454545,1.2026191563880004,0.5589144894463888,0.34576621296832344,0.9999999999999981,0.963097398669085,NRXN1/GRIN1/DLGAP1/LRRTM2/NRXN3/LRRTM1/GRIN2B/NLGN4X,8,2.3761230394396224,1.1292121238333948,4.999911512984076
R-HSA-211945,Phase I - Functionalization of compounds,13/1194,94/9872,0.13829787234042554,1.1434477351295484,0.5183290173755573,0.34697628152188875,0.9999999999999981,0.963097398669085,AHR/PTGES3/NCOA1/ALDH3A1/CYP8B1/CYP27A1/AOC2/CBR3/CYP26C1/CYP39A1/FMO3/ADH1A/ADH4,13,2.2592127303182576,1.261247340720238,4.046820949424085
R-HSA-165159,MTOR signalling,6/1194,40/9872,0.15,1.2402010050251255,0.5646207016506736,0.3533788711640374,0.9999999999999981,0.963097398669085,EIF4EBP1/PRKAG3/CAB39/RRAGD/EEF2K/EIF4G1,6,2.4503768844221105,1.036833620098851,5.791041840577816
R-HSA-419037,NCAM1 interactions,6/1194,40/9872,0.15,1.2402010050251255,0.5646207016506736,0.3533788711640374,0.9999999999999981,0.963097398669085,CACNB4/COL9A1/COL5A3/COL4A2/COL5A2/CACNA1D,6,2.4503768844221105,1.036833620098851,5.791041840577816
R-HSA-9609736,Assembly and cell surface presentation of NMDA receptors,6/1194,40/9872,0.15,1.2402010050251255,0.5646207016506736,0.3533788711640374,0.9999999999999981,0.963097398669085,GRIN1/CAMK2D/TUBB2A/GRIN2B/TUBB4A/CAMK2G,6,2.4503768844221105,1.036833620098851,5.791041840577816
R-HSA-1169408,ISG15 antiviral mechanism,10/1194,71/9872,0.14084507042253522,1.164507985939085,0.516004966358679,0.3543515607282044,0.9999999999999981,0.963097398669085,NUP205/PPM1B/UBA7/KPNA3/NUP58/NUP98/NUP188/NUP153/STAT1/EIF4G1,10,2.300823365654564,1.1837364022011108,4.472100503201902
R-HSA-375276,Peptide ligand-binding receptors,19/1194,142/9872,0.13380281690140844,1.1062825866421309,0.4731760820967929,0.35515502840648633,0.9999999999999981,0.963097398669085,EDNRB/CX3CR1/CXCL12/TACR1/PENK/C5AR1/NPFFR1/CX3CL1/OPRM1/PROK2/QRFP/CCRL2/HCRTR2/ACKR3/CCL2/PDYN/KEL/NTSR2/CCL3,19,2.185782197371836,1.3493568265560543,3.540682286791084
R-HSA-8978868,Fatty acid metabolism,22/1194,166/9872,0.13253012048192772,1.095759924118585,0.46152008957646773,0.35672627019781217,0.9999999999999981,0.963097398669085,ALDH3A2/ELOVL5/ACSL1/LTC4S/ACSF2/TECR/ACSM6/ACSL4/PTGES3/ALOX15B/ACSM3/DPEP2/CYP8B1/FADS1/PPARD/ACSL6/HACD2/HACD4/ELOVL2/AKR1C3/PCTP/ALOX5AP,22,2.16499162479062,1.382497211382739,3.390378437527205
R-HSA-2219530,Constitutive Signaling by Aberrant PI3K in Cancer,11/1194,79/9872,0.13924050632911392,1.1512414392638295,0.5006098452879123,0.3573124338144751,0.9999999999999981,0.963097398669085,FGF20/FGFR3/PDGFRA/FGFR2/PDGFRB/BDNF/PTPN11/PDGFA/GAB1/NRG1/GRB2,11,2.2746114538939426,1.2072483887614889,4.2856609413190885
R-HSA-2029485,Role of phospholipids in phagocytosis,4/1194,25/9872,0.16,1.3228810720268007,0.5995612250915173,0.35809472636998485,0.9999999999999981,0.963097398669085,PLD4/FCGR2A/FCGR3A/FCGR1A,4,2.613735343383585,0.9081659678940998,7.522427272950986
R-HSA-420029,Tight junction interactions,4/1194,25/9872,0.16,1.3228810720268007,0.5995612250915173,0.35809472636998485,0.9999999999999981,0.963097398669085,CLDN11/CLDN10/CLDN15/CLDN20,4,2.613735343383585,0.9081659678940998,7.522427272950986
R-HSA-5654732,Negative regulation of FGFR3 signaling,4/1194,25/9872,0.16,1.3228810720268007,0.5995612250915173,0.35809472636998485,0.9999999999999981,0.963097398669085,FGF20/FGFR3/PTPN11/GRB2,4,2.613735343383585,0.9081659678940998,7.522427272950986
R-HSA-9648002,RAS processing,4/1194,25/9872,0.16,1.3228810720268007,0.5995612250915173,0.35809472636998485,0.9999999999999981,0.963097398669085,BCL2L1/ABHD17C/ABHD17B/FNTB,4,2.613735343383585,0.9081659678940998,7.522427272950986
R-HSA-9664565,Signaling by ERBB2 KD Mutants,4/1194,25/9872,0.16,1.3228810720268007,0.5995612250915173,0.35809472636998485,0.9999999999999981,0.963097398669085,ERBIN/GAB1/NRG1/GRB2,4,2.613735343383585,0.9081659678940998,7.522427272950986
R-HSA-2122947,NOTCH1 Intracellular Domain Regulates Transcription,7/1194,48/9872,0.14583333333333334,1.205750977107761,0.5300187879167351,0.36005655510048457,0.9999999999999981,0.963097398669085,HES5/KAT2B/HDAC4/HIF1A/CUL1/HES1/TLE1,7,2.38231085985483,1.0756562175809443,5.276225749659815
R-HSA-381038,XBP1(S) activates chaperone genes,7/1194,48/9872,0.14583333333333334,1.205750977107761,0.5300187879167351,0.36005655510048457,0.9999999999999981,0.963097398669085,SRPRB/LMNA/GOSR2/ADD1/SEC31A/EDEM1/DDX11,7,2.38231085985483,1.0756562175809443,5.276225749659815
R-HSA-163685,Integration of energy metabolism,14/1194,103/9872,0.13592233009708737,1.1238067359450976,0.46850124353279116,0.363076249847776,0.9999999999999981,0.963097398669085,ADIPOR2/GNB3/GNAI1/PRKAR2A/MARCKS/IQGAP1/RAP1A/ACSL4/PLCB1/ADCY3/SLC2A1/GNG3/KCNB1/CACNA1D,14,2.2204062383112975,1.2666077597287602,3.892447227851749
R-HSA-159227,Transport of the SLBP independent Mature mRNA,5/1194,33/9872,0.15151515151515152,1.2527282879041672,0.5393966704915151,0.36903116733493996,0.9999999999999981,0.963097398669085,NUP205/NUP58/NUP98/NUP188/NUP153,5,2.4751281660829396,0.9645215851630167,6.351604290433458
R-HSA-165054,Rev-mediated nuclear export of HIV RNA,5/1194,33/9872,0.15151515151515152,1.2527282879041672,0.5393966704915151,0.36903116733493996,0.9999999999999981,0.963097398669085,NUP205/NUP58/NUP98/NUP188/NUP153,5,2.4751281660829396,0.9645215851630167,6.351604290433458
R-HSA-4085377,SUMOylation of SUMOylation proteins,5/1194,33/9872,0.15151515151515152,1.2527282879041672,0.5393966704915151,0.36903116733493996,0.9999999999999981,0.963097398669085,NUP205/NUP58/NUP98/NUP188/NUP153,5,2.4751281660829396,0.9645215851630167,6.351604290433458
R-HSA-8936459,RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function,5/1194,33/9872,0.15151515151515152,1.2527282879041672,0.5393966704915151,0.36903116733493996,0.9999999999999981,0.963097398669085,CBFB/KAT2B/TNRC6C/RUNX1/WDR5,5,2.4751281660829396,0.9645215851630167,6.351604290433458
R-HSA-181429,Serotonin Neurotransmitter Release Cycle,3/1194,18/9872,0.16666666666666666,1.378001116694584,0.5953823732380484,0.3739684043024597,0.9999999999999981,0.963097398669085,PPFIA2/SYN2/PPFIA4,3,2.722640982691234,0.8008606474826132,9.256009698979275
R-HSA-210993,Tie2 Signaling,3/1194,18/9872,0.16666666666666666,1.378001116694584,0.5953823732380484,0.3739684043024597,0.9999999999999981,0.963097398669085,PTPN11/ANGPT2/GRB2,3,2.722640982691234,0.8008606474826132,9.256009698979275
R-HSA-446353,Cell-extracellular matrix interactions,3/1194,18/9872,0.16666666666666666,1.378001116694584,0.5953823732380484,0.3739684043024597,0.9999999999999981,0.963097398669085,PXN/FERMT2/FLNA,3,2.722640982691234,0.8008606474826132,9.256009698979275
R-HSA-5635838,Activation of SMO,3/1194,18/9872,0.16666666666666666,1.378001116694584,0.5953823732380484,0.3739684043024597,0.9999999999999981,0.963097398669085,DHH/CDON/ARRB1,3,2.722640982691234,0.8008606474826132,9.256009698979275
R-HSA-5654699,SHC-mediated cascade:FGFR2,3/1194,18/9872,0.16666666666666666,1.378001116694584,0.5953823732380484,0.3739684043024597,0.9999999999999981,0.963097398669085,FGF20/FGFR2/GRB2,3,2.722640982691234,0.8008606474826132,9.256009698979275
R-HSA-5654712,FRS-mediated FGFR4 signaling,3/1194,18/9872,0.16666666666666666,1.378001116694584,0.5953823732380484,0.3739684043024597,0.9999999999999981,0.963097398669085,FGF20/PTPN11/GRB2,3,2.722640982691234,0.8008606474826132,9.256009698979275
R-HSA-933541,TRAF6 mediated IRF7 activation,3/1194,18/9872,0.16666666666666666,1.378001116694584,0.5953823732380484,0.3739684043024597,0.9999999999999981,0.963097398669085,RNF135/TRAF6/IKBKE,3,2.722640982691234,0.8008606474826132,9.256009698979275
R-HSA-157858,Gap junction trafficking and regulation,6/1194,41/9872,0.14634146341463414,1.2099522000245126,0.49967362563161843,0.3760344991823695,0.9999999999999981,0.963097398669085,GJA1/GJB6/GJB7/TUBB2A/TUBB4A/DNM1,6,2.3906115945581567,1.0129245206632467,5.64210232791461
R-HSA-2426168,Activation of gene expression by SREBF (SREBP),6/1194,41/9872,0.14634146341463414,1.2099522000245126,0.49967362563161843,0.3760344991823695,0.9999999999999981,0.963097398669085,MVK/TM7SF2/HELZ2/DHCR7/NCOA1/LSS,6,2.3906115945581567,1.0129245206632467,5.64210232791461
R-HSA-9660821,ADORA2B mediated anti-inflammatory cytokines production,6/1194,41/9872,0.14634146341463414,1.2099522000245126,0.49967362563161843,0.3760344991823695,0.9999999999999981,0.963097398669085,GNB3/GNAI1/PRKAR2A/ADCY3/GNG3/GNAZ,6,2.3906115945581567,1.0129245206632467,5.64210232791461
R-HSA-9694548,Maturation of spike protein,6/1194,41/9872,0.14634146341463414,1.2099522000245126,0.49967362563161843,0.3760344991823695,0.9999999999999981,0.963097398669085,ZDHHC11/MGAT4C/ST3GAL4/ZDHHC2/EDEM2/TUSC3,6,2.3906115945581567,1.0129245206632467,5.64210232791461
R-HSA-199418,Negative regulation of the PI3K/AKT network,15/1194,112/9872,0.13392857142857142,1.1073223259152907,0.4236889086751251,0.3778867251530855,0.9999999999999981,0.963097398669085,PIP4K2A/FGF20/FGFR3/PIP5K1B/PDGFRA/FGFR2/PDGFRB/BDNF/PTPN11/PDGFA/GAB1/NRG1/GRB2/IL1RAP/TRAF6,15,2.187836503948313,1.2723435804077363,3.762056603040234
R-HSA-1483249,Inositol phosphate metabolism,7/1194,49/9872,0.14285714285714285,1.1811438143096433,0.47148989874977737,0.3807918988320279,0.9999999999999981,0.963097398669085,IP6K3/ITPK1/ITPKC/PLD4/PLCZ1/PLCB1/PLCH2,7,2.3336922708782004,1.0547875370996525,5.163238494580469
R-HSA-6811440,Retrograde transport at the Trans-Golgi-Network,7/1194,49/9872,0.14285714285714285,1.1811438143096433,0.47148989874977737,0.3807918988320279,0.9999999999999981,0.963097398669085,PLIN3/STX6/RHOBTB3/VPS53/IGF2R/TMF1/NSF,7,2.3336922708782004,1.0547875370996525,5.163238494580469
R-HSA-9012852,Signaling by NOTCH3,7/1194,49/9872,0.14285714285714285,1.1811438143096433,0.47148989874977737,0.3807918988320279,0.9999999999999981,0.963097398669085,NEURL1B/HES5/KAT2B/HES1/PLXND1/STAT1/FABP7,7,2.3336922708782004,1.0547875370996525,5.163238494580469
R-HSA-9856649,Transcriptional and post-translational regulation of MITF-M expression and activity,7/1194,49/9872,0.14285714285714285,1.1811438143096433,0.47148989874977737,0.3807918988320279,0.9999999999999981,0.963097398669085,EDNRB/MARK3/TFEB/YWHAG/CSF1/SOX10/TFE3,7,2.3336922708782004,1.0547875370996525,5.163238494580469
R-HSA-373755,Semaphorin interactions,9/1194,65/9872,0.13846153846153847,1.1448009277155005,0.4344430474560986,0.3865366010455632,0.9999999999999981,0.963097398669085,PAK2/SEMA3A/LIMK2/RHOB/PLXNA3/PLXNA2/PLXND1/CRMP1/PAK3,9,2.2618863548511787,1.1237329921635204,4.5527985010139105
R-HSA-1227990,Signaling by ERBB2 in Cancer,4/1194,26/9872,0.15384615384615385,1.2720010307950007,0.5151102888453782,0.3870014495339805,0.9999999999999981,0.963097398669085,ERBIN/GAB1/NRG1/GRB2,4,2.5132070609457546,0.8756842428712379,7.212884989774042
R-HSA-9717189,Sensory perception of taste,4/1194,26/9872,0.15384615384615385,1.2720010307950007,0.5151102888453782,0.3870014495339805,0.9999999999999981,0.963097398669085,GNB3/SCN2A/SCN1B/SCN4B,4,2.5132070609457546,0.8756842428712379,7.212884989774042
R-HSA-1483257,Phospholipid metabolism,26/1194,201/9872,0.12935323383084577,1.0694934040017665,0.3692145767341915,0.3879995084761872,0.9999999999999981,0.963097398669085,PIP4K2A/ETNPPL/OSBPL5/PTPN13/SYNJ2/PIK3C2B/INPP5F/MTMR10/MBOAT2/PLEKHA1/PIP5K1B/MGLL/PGS1/CHPT1/PLD4/PLAAT1/PLAAT3/GPAT4/PLEKHA8/AGPAT5/MBOAT7/PCTP/TPTE2/SBF1/PLA2G12A/CHKA,26,2.1130944940290175,1.3986432878935915,3.192499745535874
R-HSA-9818564,Epigenetic regulation of gene expression by MLL3 and MLL4 complexes,10/1194,73/9872,0.136986301369863,1.1326036575571923,0.4217926143367931,0.3882677754507412,0.9999999999999981,0.963097398669085,ELOVL5/ACSL1/MGLL/NCOA1/CEBPA/WDR5/PPARG/KDM6A/PHLDA1/LPL,10,2.237787109061288,1.1525910699662394,4.344724921066374
R-HSA-9841922,MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis,10/1194,73/9872,0.136986301369863,1.1326036575571923,0.4217926143367931,0.3882677754507412,0.9999999999999981,0.963097398669085,ELOVL5/ACSL1/MGLL/NCOA1/CEBPA/WDR5/PPARG/KDM6A/PHLDA1/LPL,10,2.237787109061288,1.1525910699662394,4.344724921066374
R-HSA-9851695,Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes,10/1194,73/9872,0.136986301369863,1.1326036575571923,0.4217926143367931,0.3882677754507412,0.9999999999999981,0.963097398669085,ELOVL5/ACSL1/MGLL/NCOA1/CEBPA/WDR5/PPARG/KDM6A/PHLDA1/LPL,10,2.237787109061288,1.1525910699662394,4.344724921066374
R-HSA-156581,Methylation,2/1194,11/9872,0.18181818181818182,1.5032739454850008,0.6194599414806211,0.39129935699204643,0.9999999999999981,0.963097398669085,MAT2A/NNMT,2,2.9701537992995277,0.6575839025933642,13.415495051965467
R-HSA-156588,Glucuronidation,2/1194,11/9872,0.18181818181818182,1.5032739454850008,0.6194599414806211,0.39129935699204643,0.9999999999999981,0.963097398669085,SLC35D2/UGT3A2,2,2.9701537992995277,0.6575839025933642,13.415495051965467
R-HSA-193692,Regulated proteolysis of p75NTR,2/1194,11/9872,0.18181818181818182,1.5032739454850008,0.6194599414806211,0.39129935699204643,0.9999999999999981,0.963097398669085,RELA/TRAF6,2,2.9701537992995277,0.6575839025933642,13.415495051965467
R-HSA-196025,Formation of annular gap junctions,2/1194,11/9872,0.18181818181818182,1.5032739454850008,0.6194599414806211,0.39129935699204643,0.9999999999999981,0.963097398669085,GJA1/DNM1,2,2.9701537992995277,0.6575839025933642,13.415495051965467
R-HSA-2022923,Dermatan sulfate biosynthesis,2/1194,11/9872,0.18181818181818182,1.5032739454850008,0.6194599414806211,0.39129935699204643,0.9999999999999981,0.963097398669085,CSPG5/BCAN,2,2.9701537992995277,0.6575839025933642,13.415495051965467
R-HSA-400451,Free fatty acids regulate insulin secretion,2/1194,11/9872,0.18181818181818182,1.5032739454850008,0.6194599414806211,0.39129935699204643,0.9999999999999981,0.963097398669085,ACSL4/PLCB1,2,2.9701537992995277,0.6575839025933642,13.415495051965467
R-HSA-549132,Organic cation/anion/zwitterion transport,2/1194,11/9872,0.18181818181818182,1.5032739454850008,0.6194599414806211,0.39129935699204643,0.9999999999999981,0.963097398669085,RUNX1/SLC22A3,2,2.9701537992995277,0.6575839025933642,13.415495051965467
R-HSA-5655291,Signaling by FGFR4 in disease,2/1194,11/9872,0.18181818181818182,1.5032739454850008,0.6194599414806211,0.39129935699204643,0.9999999999999981,0.963097398669085,GAB1/GRB2,2,2.9701537992995277,0.6575839025933642,13.415495051965467
R-HSA-71384,Ethanol oxidation,2/1194,11/9872,0.18181818181818182,1.5032739454850008,0.6194599414806211,0.39129935699204643,0.9999999999999981,0.963097398669085,ADH1A/ADH4,2,2.9701537992995277,0.6575839025933642,13.415495051965467
R-HSA-77286,mitochondrial fatty acid beta-oxidation of saturated fatty acids,2/1194,11/9872,0.18181818181818182,1.5032739454850008,0.6194599414806211,0.39129935699204643,0.9999999999999981,0.963097398669085,ACSM6/ACSM3,2,2.9701537992995277,0.6575839025933642,13.415495051965467
R-HSA-8851680,Butyrophilin (BTN) family interactions,2/1194,11/9872,0.18181818181818182,1.5032739454850008,0.6194599414806211,0.39129935699204643,0.9999999999999981,0.963097398669085,BTN1A1/BTNL2,2,2.9701537992995277,0.6575839025933642,13.415495051965467
R-HSA-9020956,Interleukin-27 signaling,2/1194,11/9872,0.18181818181818182,1.5032739454850008,0.6194599414806211,0.39129935699204643,0.9999999999999981,0.963097398669085,STAT3/STAT1,2,2.9701537992995277,0.6575839025933642,13.415495051965467
R-HSA-9634285,Constitutive Signaling by Overexpressed ERBB2,2/1194,11/9872,0.18181818181818182,1.5032739454850008,0.6194599414806211,0.39129935699204643,0.9999999999999981,0.963097398669085,ERBIN/GRB2,2,2.9701537992995277,0.6575839025933642,13.415495051965467
R-HSA-9634600,"Regulation of glycolysis by fructose 2,6-bisphosphate metabolism",2/1194,11/9872,0.18181818181818182,1.5032739454850008,0.6194599414806211,0.39129935699204643,0.9999999999999981,0.963097398669085,PFKFB3/PFKFB4,2,2.9701537992995277,0.6575839025933642,13.415495051965467
R-HSA-9645460,Alpha-protein kinase 1 signaling pathway,2/1194,11/9872,0.18181818181818182,1.5032739454850008,0.6194599414806211,0.39129935699204643,0.9999999999999981,0.963097398669085,TIFA/TRAF6,2,2.9701537992995277,0.6575839025933642,13.415495051965467
R-HSA-9701898,STAT3 nuclear events downstream of ALK signaling,2/1194,11/9872,0.18181818181818182,1.5032739454850008,0.6194599414806211,0.39129935699204643,0.9999999999999981,0.963097398669085,STAT3/HIF1A,2,2.9701537992995277,0.6575839025933642,13.415495051965467
R-HSA-9708530,Regulation of BACH1 activity,2/1194,11/9872,0.18181818181818182,1.5032739454850008,0.6194599414806211,0.39129935699204643,0.9999999999999981,0.963097398669085,CUL1/BACH1,2,2.9701537992995277,0.6575839025933642,13.415495051965467
R-HSA-9931521,The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex,2/1194,11/9872,0.18181818181818182,1.5032739454850008,0.6194599414806211,0.39129935699204643,0.9999999999999981,0.963097398669085,CRY1/PER1,2,2.9701537992995277,0.6575839025933642,13.415495051965467
R-HSA-159230,Transport of the SLBP Dependant Mature mRNA,5/1194,34/9872,0.14705882352941177,1.215883338259927,0.4677115458003553,0.3942704591502316,0.9999999999999981,0.963097398669085,NUP205/NUP58/NUP98/NUP188/NUP153,5,2.402330278845206,0.9378570617153648,6.153593126548334
R-HSA-1912408,Pre-NOTCH Transcription and Translation,5/1194,34/9872,0.14705882352941177,1.215883338259927,0.4677115458003553,0.3942704591502316,0.9999999999999981,0.963097398669085,KAT2B/TNRC6C/AGO2/RUNX1/JUN,5,2.402330278845206,0.9378570617153648,6.153593126548334
R-HSA-8956319,Nucleotide catabolism,5/1194,34/9872,0.14705882352941177,1.215883338259927,0.4677115458003553,0.3942704591502316,0.9999999999999981,0.963097398669085,NT5E/DPYD/ENTPD1/SAMHD1/NT5C1B,5,2.402330278845206,0.9378570617153648,6.153593126548334
R-HSA-112399,IRS-mediated signalling,6/1194,42/9872,0.14285714285714285,1.1811438143096433,0.43635937505406097,0.39871874152083486,0.9999999999999981,0.963097398669085,FGF20/FGFR3/FGFR2/PTPN11/GAB1/GRB2,6,2.3336922708782004,0.9900935236327085,5.5006112909157645
R-HSA-1489509,DAG and IP3 signaling,6/1194,42/9872,0.14285714285714285,1.1811438143096433,0.43635937505406097,0.39871874152083486,0.9999999999999981,0.963097398669085,PRKAR2A/CAMK2D/PRKCG/ADCY3/CAMK4/CAMK2G,6,2.3336922708782004,0.9900935236327085,5.5006112909157645
R-HSA-9696264,RND3 GTPase cycle,6/1194,42/9872,0.14285714285714285,1.1811438143096433,0.43635937505406097,0.39871874152083486,0.9999999999999981,0.963097398669085,ARHGAP21/PTPN13/DLG5/PICALM/FLOT2/ARHGAP5,6,2.3336922708782004,0.9900935236327085,5.5006112909157645
R-HSA-977444,GABA B receptor activation,6/1194,42/9872,0.14285714285714285,1.1811438143096433,0.43635937505406097,0.39871874152083486,0.9999999999999981,0.963097398669085,GNB3/GNAI1/KCNJ16/ADCY3/GNG3/GNAL,6,2.3336922708782004,0.9900935236327085,5.5006112909157645
R-HSA-991365,Activation of GABAB receptors,6/1194,42/9872,0.14285714285714285,1.1811438143096433,0.43635937505406097,0.39871874152083486,0.9999999999999981,0.963097398669085,GNB3/GNAI1/KCNJ16/ADCY3/GNG3/GNAL,6,2.3336922708782004,0.9900935236327085,5.5006112909157645
R-HSA-112043,PLC beta mediated events,7/1194,50/9872,0.14,1.1575209380234508,0.41418678960008687,0.40156528780478795,0.9999999999999981,0.963097398669085,PRKAR2A/CAMK2D/PRKCG/PLCB1/ADCY3/CAMK4/CAMK2G,7,2.2870184254606363,1.034713454719022,5.054977544306491
R-HSA-166658,Complement cascade,7/1194,50/9872,0.14,1.1575209380234508,0.41418678960008687,0.40156528780478795,0.9999999999999981,0.963097398669085,CD55/PROS1/C5AR1/C4BPA/CFB/CD59/CPB2,7,2.2870184254606363,1.034713454719022,5.054977544306491
R-HSA-381070,IRE1alpha activates chaperones,7/1194,50/9872,0.14,1.1575209380234508,0.41418678960008687,0.40156528780478795,0.9999999999999981,0.963097398669085,SRPRB/LMNA/GOSR2/ADD1/SEC31A/EDEM1/DDX11,7,2.2870184254606363,1.034713454719022,5.054977544306491
R-HSA-9843745,Adipogenesis,14/1194,106/9872,0.1320754716981132,1.0920008849277836,0.3532315555220904,0.4055719712312924,0.9999999999999981,0.963097398669085,GATAD2A/MED28/HELZ2/FAM120B/CEBPD/NCOA1/MED15/PCK1/HNRNPU/CEBPA/MED29/PPARG/RELA/LPL,14,2.157564552321355,1.2319190682336105,3.778726149688024
R-HSA-418217,G beta:gamma signalling through PLC beta,3/1194,19/9872,0.15789473684210525,1.3054747421317112,0.4943571073863003,0.4084150865377564,0.9999999999999981,0.963097398669085,GNB3/PLCB1/GNG3,3,2.57934408886538,0.7622069857245956,8.728621035190402
R-HSA-5621575,CD209 (DC-SIGN) signaling,3/1194,19/9872,0.15789473684210525,1.3054747421317112,0.4943571073863003,0.4084150865377564,0.9999999999999981,0.963097398669085,PAK2/RELA/PAK3,3,2.57934408886538,0.7622069857245956,8.728621035190402
R-HSA-5654693,FRS-mediated FGFR1 signaling,3/1194,19/9872,0.15789473684210525,1.3054747421317112,0.4943571073863003,0.4084150865377564,0.9999999999999981,0.963097398669085,FGF20/PTPN11/GRB2,3,2.57934408886538,0.7622069857245956,8.728621035190402
R-HSA-6804115,TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain,3/1194,19/9872,0.15789473684210525,1.3054747421317112,0.4943571073863003,0.4084150865377564,0.9999999999999981,0.963097398669085,CNOT2/PLAGL1/BTG2,3,2.57934408886538,0.7622069857245956,8.728621035190402
R-HSA-888590,"GABA synthesis, release, reuptake and degradation",3/1194,19/9872,0.15789473684210525,1.3054747421317112,0.4943571073863003,0.4084150865377564,0.9999999999999981,0.963097398669085,SLC32A1/ALDH5A1/GAD2,3,2.57934408886538,0.7622069857245956,8.728621035190402
R-HSA-9033658,Blood group systems biosynthesis,3/1194,19/9872,0.15789473684210525,1.3054747421317112,0.4943571073863003,0.4084150865377564,0.9999999999999981,0.963097398669085,B3GALT5/ST3GAL4/B3GALT1,3,2.57934408886538,0.7622069857245956,8.728621035190402
R-HSA-400042,"Adrenaline,noradrenaline inhibits insulin secretion",4/1194,27/9872,0.14814814814814814,1.224889881506297,0.434027106856903,0.4157292113635309,0.9999999999999981,0.963097398669085,GNB3/GNAI1/GNG3/CACNA1D,4,2.4201253179477638,0.845445479717811,6.9277164466320045
R-HSA-8953897,Cellular responses to stimuli,100/1194,808/9872,0.12376237623762376,1.0232681559613248,0.2560239622820682,0.41639391475286497,0.9999999999999981,0.963097398669085,STAT3/SRPRB/PHC2/LMNA/VEGFA/FNIP2/DNAJB1/HSPA12A/CALCRL/FNIP1/GNB3/FKBP5/ERO1A/HMOX1/ATF3/HSPH1/HSPA1A/PPP1R15A/GOSR2/MAP3K5/HSPA1B/PPP2R2A/MAP2K4/HIF1A/PRKAR2A/ADD1/CABIN1/NFE2L2/ITGB3/TNRC6C/CDKN1A/GRB10/SPP1/BCL2L1/FOS/NUP205/GJA1/CAMK2D/HELZ2/CUL1/MT1M/PDE4D/STIP1/PTPN1/SEC31A/PTGES3/EDEM1/DNAJA4/ADM/BACH1/NUP58/JUN/MAP2K3/NCOA1/HSPD1/EGLN1/PTK2/GCLC/NUP98/RPA3/NUP188/NUP153/NFKBIA/PDGFA/ATF6/RAI1/HSPA9/ADCY3/DYNC1I1/LMNB1/NDUFA4/CREB3L1/ETS2/ERF/GNG3/CDK2/UBE2D1/RORA/RELA/TUBB2A/CCNA2/TLR4/MT1X/ST13/RRAGD/IL1A/TRPV4/TUBB4A/EIF2S1/CAMK2G/DDX11/CCL2/STAT1/SLC7A11/IKBKE/PRR5/DNAJA1/EIF2AK3/RPS6KA3/PECAM1,100,2.0217631059588372,1.6292744003075394,2.5088014982895266
R-HSA-1660661,Sphingolipid de novo biosynthesis,5/1194,35/9872,0.14285714285714285,1.1811438143096433,0.3981980338270383,0.4194179064191733,0.9999999999999981,0.963097398669085,SGMS1/SPTLC3/PPM1L/VAPA/CERS5,5,2.3336922708782004,0.9126273517002677,5.9675174155259265
R-HSA-176033,Interactions of Vpr with host cellular proteins,5/1194,35/9872,0.14285714285714285,1.1811438143096433,0.3981980338270383,0.4194179064191733,0.9999999999999981,0.963097398669085,NUP205/NUP58/NUP98/NUP188/NUP153,5,2.3336922708782004,0.9126273517002677,5.9675174155259265
R-HSA-177243,Interactions of Rev with host cellular proteins,5/1194,35/9872,0.14285714285714285,1.1811438143096433,0.3981980338270383,0.4194179064191733,0.9999999999999981,0.963097398669085,NUP205/NUP58/NUP98/NUP188/NUP153,5,2.3336922708782004,0.9126273517002677,5.9675174155259265
R-HSA-9706574,RHOBTB GTPase Cycle,5/1194,35/9872,0.14285714285714285,1.1811438143096433,0.3981980338270383,0.4194179064191733,0.9999999999999981,0.963097398669085,TRA2B/RBBP6/PDE5A/STK38/RHOBTB2,5,2.3336922708782004,0.9126273517002677,5.9675174155259265
R-HSA-9840310,Glycosphingolipid catabolism,5/1194,35/9872,0.14285714285714285,1.1811438143096433,0.3981980338270383,0.4194179064191733,0.9999999999999981,0.963097398669085,NEU4/GLB1L3/STS/SMPD3/ARSG,5,2.3336922708782004,0.9126273517002677,5.9675174155259265
R-HSA-8948216,Collagen chain trimerization,6/1194,43/9872,0.13953488372093023,1.1536753535117448,0.3745904469735287,0.42135645655792076,0.9999999999999981,0.963097398669085,COL10A1/COL9A1/COL5A3/COL4A2/COL5A2/COL12A1,6,2.279420357601963,0.9682693008900686,5.3660248877808385
R-HSA-9634597,GPER1 signaling,6/1194,43/9872,0.13953488372093023,1.1536753535117448,0.3745904469735287,0.42135645655792076,0.9999999999999981,0.963097398669085,GNB3/GNAI1/PRKAR2A/ADCY3/GNG3/GNAZ,6,2.279420357601963,0.9682693008900686,5.3660248877808385
R-HSA-9645723,Diseases of programmed cell death,6/1194,43/9872,0.13953488372093023,1.1536753535117448,0.3745904469735287,0.42135645655792076,0.9999999999999981,0.963097398669085,MLKL/LMNA/CAST/JUN/LMNB1/GSDME,6,2.279420357601963,0.9682693008900686,5.3660248877808385
R-HSA-977225,Amyloid fiber formation,6/1194,43/9872,0.13953488372093023,1.1536753535117448,0.3745904469735287,0.42135645655792076,0.9999999999999981,0.963097398669085,SORL1/TSPAN15/MFGE8/SNCAIP/CALB1/TSPAN14,6,2.279420357601963,0.9682693008900686,5.3660248877808385
R-HSA-1483255,PI Metabolism,11/1194,83/9872,0.13253012048192772,1.095759924118585,0.32495752000525896,0.4219039543943982,0.9999999999999981,0.963097398669085,PIP4K2A/PTPN13/SYNJ2/PIK3C2B/INPP5F/MTMR10/PLEKHA1/PIP5K1B/PLEKHA8/TPTE2/SBF1,11,2.16499162479062,1.1511983212813426,4.071573636588045
R-HSA-5687128,MAPK6/MAPK4 signaling,10/1194,75/9872,0.13333333333333333,1.1024008933556673,0.33018758483216615,0.422375384200941,0.9999999999999981,0.963097398669085,PAK2/DNAJB1/TNRC6C/CDC14B/AGO2/JUN/MAPK6/CDC14A/HSPB1/PAK3,10,2.178112786152987,1.1230433088460994,4.224392124358639
R-HSA-8939211,ESR-mediated signaling,20/1194,156/9872,0.1282051282051282,1.0600008589958339,0.28018761245915913,0.4262317874402384,0.9999999999999981,0.963097398669085,CXXC5/CBFB/CXCL12/KAT2B/GNB3/FKBP5/GNAI1/TNRC6C/FOS/KDM4B/AGO2/RUNX1/PTGES3/JUN/NCOA1/PRKCZ/PTK2/GNG3/HSPB1/GREB1,20,2.0943392174547952,1.3100543149848967,3.348148781006635
R-HSA-9730414,MITF-M-regulated melanocyte development,18/1194,140/9872,0.12857142857142856,1.0630294328786791,0.2785988270565493,0.4287963381293382,0.9999999999999981,0.963097398669085,EDNRB/DICER1/TRPM1/PXN/MARK3/TNRC6C/CDKN1A/SS18L1/BCL2A1/AGO2/TFEB/YWHAG/CDK2/CSF1/ZEB1/ITGA2/SOX10/TFE3,18,2.10032304379038,1.281264785510384,3.442970522693051
R-HSA-428157,Sphingolipid metabolism,13/1194,100/9872,0.13,1.0748408710217756,0.27901016158279607,0.43542452859230574,0.9999999999999981,0.963097398669085,ALDH3A2/SGMS1/NEU4/SPTLC3/GLB1L3/B4GALT5/STS/UGCG/SMPD3/PPM1L/ARSG/VAPA/CERS5,13,2.1236599664991624,1.1880732575805226,3.7960046861887724
R-HSA-8957275,Post-translational protein phosphorylation,13/1194,100/9872,0.13,1.0748408710217756,0.27901016158279607,0.43542452859230574,0.9999999999999981,0.963097398669085,FAM20C/VGF/CHRDL1/SERPINA1/PENK/SPP1/MFGE8/SCG2/SHISA5/CALU/CSF1/SPARCL1/PRSS23,13,2.1236599664991624,1.1880732575805226,3.7960046861887724
R-HSA-1663150,The activation of arylsulfatases,2/1194,12/9872,0.16666666666666666,1.378001116694584,0.4859797405572592,0.43566266496108774,0.9999999999999981,0.963097398669085,STS/ARSG,2,2.7226409826912343,0.6086497138437323,12.179047738011558
R-HSA-174403,Glutathione synthesis and recycling,2/1194,12/9872,0.16666666666666666,1.378001116694584,0.4859797405572592,0.43566266496108774,0.9999999999999981,0.963097398669085,GCLC/CHAC2,2,2.7226409826912343,0.6086497138437323,12.179047738011558
R-HSA-176974,Unwinding of DNA,2/1194,12/9872,0.16666666666666666,1.378001116694584,0.4859797405572592,0.43566266496108774,0.9999999999999981,0.963097398669085,GINS3/MCM7,2,2.7226409826912343,0.6086497138437323,12.179047738011558
R-HSA-189483,Heme degradation,2/1194,12/9872,0.16666666666666666,1.378001116694584,0.4859797405572592,0.43566266496108774,0.9999999999999981,0.963097398669085,HMOX1/ABCC2,2,2.7226409826912343,0.6086497138437323,12.179047738011558
R-HSA-190873,Gap junction degradation,2/1194,12/9872,0.16666666666666666,1.378001116694584,0.4859797405572592,0.43566266496108774,0.9999999999999981,0.963097398669085,GJA1/DNM1,2,2.7226409826912343,0.6086497138437323,12.179047738011558
R-HSA-196791,Vitamin D (calciferol) metabolism,2/1194,12/9872,0.16666666666666666,1.378001116694584,0.4859797405572592,0.43566266496108774,0.9999999999999981,0.963097398669085,CUBN/GC,2,2.7226409826912343,0.6086497138437323,12.179047738011558
R-HSA-2033519,Activated point mutants of FGFR2,2/1194,12/9872,0.16666666666666666,1.378001116694584,0.4859797405572592,0.43566266496108774,0.9999999999999981,0.963097398669085,FGF20/FGFR2,2,2.7226409826912343,0.6086497138437323,12.179047738011558
R-HSA-2197563,NOTCH2 intracellular domain regulates transcription,2/1194,12/9872,0.16666666666666666,1.378001116694584,0.4859797405572592,0.43566266496108774,0.9999999999999981,0.963097398669085,HES5/HES1,2,2.7226409826912343,0.6086497138437323,12.179047738011558
R-HSA-264870,Caspase-mediated cleavage of cytoskeletal proteins,2/1194,12/9872,0.16666666666666666,1.378001116694584,0.4859797405572592,0.43566266496108774,0.9999999999999981,0.963097398669085,ADD1/CASP7,2,2.7226409826912343,0.6086497138437323,12.179047738011558
R-HSA-3371511,HSF1 activation,2/1194,12/9872,0.16666666666666666,1.378001116694584,0.4859797405572592,0.43566266496108774,0.9999999999999981,0.963097398669085,PTGES3/RPA3,2,2.7226409826912343,0.6086497138437323,12.179047738011558
R-HSA-400511,"Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)",2/1194,12/9872,0.16666666666666666,1.378001116694584,0.4859797405572592,0.43566266496108774,0.9999999999999981,0.963097398669085,DPP4/PAX6,2,2.7226409826912343,0.6086497138437323,12.179047738011558
R-HSA-6803207,TP53 Regulates Transcription of Caspase Activators and Caspases,2/1194,12/9872,0.16666666666666666,1.378001116694584,0.4859797405572592,0.43566266496108774,0.9999999999999981,0.963097398669085,CASP1/CASP2,2,2.7226409826912343,0.6086497138437323,12.179047738011558
R-HSA-73621,Pyrimidine catabolism,2/1194,12/9872,0.16666666666666666,1.378001116694584,0.4859797405572592,0.43566266496108774,0.9999999999999981,0.963097398669085,NT5E/DPYD,2,2.7226409826912343,0.6086497138437323,12.179047738011558
R-HSA-8984722,Interleukin-35 Signalling,2/1194,12/9872,0.16666666666666666,1.378001116694584,0.4859797405572592,0.43566266496108774,0.9999999999999981,0.963097398669085,STAT3/STAT1,2,2.7226409826912343,0.6086497138437323,12.179047738011558
R-HSA-9700645,ALK mutants bind TKIs,2/1194,12/9872,0.16666666666666666,1.378001116694584,0.4859797405572592,0.43566266496108774,0.9999999999999981,0.963097398669085,PPM1B/EIF2AK3,2,2.7226409826912343,0.6086497138437323,12.179047738011558
R-HSA-9842663,Signaling by LTK,2/1194,12/9872,0.16666666666666666,1.378001116694584,0.4859797405572592,0.43566266496108774,0.9999999999999981,0.963097398669085,GRB2/ALKAL2,2,2.7226409826912343,0.6086497138437323,12.179047738011558
R-HSA-9856530,High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells,9/1194,68/9872,0.1323529411764706,1.0942950044339343,0.2894105821215446,0.44069801475757575,0.9999999999999981,0.963097398669085,CALCRL/GNB3/PRKAR2A/ADM/ADCY3/GNG3/TRPV4/PRR5/PECAM1,9,2.1620972509606857,1.076162944722108,4.34382594711888
R-HSA-375165,NCAM signaling for neurite out-growth,8/1194,60/9872,0.13333333333333333,1.1024008933556673,0.29510292717717346,0.44190691248888003,0.9999999999999981,0.963097398669085,CACNB4/COL9A1/COL5A3/COL4A2/PTK2/COL5A2/GRB2/CACNA1D,8,2.178112786152987,1.039179102618452,4.565310539106379
R-HSA-167044,Signalling to RAS,3/1194,20/9872,0.15,1.2402010050251255,0.3988416763110177,0.44226065205032483,0.9999999999999981,0.963097398669085,RALGDS/SHC2/GRB2,3,2.4503768844221105,0.7271103940428575,8.25782016720325
R-HSA-500657,Presynaptic function of Kainate receptors,3/1194,20/9872,0.15,1.2402010050251255,0.3988416763110177,0.44226065205032483,0.9999999999999981,0.963097398669085,GNB3/PLCB1/GNG3,3,2.4503768844221105,0.7271103940428575,8.25782016720325
R-HSA-5627117,RHO GTPases Activate ROCKs,3/1194,20/9872,0.15,1.2402010050251255,0.3988416763110177,0.44226065205032483,0.9999999999999981,0.963097398669085,LIMK2/PPP1CB/RHOB,3,2.4503768844221105,0.7271103940428575,8.25782016720325
R-HSA-5651801,PCNA-Dependent Long Patch Base Excision Repair,3/1194,20/9872,0.15,1.2402010050251255,0.3988416763110177,0.44226065205032483,0.9999999999999981,0.963097398669085,RPA3/POLE/POLB,3,2.4503768844221105,0.7271103940428575,8.25782016720325
R-HSA-9013695,NOTCH4 Intracellular Domain Regulates Transcription,3/1194,20/9872,0.15,1.2402010050251255,0.3988416763110177,0.44226065205032483,0.9999999999999981,0.963097398669085,HES5/KAT2B/HES1,3,2.4503768844221105,0.7271103940428575,8.25782016720325
R-HSA-4615885,SUMOylation of DNA replication proteins,6/1194,44/9872,0.13636363636363635,1.1274554591137504,0.3142860628709453,0.4438766500570851,0.9999999999999981,0.963097398669085,TOP1/NUP205/NUP58/NUP98/NUP188/NUP153,6,2.227615349474646,0.9473866818320787,5.237850858974387
R-HSA-512988,"Interleukin-3, Interleukin-5 and GM-CSF signaling",6/1194,44/9872,0.13636363636363635,1.1274554591137504,0.3142860628709453,0.4438766500570851,0.9999999999999981,0.963097398669085,CSF2RA/STAT5B/JAK3/PTPN11/GRB2/STAT5A,6,2.227615349474646,0.9473866818320787,5.237850858974387
R-HSA-8982491,Glycogen metabolism,4/1194,28/9872,0.14285714285714285,1.1811438143096433,0.3560324951899583,0.4441414638738508,0.9999999999999981,0.963097398669085,GYS1/AKR1E2/PYGL/GBE1,4,2.3336922708782004,0.8172251488169611,6.664160571955737
R-HSA-9619665,EGR2 and SOX10-mediated initiation of Schwann cell myelination,4/1194,28/9872,0.14285714285714285,1.1811438143096433,0.3560324951899583,0.4441414638738508,0.9999999999999981,0.963097398669085,ADGRV1/MPZ/LAMA2/SOX10,4,2.3336922708782004,0.8172251488169611,6.664160571955737
R-HSA-5654741,Signaling by FGFR3,5/1194,36/9872,0.1388888888888889,1.1483342639121534,0.3307168994074329,0.4443784055857931,0.9999999999999981,0.963097398669085,FGF20/FGFR3/PTPN11/GAB1/GRB2,5,2.268867485576028,0.8887196699275907,5.792332319508026
R-HSA-5663213,RHO GTPases Activate WASPs and WAVEs,5/1194,36/9872,0.1388888888888889,1.1483342639121534,0.3307168994074329,0.4443784055857931,0.9999999999999981,0.963097398669085,WIPF3/WIPF1/PTK2/ACTR3/GRB2,5,2.268867485576028,0.8887196699275907,5.792332319508026
R-HSA-9913351,Formation of the dystrophin-glycoprotein complex (DGC),5/1194,36/9872,0.1388888888888889,1.1483342639121534,0.3307168994074329,0.4443784055857931,0.9999999999999981,0.963097398669085,SGCZ/LAMA1/SSPN/SNTB2/LAMA2,5,2.268867485576028,0.8887196699275907,5.792332319508026
R-HSA-9020702,Interleukin-1 signaling,13/1194,101/9872,0.12871287128712872,1.0641988821997777,0.24054235751955344,0.4502380103668465,0.9999999999999981,0.963097398669085,IL1B/MAP2K4/NLRC5/TIFA/NOD2/CUL1/IRAK2/NFKBIA/TNIP2/RELA/IL1RAP/IL1A/TRAF6,13,2.1026336301971904,1.1766954955285525,3.7571896889520624
R-HSA-418346,Platelet homeostasis,11/1194,85/9872,0.12941176470588237,1.069977337668736,0.24033388152558824,0.45427045182965775,0.9999999999999981,0.963097398669085,KCNMB4/GNB3/GUCY1A1/SLC8A1/FGR/KCNMA1/KCNMB2/PDE5A/PTPN11/GNG3/PECAM1,11,2.1140506453837817,1.1250814932453028,3.972343477409914
R-HSA-983231,Factors involved in megakaryocyte development and platelet production,17/1194,134/9872,0.12686567164179105,1.048926223155579,0.21151059276022116,0.45586288022989474,0.9999999999999981,0.963097398669085,DOCK1/KIF19/ITPK1/PRKAR2A/JMJD1C/DOCK9/MAFF/KIF26B/IRF1/CARMIL1/KIF21B/CDK2/TUBB2A/TUBB4A/CABLES1/AK3/SH2B2,17,2.0724580614515364,1.2469989178773841,3.44433531970217
R-HSA-198725,Nuclear Events (kinase and transcription factor activation),8/1194,61/9872,0.13114754098360656,1.0843287475629515,0.2450512072448666,0.46103824842323293,0.9999999999999981,0.963097398669085,SGK1/VGF/ID4/FOS/DUSP3/EGR1/JUNB/RPS6KA3,8,2.142406019166873,1.0228688625736608,4.487284459333035
R-HSA-1989781,PPARA activates gene expression,14/1194,110/9872,0.12727272727272726,1.0522917618395005,0.20456584864841015,0.4625603293007249,0.9999999999999981,0.963097398669085,AHR/ACSL1/MED28/RGL1/GLIPR1/HELZ2/FAM120B/NCOA1/MED15/FADS1/MED29/PPARG/ALAS1/RORA,14,2.0791076595096696,1.1885201407843482,3.6370344191046486
R-HSA-1660499,Synthesis of PIPs at the plasma membrane,7/1194,53/9872,0.1320754716981132,1.0920008849277836,0.2490974180202373,0.4635455216147406,0.9999999999999981,0.963097398669085,PIP4K2A/PTPN13/SYNJ2/PIK3C2B/PLEKHA1/PIP5K1B/PLEKHA8,7,2.157564552321355,0.9788293682744788,4.755767397580057
R-HSA-2142753,Arachidonate metabolism,7/1194,53/9872,0.1320754716981132,1.0920008849277836,0.2490974180202373,0.4635455216147406,0.9999999999999981,0.963097398669085,LTC4S/PTGES3/ALOX15B/DPEP2/CYP8B1/AKR1C3/ALOX5AP,7,2.157564552321355,0.9788293682744788,4.755767397580057
R-HSA-4551638,SUMOylation of chromatin organization proteins,7/1194,53/9872,0.1320754716981132,1.0920008849277836,0.2490974180202373,0.4635455216147406,0.9999999999999981,0.963097398669085,PHC2/HDAC4/NUP205/NUP58/NUP98/NUP188/NUP153,7,2.157564552321355,0.9788293682744788,4.755767397580057
R-HSA-8878166,Transcriptional regulation by RUNX2,13/1194,102/9872,0.12745098039215685,1.05376555982527,0.2024556459816454,0.46501692924140403,0.9999999999999981,0.963097398669085,CBFB/HDAC4/CDKN1A/WWP1/CUL1/RUNX1/BMP2/GLI3/MAF/HES1/ZNF521/SMAD6/STAT1,13,2.082019574999179,1.1655336758077708,3.719159386514965
R-HSA-445717,Aquaporin-mediated transport,6/1194,45/9872,0.13333333333333333,1.1024008933556673,0.25537150785145557,0.4662128239418578,0.9999999999999981,0.963097398669085,GNB3/PRKAR2A/RAB11FIP2/ADCY3/GNG3/AQP4,6,2.178112786152987,0.9273860028646086,5.115642563666925
R-HSA-4570464,SUMOylation of RNA binding proteins,6/1194,45/9872,0.13333333333333333,1.1024008933556673,0.25537150785145557,0.4662128239418578,0.9999999999999981,0.963097398669085,PHC2/NUP205/NUP58/NUP98/NUP188/NUP153,6,2.178112786152987,0.9273860028646086,5.115642563666925
R-HSA-5578749,Transcriptional regulation by small RNAs,6/1194,45/9872,0.13333333333333333,1.1024008933556673,0.25537150785145557,0.4662128239418578,0.9999999999999981,0.963097398669085,NUP205/AGO2/NUP58/NUP98/NUP188/NUP153,6,2.178112786152987,0.9273860028646086,5.115642563666925
R-HSA-176187,Activation of ATR in response to replication stress,5/1194,37/9872,0.13513513513513514,1.1172982027253384,0.26514164972034915,0.4690645194359847,0.9999999999999981,0.963097398669085,ORC4/RPA3/CDK2/MCM7/CDC7,5,2.207546742722622,0.8660327506460372,5.627111235308288
R-HSA-3232142,SUMOylation of ubiquitinylation proteins,5/1194,37/9872,0.13513513513513514,1.1172982027253384,0.26514164972034915,0.4690645194359847,0.9999999999999981,0.963097398669085,NUP205/NUP58/NUP98/NUP188/NUP153,5,2.207546742722622,0.8660327506460372,5.627111235308288
R-HSA-8950505,Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation,5/1194,37/9872,0.13513513513513514,1.1172982027253384,0.26514164972034915,0.4690645194359847,0.9999999999999981,0.963097398669085,PAK2/HNRNPF/MSN/HSPA9/LMNB1,5,2.207546742722622,0.8660327506460372,5.627111235308288
R-HSA-9029569,NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux,5/1194,37/9872,0.13513513513513514,1.1172982027253384,0.26514164972034915,0.4690645194359847,0.9999999999999981,0.963097398669085,KDM3A/TNRC6C/AGO2/EEPD1/NCOA1,5,2.207546742722622,0.8660327506460372,5.627111235308288
R-HSA-163359,Glucagon signaling in metabolic regulation,4/1194,29/9872,0.13793103448275862,1.1404147172644832,0.28087999108029305,0.47211639166857144,0.9999999999999981,0.963097398669085,GNB3/PRKAR2A/ADCY3/GNG3,4,2.2532201236065386,0.790827714624912,6.419857108616227
R-HSA-201451,Signaling by BMP,4/1194,29/9872,0.13793103448275862,1.1404147172644832,0.28087999108029305,0.47211639166857144,0.9999999999999981,0.963097398669085,CHRDL1/BMP2/UBE2D1/SMAD6,4,2.2532201236065386,0.790827714624912,6.419857108616227
R-HSA-4090294,SUMOylation of intracellular receptors,4/1194,29/9872,0.13793103448275862,1.1404147172644832,0.28087999108029305,0.47211639166857144,0.9999999999999981,0.963097398669085,HDAC4/RARA/PPARG/RORA,4,2.2532201236065386,0.790827714624912,6.419857108616227
R-HSA-5218920,VEGFR2 mediated vascular permeability,4/1194,29/9872,0.13793103448275862,1.1404147172644832,0.28087999108029305,0.47211639166857144,0.9999999999999981,0.963097398669085,PAK2/CTNNA1/PAK3/PRR5,4,2.2532201236065386,0.790827714624912,6.419857108616227
R-HSA-5579029,Metabolic disorders of biological oxidation enzymes,4/1194,29/9872,0.13793103448275862,1.1404147172644832,0.28087999108029305,0.47211639166857144,0.9999999999999981,0.963097398669085,GCLC/CYP27A1/CYP26C1/FMO3,4,2.2532201236065386,0.790827714624912,6.419857108616227
R-HSA-5654727,Negative regulation of FGFR2 signaling,4/1194,29/9872,0.13793103448275862,1.1404147172644832,0.28087999108029305,0.47211639166857144,0.9999999999999981,0.963097398669085,FGF20/FGFR2/PTPN11/GRB2,4,2.2532201236065386,0.790827714624912,6.419857108616227
R-HSA-8963899,Plasma lipoprotein remodeling,4/1194,29/9872,0.13793103448275862,1.1404147172644832,0.28087999108029305,0.47211639166857144,0.9999999999999981,0.963097398669085,PCSK6/ANGPTL3/LPA/LPL,4,2.2532201236065386,0.790827714624912,6.419857108616227
R-HSA-9843743,Transcriptional regulation of brown and beige adipocyte differentiation,4/1194,29/9872,0.13793103448275862,1.1404147172644832,0.28087999108029305,0.47211639166857144,0.9999999999999981,0.963097398669085,GATAD2A/NCOA1/HNRNPU/PPARG,4,2.2532201236065386,0.790827714624912,6.419857108616227
R-HSA-9844594,Transcriptional regulation of brown and beige adipocyte differentiation by EBF2,4/1194,29/9872,0.13793103448275862,1.1404147172644832,0.28087999108029305,0.47211639166857144,0.9999999999999981,0.963097398669085,GATAD2A/NCOA1/HNRNPU/PPARG,4,2.2532201236065386,0.790827714624912,6.419857108616227
R-HSA-1483206,Glycerophospholipid biosynthesis,15/1194,119/9872,0.12605042016806722,1.0421857185085088,0.17172864194301637,0.473922082055911,0.9999999999999981,0.963097398669085,ETNPPL/OSBPL5/MBOAT2/MGLL/PGS1/CHPT1/PLD4/PLAAT1/PLAAT3/GPAT4/AGPAT5/MBOAT7/PCTP/PLA2G12A/CHKA,15,2.0591402390101767,1.1997344497248186,3.534164185152326
R-HSA-111448,Activation of NOXA and translocation to mitochondria,1/1194,5/9872,0.2,1.653601340033501,0.5422234406306013,0.47517810286705264,0.9999999999999981,0.963097398669085,PMAIP1,1,3.267169179229481,0.38138592649356756,27.988432986624844
R-HSA-114516,Disinhibition of SNARE formation,1/1194,5/9872,0.2,1.653601340033501,0.5422234406306013,0.47517810286705264,0.9999999999999981,0.963097398669085,PRKCG,1,3.267169179229481,0.38138592649356756,27.988432986624844
R-HSA-1169092,Activation of RAS in B cells,1/1194,5/9872,0.2,1.653601340033501,0.5422234406306013,0.47517810286705264,0.9999999999999981,0.963097398669085,RASGRP1,1,3.267169179229481,0.38138592649356756,27.988432986624844
R-HSA-1306955,GRB7 events in ERBB2 signaling,1/1194,5/9872,0.2,1.653601340033501,0.5422234406306013,0.47517810286705264,0.9999999999999981,0.963097398669085,NRG1,1,3.267169179229481,0.38138592649356756,27.988432986624844
R-HSA-1483248,Synthesis of PIPs at the ER membrane,1/1194,5/9872,0.2,1.653601340033501,0.5422234406306013,0.47517810286705264,0.9999999999999981,0.963097398669085,SBF1,1,3.267169179229481,0.38138592649356756,27.988432986624844
R-HSA-173599,"Formation of the active cofactor, UDP-glucuronate",1/1194,5/9872,0.2,1.653601340033501,0.5422234406306013,0.47517810286705264,0.9999999999999981,0.963097398669085,SLC35D2,1,3.267169179229481,0.38138592649356756,27.988432986624844
R-HSA-173736,Alternative complement activation,1/1194,5/9872,0.2,1.653601340033501,0.5422234406306013,0.47517810286705264,0.9999999999999981,0.963097398669085,CFB,1,3.267169179229481,0.38138592649356756,27.988432986624844
R-HSA-187015,Activation of TRKA receptors,1/1194,5/9872,0.2,1.653601340033501,0.5422234406306013,0.47517810286705264,0.9999999999999981,0.963097398669085,ADORA2A,1,3.267169179229481,0.38138592649356756,27.988432986624844
R-HSA-2142770,Synthesis of 15-eicosatetraenoic acid derivatives,1/1194,5/9872,0.2,1.653601340033501,0.5422234406306013,0.47517810286705264,0.9999999999999981,0.963097398669085,ALOX15B,1,3.267169179229481,0.38138592649356756,27.988432986624844
R-HSA-2142850,Hyaluronan biosynthesis and export,1/1194,5/9872,0.2,1.653601340033501,0.5422234406306013,0.47517810286705264,0.9999999999999981,0.963097398669085,HAS2,1,3.267169179229481,0.38138592649356756,27.988432986624844
R-HSA-2161517,Abacavir transmembrane transport,1/1194,5/9872,0.2,1.653601340033501,0.5422234406306013,0.47517810286705264,0.9999999999999981,0.963097398669085,SLC22A3,1,3.267169179229481,0.38138592649356756,27.988432986624844
R-HSA-2644605,FBXW7 Mutants and NOTCH1 in Cancer,1/1194,5/9872,0.2,1.653601340033501,0.5422234406306013,0.47517810286705264,0.9999999999999981,0.963097398669085,CUL1,1,3.267169179229481,0.38138592649356756,27.988432986624844
R-HSA-2644607,Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling,1/1194,5/9872,0.2,1.653601340033501,0.5422234406306013,0.47517810286705264,0.9999999999999981,0.963097398669085,CUL1,1,3.267169179229481,0.38138592649356756,27.988432986624844
R-HSA-380095,Tachykinin receptors bind tachykinins,1/1194,5/9872,0.2,1.653601340033501,0.5422234406306013,0.47517810286705264,0.9999999999999981,0.963097398669085,TACR1,1,3.267169179229481,0.38138592649356756,27.988432986624844
R-HSA-426048,Arachidonate production from DAG,1/1194,5/9872,0.2,1.653601340033501,0.5422234406306013,0.47517810286705264,0.9999999999999981,0.963097398669085,MGLL,1,3.267169179229481,0.38138592649356756,27.988432986624844
R-HSA-5250955,Toxicity of botulinum toxin type D (botD),1/1194,5/9872,0.2,1.653601340033501,0.5422234406306013,0.47517810286705264,0.9999999999999981,0.963097398669085,SV2B,1,3.267169179229481,0.38138592649356756,27.988432986624844
R-HSA-5250981,Toxicity of botulinum toxin type F (botF),1/1194,5/9872,0.2,1.653601340033501,0.5422234406306013,0.47517810286705264,0.9999999999999981,0.963097398669085,SV2B,1,3.267169179229481,0.38138592649356756,27.988432986624844
R-HSA-5334118,DNA methylation,1/1194,5/9872,0.2,1.653601340033501,0.5422234406306013,0.47517810286705264,0.9999999999999981,0.963097398669085,UHRF1,1,3.267169179229481,0.38138592649356756,27.988432986624844
R-HSA-5339717,Signaling by LRP5 mutants,1/1194,5/9872,0.2,1.653601340033501,0.5422234406306013,0.47517810286705264,0.9999999999999981,0.963097398669085,KREMEN2,1,3.267169179229481,0.38138592649356756,27.988432986624844
R-HSA-5662702,Melanin biosynthesis,1/1194,5/9872,0.2,1.653601340033501,0.5422234406306013,0.47517810286705264,0.9999999999999981,0.963097398669085,SLC45A2,1,3.267169179229481,0.38138592649356756,27.988432986624844
R-HSA-8849468,PTK6 Regulates Proteins Involved in RNA Processing,1/1194,5/9872,0.2,1.653601340033501,0.5422234406306013,0.47517810286705264,0.9999999999999981,0.963097398669085,KHDRBS1,1,3.267169179229481,0.38138592649356756,27.988432986624844
R-HSA-8849473,PTK6 Expression,1/1194,5/9872,0.2,1.653601340033501,0.5422234406306013,0.47517810286705264,0.9999999999999981,0.963097398669085,HIF1A,1,3.267169179229481,0.38138592649356756,27.988432986624844
R-HSA-8866376,Reelin signalling pathway,1/1194,5/9872,0.2,1.653601340033501,0.5422234406306013,0.47517810286705264,0.9999999999999981,0.963097398669085,DAB1,1,3.267169179229481,0.38138592649356756,27.988432986624844
R-HSA-8866911,TFAP2 (AP-2) family regulates transcription of cell cycle factors,1/1194,5/9872,0.2,1.653601340033501,0.5422234406306013,0.47517810286705264,0.9999999999999981,0.963097398669085,CDKN1A,1,3.267169179229481,0.38138592649356756,27.988432986624844
R-HSA-8869496,TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation,1/1194,5/9872,0.2,1.653601340033501,0.5422234406306013,0.47517810286705264,0.9999999999999981,0.963097398669085,HSPD1,1,3.267169179229481,0.38138592649356756,27.988432986624844
R-HSA-8964011,HDL clearance,1/1194,5/9872,0.2,1.653601340033501,0.5422234406306013,0.47517810286705264,0.9999999999999981,0.963097398669085,CUBN,1,3.267169179229481,0.38138592649356756,27.988432986624844
R-HSA-9022707,MECP2 regulates transcription factors,1/1194,5/9872,0.2,1.653601340033501,0.5422234406306013,0.47517810286705264,0.9999999999999981,0.963097398669085,PPARG,1,3.267169179229481,0.38138592649356756,27.988432986624844
R-HSA-9032759,NTRK2 activates RAC1,1/1194,5/9872,0.2,1.653601340033501,0.5422234406306013,0.47517810286705264,0.9999999999999981,0.963097398669085,BDNF,1,3.267169179229481,0.38138592649356756,27.988432986624844
R-HSA-9632974,NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis,1/1194,5/9872,0.2,1.653601340033501,0.5422234406306013,0.47517810286705264,0.9999999999999981,0.963097398669085,PCK1,1,3.267169179229481,0.38138592649356756,27.988432986624844
R-HSA-9667769,Acetylcholine inhibits contraction of outer hair cells,1/1194,5/9872,0.2,1.653601340033501,0.5422234406306013,0.47517810286705264,0.9999999999999981,0.963097398669085,KCNMA1,1,3.267169179229481,0.38138592649356756,27.988432986624844
R-HSA-9673768,Signaling by membrane-tethered fusions of PDGFRA or PDGFRB,1/1194,5/9872,0.2,1.653601340033501,0.5422234406306013,0.47517810286705264,0.9999999999999981,0.963097398669085,ETV6,1,3.267169179229481,0.38138592649356756,27.988432986624844
R-HSA-9818035,NFE2L2 regulating ER-stress associated genes,1/1194,5/9872,0.2,1.653601340033501,0.5422234406306013,0.47517810286705264,0.9999999999999981,0.963097398669085,NFE2L2,1,3.267169179229481,0.38138592649356756,27.988432986624844
R-HSA-9861559,PDH complex synthesizes acetyl-CoA from PYR,1/1194,5/9872,0.2,1.653601340033501,0.5422234406306013,0.47517810286705264,0.9999999999999981,0.963097398669085,PDHX,1,3.267169179229481,0.38138592649356756,27.988432986624844
R-HSA-140837,Intrinsic Pathway of Fibrin Clot Formation,3/1194,21/9872,0.14285714285714285,1.1811438143096433,0.30822361704591766,0.4753206559868465,0.9999999999999981,0.963097398669085,A2M/PROS1/SERPINE2,3,2.3336922708782004,0.6951018018492595,7.834995680730088
R-HSA-1482788,Acyl chain remodelling of PC,3/1194,21/9872,0.14285714285714285,1.1811438143096433,0.30822361704591766,0.4753206559868465,0.9999999999999981,0.963097398669085,MBOAT2/PLAAT3/PLA2G12A,3,2.3336922708782004,0.6951018018492595,7.834995680730088
R-HSA-4641263,Regulation of FZD by ubiquitination,3/1194,21/9872,0.14285714285714285,1.1811438143096433,0.30822361704591766,0.4753206559868465,0.9999999999999981,0.963097398669085,FZD5/RNF43/RSPO2,3,2.3336922708782004,0.6951018018492595,7.834995680730088
R-HSA-9839394,TGFBR3 expression,3/1194,21/9872,0.14285714285714285,1.1811438143096433,0.30822361704591766,0.4753206559868465,0.9999999999999981,0.963097398669085,TNRC6C/RARA/AGO2,3,2.3336922708782004,0.6951018018492595,7.834995680730088
R-HSA-168928,DDX58/IFIH1-mediated induction of interferon-alpha/beta,9/1194,70/9872,0.12857142857142856,1.0630294328786791,0.19629443474951816,0.47653876954943974,0.9999999999999981,0.963097398669085,NLRC5/UBA7/NFKBIA/RNF125/UBE2D1/RELA/RNF135/TRAF6/IKBKE,9,2.10032304379038,1.0466264531420295,4.214834122559919
R-HSA-381426,Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),14/1194,111/9872,0.12612612612612611,1.0428116558769824,0.16824775398449346,0.4767432931785476,0.9999999999999981,0.963097398669085,FAM20C/VGF/CHRDL1/SERPINA1/IGF1/PENK/SPP1/MFGE8/SCG2/SHISA5/CALU/CSF1/SPARCL1/PRSS23,14,2.0603769598744472,1.1781442057528084,3.6032543351252224
R-HSA-1461957,Beta defensins,2/1194,13/9872,0.15384615384615385,1.2720010307950007,0.36399775841806015,0.47820824712693444,0.9999999999999981,0.963097398669085,TLR2/DEFB107B,2,2.5132070609457546,0.5664799904566052,11.149925571239475
R-HSA-1483213,Synthesis of PE,2/1194,13/9872,0.15384615384615385,1.2720010307950007,0.36399775841806015,0.47820824712693444,0.9999999999999981,0.963097398669085,ETNPPL/CHKA,2,2.5132070609457546,0.5664799904566052,11.149925571239475
R-HSA-177504,Retrograde neurotrophin signalling,2/1194,13/9872,0.15384615384615385,1.2720010307950007,0.36399775841806015,0.47820824712693444,0.9999999999999981,0.963097398669085,DNM3/DNM1,2,2.5132070609457546,0.5664799904566052,11.149925571239475
R-HSA-212300,PRC2 methylates histones and DNA,2/1194,13/9872,0.15384615384615385,1.2720010307950007,0.36399775841806015,0.47820824712693444,0.9999999999999981,0.963097398669085,PHF19/AEBP2,2,2.5132070609457546,0.5664799904566052,11.149925571239475
R-HSA-3772470,Negative regulation of TCF-dependent signaling by WNT ligand antagonists,2/1194,13/9872,0.15384615384615385,1.2720010307950007,0.36399775841806015,0.47820824712693444,0.9999999999999981,0.963097398669085,WIF1/KREMEN2,2,2.5132070609457546,0.5664799904566052,11.149925571239475
R-HSA-5140745,"WNT5A-dependent internalization of FZD2, FZD5 and ROR2",2/1194,13/9872,0.15384615384615385,1.2720010307950007,0.36399775841806015,0.47820824712693444,0.9999999999999981,0.963097398669085,FZD5/ROR2,2,2.5132070609457546,0.5664799904566052,11.149925571239475
R-HSA-5210891,Uptake and function of anthrax toxins,2/1194,13/9872,0.15384615384615385,1.2720010307950007,0.36399775841806015,0.47820824712693444,0.9999999999999981,0.963097398669085,MAP2K4/MAP2K3,2,2.5132070609457546,0.5664799904566052,11.149925571239475
R-HSA-5578768,Physiological factors,2/1194,13/9872,0.15384615384615385,1.2720010307950007,0.36399775841806015,0.47820824712693444,0.9999999999999981,0.963097398669085,KAT2B/NPPC,2,2.5132070609457546,0.5664799904566052,11.149925571239475
R-HSA-5654221,Phospholipase C-mediated cascade; FGFR2,2/1194,13/9872,0.15384615384615385,1.2720010307950007,0.36399775841806015,0.47820824712693444,0.9999999999999981,0.963097398669085,FGF20/FGFR2,2,2.5132070609457546,0.5664799904566052,11.149925571239475
R-HSA-5660526,Response to metal ions,2/1194,13/9872,0.15384615384615385,1.2720010307950007,0.36399775841806015,0.47820824712693444,0.9999999999999981,0.963097398669085,MT1M/MT1X,2,2.5132070609457546,0.5664799904566052,11.149925571239475
R-HSA-918233,TRAF3-dependent IRF activation pathway,2/1194,13/9872,0.15384615384615385,1.2720010307950007,0.36399775841806015,0.47820824712693444,0.9999999999999981,0.963097398669085,RNF135/IKBKE,2,2.5132070609457546,0.5664799904566052,11.149925571239475
R-HSA-9768759,Regulation of NPAS4 gene expression,2/1194,13/9872,0.15384615384615385,1.2720010307950007,0.36399775841806015,0.47820824712693444,0.9999999999999981,0.963097398669085,TNRC6C/AGO2,2,2.5132070609457546,0.5664799904566052,11.149925571239475
R-HSA-168249,Innate Immune System,112/1194,919/9872,0.12187159956474429,1.0076352017614367,0.09015024217914024,0.48087705733654384,0.9999999999999981,0.963097398669085,SLC11A1/SLC2A3/DOCK1/ELMO1/MVP/WIPF3/PTPRJ/PAK2/CD55/IL1B/NFASC/PROS1/PLAUR/SIGLEC9/TLR2/ATP11A/HMOX1/MUC15/HSPA1A/SERPINB6/HSPA1B/WIPF1/GGH/MAP2K4/IQGAP1/SERPINA1/NLRC5/CD47/CD93/FGR/BCL2L1/FOS/RAP1A/C5AR1/GLIPR1/FCAR/TIFA/NOD2/RAB10/CUL1/DNM3/TMC6/TRIM56/PRSS3/SIGLEC5/IRAK2/RASGRP1/UBA7/EEA1/C4BPA/DUSP3/IGF2R/FRK/JUN/MAP2K3/CFB/HVCN1/PYGL/PTPN11/SELL/MYO9B/PLD4/GDI2/PTK2/DEFB107B/NFKBIA/MYO10/TNIP2/CD14/FCGR2A/RNF125/ACTR3/CD59/GCA/CAB39/GRB2/HRNR/UBE2D1/RELA/NLRP1/CASP1/TLR4/RAB37/ADA2/KLRD1/VAPA/ADAM8/CASP2/GSDME/PAK3/CASP4/RNF135/PFKL/TRAF6/SFTPD/LRG1/FCGR3A/CPB2/PTAFR/IFI16/TOM1/DSC1/IKBKE/MGAM/FCGR1A/SLC2A5/BST1/PDXK/TSPAN14/RPS6KA3/PECAM1/DNM1,112,1.9908756696066476,1.6223779507848022,2.4430718686200024
R-HSA-6807878,COPI-mediated anterograde transport,12/1194,95/9872,0.12631578947368421,1.0443797937053692,0.16121935920374422,0.4829479006108268,0.9999999999999981,0.963097398669085,CD55/TMED10/COPA/GOSR2/ARFGAP3/RAB1A/DYNC1I1/CD59/TUBB2A/ANK1/TUBB4A/NSF,12,2.0634752710923037,1.1287145201889244,3.772371240246616
R-HSA-6798695,Neutrophil degranulation,54/1194,441/9872,0.12244897959183673,1.0124089836939802,0.0988893569124516,0.48348865033151367,0.9999999999999981,0.963097398669085,SLC11A1/SLC2A3/MVP/PTPRJ/CD55/NFASC/PLAUR/SIGLEC9/TLR2/ATP11A/HSPA1A/SERPINB6/HSPA1B/GGH/IQGAP1/SERPINA1/CD47/CD93/FGR/RAP1A/C5AR1/GLIPR1/FCAR/RAB10/TMC6/PRSS3/SIGLEC5/IGF2R/FRK/HVCN1/PYGL/SELL/GDI2/CD14/FCGR2A/CD59/GCA/CAB39/HRNR/RAB37/ADA2/VAPA/ADAM8/PFKL/LRG1/PTAFR/TOM1/DSC1/MGAM/SLC2A5/BST1/PDXK/TSPAN14/PECAM1,54,2.0003076607527435,1.4989159092481403,2.669416418211972
R-HSA-1660662,Glycosphingolipid metabolism,7/1194,54/9872,0.12962962962962962,1.07177864631801,0.19617946513987738,0.4839168353398219,0.9999999999999981,0.963097398669085,NEU4/GLB1L3/B4GALT5/STS/UGCG/SMPD3/ARSG,7,2.1176096532042927,0.9615194521900409,4.6637336697975655
R-HSA-437239,Recycling pathway of L1,6/1194,46/9872,0.13043478260869565,1.0784356565435875,0.19777754810909623,0.488303236271599,0.9999999999999981,0.963097398669085,MSN/DNM3/TUBB2A/TUBB4A/RPS6KA3/DNM1,6,2.1307625081931394,0.9082125376670398,4.9989938236087035
R-HSA-416482,G alpha (12/13) signalling events,10/1194,79/9872,0.12658227848101267,1.0465831266034815,0.15419035890895064,0.49015383548828995,0.9999999999999981,0.963097398669085,GNB3/ARHGEF10/ARHGEF7/ARHGEF3/PREX1/RHOB/ABR/GNG3/NGEF/GNA12,10,2.0678285944490384,1.0682726480809726,4.002643991402635
R-HSA-400206,Regulation of lipid metabolism by PPARalpha,14/1194,112/9872,0.125,1.033500837520938,0.13225517773582496,0.4908656600393284,0.9999999999999981,0.963097398669085,AHR/ACSL1/MED28/RGL1/GLIPR1/HELZ2/FAM120B/NCOA1/MED15/FADS1/MED29/PPARG/ALAS1/RORA,14,2.041980737018425,1.1679479403966775,3.5700951952859588
R-HSA-5173105,O-linked glycosylation,14/1194,112/9872,0.125,1.033500837520938,0.13225517773582496,0.4908656600393284,0.9999999999999981,0.963097398669085,MUC15/ADAMTS2/SPON1/GALNT15/ST3GAL4/B3GLCT/B4GALT5/GALNTL6/GALNT7/GALNT8/ADAMTS10/B3GALNT2/ADAMTS18/THSD7B,14,2.041980737018425,1.1679479403966775,3.5700951952859588
R-HSA-8853659,RET signaling,5/1194,38/9872,0.13157894736842105,1.0878956184430926,0.20135704958237405,0.4933967195034743,0.9999999999999981,0.963097398669085,GRB10/DOK6/PTPN11/GAB1/GRB2,5,2.149453407387816,0.8444754134692908,5.471029560885024
R-HSA-2219528,PI3K/AKT Signaling in Cancer,13/1194,104/9872,0.125,1.033500837520938,0.1273920789839697,0.49439333019125253,0.9999999999999981,0.963097398669085,FGF20/FGFR3/CDKN1A/PDGFRA/FGFR2/PDGFRB/BDNF/PTPN11/PDGFA/GAB1/NRG1/GRB2/PRR5,13,2.0419807370184255,1.1438337216593248,3.645359680693341
R-HSA-446219,Synthesis of substrates in N-glycan biosythesis,8/1194,63/9872,0.12698412698412698,1.0499056127196829,0.1473941394849837,0.4988647358980113,0.9999999999999981,0.963097398669085,NEU4/ST6GAL2/PMM2/ST3GAL4/ST8SIA3/PGM3/GFPT2/HK1,8,2.0743931296695117,0.9917380896520561,4.33895491291434
R-HSA-156590,Glutathione conjugation,4/1194,30/9872,0.13333333333333333,1.1024008933556673,0.20835100945809382,0.49954683601411864,0.9999999999999981,0.963097398669085,GSTO2/GCLC/GSTA4/CHAC2,4,2.178112786152987,0.7660821031602144,6.19277658312683
R-HSA-456926,Thrombin signalling through proteinase activated receptors (PARs),4/1194,30/9872,0.13333333333333333,1.1024008933556673,0.20835100945809382,0.49954683601411864,0.9999999999999981,0.963097398669085,GNB3/GNG3/GNA12/ARRB1,4,2.178112786152987,0.7660821031602144,6.19277658312683
R-HSA-5339562,Uptake and actions of bacterial toxins,4/1194,30/9872,0.13333333333333333,1.1024008933556673,0.20835100945809382,0.49954683601411864,0.9999999999999981,0.963097398669085,MAP2K4/SV2B/MAP2K3/GUCY2C,4,2.178112786152987,0.7660821031602144,6.19277658312683
R-HSA-156584,Cytosolic sulfonation of small molecules,3/1194,22/9872,0.13636363636363635,1.1274554591137504,0.22198548767069787,0.5074429215110297,0.9999999999999981,0.963097398669085,TPST1/SULT4A1/TPST2,3,2.227615349474646,0.6657910812906286,7.4531940794336595
R-HSA-3296482,Defects in vitamin and cofactor metabolism,3/1194,22/9872,0.13636363636363635,1.1274554591137504,0.22198548767069787,0.5074429215110297,0.9999999999999981,0.963097398669085,MMAB/ABCD4/CUBN,3,2.227615349474646,0.6657910812906286,7.4531940794336595
R-HSA-5620922,BBSome-mediated cargo-targeting to cilium,3/1194,22/9872,0.13636363636363635,1.1274554591137504,0.22198548767069787,0.5074429215110297,0.9999999999999981,0.963097398669085,RAB3IP/BBS2/BBS7,3,2.227615349474646,0.6657910812906286,7.4531940794336595
R-HSA-9665686,Signaling by ERBB2 TMD/JMD mutants,3/1194,22/9872,0.13636363636363635,1.1274554591137504,0.22198548767069787,0.5074429215110297,0.9999999999999981,0.963097398669085,ERBIN/NRG1/GRB2,3,2.227615349474646,0.6657910812906286,7.4531940794336595
R-HSA-2173789,TGF-beta receptor signaling activates SMADs,6/1194,47/9872,0.1276595744680851,1.0554902170426599,0.1414399158879922,0.5100910792724931,0.9999999999999981,0.963097398669085,ITGB8/PPP1R15A/ITGB3/TGFB3/PPP1CB/TGFBR1,6,2.0854271356783918,0.88981599676206,4.8875344498742725
R-HSA-6791312,TP53 Regulates Transcription of Cell Cycle Genes,6/1194,47/9872,0.1276595744680851,1.0554902170426599,0.1414399158879922,0.5100910792724931,0.9999999999999981,0.963097398669085,CNOT2/CDKN1A/PLAGL1/BTG2/CDK2/CCNA2,6,2.0854271356783918,0.88981599676206,4.8875344498742725
R-HSA-70268,Pyruvate metabolism,6/1194,47/9872,0.1276595744680851,1.0554902170426599,0.1414399158879922,0.5100910792724931,0.9999999999999981,0.963097398669085,PDK1/MKLN1/LDHA/LDHC/PDK3/PDHX,6,2.0854271356783918,0.88981599676206,4.8875344498742725
R-HSA-1250347,SHC1 events in ERBB4 signaling,2/1194,14/9872,0.14285714285714285,1.1811438143096433,0.2515741625920714,0.5187266675905391,0.9999999999999981,0.963097398669085,NRG1/GRB2,2,2.3336922708782004,0.5297654853428561,10.280246195412309
R-HSA-2024101,CS/DS degradation,2/1194,14/9872,0.14285714285714285,1.1811438143096433,0.2515741625920714,0.5187266675905391,0.9999999999999981,0.963097398669085,CSPG5/BCAN,2,2.3336922708782004,0.5297654853428561,10.280246195412309
R-HSA-3322077,Glycogen synthesis,2/1194,14/9872,0.14285714285714285,1.1811438143096433,0.2515741625920714,0.5187266675905391,0.9999999999999981,0.963097398669085,GYS1/GBE1,2,2.3336922708782004,0.5297654853428561,10.280246195412309
R-HSA-3656237,Defective EXT2 causes exostoses 2,2/1194,14/9872,0.14285714285714285,1.1811438143096433,0.2515741625920714,0.5187266675905391,0.9999999999999981,0.963097398669085,GPC5/GPC2,2,2.3336922708782004,0.5297654853428561,10.280246195412309
R-HSA-3656253,"Defective EXT1 causes exostoses 1, TRPS2 and CHDS",2/1194,14/9872,0.14285714285714285,1.1811438143096433,0.2515741625920714,0.5187266675905391,0.9999999999999981,0.963097398669085,GPC5/GPC2,2,2.3336922708782004,0.5297654853428561,10.280246195412309
R-HSA-442660,Na+/Cl- dependent neurotransmitter transporters,2/1194,14/9872,0.14285714285714285,1.1811438143096433,0.2515741625920714,0.5187266675905391,0.9999999999999981,0.963097398669085,SLC6A6/SLC6A15,2,2.3336922708782004,0.5297654853428561,10.280246195412309
R-HSA-71240,Tryptophan catabolism,2/1194,14/9872,0.14285714285714285,1.1811438143096433,0.2515741625920714,0.5187266675905391,0.9999999999999981,0.963097398669085,KYAT3/ACMSD,2,2.3336922708782004,0.5297654853428561,10.280246195412309
R-HSA-8941856,RUNX3 regulates NOTCH signaling,2/1194,14/9872,0.14285714285714285,1.1811438143096433,0.2515741625920714,0.5187266675905391,0.9999999999999981,0.963097398669085,KAT2B/HES1,2,2.3336922708782004,0.5297654853428561,10.280246195412309
R-HSA-8964539,Glutamate and glutamine metabolism,2/1194,14/9872,0.14285714285714285,1.1811438143096433,0.2515741625920714,0.5187266675905391,0.9999999999999981,0.963097398669085,GLUL/GLS2,2,2.3336922708782004,0.5297654853428561,10.280246195412309
R-HSA-9651496,Defects of contact activation system (CAS) and kallikrein/kinin system (KKS),2/1194,14/9872,0.14285714285714285,1.1811438143096433,0.2515741625920714,0.5187266675905391,0.9999999999999981,0.963097398669085,TPST1/TPST2,2,2.3336922708782004,0.5297654853428561,10.280246195412309
R-HSA-190236,Signaling by FGFR,10/1194,81/9872,0.12345679012345678,1.020741567921914,0.06952539799173536,0.5233615151893312,0.9999999999999981,0.963097398669085,FGF20/FGFR3/HNRNPF/SPRED1/FGFR2/PTPN11/FGFBP2/GAB1/FLRT2/GRB2,10,2.016771098289803,1.0428436955052776,3.9002639421685723
R-HSA-447115,Interleukin-12 family signaling,7/1194,56/9872,0.125,1.033500837520938,0.0932513911882789,0.5239434295252784,0.9999999999999981,0.963097398669085,STAT3/PAK2/HNRNPF/MSN/HSPA9/LMNB1/STAT1,7,2.041980737018425,0.9286740526026938,4.489934136383359
R-HSA-9705683,SARS-CoV-2-host interactions,22/1194,181/9872,0.12154696132596685,1.0049510906280943,0.024936114482096577,0.5247329910900673,0.9999999999999981,0.963097398669085,IFNAR2/TLR2/NUP205/GJA1/NOD2/G3BP1/IRAK2/YWHAG/SEC24D/NUP58/PTPN11/NUP98/NUP188/NUP153/GEMIN8/SEC23A/RNF135/TRAF6/SFTPD/SEC24A/STAT1/IKBKE,22,1.9855724293659827,1.2706458017908697,3.1027512676638183
R-HSA-1251985,Nuclear signaling by ERBB4,4/1194,31/9872,0.12903225806451613,1.0668395742151617,0.1382508538199243,0.5263399679969668,0.9999999999999981,0.963097398669085,CXCL12/MXD4/NRG1/STAT5A,4,2.1078510833738586,0.7428379937193804,5.981164435914382
R-HSA-450282,MAPK targets/ Nuclear events mediated by MAP kinases,4/1194,31/9872,0.12903225806451613,1.0668395742151617,0.1382508538199243,0.5263399679969668,0.9999999999999981,0.963097398669085,FOS/DUSP3/JUN/RPS6KA3,4,2.1078510833738586,0.7428379937193804,5.981164435914382
R-HSA-5626467,RHO GTPases activate IQGAPs,4/1194,31/9872,0.12903225806451613,1.0668395742151617,0.1382508538199243,0.5263399679969668,0.9999999999999981,0.963097398669085,CTNNA1/IQGAP1/TUBB2A/TUBB4A,4,2.1078510833738586,0.7428379937193804,5.981164435914382
R-HSA-74752,Signaling by Insulin receptor,9/1194,73/9872,0.1232876712328767,1.019343291801473,0.06152814914101339,0.5292264293201987,0.9999999999999981,0.963097398669085,FGF20/PTPRF/FGFR3/GRB10/FGFR2/PTPN1/PTPN11/GAB1/GRB2,9,2.014008398155159,1.0052424806756115,4.035076019781183
R-HSA-5654736,Signaling by FGFR1,6/1194,48/9872,0.125,1.033500837520938,0.08629885284940071,0.5315245827256374,0.9999999999999981,0.963097398669085,FGF20/SPRED1/PTPN11/GAB1/FLRT2/GRB2,6,2.0419807370184255,0.8721500867497243,4.780926349378283
R-HSA-3781865,Diseases of glycosylation,17/1194,140/9872,0.12142857142857143,1.003972242163197,0.017557860778810785,0.5322337381560466,0.9999999999999981,0.963097398669085,CSPG5/MUC15/CHSY1/OMD/CHST3/ADAMTS2/SPON1/GPC5/ACAN/PMM2/B3GLCT/BCAN/GPC2/OGN/ADAMTS10/ADAMTS18/THSD7B,17,1.9836384302464705,1.1950020937308,3.2927318224741833
R-HSA-9692914,SARS-CoV-1-host interactions,11/1194,90/9872,0.12222222222222222,1.010534152242695,0.03723744995449451,0.5337345316956297,0.9999999999999981,0.963097398669085,BCL2L1/RUNX1/IRAK2/YWHAG/NFKBIA/RELA/CASP1/TRAF6/SFTPD/RCAN3/IKBKE,11,1.996603387306905,1.0646973443997056,3.744186183213428
R-HSA-9734767,Developmental Cell Lineages,11/1194,90/9872,0.12222222222222222,1.010534152242695,0.03723744995449451,0.5337345316956297,0.9999999999999981,0.963097398669085,PROM1/ITGB4/TFRC/COL5A3/PRSS3/LAMA1/COL5A2/CLDN10/SLC4A4/LAMA2/CFTR,11,1.996603387306905,1.0646973443997056,3.744186183213428
R-HSA-212676,Dopamine Neurotransmitter Release Cycle,3/1194,23/9872,0.13043478260869565,1.0784356565435875,0.13968645694261986,0.5385049892157298,0.9999999999999981,0.963097398669085,PPFIA2/SYN2/PPFIA4,3,2.1307625081931394,0.6388511231928332,7.106740054914332
R-HSA-9013418,RHOBTB2 GTPase cycle,3/1194,23/9872,0.13043478260869565,1.0784356565435875,0.13968645694261986,0.5385049892157298,0.9999999999999981,0.963097398669085,TRA2B/STK38/RHOBTB2,3,2.1307625081931394,0.6388511231928332,7.106740054914332
R-HSA-111457,Release of apoptotic factors from the mitochondria,1/1194,6/9872,0.16666666666666666,1.378001116694584,0.34353506211110607,0.5386864990540132,0.9999999999999981,0.963097398669085,GSDME,1,2.7226409826912343,0.32750699953594314,22.633940438321392
R-HSA-111459,Activation of caspases through apoptosome-mediated cleavage,1/1194,6/9872,0.16666666666666666,1.378001116694584,0.34353506211110607,0.5386864990540132,0.9999999999999981,0.963097398669085,CASP7,1,2.7226409826912343,0.32750699953594314,22.633940438321392
R-HSA-111463,SMAC (DIABLO) binds to IAPs,1/1194,6/9872,0.16666666666666666,1.378001116694584,0.34353506211110607,0.5386864990540132,0.9999999999999981,0.963097398669085,CASP7,1,2.7226409826912343,0.32750699953594314,22.633940438321392
R-HSA-111464,SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes,1/1194,6/9872,0.16666666666666666,1.378001116694584,0.34353506211110607,0.5386864990540132,0.9999999999999981,0.963097398669085,CASP7,1,2.7226409826912343,0.32750699953594314,22.633940438321392
R-HSA-1614517,Sulfide oxidation to sulfate,1/1194,6/9872,0.16666666666666666,1.378001116694584,0.34353506211110607,0.5386864990540132,0.9999999999999981,0.963097398669085,SQOR,1,2.7226409826912343,0.32750699953594314,22.633940438321392
R-HSA-193144,Estrogen biosynthesis,1/1194,6/9872,0.16666666666666666,1.378001116694584,0.34353506211110607,0.5386864990540132,0.9999999999999981,0.963097398669085,HSD17B1,1,2.7226409826912343,0.32750699953594314,22.633940438321392
R-HSA-205025,NADE modulates death signalling,1/1194,6/9872,0.16666666666666666,1.378001116694584,0.34353506211110607,0.5386864990540132,0.9999999999999981,0.963097398669085,CASP2,1,2.7226409826912343,0.32750699953594314,22.633940438321392
R-HSA-211916,Vitamins,1/1194,6/9872,0.16666666666666666,1.378001116694584,0.34353506211110607,0.5386864990540132,0.9999999999999981,0.963097398669085,CYP26C1,1,2.7226409826912343,0.32750699953594314,22.633940438321392
R-HSA-3000484,Scavenging by Class F Receptors,1/1194,6/9872,0.16666666666666666,1.378001116694584,0.34353506211110607,0.5386864990540132,0.9999999999999981,0.963097398669085,HSPH1,1,2.7226409826912343,0.32750699953594314,22.633940438321392
R-HSA-3065679,SUMO is proteolytically processed,1/1194,6/9872,0.16666666666666666,1.378001116694584,0.34353506211110607,0.5386864990540132,0.9999999999999981,0.963097398669085,SENP5,1,2.7226409826912343,0.32750699953594314,22.633940438321392
R-HSA-3304356,SMAD2/3 Phosphorylation Motif Mutants in Cancer,1/1194,6/9872,0.16666666666666666,1.378001116694584,0.34353506211110607,0.5386864990540132,0.9999999999999981,0.963097398669085,TGFBR1,1,2.7226409826912343,0.32750699953594314,22.633940438321392
R-HSA-3656532,TGFBR1 KD Mutants in Cancer,1/1194,6/9872,0.16666666666666666,1.378001116694584,0.34353506211110607,0.5386864990540132,0.9999999999999981,0.963097398669085,TGFBR1,1,2.7226409826912343,0.32750699953594314,22.633940438321392
R-HSA-389599,Alpha-oxidation of phytanate,1/1194,6/9872,0.16666666666666666,1.378001116694584,0.34353506211110607,0.5386864990540132,0.9999999999999981,0.963097398669085,ALDH3A2,1,2.7226409826912343,0.32750699953594314,22.633940438321392
R-HSA-433692,Proton-coupled monocarboxylate transport,1/1194,6/9872,0.16666666666666666,1.378001116694584,0.34353506211110607,0.5386864990540132,0.9999999999999981,0.963097398669085,SLC16A7,1,2.7226409826912343,0.32750699953594314,22.633940438321392
R-HSA-5625886,Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3,1/1194,6/9872,0.16666666666666666,1.378001116694584,0.34353506211110607,0.5386864990540132,0.9999999999999981,0.963097398669085,KDM4C,1,2.7226409826912343,0.32750699953594314,22.633940438321392
R-HSA-5626978,TNFR1-mediated ceramide production,1/1194,6/9872,0.16666666666666666,1.378001116694584,0.34353506211110607,0.5386864990540132,0.9999999999999981,0.963097398669085,SMPD3,1,2.7226409826912343,0.32750699953594314,22.633940438321392
R-HSA-6783984,Glycine degradation,1/1194,6/9872,0.16666666666666666,1.378001116694584,0.34353506211110607,0.5386864990540132,0.9999999999999981,0.963097398669085,GLDC,1,2.7226409826912343,0.32750699953594314,22.633940438321392
R-HSA-6806942,MET Receptor Activation,1/1194,6/9872,0.16666666666666666,1.378001116694584,0.34353506211110607,0.5386864990540132,0.9999999999999981,0.963097398669085,HPN,1,2.7226409826912343,0.32750699953594314,22.633940438321392
R-HSA-8849470,PTK6 Regulates Cell Cycle,1/1194,6/9872,0.16666666666666666,1.378001116694584,0.34353506211110607,0.5386864990540132,0.9999999999999981,0.963097398669085,CDK2,1,2.7226409826912343,0.32750699953594314,22.633940438321392
R-HSA-8963901,Chylomicron remodeling,1/1194,6/9872,0.16666666666666666,1.378001116694584,0.34353506211110607,0.5386864990540132,0.9999999999999981,0.963097398669085,LPL,1,2.7226409826912343,0.32750699953594314,22.633940438321392
R-HSA-8964041,LDL remodeling,1/1194,6/9872,0.16666666666666666,1.378001116694584,0.34353506211110607,0.5386864990540132,0.9999999999999981,0.963097398669085,LPA,1,2.7226409826912343,0.32750699953594314,22.633940438321392
R-HSA-8964208,Phenylalanine metabolism,1/1194,6/9872,0.16666666666666666,1.378001116694584,0.34353506211110607,0.5386864990540132,0.9999999999999981,0.963097398669085,QDPR,1,2.7226409826912343,0.32750699953594314,22.633940438321392
R-HSA-8964572,Lipid particle organization,1/1194,6/9872,0.16666666666666666,1.378001116694584,0.34353506211110607,0.5386864990540132,0.9999999999999981,0.963097398669085,HILPDA,1,2.7226409826912343,0.32750699953594314,22.633940438321392
R-HSA-9022535,Loss of phosphorylation of MECP2 at T308,1/1194,6/9872,0.16666666666666666,1.378001116694584,0.34353506211110607,0.5386864990540132,0.9999999999999981,0.963097398669085,CAMK4,1,2.7226409826912343,0.32750699953594314,22.633940438321392
R-HSA-9032845,Activated NTRK2 signals through CDK5,1/1194,6/9872,0.16666666666666666,1.378001116694584,0.34353506211110607,0.5386864990540132,0.9999999999999981,0.963097398669085,BDNF,1,2.7226409826912343,0.32750699953594314,22.633940438321392
R-HSA-947581,Molybdenum cofactor biosynthesis,1/1194,6/9872,0.16666666666666666,1.378001116694584,0.34353506211110607,0.5386864990540132,0.9999999999999981,0.963097398669085,MOCOS,1,2.7226409826912343,0.32750699953594314,22.633940438321392
R-HSA-9634635,Estrogen-stimulated signaling through PRKCZ,1/1194,6/9872,0.16666666666666666,1.378001116694584,0.34353506211110607,0.5386864990540132,0.9999999999999981,0.963097398669085,PRKCZ,1,2.7226409826912343,0.32750699953594314,22.633940438321392
R-HSA-9833110,RSV-host interactions,10/1194,82/9872,0.12195121951219512,1.0082935000204272,0.027972182097230697,0.5397037757025063,0.9999999999999981,0.963097398669085,IFNAR2/CX3CR1/TLR2/MED28/GPC5/MED15/CD14/MED29/GPC2/TLR4,10,1.9921763287984637,1.0305780161064788,3.8510102709340868
R-HSA-159231,Transport of Mature mRNA Derived from an Intronless Transcript,5/1194,40/9872,0.125,1.033500837520938,0.07874765713398517,0.5407212888900594,0.9999999999999981,0.963097398669085,NUP205/NUP58/NUP98/NUP188/NUP153,5,2.041980737018425,0.8044280147441274,5.183416357870883
R-HSA-425397,"Transport of vitamins, nucleosides, and related molecules",5/1194,40/9872,0.125,1.033500837520938,0.07874765713398517,0.5407212888900594,0.9999999999999981,0.963097398669085,SLC35D2/SLCO1C1/SLC28A2/LCN12/SLC27A4,5,2.041980737018425,0.8044280147441274,5.183416357870883
R-HSA-1980143,Signaling by NOTCH1,9/1194,74/9872,0.12162162162162163,1.0055683824528046,0.0178340144832455,0.5463835342051298,0.9999999999999981,0.963097398669085,NEURL1B/HES5/KAT2B/HDAC4/HIF1A/CUL1/HES1/ARRB1/TLE1,9,1.9867920684503597,0.9921658606449655,3.9785109323266346
R-HSA-392518,Signal amplification,4/1194,32/9872,0.125,1.033500837520938,0.07040540822042954,0.5524167637940416,0.9999999999999981,0.963097398669085,GNB3/GNAI1/P2RY12/GNG3,4,2.0419807370184255,0.7209627651560861,5.783496085892298
R-HSA-4085001,Sialic acid metabolism,4/1194,32/9872,0.125,1.033500837520938,0.07040540822042954,0.5524167637940416,0.9999999999999981,0.963097398669085,NEU4/ST6GAL2/ST3GAL4/ST8SIA3,4,2.0419807370184255,0.7209627651560861,5.783496085892298
R-HSA-5656169,Termination of translesion DNA synthesis,4/1194,32/9872,0.125,1.033500837520938,0.07040540822042954,0.5524167637940416,0.9999999999999981,0.963097398669085,USP43/UBA7/RPA3/POLE,4,2.0419807370184255,0.7209627651560861,5.783496085892298
R-HSA-8856828,Clathrin-mediated endocytosis,17/1194,142/9872,0.11971830985915492,0.9898317880482224,-0.04526945424721838,0.5570603282445777,0.9999999999999981,0.963097398669085,SYNJ2/TACR1/SNX9/AMPH/PICALM/TFRC/ITSN2/DNM3/IGF2R/SGIP1/BIN1/KIAA0319/ACTR3/GRB2/ARRB1/CFTR/DNM1,17,1.9556998608063791,1.1786205753660743,3.2451172374707076
R-HSA-210744,Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells,2/1194,15/9872,0.13333333333333333,1.1024008933556673,0.14721427116849098,0.5570856485378862,0.9999999999999981,0.963097398669085,KAT2B/HES1,2,2.178112786152987,0.497513686095145,9.53576844576663
R-HSA-3229121,Glycogen storage diseases,2/1194,15/9872,0.13333333333333333,1.1024008933556673,0.14721427116849098,0.5570856485378862,0.9999999999999981,0.963097398669085,GYS1/GBE1,2,2.178112786152987,0.497513686095145,9.53576844576663
R-HSA-391903,Eicosanoid ligand-binding receptors,2/1194,15/9872,0.13333333333333333,1.1024008933556673,0.14721427116849098,0.5570856485378862,0.9999999999999981,0.963097398669085,CYSLTR1/GPR17,2,2.178112786152987,0.497513686095145,9.53576844576663
R-HSA-392517,Rap1 signalling,2/1194,15/9872,0.13333333333333333,1.1024008933556673,0.14721427116849098,0.5570856485378862,0.9999999999999981,0.963097398669085,RAP1A/RASGRP1,2,2.178112786152987,0.497513686095145,9.53576844576663
R-HSA-4419969,Depolymerization of the Nuclear Lamina,2/1194,15/9872,0.13333333333333333,1.1024008933556673,0.14721427116849098,0.5570856485378862,0.9999999999999981,0.963097398669085,LMNA/LMNB1,2,2.178112786152987,0.497513686095145,9.53576844576663
R-HSA-5637810,Constitutive Signaling by EGFRvIII,2/1194,15/9872,0.13333333333333333,1.1024008933556673,0.14721427116849098,0.5570856485378862,0.9999999999999981,0.963097398669085,GAB1/GRB2,2,2.178112786152987,0.497513686095145,9.53576844576663
R-HSA-5637812,Signaling by EGFRvIII in Cancer,2/1194,15/9872,0.13333333333333333,1.1024008933556673,0.14721427116849098,0.5570856485378862,0.9999999999999981,0.963097398669085,GAB1/GRB2,2,2.178112786152987,0.497513686095145,9.53576844576663
R-HSA-75035,Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex,2/1194,15/9872,0.13333333333333333,1.1024008933556673,0.14721427116849098,0.5570856485378862,0.9999999999999981,0.963097398669085,YWHAG/CCNA2,2,2.178112786152987,0.497513686095145,9.53576844576663
R-HSA-8949664,Processing of SMDT1,2/1194,15/9872,0.13333333333333333,1.1024008933556673,0.14721427116849098,0.5570856485378862,0.9999999999999981,0.963097398669085,MCUB/MAIP1,2,2.178112786152987,0.497513686095145,9.53576844576663
R-HSA-8963898,Plasma lipoprotein assembly,2/1194,15/9872,0.13333333333333333,1.1024008933556673,0.14721427116849098,0.5570856485378862,0.9999999999999981,0.963097398669085,A2M/BMP1,2,2.178112786152987,0.497513686095145,9.53576844576663
R-HSA-9707564,Cytoprotection by HMOX1,7/1194,58/9872,0.1206896551724138,0.997862877606423,-0.006054709089648799,0.5627460818587314,0.9999999999999981,0.963097398669085,STAT3/HMOX1/NFE2L2/HELZ2/BACH1/NCOA1/NDUFA4,7,1.971567608155721,0.8979990866267629,4.328599985697385
R-HSA-159234,Transport of Mature mRNAs Derived from Intronless Transcripts,5/1194,41/9872,0.12195121951219512,1.0082935000204272,0.019738031913449902,0.5635944541272385,0.9999999999999981,0.963097398669085,NUP205/NUP58/NUP98/NUP188/NUP153,5,1.9921763287984637,0.7857958371705926,5.050633176316158
R-HSA-9035034,RHOF GTPase cycle,5/1194,41/9872,0.12195121951219512,1.0082935000204272,0.019738031913449902,0.5635944541272385,0.9999999999999981,0.963097398669085,ARHGAP21/ARHGAP5/MYO9B/ARHGAP1/LMNB1,5,1.9921763287984637,0.7857958371705926,5.050633176316158
R-HSA-9006936,Signaling by TGFB family members,18/1194,151/9872,0.11920529801324503,0.985590202668974,-0.06618564281053714,0.5642519381981081,0.9999999999999981,0.963097398669085,ITGB8/PPP1R15A/CHRDL1/ITGB3/TNRC6C/RARA/AGO2/BMP2/PRKCZ/TGFB3/PPP1CB/JUNB/TGFBR1/UBE2D1/SMAD6/ARRB1/CGN/STAT1,18,1.947319378348697,1.1903372448149065,3.185696135956837
R-HSA-391251,Protein folding,11/1194,92/9872,0.11956521739130435,0.9885660184982885,-0.040869082497135695,0.5644621823743293,0.9999999999999981,0.963097398669085,STAT3/GNB3/TBCD/TBCE/GNG3/CCT6B/TUBB2A/KIFC3/TUBB4A/RGS9/GAPDHS,11,1.9531989658437112,1.0423210492426096,3.6600874586050605
R-HSA-110373,Resolution of AP sites via the multiple-nucleotide patch replacement pathway,3/1194,24/9872,0.125,1.033500837520938,0.06094810146535905,0.5684114036465285,0.9999999999999981,0.963097398669085,RPA3/POLE/POLB,3,2.0419807370184255,0.6140056150473818,6.790956349857719
R-HSA-189445,Metabolism of porphyrins,3/1194,24/9872,0.125,1.033500837520938,0.06094810146535905,0.5684114036465285,0.9999999999999981,0.963097398669085,HMOX1/ABCC2/ALAS1,3,2.0419807370184255,0.6140056150473818,6.790956349857719
R-HSA-389960,Formation of tubulin folding intermediates by CCT/TriC,3/1194,24/9872,0.125,1.033500837520938,0.06094810146535905,0.5684114036465285,0.9999999999999981,0.963097398669085,CCT6B/TUBB2A/TUBB4A,3,2.0419807370184255,0.6140056150473818,6.790956349857719
R-HSA-525793,Myogenesis,3/1194,24/9872,0.125,1.033500837520938,0.06094810146535905,0.5684114036465285,0.9999999999999981,0.963097398669085,CTNNA1/CDH4/CDON,3,2.0419807370184255,0.6140056150473818,6.790956349857719
R-HSA-912526,Interleukin receptor SHC signaling,3/1194,24/9872,0.125,1.033500837520938,0.06094810146535905,0.5684114036465285,0.9999999999999981,0.963097398669085,CSF2RA/JAK3/GRB2,3,2.0419807370184255,0.6140056150473818,6.790956349857719
R-HSA-9933387,"RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression",3/1194,24/9872,0.125,1.033500837520938,0.06094810146535905,0.5684114036465285,0.9999999999999981,0.963097398669085,HELZ2/NCOA1/RORA,3,2.0419807370184255,0.6140056150473818,6.790956349857719
R-HSA-9759194,Nuclear events mediated by NFE2L2,10/1194,84/9872,0.11904761904761904,0.9842865119247028,-0.053646103041689104,0.5717511225805116,0.9999999999999981,0.963097398669085,HMOX1/NFE2L2/BCL2L1/CUL1/BACH1/GCLC/PDGFA/RELA/CCL2/SLC7A11,10,1.944743559065167,1.0068926430315683,3.7561377935372176
R-HSA-9820448,Developmental Cell Lineages of the Exocrine Pancreas,8/1194,67/9872,0.11940298507462686,0.9872246806170154,-0.03891869641475481,0.5717739687228569,0.9999999999999981,0.963097398669085,PROM1/COL5A3/LAMA1/COL5A2/CLDN10/SLC4A4/LAMA2/CFTR,8,1.950548763719093,0.9348366886389109,4.069845060515868
R-HSA-9856651,MITF-M-dependent gene expression,12/1194,101/9872,0.1188118811881188,0.9823374297228717,-0.06617866462369498,0.5724079057334301,0.9999999999999981,0.963097398669085,DICER1/TRPM1/PXN/TNRC6C/CDKN1A/SS18L1/BCL2A1/AGO2/CDK2/ZEB1/ITGA2/SOX10,12,1.9408925817204836,1.0637814318228875,3.541201135013602
R-HSA-180786,Extension of Telomeres,6/1194,50/9872,0.12,0.9921608040201004,-0.020612443378651774,0.5731468360330694,0.9999999999999981,0.963097398669085,ANKRD28/SHQ1/RPA3/CDK2/CCNA2/STN1,6,1.9603015075376886,0.8388426753837994,4.581052100975109
R-HSA-1912422,Pre-NOTCH Expression and Processing,6/1194,50/9872,0.12,0.9921608040201004,-0.020612443378651774,0.5731468360330694,0.9999999999999981,0.963097398669085,KAT2B/TNRC6C/AGO2/RUNX1/ST3GAL4/JUN,6,1.9603015075376886,0.8388426753837994,4.581052100975109
R-HSA-4791275,Signaling by WNT in cancer,4/1194,33/9872,0.12121212121212122,1.0021826303233339,0.004658376547727405,0.5777113288228826,0.9999999999999981,0.963097398669085,FZD5/KREMEN2/TNKS/RNF43,4,1.980102532866352,0.700338965820023,5.598440515262338
R-HSA-9931509,"Expression of BMAL (ARNTL), CLOCK, and NPAS2",4/1194,33/9872,0.12121212121212122,1.0021826303233339,0.004658376547727405,0.5777113288228826,0.9999999999999981,0.963097398669085,HELZ2/NCOA1/RAI1/RORA,4,1.980102532866352,0.700338965820023,5.598440515262338
R-HSA-170834,Signaling by TGF-beta Receptor Complex,11/1194,93/9872,0.11827956989247312,0.9779362763638985,-0.07929503163007642,0.5795198671524444,0.9999999999999981,0.963097398669085,ITGB8/PPP1R15A/ITGB3/PRKCZ/TGFB3/PPP1CB/JUNB/TGFBR1/UBE2D1/CGN/STAT1,11,1.932196826426037,1.0314820584047697,3.6194372414239417
R-HSA-211000,Gene Silencing by RNA,9/1194,76/9872,0.11842105263157894,0.9791060565987834,-0.0678228035993399,0.5799334626942264,0.9999999999999981,0.963097398669085,DICER1/TNRC6C/NUP205/AGO2/NUP58/MYBL1/NUP98/NUP188/NUP153,9,1.9345080666490346,0.9670076911727457,3.870001752924693
R-HSA-913709,O-linked glycosylation of mucins,7/1194,59/9872,0.11864406779661017,0.9809499474775004,-0.05443700211137405,0.581600585810377,0.9999999999999981,0.963097398669085,MUC15/GALNT15/ST3GAL4/B4GALT5/GALNTL6/GALNT7/GALNT8,7,1.9381512080174883,0.8834093637710805,4.252196387305965
R-HSA-1566948,Elastic fibre formation,5/1194,42/9872,0.11904761904761904,0.9842865119247028,-0.03785239845250972,0.5858749558308068,0.9999999999999981,0.963097398669085,ITGB8/ITGB3/BMP2/TGFB3/LOXL2,5,1.944743559065167,0.7680073232266666,4.9244680306378275
R-HSA-168325,Viral Messenger RNA Synthesis,5/1194,42/9872,0.11904761904761904,0.9842865119247028,-0.03785239845250972,0.5858749558308068,0.9999999999999981,0.963097398669085,NUP205/NUP58/NUP98/NUP188/NUP153,5,1.944743559065167,0.7680073232266666,4.9244680306378275
R-HSA-3214841,PKMTs methylate histone lysines,5/1194,42/9872,0.11904761904761904,0.9842865119247028,-0.03785239845250972,0.5858749558308068,0.9999999999999981,0.963097398669085,SETD7/DOT1L/AEBP2/WDR5/RELA,5,1.944743559065167,0.7680073232266666,4.9244680306378275
R-HSA-3928662,EPHB-mediated forward signaling,5/1194,42/9872,0.11904761904761904,0.9842865119247028,-0.03785239845250972,0.5858749558308068,0.9999999999999981,0.963097398669085,GRIN1/LIMK2/PTK2/ACTR3/GRIN2B,5,1.944743559065167,0.7680073232266666,4.9244680306378275
R-HSA-9839373,Signaling by TGFBR3,5/1194,42/9872,0.11904761904761904,0.9842865119247028,-0.03785239845250972,0.5858749558308068,0.9999999999999981,0.963097398669085,TNRC6C/RARA/AGO2/TGFBR1/ARRB1,5,1.944743559065167,0.7680073232266666,4.9244680306378275
R-HSA-9007101,Rab regulation of trafficking,14/1194,119/9872,0.11764705882352941,0.9727066706079417,-0.1111050506264627,0.586711549107612,0.9999999999999981,0.963097398669085,RIN2/RAB3IP/RAB27B/TBC1D14/DENND1B/RAB8B/RAB10/DENND4A/DENND3/RAB1A/GDI2/RAB7B/RAB21/SBF1,14,1.921864223076165,1.1012351028356708,3.3540177591771823
R-HSA-1295596,Spry regulation of FGF signaling,2/1194,16/9872,0.125,1.033500837520938,0.04974371596587584,0.5932144949605265,0.9999999999999981,0.963097398669085,PTPN11/GRB2,2,2.0419807370184255,0.46895868440884786,8.8913703253208
R-HSA-140534,Caspase activation via Death Receptors in the presence of ligand,2/1194,16/9872,0.125,1.033500837520938,0.04974371596587584,0.5932144949605265,0.9999999999999981,0.963097398669085,CD14/TLR4,2,2.0419807370184255,0.46895868440884786,8.8913703253208
R-HSA-140875,Common Pathway of Fibrin Clot Formation,2/1194,16/9872,0.125,1.033500837520938,0.04974371596587584,0.5932144949605265,0.9999999999999981,0.963097398669085,PROS1/SERPINE2,2,2.0419807370184255,0.46895868440884786,8.8913703253208
R-HSA-1433559,Regulation of KIT signaling,2/1194,16/9872,0.125,1.033500837520938,0.04974371596587584,0.5932144949605265,0.9999999999999981,0.963097398669085,GRB2/SH2B2,2,2.0419807370184255,0.46895868440884786,8.8913703253208
R-HSA-164378,PKA activation in glucagon signalling,2/1194,16/9872,0.125,1.033500837520938,0.04974371596587584,0.5932144949605265,0.9999999999999981,0.963097398669085,PRKAR2A/ADCY3,2,2.0419807370184255,0.46895868440884786,8.8913703253208
R-HSA-1660516,Synthesis of PIPs at the early endosome membrane,2/1194,16/9872,0.125,1.033500837520938,0.04974371596587584,0.5932144949605265,0.9999999999999981,0.963097398669085,INPP5F/MTMR10,2,2.0419807370184255,0.46895868440884786,8.8913703253208
R-HSA-1963640,GRB2 events in ERBB2 signaling,2/1194,16/9872,0.125,1.033500837520938,0.04974371596587584,0.5932144949605265,0.9999999999999981,0.963097398669085,NRG1/GRB2,2,2.0419807370184255,0.46895868440884786,8.8913703253208
R-HSA-210745,Regulation of gene expression in beta cells,2/1194,16/9872,0.125,1.033500837520938,0.04974371596587584,0.5932144949605265,0.9999999999999981,0.963097398669085,HNF4G/PAX6,2,2.0419807370184255,0.46895868440884786,8.8913703253208
R-HSA-264642,Acetylcholine Neurotransmitter Release Cycle,2/1194,16/9872,0.125,1.033500837520938,0.04974371596587584,0.5932144949605265,0.9999999999999981,0.963097398669085,PPFIA2/PPFIA4,2,2.0419807370184255,0.46895868440884786,8.8913703253208
R-HSA-5423646,Aflatoxin activation and detoxification,2/1194,16/9872,0.125,1.033500837520938,0.04974371596587584,0.5932144949605265,0.9999999999999981,0.963097398669085,ACY3/DPEP2,2,2.0419807370184255,0.46895868440884786,8.8913703253208
R-HSA-5654719,SHC-mediated cascade:FGFR4,2/1194,16/9872,0.125,1.033500837520938,0.04974371596587584,0.5932144949605265,0.9999999999999981,0.963097398669085,FGF20/GRB2,2,2.0419807370184255,0.46895868440884786,8.8913703253208
R-HSA-881907,Gastrin-CREB signalling pathway via PKC and MAPK,2/1194,16/9872,0.125,1.033500837520938,0.04974371596587584,0.5932144949605265,0.9999999999999981,0.963097398669085,GRB2/RPS6KA3,2,2.0419807370184255,0.46895868440884786,8.8913703253208
R-HSA-9830364,Formation of the nephric duct,2/1194,16/9872,0.125,1.033500837520938,0.04974371596587584,0.5932144949605265,0.9999999999999981,0.963097398669085,ID4/PCDH19,2,2.0419807370184255,0.46895868440884786,8.8913703253208
R-HSA-191859,snRNP Assembly,6/1194,51/9872,0.11764705882352941,0.9727066706079417,-0.0724830843632574,0.5932572695822859,0.9999999999999981,0.963097398669085,NUP205/NUP58/NUP98/NUP188/NUP153/GEMIN8,6,1.9218642230761653,0.8231252817620813,4.487241704000717
R-HSA-194441,Metabolism of non-coding RNA,6/1194,51/9872,0.11764705882352941,0.9727066706079417,-0.0724830843632574,0.5932572695822859,0.9999999999999981,0.963097398669085,NUP205/NUP58/NUP98/NUP188/NUP153/GEMIN8,6,1.9218642230761653,0.8231252817620813,4.487241704000717
R-HSA-110362,POLB-Dependent Long Patch Base Excision Repair,1/1194,7/9872,0.14285714285714285,1.1811438143096433,0.17782667167977026,0.5945154388603691,0.9999999999999981,0.963097398669085,POLB,1,2.3336922708782004,0.28688006046731773,18.98396007824702
R-HSA-111469,"SMAC, XIAP-regulated apoptotic response",1/1194,7/9872,0.14285714285714285,1.1811438143096433,0.17782667167977026,0.5945154388603691,0.9999999999999981,0.963097398669085,CASP7,1,2.3336922708782004,0.28688006046731773,18.98396007824702
R-HSA-112412,SOS-mediated signalling,1/1194,7/9872,0.14285714285714285,1.1811438143096433,0.17782667167977026,0.5945154388603691,0.9999999999999981,0.963097398669085,GRB2,1,2.3336922708782004,0.28688006046731773,18.98396007824702
R-HSA-1482883,Acyl chain remodeling of DAG and TAG,1/1194,7/9872,0.14285714285714285,1.1811438143096433,0.17782667167977026,0.5945154388603691,0.9999999999999981,0.963097398669085,MGLL,1,2.3336922708782004,0.28688006046731773,18.98396007824702
R-HSA-170984,ARMS-mediated activation,1/1194,7/9872,0.14285714285714285,1.1811438143096433,0.17782667167977026,0.5945154388603691,0.9999999999999981,0.963097398669085,RAP1A,1,2.3336922708782004,0.28688006046731773,18.98396007824702
R-HSA-174577,Activation of C3 and C5,1/1194,7/9872,0.14285714285714285,1.1811438143096433,0.17782667167977026,0.5945154388603691,0.9999999999999981,0.963097398669085,CFB,1,2.3336922708782004,0.28688006046731773,18.98396007824702
R-HSA-177128,Conjugation of salicylate with glycine,1/1194,7/9872,0.14285714285714285,1.1811438143096433,0.17782667167977026,0.5945154388603691,0.9999999999999981,0.963097398669085,ACSM5,1,2.3336922708782004,0.28688006046731773,18.98396007824702
R-HSA-199920,CREB phosphorylation,1/1194,7/9872,0.14285714285714285,1.1811438143096433,0.17782667167977026,0.5945154388603691,0.9999999999999981,0.963097398669085,RPS6KA3,1,2.3336922708782004,0.28688006046731773,18.98396007824702
R-HSA-2408508,"Metabolism of ingested SeMet, Sec, MeSec into H2Se",1/1194,7/9872,0.14285714285714285,1.1811438143096433,0.17782667167977026,0.5945154388603691,0.9999999999999981,0.963097398669085,NNMT,1,2.3336922708782004,0.28688006046731773,18.98396007824702
R-HSA-2980767,"Activation of NIMA Kinases NEK9, NEK6, NEK7",1/1194,7/9872,0.14285714285714285,1.1811438143096433,0.17782667167977026,0.5945154388603691,0.9999999999999981,0.963097398669085,NEK9,1,2.3336922708782004,0.28688006046731773,18.98396007824702
R-HSA-3134963,DEx/H-box helicases activate type I IFN and inflammatory cytokines production,1/1194,7/9872,0.14285714285714285,1.1811438143096433,0.17782667167977026,0.5945154388603691,0.9999999999999981,0.963097398669085,RELA,1,2.3336922708782004,0.28688006046731773,18.98396007824702
R-HSA-3304349,Loss of Function of SMAD2/3 in Cancer,1/1194,7/9872,0.14285714285714285,1.1811438143096433,0.17782667167977026,0.5945154388603691,0.9999999999999981,0.963097398669085,TGFBR1,1,2.3336922708782004,0.28688006046731773,18.98396007824702
R-HSA-3656534,Loss of Function of TGFBR1 in Cancer,1/1194,7/9872,0.14285714285714285,1.1811438143096433,0.17782667167977026,0.5945154388603691,0.9999999999999981,0.963097398669085,TGFBR1,1,2.3336922708782004,0.28688006046731773,18.98396007824702
R-HSA-426117,Cation-coupled Chloride cotransporters,1/1194,7/9872,0.14285714285714285,1.1811438143096433,0.17782667167977026,0.5945154388603691,0.9999999999999981,0.963097398669085,SLC12A5,1,2.3336922708782004,0.28688006046731773,18.98396007824702
R-HSA-444257,RSK activation,1/1194,7/9872,0.14285714285714285,1.1811438143096433,0.17782667167977026,0.5945154388603691,0.9999999999999981,0.963097398669085,RPS6KA3,1,2.3336922708782004,0.28688006046731773,18.98396007824702
R-HSA-447038,NrCAM interactions,1/1194,7/9872,0.14285714285714285,1.1811438143096433,0.17782667167977026,0.5945154388603691,0.9999999999999981,0.963097398669085,ANK1,1,2.3336922708782004,0.28688006046731773,18.98396007824702
R-HSA-5576894,Phase 1 - inactivation of fast Na+ channels,1/1194,7/9872,0.14285714285714285,1.1811438143096433,0.17782667167977026,0.5945154388603691,0.9999999999999981,0.963097398669085,KCND2,1,2.3336922708782004,0.28688006046731773,18.98396007824702
R-HSA-5649702,APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway,1/1194,7/9872,0.14285714285714285,1.1811438143096433,0.17782667167977026,0.5945154388603691,0.9999999999999981,0.963097398669085,POLB,1,2.3336922708782004,0.28688006046731773,18.98396007824702
R-HSA-629587,Highly sodium permeable postsynaptic acetylcholine nicotinic receptors,1/1194,7/9872,0.14285714285714285,1.1811438143096433,0.17782667167977026,0.5945154388603691,0.9999999999999981,0.963097398669085,CHRNB2,1,2.3336922708782004,0.28688006046731773,18.98396007824702
R-HSA-69478,G2/M DNA replication checkpoint,1/1194,7/9872,0.14285714285714285,1.1811438143096433,0.17782667167977026,0.5945154388603691,0.9999999999999981,0.963097398669085,CCNA2,1,2.3336922708782004,0.28688006046731773,18.98396007824702
R-HSA-73943,Reversal of alkylation damage by DNA dioxygenases,1/1194,7/9872,0.14285714285714285,1.1811438143096433,0.17782667167977026,0.5945154388603691,0.9999999999999981,0.963097398669085,ALKBH5,1,2.3336922708782004,0.28688006046731773,18.98396007824702
R-HSA-8848584,Wax and plasmalogen biosynthesis,1/1194,7/9872,0.14285714285714285,1.1811438143096433,0.17782667167977026,0.5945154388603691,0.9999999999999981,0.963097398669085,AGPS,1,2.3336922708782004,0.28688006046731773,18.98396007824702
R-HSA-8850843,Phosphate bond hydrolysis by NTPDase proteins,1/1194,7/9872,0.14285714285714285,1.1811438143096433,0.17782667167977026,0.5945154388603691,0.9999999999999981,0.963097398669085,ENTPD1,1,2.3336922708782004,0.28688006046731773,18.98396007824702
R-HSA-8941332,RUNX2 regulates genes involved in cell migration,1/1194,7/9872,0.14285714285714285,1.1811438143096433,0.17782667167977026,0.5945154388603691,0.9999999999999981,0.963097398669085,CBFB,1,2.3336922708782004,0.28688006046731773,18.98396007824702
R-HSA-8941855,RUNX3 regulates CDKN1A transcription,1/1194,7/9872,0.14285714285714285,1.1811438143096433,0.17782667167977026,0.5945154388603691,0.9999999999999981,0.963097398669085,CDKN1A,1,2.3336922708782004,0.28688006046731773,18.98396007824702
R-HSA-9033500,TYSND1 cleaves peroxisomal proteins,1/1194,7/9872,0.14285714285714285,1.1811438143096433,0.17782667167977026,0.5945154388603691,0.9999999999999981,0.963097398669085,AGPS,1,2.3336922708782004,0.28688006046731773,18.98396007824702
R-HSA-9637628,Modulation by Mtb of host immune system,1/1194,7/9872,0.14285714285714285,1.1811438143096433,0.17782667167977026,0.5945154388603691,0.9999999999999981,0.963097398669085,TLR2,1,2.3336922708782004,0.28688006046731773,18.98396007824702
R-HSA-9693928,Defective RIPK1-mediated regulated necrosis,1/1194,7/9872,0.14285714285714285,1.1811438143096433,0.17782667167977026,0.5945154388603691,0.9999999999999981,0.963097398669085,MLKL,1,2.3336922708782004,0.28688006046731773,18.98396007824702
R-HSA-9759218,Cobalamin (Cbl) metabolism,1/1194,7/9872,0.14285714285714285,1.1811438143096433,0.17782667167977026,0.5945154388603691,0.9999999999999981,0.963097398669085,MMAB,1,2.3336922708782004,0.28688006046731773,18.98396007824702
R-HSA-9832991,Formation of the posterior neural plate,1/1194,7/9872,0.14285714285714285,1.1811438143096433,0.17782667167977026,0.5945154388603691,0.9999999999999981,0.963097398669085,ZNF521,1,2.3336922708782004,0.28688006046731773,18.98396007824702
R-HSA-380994,ATF4 activates genes in response to endoplasmic reticulum  stress,3/1194,25/9872,0.12,0.9921608040201004,-0.01455668465152682,0.5970909505478759,0.9999999999999981,0.963097398669085,ATF3/ATF6/CCL2,3,1.9603015075376886,0.5910195552248836,6.501954066464606
R-HSA-9614085,FOXO-mediated transcription,7/1194,60/9872,0.11666666666666667,0.9646007816862089,-0.10201486141239277,0.6000506936075561,0.9999999999999981,0.963097398669085,BCL6/KAT2B/CDKN1A/YWHAG/PCK1/FOXG1/CCNG2,7,1.9058486878838636,0.8692862531055316,4.178438584680674
R-HSA-5357801,Programmed Cell Death,22/1194,188/9872,0.11702127659574468,0.9675326989557719,-0.16671344986101017,0.6002009959133032,0.9999999999999981,0.963097398669085,STAT3/PAK2/MLKL/LMNA/IL1B/ADD1/TJP2/FLOT2/BCL2L1/PMAIP1/YWHAG/IRF1/FLOT1/PTK2/CASP7/CD14/LMNB1/CASP1/TLR4/IL1A/GSDME/CASP4,22,1.911641541038526,1.224418963167237,2.984577576266285
R-HSA-9917777,Epigenetic regulation by WDR5-containing histone modifying complexes,12/1194,103/9872,0.11650485436893204,0.9632629165243695,-0.13901803614088762,0.6008346158152524,0.9999999999999981,0.963097398669085,ELOVL5/ACSL1/KAT2B/YEATS2/MGLL/NCOA1/CEBPA/WDR5/PPARG/KDM6A/PHLDA1/LPL,12,1.9032053471239694,1.0437666045352314,3.4703070375911853
R-HSA-187687,Signalling to ERKs,4/1194,34/9872,0.11764705882352941,0.9727066706079417,-0.05913103522898147,0.602170111445903,0.9999999999999981,0.963097398669085,RALGDS/SHC2/RAP1A/GRB2,4,1.9218642230761651,0.6808622053296463,5.424830550187283
R-HSA-5625740,RHO GTPases activate PKNs,4/1194,34/9872,0.11764705882352941,0.9727066706079417,-0.05913103522898147,0.602170111445903,0.9999999999999981,0.963097398669085,KDM4C/YWHAG/PPP1CB/RHOB,4,1.9218642230761651,0.6808622053296463,5.424830550187283
R-HSA-8878159,Transcriptional regulation by RUNX3,10/1194,86/9872,0.11627906976744186,0.961396127926454,-0.13336762094047822,0.6028148610094779,0.9999999999999981,0.963097398669085,CBFB/KAT2B/HDAC4/CDKN1A/SPP1/RUNX1/ITGA4/TEAD3/HES1/TEAD4,10,1.8995169646683026,0.9842718561223526,3.665821263321948
R-HSA-174824,"Plasma lipoprotein assembly, remodeling, and clearance",8/1194,69/9872,0.11594202898550725,0.9586094724831888,-0.12797316824807664,0.6063762928907025,0.9999999999999981,0.963097398669085,A2M/PCSK6/BMP1/ANGPTL3/NCEH1/CUBN/LPA/LPL,8,1.894011118393902,0.9087669246147119,3.9474127187459103
R-HSA-5668914,Diseases of metabolism,29/1194,248/9872,0.11693548387096774,0.9668233641324903,-0.19626971682476232,0.6075515594692322,0.9999999999999981,0.963097398669085,CSPG5/MUC15/CHSY1/MMAB/CSF2RA/HPRT1/OMD/CHST3/ADAMTS2/SPON1/GYS1/GPC5/ABCD4/ACAN/PMM2/B3GLCT/GCLC/CYP27A1/BCAN/CYP26C1/GPC2/GBE1/CUBN/FMO3/OGN/SFTPD/ADAMTS10/ADAMTS18/THSD7B,29,1.9102400443075593,1.2945475181497985,2.8187586594669134
R-HSA-9610379,HCMV Late Events,6/1194,52/9872,0.11538461538461539,0.9540007730962505,-0.1233585844169824,0.6128565356057343,0.9999999999999981,0.963097398669085,NUP205/CEBPD/NUP58/NUP98/NUP188/NUP153,6,1.884905295709316,0.807986156605158,4.397189165617374
R-HSA-4086398,Ca2+ pathway,7/1194,61/9872,0.11475409836065574,0.9487876541175824,-0.1488181379067654,0.6180708253907087,0.9999999999999981,0.963097398669085,GNAO1/GNB3/FZD5/TNRC6C/AGO2/PLCB1/GNG3,7,1.8746052667710136,0.8556077170610408,4.1071916909264115
R-HSA-9694635,Translation of Structural Proteins,7/1194,61/9872,0.11475409836065574,0.9487876541175824,-0.1488181379067654,0.6180708253907087,0.9999999999999981,0.963097398669085,ZDHHC11/MGAT4C/PARP9/ST3GAL4/ZDHHC2/EDEM2/TUSC3,7,1.8746052667710136,0.8556077170610408,4.1071916909264115
R-HSA-2173788,Downregulation of TGF-beta receptor signaling,3/1194,26/9872,0.11538461538461539,0.9540007730962505,-0.08711244581610607,0.6244939289409925,0.9999999999999981,0.963097398669085,PPP1R15A/PPP1CB/TGFBR1,3,1.884905295709316,0.5696918149716701,6.236473616826849
R-HSA-9635486,Infection with Mycobacterium tuberculosis,3/1194,26/9872,0.11538461538461539,0.9540007730962505,-0.08711244581610607,0.6244939289409925,0.9999999999999981,0.963097398669085,PGK1/TLR2/ENO1,3,1.884905295709316,0.5696918149716701,6.236473616826849
R-HSA-9725554,Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin,3/1194,26/9872,0.11538461538461539,0.9540007730962505,-0.08711244581610607,0.6244939289409925,0.9999999999999981,0.963097398669085,ITGB4/TFRC/PRSS3,3,1.884905295709316,0.5696918149716701,6.236473616826849
R-HSA-114604,GPVI-mediated activation cascade,4/1194,35/9872,0.11428571428571428,0.9449150514477146,-0.12109007580843346,0.6257510411267713,0.9999999999999981,0.963097398669085,PTPN11/PRKCZ/PDPN/RHOB,4,1.8669538167025603,0.6624393883634475,5.261638445611159
R-HSA-186712,Regulation of beta-cell development,4/1194,35/9872,0.11428571428571428,0.9449150514477146,-0.12109007580843346,0.6257510411267713,0.9999999999999981,0.963097398669085,HNF4G/KAT2B/PAX6/HES1,4,1.8669538167025603,0.6624393883634475,5.261638445611159
R-HSA-2129379,Molecules associated with elastic fibres,4/1194,35/9872,0.11428571428571428,0.9449150514477146,-0.12109007580843346,0.6257510411267713,0.9999999999999981,0.963097398669085,ITGB8/ITGB3/BMP2/TGFB3,4,1.8669538167025603,0.6624393883634475,5.261638445611159
R-HSA-5673000,RAF activation,4/1194,35/9872,0.11428571428571428,0.9449150514477146,-0.12109007580843346,0.6257510411267713,0.9999999999999981,0.963097398669085,MARK3/CAMK2D/PPP1CB/CAMK2G,4,1.8669538167025603,0.6624393883634475,5.261638445611159
R-HSA-159418,Recycling of bile acids and salts,2/1194,17/9872,0.11764705882352941,0.9727066706079417,-0.04177587734603839,0.6270911535542227,0.9999999999999981,0.963097398669085,NCOA1/FABP6,2,1.9218642230761651,0.4435001044355065,8.32821019657114
R-HSA-1810476,RIP-mediated NFkB activation via ZBP1,2/1194,17/9872,0.11764705882352941,0.9727066706079417,-0.04177587734603839,0.6270911535542227,0.9999999999999981,0.963097398669085,NFKBIA/RELA,2,1.9218642230761651,0.4435001044355065,8.32821019657114
R-HSA-5654688,SHC-mediated cascade:FGFR1,2/1194,17/9872,0.11764705882352941,0.9727066706079417,-0.04177587734603839,0.6270911535542227,0.9999999999999981,0.963097398669085,FGF20/GRB2,2,1.9218642230761651,0.4435001044355065,8.32821019657114
R-HSA-70221,Glycogen breakdown (glycogenolysis),2/1194,17/9872,0.11764705882352941,0.9727066706079417,-0.04177587734603839,0.6270911535542227,0.9999999999999981,0.963097398669085,AKR1E2/PYGL,2,1.9218642230761651,0.4435001044355065,8.32821019657114
R-HSA-74259,Purine catabolism,2/1194,17/9872,0.11764705882352941,0.9727066706079417,-0.04177587734603839,0.6270911535542227,0.9999999999999981,0.963097398669085,NT5E/NT5C1B,2,1.9218642230761651,0.4435001044355065,8.32821019657114
R-HSA-8964315,G beta:gamma signalling through BTK,2/1194,17/9872,0.11764705882352941,0.9727066706079417,-0.04177587734603839,0.6270911535542227,0.9999999999999981,0.963097398669085,GNB3/GNG3,2,1.9218642230761651,0.4435001044355065,8.32821019657114
R-HSA-9018678,Biosynthesis of specialized proresolving mediators (SPMs),2/1194,17/9872,0.11764705882352941,0.9727066706079417,-0.04177587734603839,0.6270911535542227,0.9999999999999981,0.963097398669085,LTC4S/ALOX5AP,2,1.9218642230761651,0.4435001044355065,8.32821019657114
R-HSA-9034015,Signaling by NTRK3 (TRKC),2/1194,17/9872,0.11764705882352941,0.9727066706079417,-0.04177587734603839,0.6270911535542227,0.9999999999999981,0.963097398669085,PTPRO/GRB2,2,1.9218642230761651,0.4435001044355065,8.32821019657114
R-HSA-9659787,Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects,2/1194,17/9872,0.11764705882352941,0.9727066706079417,-0.04177587734603839,0.6270911535542227,0.9999999999999981,0.963097398669085,CDKN1A/CDK2,2,1.9218642230761651,0.4435001044355065,8.32821019657114
R-HSA-9661069,"Defective binding of RB1 mutants to E2F1,(E2F2, E2F3)",2/1194,17/9872,0.11764705882352941,0.9727066706079417,-0.04177587734603839,0.6270911535542227,0.9999999999999981,0.963097398669085,CDKN1A/CDK2,2,1.9218642230761651,0.4435001044355065,8.32821019657114
R-HSA-9671793,Diseases of hemostasis,2/1194,17/9872,0.11764705882352941,0.9727066706079417,-0.04177587734603839,0.6270911535542227,0.9999999999999981,0.963097398669085,TPST1/TPST2,2,1.9218642230761651,0.4435001044355065,8.32821019657114
R-HSA-9909396,Circadian clock,12/1194,105/9872,0.11428571428571428,0.9449150514477146,-0.21048440317211492,0.6283653234356841,0.9999999999999981,0.963097398669085,NAMPT/CRY1/KLF15/PER1/HELZ2/CUL1/TFEB/NCOA1/PPP1CB/RAI1/UBE2D1/RORA,12,1.8669538167025606,1.0244912612065593,3.4021925668700295
R-HSA-445355,Smooth Muscle Contraction,5/1194,44/9872,0.11363636363636363,0.9395462159281254,-0.14906997247283799,0.6285023161122114,0.9999999999999981,0.963097398669085,PAK2/PXN/TPM4/GUCY1A1/PDE5A,5,1.8563461245622046,0.7347419932574081,4.690110223453423
R-HSA-9006925,Intracellular signaling by second messengers,34/1194,293/9872,0.11604095563139932,0.9594273986542498,-0.2615046969523687,0.6305183618872507,0.9999999999999981,0.963097398669085,PIP4K2A/SGK1/FGF20/PHC2/FGFR3/GATAD2A/PRKAR2A/TNKS/PIP5K1B/TNRC6C/CDKN1A/CAMK2D/PDGFRA/FGFR2/AGO2/PDGFRB/PRKCG/FRK/BDNF/JUN/PTPN11/PDGFA/GAB1/EGR1/ADCY3/NRG1/GRB2/PPARG/CAMK4/RRAGD/IL1RAP/TRAF6/CAMK2G/PRR5,34,1.8956271688362174,1.3226924368699104,2.716733129383904
R-HSA-9013405,RHOD GTPase cycle,6/1194,53/9872,0.11320754716981132,0.9360007585095288,-0.173281439880103,0.6319175161152228,0.9999999999999981,0.963097398669085,ARHGAP21/ARHGAP26/LBR/ARHGAP5/ARHGAP1/LMNB1,6,1.849341044846876,0.7933939580999173,4.310673487287413
R-HSA-2990846,SUMOylation,19/1194,166/9872,0.1144578313253012,0.9463381162842324,-0.258626326276887,0.637938267051956,0.9999999999999981,0.963097398669085,PHC2/HDAC4/TOP1/NUP205/RARA/NUP58/SENP5/NCOA1/NUP98/NUP188/NUP153/NFKBIA/SMC5/PPARG/RORA/RELA/SMC6/UHRF2/IKBKE,19,1.8697654941373534,1.1589785079005503,3.016469226335893
R-HSA-199992,trans-Golgi Network Vesicle Budding,8/1194,71/9872,0.11267605633802817,0.931606388751268,-0.21452723325309217,0.6394919216157343,0.9999999999999981,0.963097398669085,SNX9/DTNBP1/PICALM/TFRC/IGF2R/SORT1/TPD52L1/ARRB1,8,1.840658692523651,0.8841121020487199,3.832120852674603
R-HSA-9609690,HCMV Early Events,8/1194,71/9872,0.11267605633802817,0.931606388751268,-0.21452723325309217,0.6394919216157343,0.9999999999999981,0.963097398669085,NUP205/NUP58/NUP98/NUP188/NUP153/DYNC1I1/TUBB2A/TUBB4A,8,1.840658692523651,0.8841121020487199,3.832120852674603
R-HSA-9824439,Bacterial Infection Pathways,8/1194,71/9872,0.11267605633802817,0.931606388751268,-0.21452723325309217,0.6394919216157343,0.9999999999999981,0.963097398669085,PGK1/TLR2/MAP2K4/SV2B/ENO1/MAP2K3/GUCY2C/GRB2,8,1.840658692523651,0.8841121020487199,3.832120852674603
R-HSA-68875,Mitotic Prophase,9/1194,80/9872,0.1125,0.9301507537688444,-0.23267189736691463,0.6433855734618115,0.9999999999999981,0.963097398669085,LMNA/NUP205/NEK9/NUP58/RAB1A/NUP98/NUP188/NUP153/LMNB1,9,1.8377826633165828,0.9203352420126188,3.6697987465970403
R-HSA-156587,Amino Acid conjugation,1/1194,8/9872,0.125,1.033500837520938,0.035159852354695764,0.6435928403809693,0.9999999999999981,0.963097398669085,ACSM5,1,2.0419807370184255,0.25517780860528716,16.340313262914027
R-HSA-159424,Conjugation of carboxylic acids,1/1194,8/9872,0.125,1.033500837520938,0.035159852354695764,0.6435928403809693,0.9999999999999981,0.963097398669085,ACSM5,1,2.0419807370184255,0.25517780860528716,16.340313262914027
R-HSA-163680,AMPK inhibits chREBP transcriptional activation activity,1/1194,8/9872,0.125,1.033500837520938,0.035159852354695764,0.6435928403809693,0.9999999999999981,0.963097398669085,ADIPOR2,1,2.0419807370184255,0.25517780860528716,16.340313262914027
R-HSA-1839122,Signaling by activated point mutants of FGFR1,1/1194,8/9872,0.125,1.033500837520938,0.035159852354695764,0.6435928403809693,0.9999999999999981,0.963097398669085,FGF20,1,2.0419807370184255,0.25517780860528716,16.340313262914027
R-HSA-189085,Digestion of dietary carbohydrate,1/1194,8/9872,0.125,1.033500837520938,0.035159852354695764,0.6435928403809693,0.9999999999999981,0.963097398669085,MGAM,1,2.0419807370184255,0.25517780860528716,16.340313262914027
R-HSA-201688,WNT mediated activation of DVL,1/1194,8/9872,0.125,1.033500837520938,0.035159852354695764,0.6435928403809693,0.9999999999999981,0.963097398669085,PIP5K1B,1,2.0419807370184255,0.25517780860528716,16.340313262914027
R-HSA-209968,Thyroxine biosynthesis,1/1194,8/9872,0.125,1.033500837520938,0.035159852354695764,0.6435928403809693,0.9999999999999981,0.963097398669085,DUOX2,1,2.0419807370184255,0.25517780860528716,16.340313262914027
R-HSA-2179392,EGFR Transactivation by Gastrin,1/1194,8/9872,0.125,1.033500837520938,0.035159852354695764,0.6435928403809693,0.9999999999999981,0.963097398669085,GRB2,1,2.0419807370184255,0.25517780860528716,16.340313262914027
R-HSA-3304351,Signaling by TGF-beta Receptor Complex in Cancer,1/1194,8/9872,0.125,1.033500837520938,0.035159852354695764,0.6435928403809693,0.9999999999999981,0.963097398669085,TGFBR1,1,2.0419807370184255,0.25517780860528716,16.340313262914027
R-HSA-390696,Adrenoceptors,1/1194,8/9872,0.125,1.033500837520938,0.035159852354695764,0.6435928403809693,0.9999999999999981,0.963097398669085,ADRB1,1,2.0419807370184255,0.25517780860528716,16.340313262914027
R-HSA-425986,Sodium/Proton exchangers,1/1194,8/9872,0.125,1.033500837520938,0.035159852354695764,0.6435928403809693,0.9999999999999981,0.963097398669085,SLC9A7,1,2.0419807370184255,0.25517780860528716,16.340313262914027
R-HSA-428543,Inactivation of CDC42 and RAC1,1/1194,8/9872,0.125,1.033500837520938,0.035159852354695764,0.6435928403809693,0.9999999999999981,0.963097398669085,ROBO1,1,2.0419807370184255,0.25517780860528716,16.340313262914027
R-HSA-428890,Role of ABL in ROBO-SLIT signaling,1/1194,8/9872,0.125,1.033500837520938,0.035159852354695764,0.6435928403809693,0.9999999999999981,0.963097398669085,ROBO1,1,2.0419807370184255,0.25517780860528716,16.340313262914027
R-HSA-434316,Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion,1/1194,8/9872,0.125,1.033500837520938,0.035159852354695764,0.6435928403809693,0.9999999999999981,0.963097398669085,PLCB1,1,2.0419807370184255,0.25517780860528716,16.340313262914027
R-HSA-446388,Regulation of cytoskeletal remodeling and cell spreading by IPP complex components,1/1194,8/9872,0.125,1.033500837520938,0.035159852354695764,0.6435928403809693,0.9999999999999981,0.963097398669085,PXN,1,2.0419807370184255,0.25517780860528716,16.340313262914027
R-HSA-68689,CDC6 association with the ORC:origin complex,1/1194,8/9872,0.125,1.033500837520938,0.035159852354695764,0.6435928403809693,0.9999999999999981,0.963097398669085,ORC4,1,2.0419807370184255,0.25517780860528716,16.340313262914027
R-HSA-68952,DNA replication initiation,1/1194,8/9872,0.125,1.033500837520938,0.035159852354695764,0.6435928403809693,0.9999999999999981,0.963097398669085,POLE,1,2.0419807370184255,0.25517780860528716,16.340313262914027
R-HSA-72731,Recycling of eIF2:GDP,1/1194,8/9872,0.125,1.033500837520938,0.035159852354695764,0.6435928403809693,0.9999999999999981,0.963097398669085,EIF2S1,1,2.0419807370184255,0.25517780860528716,16.340313262914027
R-HSA-73942,DNA Damage Reversal,1/1194,8/9872,0.125,1.033500837520938,0.035159852354695764,0.6435928403809693,0.9999999999999981,0.963097398669085,ALKBH5,1,2.0419807370184255,0.25517780860528716,16.340313262914027
R-HSA-75158,TRAIL  signaling,1/1194,8/9872,0.125,1.033500837520938,0.035159852354695764,0.6435928403809693,0.9999999999999981,0.963097398669085,TNFRSF10D,1,2.0419807370184255,0.25517780860528716,16.340313262914027
R-HSA-8874211,CREB3 factors activate genes,1/1194,8/9872,0.125,1.033500837520938,0.035159852354695764,0.6435928403809693,0.9999999999999981,0.963097398669085,CREB3L1,1,2.0419807370184255,0.25517780860528716,16.340313262914027
R-HSA-9010642,ROBO receptors bind AKAP5,1/1194,8/9872,0.125,1.033500837520938,0.035159852354695764,0.6435928403809693,0.9999999999999981,0.963097398669085,PRKAR2A,1,2.0419807370184255,0.25517780860528716,16.340313262914027
R-HSA-9034864,Activated NTRK3 signals through RAS,1/1194,8/9872,0.125,1.033500837520938,0.035159852354695764,0.6435928403809693,0.9999999999999981,0.963097398669085,GRB2,1,2.0419807370184255,0.25517780860528716,16.340313262914027
R-HSA-9660537,Signaling by MRAS-complex mutants,1/1194,8/9872,0.125,1.033500837520938,0.035159852354695764,0.6435928403809693,0.9999999999999981,0.963097398669085,PPP1CB,1,2.0419807370184255,0.25517780860528716,16.340313262914027
R-HSA-9726840,SHOC2 M1731 mutant abolishes MRAS complex function,1/1194,8/9872,0.125,1.033500837520938,0.035159852354695764,0.6435928403809693,0.9999999999999981,0.963097398669085,PPP1CB,1,2.0419807370184255,0.25517780860528716,16.340313262914027
R-HSA-9726842,Gain-of-function MRAS complexes activate RAF signaling,1/1194,8/9872,0.125,1.033500837520938,0.035159852354695764,0.6435928403809693,0.9999999999999981,0.963097398669085,PPP1CB,1,2.0419807370184255,0.25517780860528716,16.340313262914027
R-HSA-9754706,Atorvastatin ADME,1/1194,8/9872,0.125,1.033500837520938,0.035159852354695764,0.6435928403809693,0.9999999999999981,0.963097398669085,ABCC2,1,2.0419807370184255,0.25517780860528716,16.340313262914027
R-HSA-9758890,Transport of RCbl within the body,1/1194,8/9872,0.125,1.033500837520938,0.035159852354695764,0.6435928403809693,0.9999999999999981,0.963097398669085,ABCD4,1,2.0419807370184255,0.25517780860528716,16.340313262914027
R-HSA-9818028,NFE2L2 regulates pentose phosphate pathway genes,1/1194,8/9872,0.125,1.033500837520938,0.035159852354695764,0.6435928403809693,0.9999999999999981,0.963097398669085,NFE2L2,1,2.0419807370184255,0.25517780860528716,16.340313262914027
R-HSA-9818032,NFE2L2 regulating MDR associated enzymes,1/1194,8/9872,0.125,1.033500837520938,0.035159852354695764,0.6435928403809693,0.9999999999999981,0.963097398669085,NFE2L2,1,2.0419807370184255,0.25517780860528716,16.340313262914027
R-HSA-9840373,Cellular response to mitochondrial stress,1/1194,8/9872,0.125,1.033500837520938,0.035159852354695764,0.6435928403809693,0.9999999999999981,0.963097398669085,EIF2S1,1,2.0419807370184255,0.25517780860528716,16.340313262914027
R-HSA-9845576,Glycosphingolipid transport,1/1194,8/9872,0.125,1.033500837520938,0.035159852354695764,0.6435928403809693,0.9999999999999981,0.963097398669085,PLEKHA8,1,2.0419807370184255,0.25517780860528716,16.340313262914027
R-HSA-390471,Association of TriC/CCT with target proteins during biosynthesis,4/1194,36/9872,0.1111111111111111,0.9186674111297227,-0.18133410921085066,0.6484226205693933,0.9999999999999981,0.963097398669085,STAT3/CCT6B/KIFC3/GAPDHS,4,1.8150939884608226,0.6449872274548628,5.107955703164952
R-HSA-6804757,Regulation of TP53 Degradation,4/1194,36/9872,0.1111111111111111,0.9186674111297227,-0.18133410921085066,0.6484226205693933,0.9999999999999981,0.963097398669085,SGK1/CDK2/CCNA2/PRR5,4,1.8150939884608226,0.6449872274548628,5.107955703164952
R-HSA-8939243,RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known,4/1194,36/9872,0.1111111111111111,0.9186674111297227,-0.18133410921085066,0.6484226205693933,0.9999999999999981,0.963097398669085,PHC2/CBFB/RUNX1/ACTL6B,4,1.8150939884608226,0.6449872274548628,5.107955703164952
R-HSA-109606,Intrinsic Pathway for Apoptosis,6/1194,54/9872,0.1111111111111111,0.9186674111297227,-0.22229151149384588,0.6504176012121482,0.9999999999999981,0.963097398669085,STAT3/BCL2L1/PMAIP1/YWHAG/CASP7/GSDME,6,1.8150939884608226,0.7793195694993474,4.2274906416928815
R-HSA-917937,Iron uptake and transport,6/1194,54/9872,0.1111111111111111,0.9186674111297227,-0.22229151149384588,0.6504176012121482,0.9999999999999981,0.963097398669085,HMOX1/TFRC/CUL1/SLC40A1/SLC11A2/TFR2,6,1.8150939884608226,0.7793195694993474,4.2274906416928815
R-HSA-1483191,Synthesis of PC,3/1194,27/9872,0.1111111111111111,0.9186674111297227,-0.15696814816259322,0.6505895186381754,0.9999999999999981,0.963097398669085,CHPT1/PCTP/CHKA,3,1.8150939884608226,0.5498492506869701,5.9917626200826035
R-HSA-5654733,Negative regulation of FGFR4 signaling,3/1194,27/9872,0.1111111111111111,0.9186674111297227,-0.15696814816259322,0.6505895186381754,0.9999999999999981,0.963097398669085,FGF20/PTPN11/GRB2,3,1.8150939884608226,0.5498492506869701,5.9917626200826035
R-HSA-2559580,Oxidative Stress Induced Senescence,7/1194,63/9872,0.1111111111111111,0.9186674111297227,-0.2402123988729701,0.6527355072825701,0.9999999999999981,0.963097398669085,PHC2/MAP3K5/MAP2K4/TNRC6C/FOS/JUN/MAP2K3,7,1.8150939884608226,0.8295029468086993,3.971735362269198
R-HSA-2980736,Peptide hormone metabolism,8/1194,72/9872,0.1111111111111111,0.9186674111297227,-0.25691574650470694,0.6554474161746373,0.9999999999999981,0.963097398669085,DPP4/GNB3/IGF1/PAX6/KIF5C/CPE/CPB2/FFAR4,8,1.8150939884608226,0.8722797687651226,3.7769604488370745
R-HSA-5628897,TP53 Regulates Metabolic Genes,9/1194,81/9872,0.1111111111111111,0.9186674111297227,-0.2726255137602156,0.6583885807458718,0.9999999999999981,0.963097398669085,SESN3/TNRC6C/DDIT4/AGO2/GLS2/YWHAG/PRKAG3/NDUFA4/RRAGD,9,1.8150939884608226,0.9093628816723228,3.622938931582399
R-HSA-181430,Norepinephrine Neurotransmitter Release Cycle,2/1194,18/9872,0.1111111111111111,0.9186674111297227,-0.12810541462581332,0.6587314972106931,0.9999999999999981,0.963097398669085,PPFIA2/PPFIA4,2,1.8150939884608226,0.4206607390693345,7.831884178769527
R-HSA-392851,Prostacyclin signalling through prostacyclin receptor,2/1194,18/9872,0.1111111111111111,0.9186674111297227,-0.12810541462581332,0.6587314972106931,0.9999999999999981,0.963097398669085,GNB3/GNG3,2,1.8150939884608226,0.4206607390693345,7.831884178769527
R-HSA-9758274,Regulation of NF-kappa B signaling,2/1194,18/9872,0.1111111111111111,0.9186674111297227,-0.12810541462581332,0.6587314972106931,0.9999999999999981,0.963097398669085,NLRC5/TRAF6,2,1.8150939884608226,0.4206607390693345,7.831884178769527
R-HSA-9825892,Regulation of MITF-M-dependent genes involved in cell cycle and proliferation,2/1194,18/9872,0.1111111111111111,0.9186674111297227,-0.12810541462581332,0.6587314972106931,0.9999999999999981,0.963097398669085,CDKN1A/CDK2,2,1.8150939884608226,0.4206607390693345,7.831884178769527
R-HSA-5619115,Disorders of transmembrane transporters,17/1194,151/9872,0.11258278145695365,0.9308351914095866,-0.3176808952453416,0.6620311237775376,0.9999999999999981,0.963097398669085,NUP205/ABCD4/SLC40A1/SLC24A5/NUP58/SLC11A2/NUP98/NUP188/NUP153/SLC2A1/ABCC2/SLC4A4/ABCB6/CFTR/SLC27A4/SLC24A1/HK1,17,1.8391349684404363,1.110140467205293,3.046837343616004
R-HSA-9694516,SARS-CoV-2 Infection,32/1194,280/9872,0.11428571428571428,0.9449150514477146,-0.34684089261125245,0.6633499048296541,0.9999999999999981,0.963097398669085,ZDHHC11/IFNAR2/MGAT4C/TLR2/PARP9/ANO3/NUP205/GJA1/NOD2/G3BP1/GPC5/ST3GAL4/IRAK2/YWHAG/SEC24D/NUP58/ZDHHC2/PTPN11/NUP98/NUP188/NUP153/GEMIN8/SEC23A/EDEM2/GPC2/TUSC3/RNF135/TRAF6/SFTPD/SEC24A/STAT1/IKBKE,32,1.8669538167025603,1.2890738777957267,2.703892006298642
R-HSA-3108232,SUMO E3 ligases SUMOylate target proteins,18/1194,160/9872,0.1125,0.9301507537688444,-0.3304001948438134,0.6657604097828285,0.9999999999999981,0.963097398669085,PHC2/HDAC4/TOP1/NUP205/RARA/NUP58/NCOA1/NUP98/NUP188/NUP153/NFKBIA/SMC5/PPARG/RORA/RELA/SMC6/UHRF2/IKBKE,18,1.8377826633165828,1.1250174290251955,3.002126927503229
R-HSA-9020591,Interleukin-12 signaling,5/1194,46/9872,0.10869565217391304,0.8986963804529895,-0.25543971162465434,0.6683598765800798,0.9999999999999981,0.963097398669085,PAK2/HNRNPF/MSN/HSPA9/LMNB1,5,1.7756354234942826,0.7042389692543167,4.477004674288541
R-HSA-5654743,Signaling by FGFR4,4/1194,37/9872,0.10810810810810811,0.8938385621802708,-0.23996803110544954,0.6701629964643516,0.9999999999999981,0.963097398669085,FGF20/PTPN11/GAB1/GRB2,4,1.7660373941780976,0.6284309847011234,4.962976291053955
R-HSA-6806003,Regulation of TP53 Expression and Degradation,4/1194,37/9872,0.10810810810810811,0.8938385621802708,-0.23996803110544954,0.6701629964643516,0.9999999999999981,0.963097398669085,SGK1/CDK2/CCNA2/PRR5,4,1.7660373941780976,0.6284309847011234,4.962976291053955
R-HSA-6814122,Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding,4/1194,37/9872,0.10810810810810811,0.8938385621802708,-0.23996803110544954,0.6701629964643516,0.9999999999999981,0.963097398669085,GNB3/GNG3/CCT6B/RGS9,4,1.7660373941780976,0.6284309847011234,4.962976291053955
R-HSA-77289,Mitochondrial Fatty Acid Beta-Oxidation,4/1194,37/9872,0.10810810810810811,0.8938385621802708,-0.23996803110544954,0.6701629964643516,0.9999999999999981,0.963097398669085,ACSF2/ACSM6/ACSM3/PCTP,4,1.7660373941780976,0.6284309847011234,4.962976291053955
R-HSA-3108214,SUMOylation of DNA damage response and repair proteins,8/1194,73/9872,0.1095890410958904,0.9060829260457538,-0.2987363160547663,0.670982306864414,0.9999999999999981,0.963097398669085,PHC2/NUP205/NUP58/NUP98/NUP188/NUP153/SMC5/SMC6,8,1.7902296872490304,0.8607600432440209,3.7233632744255796
R-HSA-9833482,PKR-mediated signaling,8/1194,73/9872,0.1095890410958904,0.9060829260457538,-0.2987363160547663,0.670982306864414,0.9999999999999981,0.963097398669085,STAT3/PTPN2/HSPA1A/HSPA1B/TUBB2A/TUBB4A/EIF2S1/STAT1,8,1.7902296872490304,0.8607600432440209,3.7233632744255796
R-HSA-1296041,Activation of G protein gated Potassium channels,3/1194,28/9872,0.10714285714285714,0.8858578607322325,-0.2243428008000134,0.6753632852098941,0.9999999999999981,0.963097398669085,GNB3/KCNJ16/GNG3,3,1.7502692031586504,0.5313420023844969,5.765481120968877
R-HSA-1296059,G protein gated Potassium channels,3/1194,28/9872,0.10714285714285714,0.8858578607322325,-0.2243428008000134,0.6753632852098941,0.9999999999999981,0.963097398669085,GNB3/KCNJ16/GNG3,3,1.7502692031586504,0.5313420023844969,5.765481120968877
R-HSA-389957,Prefoldin mediated transfer of substrate  to CCT/TriC,3/1194,28/9872,0.10714285714285714,0.8858578607322325,-0.2243428008000134,0.6753632852098941,0.9999999999999981,0.963097398669085,CCT6B/TUBB2A/TUBB4A,3,1.7502692031586504,0.5313420023844969,5.765481120968877
R-HSA-9619483,Activation of AMPK downstream of NMDARs,3/1194,28/9872,0.10714285714285714,0.8858578607322325,-0.2243428008000134,0.6753632852098941,0.9999999999999981,0.963097398669085,PRKAG3/TUBB2A/TUBB4A,3,1.7502692031586504,0.5313420023844969,5.765481120968877
R-HSA-9749641,Aspirin ADME,3/1194,28/9872,0.10714285714285714,0.8858578607322325,-0.2243428008000134,0.6753632852098941,0.9999999999999981,0.963097398669085,ACSM5/ABCC2/UGT3A2,3,1.7502692031586504,0.5313420023844969,5.765481120968877
R-HSA-997272,Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits,3/1194,28/9872,0.10714285714285714,0.8858578607322325,-0.2243428008000134,0.6753632852098941,0.9999999999999981,0.963097398669085,GNB3/KCNJ16/GNG3,3,1.7502692031586504,0.5313420023844969,5.765481120968877
R-HSA-446203,Asparagine N-linked glycosylation,34/1194,300/9872,0.11333333333333333,0.9370407593523171,-0.4107633434592319,0.6859528486813795,0.9999999999999981,0.963097398669085,MGAT4C/CD55/TMED10/COPA/GOSR2/SERPINA1/NEU4/ARFGAP3/SEC31A/ST6GAL2/ANKRD28/PMM2/ST3GAL4/EDEM1/SEC24D/RAB1A/B4GALT5/ST8SIA3/TFG/DYNC1I1/SEC22A/PGM3/CD59/SEC23A/EDEM2/TUBB2A/GFPT2/TUSC3/ANK1/TUBB4A/GRIA1/NSF/SEC24A/HK1,34,1.851395868230039,1.2923791383370455,2.6522144773319165
R-HSA-9772573,Late SARS-CoV-2 Infection Events,8/1194,74/9872,0.10810810810810811,0.8938385621802708,-0.3400062110830197,0.6860851883988728,0.9999999999999981,0.963097398669085,ZDHHC11/MGAT4C/PARP9/ANO3/ST3GAL4/ZDHHC2/EDEM2/TUSC3,8,1.7660373941780976,0.849540695581818,3.6712638886585154
R-HSA-112411,MAPK1 (ERK2) activation,1/1194,9/9872,0.1111111111111111,0.9186674111297227,-0.09054286885408576,0.6867345829382607,0.9999999999999981,0.963097398669085,PTPN11,1,1.8150939884608226,0.22976222588692624,14.339024503392404
R-HSA-113507,E2F-enabled inhibition of pre-replication complex formation,1/1194,9/9872,0.1111111111111111,0.9186674111297227,-0.09054286885408576,0.6867345829382607,0.9999999999999981,0.963097398669085,ORC4,1,1.8150939884608226,0.22976222588692624,14.339024503392404
R-HSA-1253288,Downregulation of ERBB4 signaling,1/1194,9/9872,0.1111111111111111,0.9186674111297227,-0.09054286885408576,0.6867345829382607,0.9999999999999981,0.963097398669085,WWP1,1,1.8150939884608226,0.22976222588692624,14.339024503392404
R-HSA-1300642,Sperm Motility And Taxes,1/1194,9/9872,0.1111111111111111,0.9186674111297227,-0.09054286885408576,0.6867345829382607,0.9999999999999981,0.963097398669085,HVCN1,1,1.8150939884608226,0.22976222588692624,14.339024503392404
R-HSA-159763,Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus,1/1194,9/9872,0.1111111111111111,0.9186674111297227,-0.09054286885408576,0.6867345829382607,0.9999999999999981,0.963097398669085,PROS1,1,1.8150939884608226,0.22976222588692624,14.339024503392404
R-HSA-211979,Eicosanoids,1/1194,9/9872,0.1111111111111111,0.9186674111297227,-0.09054286885408576,0.6867345829382607,0.9999999999999981,0.963097398669085,CYP8B1,1,1.8150939884608226,0.22976222588692624,14.339024503392404
R-HSA-2485179,Activation of the phototransduction cascade,1/1194,9/9872,0.1111111111111111,0.9186674111297227,-0.09054286885408576,0.6867345829382607,0.9999999999999981,0.963097398669085,SLC24A1,1,1.8150939884608226,0.22976222588692624,14.339024503392404
R-HSA-3785653,Myoclonic epilepsy of Lafora,1/1194,9/9872,0.1111111111111111,0.9186674111297227,-0.09054286885408576,0.6867345829382607,0.9999999999999981,0.963097398669085,GYS1,1,1.8150939884608226,0.22976222588692624,14.339024503392404
R-HSA-442380,Zinc influx into cells by the SLC39 gene family,1/1194,9/9872,0.1111111111111111,0.9186674111297227,-0.09054286885408576,0.6867345829382607,0.9999999999999981,0.963097398669085,SLC39A14,1,1.8150939884608226,0.22976222588692624,14.339024503392404
R-HSA-446107,Type I hemidesmosome assembly,1/1194,9/9872,0.1111111111111111,0.9186674111297227,-0.09054286885408576,0.6867345829382607,0.9999999999999981,0.963097398669085,ITGB4,1,1.8150939884608226,0.22976222588692624,14.339024503392404
R-HSA-5576890,Phase 3 - rapid repolarisation,1/1194,9/9872,0.1111111111111111,0.9186674111297227,-0.09054286885408576,0.6867345829382607,0.9999999999999981,0.963097398669085,KCNH2,1,1.8150939884608226,0.22976222588692624,14.339024503392404
R-HSA-5658623,FGFRL1 modulation of FGFR1 signaling,1/1194,9/9872,0.1111111111111111,0.9186674111297227,-0.09054286885408576,0.6867345829382607,0.9999999999999981,0.963097398669085,SPRED1,1,1.8150939884608226,0.22976222588692624,14.339024503392404
R-HSA-629597,Highly calcium permeable nicotinic acetylcholine receptors,1/1194,9/9872,0.1111111111111111,0.9186674111297227,-0.09054286885408576,0.6867345829382607,0.9999999999999981,0.963097398669085,CHRNB2,1,1.8150939884608226,0.22976222588692624,14.339024503392404
R-HSA-6787450,tRNA modification in the mitochondrion,1/1194,9/9872,0.1111111111111111,0.9186674111297227,-0.09054286885408576,0.6867345829382607,0.9999999999999981,0.963097398669085,TRIT1,1,1.8150939884608226,0.22976222588692624,14.339024503392404
R-HSA-6811555,PI5P Regulates TP53 Acetylation,1/1194,9/9872,0.1111111111111111,0.9186674111297227,-0.09054286885408576,0.6867345829382607,0.9999999999999981,0.963097398669085,PIP4K2A,1,1.8150939884608226,0.22976222588692624,14.339024503392404
R-HSA-68616,Assembly of the ORC complex at the origin of replication,1/1194,9/9872,0.1111111111111111,0.9186674111297227,-0.09054286885408576,0.6867345829382607,0.9999999999999981,0.963097398669085,ORC4,1,1.8150939884608226,0.22976222588692624,14.339024503392404
R-HSA-727802,Transport of nucleotide sugars,1/1194,9/9872,0.1111111111111111,0.9186674111297227,-0.09054286885408576,0.6867345829382607,0.9999999999999981,0.963097398669085,SLC35D2,1,1.8150939884608226,0.22976222588692624,14.339024503392404
R-HSA-9020933,Interleukin-23 signaling,1/1194,9/9872,0.1111111111111111,0.9186674111297227,-0.09054286885408576,0.6867345829382607,0.9999999999999981,0.963097398669085,STAT3,1,1.8150939884608226,0.22976222588692624,14.339024503392404
R-HSA-9029558,NR1H2 & NR1H3 regulate gene expression linked to lipogenesis,1/1194,9/9872,0.1111111111111111,0.9186674111297227,-0.09054286885408576,0.6867345829382607,0.9999999999999981,0.963097398669085,ANGPTL3,1,1.8150939884608226,0.22976222588692624,14.339024503392404
R-HSA-9683673,Maturation of protein 3a,1/1194,9/9872,0.1111111111111111,0.9186674111297227,-0.09054286885408576,0.6867345829382607,0.9999999999999981,0.963097398669085,ST3GAL4,1,1.8150939884608226,0.22976222588692624,14.339024503392404
R-HSA-9690406,Transcriptional regulation of testis differentiation,1/1194,9/9872,0.1111111111111111,0.9186674111297227,-0.09054286885408576,0.6867345829382607,0.9999999999999981,0.963097398669085,DHH,1,1.8150939884608226,0.22976222588692624,14.339024503392404
R-HSA-9694719,Maturation of protein 3a,1/1194,9/9872,0.1111111111111111,0.9186674111297227,-0.09054286885408576,0.6867345829382607,0.9999999999999981,0.963097398669085,ST3GAL4,1,1.8150939884608226,0.22976222588692624,14.339024503392404
R-HSA-69231,Cyclin D associated events in G1,5/1194,47/9872,0.10638297872340426,0.8795751808688835,-0.30695277828228973,0.6872014000690784,0.9999999999999981,0.963097398669085,PPP2R2A/CDKN1A/CUL1/CCNH/CDK2,5,1.7378559463986596,0.6899179806026748,4.377539613904463
R-HSA-69236,G1 Phase,5/1194,47/9872,0.10638297872340426,0.8795751808688835,-0.30695277828228973,0.6872014000690784,0.9999999999999981,0.963097398669085,PPP2R2A/CDKN1A/CUL1/CCNH/CDK2,5,1.7378559463986596,0.6899179806026748,4.377539613904463
R-HSA-111471,Apoptotic factor-mediated response,2/1194,19/9872,0.10526315789473684,0.8703164947544741,-0.2098699292828999,0.6881804867016268,0.9999999999999981,0.963097398669085,CASP7/GSDME,2,1.719562725910253,0.40005654435508975,7.391195094949784
R-HSA-1236382,Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants,2/1194,19/9872,0.10526315789473684,0.8703164947544741,-0.2098699292828999,0.6881804867016268,0.9999999999999981,0.963097398669085,GAB1/GRB2,2,1.719562725910253,0.40005654435508975,7.391195094949784
R-HSA-163615,PKA activation,2/1194,19/9872,0.10526315789473684,0.8703164947544741,-0.2098699292828999,0.6881804867016268,0.9999999999999981,0.963097398669085,PRKAR2A/ADCY3,2,1.719562725910253,0.40005654435508975,7.391195094949784
R-HSA-168927,"TICAM1, RIP1-mediated IKK complex recruitment",2/1194,19/9872,0.10526315789473684,0.8703164947544741,-0.2098699292828999,0.6881804867016268,0.9999999999999981,0.963097398669085,UBE2D1/TRAF6,2,1.719562725910253,0.40005654435508975,7.391195094949784
R-HSA-176407,Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase,2/1194,19/9872,0.10526315789473684,0.8703164947544741,-0.2098699292828999,0.6881804867016268,0.9999999999999981,0.963097398669085,CDC14A/UBE2D1,2,1.719562725910253,0.40005654435508975,7.391195094949784
R-HSA-416700,Other semaphorin interactions,2/1194,19/9872,0.10526315789473684,0.8703164947544741,-0.2098699292828999,0.6881804867016268,0.9999999999999981,0.963097398669085,PLXNA2/PLXND1,2,1.719562725910253,0.40005654435508975,7.391195094949784
R-HSA-5576886,Phase 4 - resting membrane potential,2/1194,19/9872,0.10526315789473684,0.8703164947544741,-0.2098699292828999,0.6881804867016268,0.9999999999999981,0.963097398669085,KCNK10/KCNK12,2,1.719562725910253,0.40005654435508975,7.391195094949784
R-HSA-5637815,Signaling by Ligand-Responsive EGFR Variants in Cancer,2/1194,19/9872,0.10526315789473684,0.8703164947544741,-0.2098699292828999,0.6881804867016268,0.9999999999999981,0.963097398669085,GAB1/GRB2,2,1.719562725910253,0.40005654435508975,7.391195094949784
R-HSA-8964616,G beta:gamma signalling through CDC42,2/1194,19/9872,0.10526315789473684,0.8703164947544741,-0.2098699292828999,0.6881804867016268,0.9999999999999981,0.963097398669085,GNB3/GNG3,2,1.719562725910253,0.40005654435508975,7.391195094949784
R-HSA-9694614,Attachment and Entry,2/1194,19/9872,0.10526315789473684,0.8703164947544741,-0.2098699292828999,0.6881804867016268,0.9999999999999981,0.963097398669085,GPC5/GPC2,2,1.719562725910253,0.40005654435508975,7.391195094949784
R-HSA-9840309,Glycosphingolipid biosynthesis,2/1194,19/9872,0.10526315789473684,0.8703164947544741,-0.2098699292828999,0.6881804867016268,0.9999999999999981,0.963097398669085,B4GALT5/UGCG,2,1.719562725910253,0.40005654435508975,7.391195094949784
R-HSA-199991,Membrane Trafficking,70/1194,607/9872,0.11532125205930807,0.9534768846980648,-0.4388472069409538,0.6887643137668014,0.9999999999999981,0.963097398669085,KIF19/RIN2/CD55/TMED10/SYNJ2/PLIN3/TACR1/TBC1D4/SNX9/AMPH/RAB3IP/COPA/GOSR2/STX6/RAB27B/TBC1D14/RHOQ/SERPINA1/DTNBP1/DENND1B/PICALM/TFRC/RAB8B/GJA1/RHOBTB3/ARFGAP3/RAB10/ITSN2/DNM3/VPS53/GJB6/SEC31A/ANKRD28/KIF26B/DENND4A/YWHAG/SEC24D/DENND3/IGF2R/GJB7/SGIP1/RAB1A/SORT1/GDI2/TFG/PRKAG3/BIN1/PAFAH1B1/RAB7B/KIAA0319/DYNC1I1/SEC22A/ACTR3/CD59/SEC23A/GRB2/TPD52L1/KIF21B/TUBB2A/ARRB1/RAB21/TMF1/ANK1/CFTR/TUBB4A/GRIA1/NSF/SEC24A/SBF1/DNM1,70,1.8838702021916283,1.4609944476277532,2.4291447133615445
R-HSA-5655253,Signaling by FGFR2 in disease,4/1194,38/9872,0.10526315789473684,0.8703164947544741,-0.297087482382821,0.6909590290479848,0.9999999999999981,0.963097398669085,FGF20/FGFR2/GAB1/GRB2,4,1.719562725910253,0.6127034023143888,4.825982616010781
R-HSA-6803157,Antimicrobial peptides,4/1194,38/9872,0.10526315789473684,0.8703164947544741,-0.297087482382821,0.6909590290479848,0.9999999999999981,0.963097398669085,SLC11A1/TLR2/PRSS3/DEFB107B,4,1.719562725910253,0.6127034023143888,4.825982616010781
R-HSA-9755511,KEAP1-NFE2L2 pathway,12/1194,110/9872,0.10909090909090909,0.9019643672910005,-0.3835162881766063,0.6926948676554543,0.9999999999999981,0.963097398669085,HMOX1/NFE2L2/CDKN1A/BCL2L1/CUL1/BACH1/GCLC/PDGFA/RELA/CCL2/SLC7A11/EIF2AK3,12,1.7820922795797167,0.9792809966644199,3.2430455648124177
R-HSA-380972,Energy dependent regulation of mTOR by LKB1-AMPK,3/1194,29/9872,0.10344827586206896,0.8553110379483625,-0.2894300196035104,0.6988148498492777,0.9999999999999981,0.963097398669085,PRKAG3/CAB39/RRAGD,3,1.6899150927049038,0.5140397087372272,5.555627263830102
R-HSA-5654726,Negative regulation of FGFR1 signaling,3/1194,29/9872,0.10344827586206896,0.8553110379483625,-0.2894300196035104,0.6988148498492777,0.9999999999999981,0.963097398669085,FGF20/PTPN11/GRB2,3,1.6899150927049038,0.5140397087372272,5.555627263830102
R-HSA-3906995,Diseases associated with O-glycosylation of proteins,7/1194,66/9872,0.10606060606060606,0.8769098015329171,-0.3721537604467865,0.7010550841529097,0.9999999999999981,0.963097398669085,MUC15/ADAMTS2/SPON1/B3GLCT/ADAMTS10/ADAMTS18/THSD7B,7,1.732589716258058,0.793202411148522,3.7844906705926507
R-HSA-5654738,Signaling by FGFR2,7/1194,66/9872,0.10606060606060606,0.8769098015329171,-0.3721537604467865,0.7010550841529097,0.9999999999999981,0.963097398669085,FGF20/HNRNPF/FGFR2/PTPN11/FGFBP2/GAB1/GRB2,7,1.732589716258058,0.793202411148522,3.7844906705926507
R-HSA-9662360,Sensory processing of sound by inner hair cells of the cochlea,7/1194,66/9872,0.10606060606060606,0.8769098015329171,-0.3721537604467865,0.7010550841529097,0.9999999999999981,0.963097398669085,MSN/KCNMA1/PCDH15/CDH23/RIPOR2/CACNA1D/BSN,7,1.732589716258058,0.793202411148522,3.7844906705926507
R-HSA-211897,Cytochrome P450 - arranged by substrate type,6/1194,57/9872,0.10526315789473684,0.8703164947544741,-0.3642083789905124,0.7023893724171246,0.9999999999999981,0.963097398669085,AHR/NCOA1/CYP8B1/CYP27A1/CYP26C1/CYP39A1,6,1.719562725910253,0.7399415342327826,3.9961210873313036
R-HSA-389356,Co-stimulation by CD28,5/1194,48/9872,0.10416666666666667,0.8612506979341151,-0.3574210822179336,0.7053033555741297,0.9999999999999981,0.963097398669085,PAK2/GRB2/PAK3/PRR5/CTLA4,5,1.7016506141820211,0.6761678785076924,4.282390371954216
R-HSA-73864,RNA Polymerase I Transcription,5/1194,48/9872,0.10416666666666667,0.8612506979341151,-0.3574210822179336,0.7053033555741297,0.9999999999999981,0.963097398669085,KAT2B/GATAD2A/MBD2/CAVIN1/CCNH,5,1.7016506141820211,0.6761678785076924,4.282390371954216
R-HSA-73893,DNA Damage Bypass,5/1194,48/9872,0.10416666666666667,0.8612506979341151,-0.3574210822179336,0.7053033555741297,0.9999999999999981,0.963097398669085,USP43/CUL4A/UBA7/RPA3/POLE,5,1.7016506141820211,0.6761678785076924,4.282390371954216
R-HSA-110313,Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template,4/1194,39/9872,0.10256410256410256,0.848000687196667,-0.35277989356729045,0.7108053767478336,0.9999999999999981,0.963097398669085,USP43/UBA7/RPA3/POLE,4,1.6754713739638363,0.5977437897629634,4.696333735370917
R-HSA-9748784,Drug ADME,9/1194,85/9872,0.10588235294117647,0.8754360035471475,-0.4278091988519412,0.714602017684128,0.9999999999999981,0.963097398669085,ACSM5/HPRT1/SLC28A2/NAT2/PCK1/ABCC2/UGT3A2/SLC22A3/ADH1A,9,1.7296778007685485,0.8679712745403358,3.446871321929318
R-HSA-1257604,PIP3 activates AKT signaling,28/1194,252/9872,0.1111111111111111,0.9186674111297227,-0.4851211925558842,0.7147115920003853,0.9999999999999981,0.963097398669085,PIP4K2A/SGK1/FGF20/PHC2/FGFR3/GATAD2A/TNKS/PIP5K1B/TNRC6C/CDKN1A/PDGFRA/FGFR2/AGO2/PDGFRB/FRK/BDNF/JUN/PTPN11/PDGFA/GAB1/EGR1/NRG1/GRB2/PPARG/RRAGD/IL1RAP/TRAF6/PRR5,28,1.8150939884608226,1.2230499055857502,2.693729971197507
R-HSA-6811434,COPI-dependent Golgi-to-ER retrograde traffic,10/1194,94/9872,0.10638297872340426,0.8795751808688835,-0.4351388198042253,0.7148286863072655,0.9999999999999981,0.963097398669085,KIF19/TMED10/COPA/ARFGAP3/KIF26B/RAB1A/KIF21B/TUBB2A/TUBB4A/NSF,10,1.7378559463986596,0.9031171287053064,3.3441324435544786
R-HSA-204998,"Cell death signalling via NRAGE, NRIF and NADE",8/1194,76/9872,0.10526315789473684,0.8703164947544741,-0.4209592577832437,0.7149601944887154,0.9999999999999981,0.963097398669085,ARHGEF10/ARHGEF7/ARHGEF3/PREX1/ABR/NGEF/CASP2/TRAF6,8,1.719562725910253,0.8279573235398199,3.5713144678738873
R-HSA-1181150,Signaling by NODAL,2/1194,20/9872,0.1,0.8268006700167505,-0.28758876799553157,0.7155049127739939,0.9999999999999981,0.963097398669085,PCSK6/LEFTY1,2,1.6335845896147405,0.3813749872115245,6.99730895027643
R-HSA-202427,Phosphorylation of CD3 and TCR zeta chains,2/1194,20/9872,0.1,0.8268006700167505,-0.28758876799553157,0.7155049127739939,0.9999999999999981,0.963097398669085,PTPRJ/PAG1,2,1.6335845896147405,0.3813749872115245,6.99730895027643
R-HSA-2028269,Signaling by Hippo,2/1194,20/9872,0.1,0.8268006700167505,-0.28758876799553157,0.7155049127739939,0.9999999999999981,0.963097398669085,STK3/TJP2,2,1.6335845896147405,0.3813749872115245,6.99730895027643
R-HSA-5625900,RHO GTPases activate CIT,2/1194,20/9872,0.1,0.8268006700167505,-0.28758876799553157,0.7155049127739939,0.9999999999999981,0.963097398669085,PPP1CB/RHOB,2,1.6335845896147405,0.3813749872115245,6.99730895027643
R-HSA-5689901,Metalloprotease DUBs,2/1194,20/9872,0.1,0.8268006700167505,-0.28758876799553157,0.7155049127739939,0.9999999999999981,0.963097398669085,KAT2B/BARD1,2,1.6335845896147405,0.3813749872115245,6.99730895027643
R-HSA-6803204,TP53 Regulates Transcription of Genes Involved in Cytochrome C Release,2/1194,20/9872,0.1,0.8268006700167505,-0.28758876799553157,0.7155049127739939,0.9999999999999981,0.963097398669085,BNIP3L/PMAIP1,2,1.6335845896147405,0.3813749872115245,6.99730895027643
R-HSA-901032,ER Quality Control Compartment (ERQC),2/1194,20/9872,0.1,0.8268006700167505,-0.28758876799553157,0.7155049127739939,0.9999999999999981,0.963097398669085,EDEM1/EDEM2,2,1.6335845896147405,0.3813749872115245,6.99730895027643
R-HSA-9748787,Azathioprine ADME,2/1194,20/9872,0.1,0.8268006700167505,-0.28758876799553157,0.7155049127739939,0.9999999999999981,0.963097398669085,HPRT1/SLC28A2,2,1.6335845896147405,0.3813749872115245,6.99730895027643
R-HSA-2644602,Signaling by NOTCH1 PEST Domain Mutants in Cancer,6/1194,58/9872,0.10344827586206896,0.8553110379483625,-0.4099201694478502,0.7185020597892469,0.9999999999999981,0.963097398669085,NEURL1B/HES5/KAT2B/HDAC4/CUL1/HES1,6,1.6899150927049038,0.7276853307831216,3.9245164080447386
R-HSA-2644603,Signaling by NOTCH1 in Cancer,6/1194,58/9872,0.10344827586206896,0.8553110379483625,-0.4099201694478502,0.7185020597892469,0.9999999999999981,0.963097398669085,NEURL1B/HES5/KAT2B/HDAC4/CUL1/HES1,6,1.6899150927049038,0.7276853307831216,3.9245164080447386
R-HSA-2644606,Constitutive Signaling by NOTCH1 PEST Domain Mutants,6/1194,58/9872,0.10344827586206896,0.8553110379483625,-0.4099201694478502,0.7185020597892469,0.9999999999999981,0.963097398669085,NEURL1B/HES5/KAT2B/HDAC4/CUL1/HES1,6,1.6899150927049038,0.7276853307831216,3.9245164080447386
R-HSA-2894858,Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer,6/1194,58/9872,0.10344827586206896,0.8553110379483625,-0.4099201694478502,0.7185020597892469,0.9999999999999981,0.963097398669085,NEURL1B/HES5/KAT2B/HDAC4/CUL1/HES1,6,1.6899150927049038,0.7276853307831216,3.9245164080447386
R-HSA-2894862,Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants,6/1194,58/9872,0.10344827586206896,0.8553110379483625,-0.4099201694478502,0.7185020597892469,0.9999999999999981,0.963097398669085,NEURL1B/HES5/KAT2B/HDAC4/CUL1/HES1,6,1.6899150927049038,0.7276853307831216,3.9245164080447386
R-HSA-110314,Recognition of DNA damage by PCNA-containing replication complex,3/1194,30/9872,0.1,0.8268006700167505,-0.35240176190785577,0.7209557402754061,0.9999999999999981,0.963097398669085,CUL4A/RPA3/POLE,3,1.6335845896147403,0.4978284368932372,5.360478457358713
R-HSA-6805567,Keratinization,5/1194,49/9872,0.10204081632653061,0.8436741530783168,-0.4068924904666415,0.7226608902705445,0.9999999999999981,0.963097398669085,PCSK6/KAZN/KRTAP5-11/SPINK6/DSC1,5,1.666923050627286,0.6629551914320604,4.191282446571401
R-HSA-110056,MAPK3 (ERK1) activation,1/1194,10/9872,0.1,0.8268006700167505,-0.2032528411188849,0.7246580248901737,0.9999999999999981,0.963097398669085,PTPN11,1,1.6335845896147405,0.20893774983957736,12.772218584127156
R-HSA-111367,SLBP independent Processing of Histone Pre-mRNAs,1/1194,10/9872,0.1,0.8268006700167505,-0.2032528411188849,0.7246580248901737,0.9999999999999981,0.963097398669085,ZNF473,1,1.6335845896147405,0.20893774983957736,12.772218584127156
R-HSA-1250342,PI3K events in ERBB4 signaling,1/1194,10/9872,0.1,0.8268006700167505,-0.2032528411188849,0.7246580248901737,0.9999999999999981,0.963097398669085,NRG1,1,1.6335845896147405,0.20893774983957736,12.772218584127156
R-HSA-1433617,Regulation of signaling by NODAL,1/1194,10/9872,0.1,0.8268006700167505,-0.2032528411188849,0.7246580248901737,0.9999999999999981,0.963097398669085,LEFTY1,1,1.6335845896147405,0.20893774983957736,12.772218584127156
R-HSA-159740,Gamma-carboxylation of protein precursors,1/1194,10/9872,0.1,0.8268006700167505,-0.2032528411188849,0.7246580248901737,0.9999999999999981,0.963097398669085,PROS1,1,1.6335845896147405,0.20893774983957736,12.772218584127156
R-HSA-159782,Removal of aminoterminal propeptides from gamma-carboxylated proteins,1/1194,10/9872,0.1,0.8268006700167505,-0.2032528411188849,0.7246580248901737,0.9999999999999981,0.963097398669085,PROS1,1,1.6335845896147405,0.20893774983957736,12.772218584127156
R-HSA-168799,Neurotoxicity of clostridium toxins,1/1194,10/9872,0.1,0.8268006700167505,-0.2032528411188849,0.7246580248901737,0.9999999999999981,0.963097398669085,SV2B,1,1.6335845896147405,0.20893774983957736,12.772218584127156
R-HSA-190322,FGFR4 ligand binding and activation,1/1194,10/9872,0.1,0.8268006700167505,-0.2032528411188849,0.7246580248901737,0.9999999999999981,0.963097398669085,FGF20,1,1.6335845896147405,0.20893774983957736,12.772218584127156
R-HSA-2151209,Activation of PPARGC1A (PGC-1alpha) by phosphorylation,1/1194,10/9872,0.1,0.8268006700167505,-0.2032528411188849,0.7246580248901737,0.9999999999999981,0.963097398669085,PRKAG3,1,1.6335845896147405,0.20893774983957736,12.772218584127156
R-HSA-2470946,Cohesin Loading onto Chromatin,1/1194,10/9872,0.1,0.8268006700167505,-0.2032528411188849,0.7246580248901737,0.9999999999999981,0.963097398669085,PDS5A,1,1.6335845896147405,0.20893774983957736,12.772218584127156
R-HSA-2892247,"POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation",1/1194,10/9872,0.1,0.8268006700167505,-0.2032528411188849,0.7246580248901737,0.9999999999999981,0.963097398669085,STAT3,1,1.6335845896147405,0.20893774983957736,12.772218584127156
R-HSA-3215018,Processing and activation of SUMO,1/1194,10/9872,0.1,0.8268006700167505,-0.2032528411188849,0.7246580248901737,0.9999999999999981,0.963097398669085,SENP5,1,1.6335845896147405,0.20893774983957736,12.772218584127156
R-HSA-381183,ATF6 (ATF6-alpha) activates chaperone genes,1/1194,10/9872,0.1,0.8268006700167505,-0.2032528411188849,0.7246580248901737,0.9999999999999981,0.963097398669085,ATF6,1,1.6335845896147405,0.20893774983957736,12.772218584127156
R-HSA-390450,Folding of actin by CCT/TriC,1/1194,10/9872,0.1,0.8268006700167505,-0.2032528411188849,0.7246580248901737,0.9999999999999981,0.963097398669085,CCT6B,1,1.6335845896147405,0.20893774983957736,12.772218584127156
R-HSA-390666,Serotonin receptors,1/1194,10/9872,0.1,0.8268006700167505,-0.2032528411188849,0.7246580248901737,0.9999999999999981,0.963097398669085,HTR2B,1,1.6335845896147405,0.20893774983957736,12.772218584127156
R-HSA-430116,GP1b-IX-V activation signalling,1/1194,10/9872,0.1,0.8268006700167505,-0.2032528411188849,0.7246580248901737,0.9999999999999981,0.963097398669085,FLNA,1,1.6335845896147405,0.20893774983957736,12.772218584127156
R-HSA-432047,Passive transport by Aquaporins,1/1194,10/9872,0.1,0.8268006700167505,-0.2032528411188849,0.7246580248901737,0.9999999999999981,0.963097398669085,AQP4,1,1.6335845896147405,0.20893774983957736,12.772218584127156
R-HSA-879518,Transport of organic anions,1/1194,10/9872,0.1,0.8268006700167505,-0.2032528411188849,0.7246580248901737,0.9999999999999981,0.963097398669085,SLCO1C1,1,1.6335845896147405,0.20893774983957736,12.772218584127156
R-HSA-8963691,Phenylalanine and tyrosine metabolism,1/1194,10/9872,0.1,0.8268006700167505,-0.2032528411188849,0.7246580248901737,0.9999999999999981,0.963097398669085,QDPR,1,1.6335845896147405,0.20893774983957736,12.772218584127156
R-HSA-9617629,Regulation of FOXO transcriptional activity by acetylation,1/1194,10/9872,0.1,0.8268006700167505,-0.2032528411188849,0.7246580248901737,0.9999999999999981,0.963097398669085,KAT2B,1,1.6335845896147405,0.20893774983957736,12.772218584127156
R-HSA-9709957,Sensory Perception,30/1194,271/9872,0.11070110701107011,0.9152774944834876,-0.524563559719756,0.7273715664425016,0.9999999999999981,0.963097398669085,RBP4/GNB3/GUCA1B/BCO1/MSN/KCNMA1/SCN2A/HSD17B1/GPC5/RLBP1/SCN1B/GRK7/RBP2/LHX2/ADCY3/PCDH15/CDH23/SCN4B/GPC2/AKR1C3/RIPOR2/FNTB/GRK4/LPL/RGS9/SLC24A1/CACNA1D/BSN/RDH10/GNAL,30,1.8083962246657643,1.2346751549560164,2.648710385285018
R-HSA-390466,Chaperonin-mediated protein folding,9/1194,86/9872,0.10465116279069768,0.8652565151338085,-0.4655081744027382,0.7276680489837625,0.9999999999999981,0.963097398669085,STAT3/GNB3/GNG3/CCT6B/TUBB2A/KIFC3/TUBB4A/RGS9/GAPDHS,9,1.7095652682014724,0.8582056541072127,3.4054930683032536
R-HSA-3769402,Deactivation of the beta-catenin transactivating complex,4/1194,40/9872,0.1,0.8268006700167505,-0.40712538738270315,0.7297036087320306,0.9999999999999981,0.963097398669085,SOX6/SOX4/TLE1/SOX3,4,1.6335845896147405,0.583497241394514,4.573455403232091
R-HSA-9646399,Aggrephagy,4/1194,40/9872,0.1,0.8268006700167505,-0.40712538738270315,0.7297036087320306,0.9999999999999981,0.963097398669085,DYNC1I1/TUBB2A/CFTR/TUBB4A,4,1.6335845896147405,0.583497241394514,4.573455403232091
R-HSA-9772755,Formation of WDR5-containing histone-modifying complexes,4/1194,40/9872,0.1,0.8268006700167505,-0.40712538738270315,0.7297036087320306,0.9999999999999981,0.963097398669085,KAT2B/YEATS2/WDR5/KDM6A,4,1.6335845896147405,0.583497241394514,4.573455403232091
R-HSA-193648,NRAGE signals death through JNK,6/1194,59/9872,0.1016949152542373,0.8408142406950004,-0.4548856495357303,0.7340003398623264,0.9999999999999981,0.963097398669085,ARHGEF10/ARHGEF7/ARHGEF3/PREX1/ABR/NGEF,6,1.66127246401499,0.7158285894604155,3.8554288559147474
R-HSA-9820952,Respiratory Syncytial Virus Infection Pathway,11/1194,105/9872,0.10476190476190476,0.8661721304937386,-0.5113679867393198,0.738991054676186,0.9999999999999981,0.963097398669085,IFNAR2/CX3CR1/TLR2/MED28/GPC5/MED15/PPP1CB/CD14/MED29/GPC2/TLR4,11,1.7113743319773471,0.9170510055376122,3.193717782833605
R-HSA-3928665,EPH-ephrin mediated repulsion of cells,5/1194,50/9872,0.1,0.8268006700167505,-0.4554116763573904,0.7392735629635976,0.9999999999999981,0.963097398669085,EFNA5/EFNA1/EPHA6/EPHA4/DNM1,5,1.6335845896147403,0.6502490144253463,4.103964100253373
R-HSA-111931,PKA-mediated phosphorylation of CREB,2/1194,21/9872,0.09523809523809523,0.7874292095397623,-0.3616979037548965,0.7407874661200091,0.9999999999999981,0.963097398669085,PRKAR2A/ADCY3,2,1.5557948472521337,0.3643591570829822,6.643163921320155
R-HSA-1606322,ZBP1(DAI) mediated induction of type I IFNs,2/1194,21/9872,0.09523809523809523,0.7874292095397623,-0.3616979037548965,0.7407874661200091,0.9999999999999981,0.963097398669085,NFKBIA/RELA,2,1.5557948472521337,0.3643591570829822,6.643163921320155
R-HSA-389513,Co-inhibition by CTLA4,2/1194,21/9872,0.09523809523809523,0.7874292095397623,-0.3616979037548965,0.7407874661200091,0.9999999999999981,0.963097398669085,PTPN11/CTLA4,2,1.5557948472521337,0.3643591570829822,6.643163921320155
R-HSA-416572,Sema4D induced cell migration and growth-cone collapse,2/1194,21/9872,0.09523809523809523,0.7874292095397623,-0.3616979037548965,0.7407874661200091,0.9999999999999981,0.963097398669085,LIMK2/RHOB,2,1.5557948472521337,0.3643591570829822,6.643163921320155
R-HSA-5218921,VEGFR2 mediated cell proliferation,2/1194,21/9872,0.09523809523809523,0.7874292095397623,-0.3616979037548965,0.7407874661200091,0.9999999999999981,0.963097398669085,VEGFA/PRKCZ,2,1.5557948472521337,0.3643591570829822,6.643163921320155
R-HSA-70895,Branched-chain amino acid catabolism,2/1194,21/9872,0.09523809523809523,0.7874292095397623,-0.3616979037548965,0.7407874661200091,0.9999999999999981,0.963097398669085,BCAT1/ACADSB,2,1.5557948472521337,0.3643591570829822,6.643163921320155
R-HSA-9613829,Chaperone Mediated Autophagy,2/1194,21/9872,0.09523809523809523,0.7874292095397623,-0.3616979037548965,0.7407874661200091,0.9999999999999981,0.963097398669085,PLIN3/CFTR,2,1.5557948472521337,0.3643591570829822,6.643163921320155
R-HSA-9753281,Paracetamol ADME,2/1194,21/9872,0.09523809523809523,0.7874292095397623,-0.3616979037548965,0.7407874661200091,0.9999999999999981,0.963097398669085,NAT2/ABCC2,2,1.5557948472521337,0.3643591570829822,6.643163921320155
R-HSA-140877,Formation of Fibrin Clot (Clotting Cascade),3/1194,31/9872,0.0967741935483871,0.8001296806613714,-0.4134114052383994,0.7418074301623818,0.9999999999999981,0.963097398669085,A2M/PROS1/SERPINE2,3,1.580888312530394,0.4826081744590893,5.1785443947283465
R-HSA-182971,EGFR downregulation,3/1194,31/9872,0.0967741935483871,0.8001296806613714,-0.4134114052383994,0.7418074301623818,0.9999999999999981,0.963097398669085,ARHGEF7/SPRY1/GRB2,3,1.580888312530394,0.4826081744590893,5.1785443947283465
R-HSA-389958,Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding,3/1194,31/9872,0.0967741935483871,0.8001296806613714,-0.4134114052383994,0.7418074301623818,0.9999999999999981,0.963097398669085,CCT6B/TUBB2A/TUBB4A,3,1.580888312530394,0.4826081744590893,5.1785443947283465
R-HSA-397795,G-protein beta:gamma signalling,3/1194,31/9872,0.0967741935483871,0.8001296806613714,-0.4134114052383994,0.7418074301623818,0.9999999999999981,0.963097398669085,GNB3/PLCB1/GNG3,3,1.580888312530394,0.4826081744590893,5.1785443947283465
R-HSA-69190,DNA strand elongation,3/1194,31/9872,0.0967741935483871,0.8001296806613714,-0.4134114052383994,0.7418074301623818,0.9999999999999981,0.963097398669085,RPA3/GINS3/MCM7,3,1.580888312530394,0.4826081744590893,5.1785443947283465
R-HSA-446193,"Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein",8/1194,78/9872,0.10256410256410256,0.848000687196667,-0.49989845261471516,0.7420232822575836,0.9999999999999981,0.963097398669085,NEU4/ST6GAL2/PMM2/ST3GAL4/ST8SIA3/PGM3/GFPT2/HK1,8,1.6754713739638363,0.8074437109492862,3.4766563748102306
R-HSA-8943724,Regulation of PTEN gene transcription,6/1194,60/9872,0.1,0.8268006700167505,-0.499132650001959,0.7488836338906342,0.9999999999999981,0.963097398669085,PHC2/GATAD2A/JUN/EGR1/PPARG/RRAGD,6,1.6335845896147403,0.7043520915298146,3.7887281709218867
R-HSA-193704,p75 NTR receptor-mediated signalling,10/1194,97/9872,0.10309278350515463,0.8523718247595364,-0.5419630176227846,0.7511106843322738,0.9999999999999981,0.963097398669085,ARHGEF10/ARHGEF7/ARHGEF3/PREX1/NFKBIA/ABR/NGEF/RELA/CASP2/TRAF6,10,1.684107824345093,0.8760317059639012,3.23757592871557
R-HSA-5653656,Vesicle-mediated transport,73/1194,646/9872,0.1130030959752322,0.9343103546628913,-0.6405888386120654,0.756800288405845,0.9999999999999981,0.963097398669085,KIF19/RIN2/CD55/TMED10/SYNJ2/PLIN3/TACR1/TBC1D4/SNX9/HSPH1/AMPH/RAB3IP/COPA/GOSR2/STX6/RAB27B/TBC1D14/RHOQ/SERPINA1/DTNBP1/DENND1B/PICALM/TFRC/RAB8B/GJA1/RHOBTB3/ARFGAP3/RAB10/ITSN2/DNM3/VPS53/GJB6/SEC31A/ANKRD28/KIF26B/DENND4A/AMBP/YWHAG/SEC24D/DENND3/IGF2R/GJB7/SGIP1/RAB1A/SORT1/COL4A2/GDI2/TFG/PRKAG3/BIN1/PAFAH1B1/RAB7B/KIAA0319/DYNC1I1/SEC22A/ACTR3/CD59/SEC23A/GRB2/TPD52L1/KIF21B/TUBB2A/ARRB1/RAB21/TMF1/ANK1/CFTR/TUBB4A/GRIA1/NSF/SEC24A/SBF1/DNM1,73,1.846001161638948,1.4391495168638369,2.3678709187898526
R-HSA-159854,"Gamma-carboxylation, transport, and amino-terminal cleavage of proteins",1/1194,11/9872,0.09090909090909091,0.7516369727425004,-0.30570020107561063,0.7579938916799862,0.9999999999999981,0.963097398669085,PROS1,1,1.4850768996497639,0.19156646755525245,11.512731982893865
R-HSA-190373,FGFR1c ligand binding and activation,1/1194,11/9872,0.09090909090909091,0.7516369727425004,-0.30570020107561063,0.7579938916799862,0.9999999999999981,0.963097398669085,FGF20,1,1.4850768996497639,0.19156646755525245,11.512731982893865
R-HSA-2468052,Establishment of Sister Chromatid Cohesion,1/1194,11/9872,0.09090909090909091,0.7516369727425004,-0.30570020107561063,0.7579938916799862,0.9999999999999981,0.963097398669085,PDS5A,1,1.4850768996497639,0.19156646755525245,11.512731982893865
R-HSA-3270619,IRF3-mediated induction of type I IFN,1/1194,11/9872,0.09090909090909091,0.7516369727425004,-0.30570020107561063,0.7579938916799862,0.9999999999999981,0.963097398669085,IFI16,1,1.4850768996497639,0.19156646755525245,11.512731982893865
R-HSA-351906,Apoptotic cleavage of cell adhesion  proteins,1/1194,11/9872,0.09090909090909091,0.7516369727425004,-0.30570020107561063,0.7579938916799862,0.9999999999999981,0.963097398669085,TJP2,1,1.4850768996497639,0.19156646755525245,11.512731982893865
R-HSA-5654228,Phospholipase C-mediated cascade; FGFR4,1/1194,11/9872,0.09090909090909091,0.7516369727425004,-0.30570020107561063,0.7579938916799862,0.9999999999999981,0.963097398669085,FGF20,1,1.4850768996497639,0.19156646755525245,11.512731982893865
R-HSA-71288,Creatine metabolism,1/1194,11/9872,0.09090909090909091,0.7516369727425004,-0.30570020107561063,0.7579938916799862,0.9999999999999981,0.963097398669085,SLC6A8,1,1.4850768996497639,0.19156646755525245,11.512731982893865
R-HSA-73614,Pyrimidine salvage,1/1194,11/9872,0.09090909090909091,0.7516369727425004,-0.30570020107561063,0.7579938916799862,0.9999999999999981,0.963097398669085,UCK2,1,1.4850768996497639,0.19156646755525245,11.512731982893865
R-HSA-77588,SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs,1/1194,11/9872,0.09090909090909091,0.7516369727425004,-0.30570020107561063,0.7579938916799862,0.9999999999999981,0.963097398669085,ZNF473,1,1.4850768996497639,0.19156646755525245,11.512731982893865
R-HSA-8851805,MET activates RAS signaling,1/1194,11/9872,0.09090909090909091,0.7516369727425004,-0.30570020107561063,0.7579938916799862,0.9999999999999981,0.963097398669085,GRB2,1,1.4850768996497639,0.19156646755525245,11.512731982893865
R-HSA-8866907,Activation of the TFAP2 (AP-2) family of transcription factors,1/1194,11/9872,0.09090909090909091,0.7516369727425004,-0.30570020107561063,0.7579938916799862,0.9999999999999981,0.963097398669085,TFAP2E,1,1.4850768996497639,0.19156646755525245,11.512731982893865
R-HSA-9014325,"TICAM1,TRAF6-dependent induction of TAK1 complex",1/1194,11/9872,0.09090909090909091,0.7516369727425004,-0.30570020107561063,0.7579938916799862,0.9999999999999981,0.963097398669085,TRAF6,1,1.4850768996497639,0.19156646755525245,11.512731982893865
R-HSA-9027276,Erythropoietin activates Phosphoinositide-3-kinase (PI3K),1/1194,11/9872,0.09090909090909091,0.7516369727425004,-0.30570020107561063,0.7579938916799862,0.9999999999999981,0.963097398669085,GAB1,1,1.4850768996497639,0.19156646755525245,11.512731982893865
R-HSA-9614399,Regulation of localization of FOXO transcription factors,1/1194,11/9872,0.09090909090909091,0.7516369727425004,-0.30570020107561063,0.7579938916799862,0.9999999999999981,0.963097398669085,YWHAG,1,1.4850768996497639,0.19156646755525245,11.512731982893865
R-HSA-9683610,Maturation of nucleoprotein,1/1194,11/9872,0.09090909090909091,0.7516369727425004,-0.30570020107561063,0.7579938916799862,0.9999999999999981,0.963097398669085,PARP9,1,1.4850768996497639,0.19156646755525245,11.512731982893865
R-HSA-9755088,Ribavirin ADME,1/1194,11/9872,0.09090909090909091,0.7516369727425004,-0.30570020107561063,0.7579938916799862,0.9999999999999981,0.963097398669085,SLC28A2,1,1.4850768996497639,0.19156646755525245,11.512731982893865
R-HSA-9796292,Formation of axial mesoderm,1/1194,11/9872,0.09090909090909091,0.7516369727425004,-0.30570020107561063,0.7579938916799862,0.9999999999999981,0.963097398669085,TEAD4,1,1.4850768996497639,0.19156646755525245,11.512731982893865
R-HSA-9819196,Zygotic genome activation (ZGA),1/1194,11/9872,0.09090909090909091,0.7516369727425004,-0.30570020107561063,0.7579938916799862,0.9999999999999981,0.963097398669085,TEAD4,1,1.4850768996497639,0.19156646755525245,11.512731982893865
R-HSA-9828211,"Regulation of TBK1, IKK-mediated activation of IRF3, IRF7 upon TLR3 ligation",1/1194,11/9872,0.09090909090909091,0.7516369727425004,-0.30570020107561063,0.7579938916799862,0.9999999999999981,0.963097398669085,IKBKE,1,1.4850768996497639,0.19156646755525245,11.512731982893865
R-HSA-9845614,Sphingolipid catabolism,1/1194,11/9872,0.09090909090909091,0.7516369727425004,-0.30570020107561063,0.7579938916799862,0.9999999999999981,0.963097398669085,ALDH3A2,1,1.4850768996497639,0.19156646755525245,11.512731982893865
R-HSA-202433,Generation of second messenger molecules,3/1194,32/9872,0.09375,0.7751256281407035,-0.4725963026796327,0.7613995680625552,0.9999999999999981,0.963097398669085,PAK2/ENAH/PAK3,3,1.5314855527638191,0.46829076716351464,5.008529236078943
R-HSA-5213460,RIPK1-mediated regulated necrosis,3/1194,32/9872,0.09375,0.7751256281407035,-0.4725963026796327,0.7613995680625552,0.9999999999999981,0.963097398669085,MLKL/FLOT2/FLOT1,3,1.5314855527638191,0.46829076716351464,5.008529236078943
R-HSA-5675482,Regulation of necroptotic cell death,3/1194,32/9872,0.09375,0.7751256281407035,-0.4725963026796327,0.7613995680625552,0.9999999999999981,0.963097398669085,MLKL/FLOT2/FLOT1,3,1.5314855527638191,0.46829076716351464,5.008529236078943
R-HSA-1250196,SHC1 events in ERBB2 signaling,2/1194,22/9872,0.09090909090909091,0.7516369727425004,-0.43256670297599564,0.7641219205809074,0.9999999999999981,0.963097398669085,NRG1/GRB2,2,1.4850768996497639,0.3487959294094611,6.323047982834435
R-HSA-198753,ERK/MAPK targets,2/1194,22/9872,0.09090909090909091,0.7516369727425004,-0.43256670297599564,0.7641219205809074,0.9999999999999981,0.963097398669085,DUSP3/RPS6KA3,2,1.4850768996497639,0.3487959294094611,6.323047982834435
R-HSA-8949215,Mitochondrial calcium ion transport,2/1194,22/9872,0.09090909090909091,0.7516369727425004,-0.43256670297599564,0.7641219205809074,0.9999999999999981,0.963097398669085,MCUB/MAIP1,2,1.4850768996497639,0.3487959294094611,6.323047982834435
R-HSA-8956321,Nucleotide salvage,2/1194,22/9872,0.09090909090909091,0.7516369727425004,-0.43256670297599564,0.7641219205809074,0.9999999999999981,0.963097398669085,HPRT1/UCK2,2,1.4850768996497639,0.3487959294094611,6.323047982834435
R-HSA-9637690,Response of Mtb to phagocytosis,2/1194,22/9872,0.09090909090909091,0.7516369727425004,-0.43256670297599564,0.7641219205809074,0.9999999999999981,0.963097398669085,PGK1/ENO1,2,1.4850768996497639,0.3487959294094611,6.323047982834435
R-HSA-977068,Termination of O-glycan biosynthesis,2/1194,22/9872,0.09090909090909091,0.7516369727425004,-0.43256670297599564,0.7641219205809074,0.9999999999999981,0.963097398669085,MUC15/ST3GAL4,2,1.4850768996497639,0.3487959294094611,6.323047982834435
R-HSA-2262752,Cellular responses to stress,79/1194,700/9872,0.11285714285714285,0.9331036133046182,-0.6810712911739746,0.7689324622149993,0.9999999999999981,0.963097398669085,STAT3/SRPRB/PHC2/LMNA/VEGFA/FNIP2/DNAJB1/HSPA12A/FNIP1/FKBP5/ERO1A/HMOX1/ATF3/HSPH1/HSPA1A/PPP1R15A/GOSR2/MAP3K5/HSPA1B/MAP2K4/HIF1A/ADD1/CABIN1/NFE2L2/TNRC6C/CDKN1A/GRB10/BCL2L1/FOS/NUP205/CAMK2D/HELZ2/CUL1/STIP1/SEC31A/PTGES3/EDEM1/DNAJA4/BACH1/NUP58/JUN/MAP2K3/NCOA1/HSPD1/EGLN1/GCLC/NUP98/RPA3/NUP188/NUP153/PDGFA/ATF6/RAI1/HSPA9/DYNC1I1/LMNB1/NDUFA4/CREB3L1/ETS2/ERF/CDK2/UBE2D1/RORA/RELA/TUBB2A/CCNA2/TLR4/ST13/RRAGD/IL1A/TUBB4A/EIF2S1/CAMK2G/DDX11/CCL2/SLC7A11/DNAJA1/EIF2AK3/RPS6KA3,79,1.8436168939937783,1.450451312308494,2.343355632123662
R-HSA-1445148,Translocation of SLC2A4 (GLUT4) to the plasma membrane,7/1194,71/9872,0.09859154929577464,0.8151555901573595,-0.5797933330589777,0.7712356471185197,0.9999999999999981,0.963097398669085,TBC1D4/RHOQ/RAB10/YWHAG/PRKAG3/TUBB2A/TUBB4A,7,1.6105763559581945,0.7392831080866196,3.5087453913090774
R-HSA-1221632,Meiotic synapsis,3/1194,33/9872,0.09090909090909091,0.7516369727425004,-0.5300799173960602,0.7797683919865226,0.9999999999999981,0.963097398669085,LMNA/LMNB1/SYCP3,3,1.485076899649764,0.45479821249521407,4.849300936723809
R-HSA-1980145,Signaling by NOTCH2,3/1194,33/9872,0.09090909090909091,0.7516369727425004,-0.5300799173960602,0.7797683919865226,0.9999999999999981,0.963097398669085,NEURL1B/HES5/HES1,3,1.485076899649764,0.45479821249521407,4.849300936723809
R-HSA-2559585,Oncogene Induced Senescence,3/1194,33/9872,0.09090909090909091,0.7516369727425004,-0.5300799173960602,0.7797683919865226,0.9999999999999981,0.963097398669085,TNRC6C/ETS2/ERF,3,1.485076899649764,0.45479821249521407,4.849300936723809
R-HSA-450408,AUF1 (hnRNP D0) binds and destabilizes mRNA,4/1194,43/9872,0.09302325581395349,0.7691169023411633,-0.5627877260360219,0.7808114384432125,0.9999999999999981,0.963097398669085,HSPA1A/HSPA1B/HSPB1/EIF4G1,4,1.5196135717346422,0.5445601906509608,4.240532905351924
R-HSA-6809371,Formation of the cornified envelope,4/1194,43/9872,0.09302325581395349,0.7691169023411633,-0.5627877260360219,0.7808114384432125,0.9999999999999981,0.963097398669085,PCSK6/KAZN/SPINK6/DSC1,4,1.5196135717346422,0.5445601906509608,4.240532905351924
R-HSA-202403,TCR signaling,10/1194,100/9872,0.1,0.8268006700167505,-0.645694957646847,0.7841011557692599,0.9999999999999981,0.963097398669085,PTPRJ/PAK2/CUL1/ENAH/NFKBIA/UBE2D1/RELA/PAK3/TRAF6/PAG1,10,1.6335845896147403,0.8505240019755288,3.1375935367236587
R-HSA-9662361,Sensory processing of sound by outer hair cells of the cochlea,5/1194,53/9872,0.09433962264150944,0.7800006320912741,-0.5956602977804433,0.7846949219745231,0.9999999999999981,0.963097398669085,MSN/KCNMA1/PCDH15/CDH23/RIPOR2,5,1.5411175373723964,0.6148941077749012,3.862524024813407
R-HSA-112409,RAF-independent MAPK1/3 activation,2/1194,23/9872,0.08695652173913043,0.7189571043623917,-0.5005107124805662,0.785609247377591,0.9999999999999981,0.963097398669085,DUSP1/PTPN11,2,1.4205083387954263,0.3345070257218918,6.032291657350634
R-HSA-373753,Nephrin family interactions,2/1194,23/9872,0.08695652173913043,0.7189571043623917,-0.5005107124805662,0.785609247377591,0.9999999999999981,0.963097398669085,NCK2/IQGAP1,2,1.4205083387954263,0.3345070257218918,6.032291657350634
R-HSA-428930,Thromboxane signalling through TP receptor,2/1194,23/9872,0.08695652173913043,0.7189571043623917,-0.5005107124805662,0.785609247377591,0.9999999999999981,0.963097398669085,GNB3/GNG3,2,1.4205083387954263,0.3345070257218918,6.032291657350634
R-HSA-111461,Cytochrome c-mediated apoptotic response,1/1194,12/9872,0.08333333333333333,0.689000558347292,-0.3998385753181584,0.7872967304726133,0.9999999999999981,0.963097398669085,CASP7,1,1.3613204913456172,0.1768569309575943,10.478489421496409
R-HSA-1296346,Tandem pore domain potassium channels,1/1194,12/9872,0.08333333333333333,0.689000558347292,-0.3998385753181584,0.7872967304726133,0.9999999999999981,0.963097398669085,KCNK10,1,1.3613204913456172,0.1768569309575943,10.478489421496409
R-HSA-1474151,"Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation",1/1194,12/9872,0.08333333333333333,0.689000558347292,-0.3998385753181584,0.7872967304726133,0.9999999999999981,0.963097398669085,GCH1,1,1.3613204913456172,0.1768569309575943,10.478489421496409
R-HSA-1475029,Reversible hydration of carbon dioxide,1/1194,12/9872,0.08333333333333333,0.689000558347292,-0.3998385753181584,0.7872967304726133,0.9999999999999981,0.963097398669085,CA12,1,1.3613204913456172,0.1768569309575943,10.478489421496409
R-HSA-1482925,Acyl chain remodelling of PG,1/1194,12/9872,0.08333333333333333,0.689000558347292,-0.3998385753181584,0.7872967304726133,0.9999999999999981,0.963097398669085,PLA2G12A,1,1.3613204913456172,0.1768569309575943,10.478489421496409
R-HSA-170968,Frs2-mediated activation,1/1194,12/9872,0.08333333333333333,0.689000558347292,-0.3998385753181584,0.7872967304726133,0.9999999999999981,0.963097398669085,RAP1A,1,1.3613204913456172,0.1768569309575943,10.478489421496409
R-HSA-381033,ATF6 (ATF6-alpha) activates chaperones,1/1194,12/9872,0.08333333333333333,0.689000558347292,-0.3998385753181584,0.7872967304726133,0.9999999999999981,0.963097398669085,ATF6,1,1.3613204913456172,0.1768569309575943,10.478489421496409
R-HSA-419408,Lysosphingolipid and LPA receptors,1/1194,12/9872,0.08333333333333333,0.689000558347292,-0.3998385753181584,0.7872967304726133,0.9999999999999981,0.963097398669085,LPAR5,1,1.3613204913456172,0.1768569309575943,10.478489421496409
R-HSA-4641265,Repression of WNT target genes,1/1194,12/9872,0.08333333333333333,0.689000558347292,-0.3998385753181584,0.7872967304726133,0.9999999999999981,0.963097398669085,TLE1,1,1.3613204913456172,0.1768569309575943,10.478489421496409
R-HSA-5654219,Phospholipase C-mediated cascade: FGFR1,1/1194,12/9872,0.08333333333333333,0.689000558347292,-0.3998385753181584,0.7872967304726133,0.9999999999999981,0.963097398669085,FGF20,1,1.3613204913456172,0.1768569309575943,10.478489421496409
R-HSA-622323,Presynaptic nicotinic acetylcholine receptors,1/1194,12/9872,0.08333333333333333,0.689000558347292,-0.3998385753181584,0.7872967304726133,0.9999999999999981,0.963097398669085,CHRNB2,1,1.3613204913456172,0.1768569309575943,10.478489421496409
R-HSA-629594,Highly calcium permeable postsynaptic nicotinic acetylcholine receptors,1/1194,12/9872,0.08333333333333333,0.689000558347292,-0.3998385753181584,0.7872967304726133,0.9999999999999981,0.963097398669085,CHRNB2,1,1.3613204913456172,0.1768569309575943,10.478489421496409
R-HSA-6803211,TP53 Regulates Transcription of Death Receptors and Ligands,1/1194,12/9872,0.08333333333333333,0.689000558347292,-0.3998385753181584,0.7872967304726133,0.9999999999999981,0.963097398669085,TNFRSF10D,1,1.3613204913456172,0.1768569309575943,10.478489421496409
R-HSA-68884,Mitotic Telophase/Cytokinesis,1/1194,12/9872,0.08333333333333333,0.689000558347292,-0.3998385753181584,0.7872967304726133,0.9999999999999981,0.963097398669085,PDS5A,1,1.3613204913456172,0.1768569309575943,10.478489421496409
R-HSA-71064,Lysine catabolism,1/1194,12/9872,0.08333333333333333,0.689000558347292,-0.3998385753181584,0.7872967304726133,0.9999999999999981,0.963097398669085,CRYM,1,1.3613204913456172,0.1768569309575943,10.478489421496409
R-HSA-74217,Purine salvage,1/1194,12/9872,0.08333333333333333,0.689000558347292,-0.3998385753181584,0.7872967304726133,0.9999999999999981,0.963097398669085,HPRT1,1,1.3613204913456172,0.1768569309575943,10.478489421496409
R-HSA-75109,Triglyceride biosynthesis,1/1194,12/9872,0.08333333333333333,0.689000558347292,-0.3998385753181584,0.7872967304726133,0.9999999999999981,0.963097398669085,GK,1,1.3613204913456172,0.1768569309575943,10.478489421496409
R-HSA-83936,Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane,1/1194,12/9872,0.08333333333333333,0.689000558347292,-0.3998385753181584,0.7872967304726133,0.9999999999999981,0.963097398669085,SLC28A2,1,1.3613204913456172,0.1768569309575943,10.478489421496409
R-HSA-933543,NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10,1/1194,12/9872,0.08333333333333333,0.689000558347292,-0.3998385753181584,0.7872967304726133,0.9999999999999981,0.963097398669085,RNF135,1,1.3613204913456172,0.1768569309575943,10.478489421496409
R-HSA-9664420,Killing mechanisms,1/1194,12/9872,0.08333333333333333,0.689000558347292,-0.3998385753181584,0.7872967304726133,0.9999999999999981,0.963097398669085,JUN,1,1.3613204913456172,0.1768569309575943,10.478489421496409
R-HSA-9673324,WNT5:FZD7-mediated leishmania damping,1/1194,12/9872,0.08333333333333333,0.689000558347292,-0.3998385753181584,0.7872967304726133,0.9999999999999981,0.963097398669085,JUN,1,1.3613204913456172,0.1768569309575943,10.478489421496409
R-HSA-9755779,SARS-CoV-2 targets host intracellular signalling and regulatory pathways,1/1194,12/9872,0.08333333333333333,0.689000558347292,-0.3998385753181584,0.7872967304726133,0.9999999999999981,0.963097398669085,YWHAG,1,1.3613204913456172,0.1768569309575943,10.478489421496409
R-HSA-9820865,Z-decay: degradation of maternal mRNAs by zygotically expressed factors,1/1194,12/9872,0.08333333333333333,0.689000558347292,-0.3998385753181584,0.7872967304726133,0.9999999999999981,0.963097398669085,EIF4G1,1,1.3613204913456172,0.1768569309575943,10.478489421496409
R-HSA-9827857,Specification of primordial germ cells,1/1194,12/9872,0.08333333333333333,0.689000558347292,-0.3998385753181584,0.7872967304726133,0.9999999999999981,0.963097398669085,PDPN,1,1.3613204913456172,0.1768569309575943,10.478489421496409
R-HSA-2871837,FCERI mediated NF-kB activation,6/1194,63/9872,0.09523809523809523,0.7874292095397623,-0.627818937230924,0.7898776381843302,0.9999999999999981,0.963097398669085,CUL1/RASGRP1/NFKBIA/UBE2D1/RELA/TRAF6,6,1.5557948472521337,0.6720295167093754,3.6017727593102933
R-HSA-9009391,Extra-nuclear estrogen signaling,7/1194,73/9872,0.0958904109589041,0.7928225602900346,-0.659000781250546,0.7956606018569677,0.9999999999999981,0.963097398669085,GNB3/GNAI1/FOS/PRKCZ/PTK2/GNG3/HSPB1,7,1.5664509763429015,0.7197139462712961,3.4093665601426064
R-HSA-9659379,Sensory processing of sound,7/1194,73/9872,0.0958904109589041,0.7928225602900346,-0.659000781250546,0.7956606018569677,0.9999999999999981,0.963097398669085,MSN/KCNMA1/PCDH15/CDH23/RIPOR2/CACNA1D/BSN,7,1.5664509763429015,0.7197139462712961,3.4093665601426064
R-HSA-1296065,Inwardly rectifying K+ channels,3/1194,34/9872,0.08823529411764706,0.7295300029559563,-0.5859736162583182,0.7969553223614212,0.9999999999999981,0.963097398669085,GNB3/KCNJ16/GNG3,3,1.441398167307124,0.44206123965937943,4.699866195727104
R-HSA-1483166,Synthesis of PA,3/1194,34/9872,0.08823529411764706,0.7295300029559563,-0.5859736162583182,0.7969553223614212,0.9999999999999981,0.963097398669085,GPAT4/AGPAT5/PLA2G12A,3,1.441398167307124,0.44206123965937943,4.699866195727104
R-HSA-157579,Telomere Maintenance,6/1194,64/9872,0.09375,0.7751256281407035,-0.6694415099771578,0.8023465071382897,0.9999999999999981,0.963097398669085,ANKRD28/SHQ1/RPA3/CDK2/CCNA2/STN1,6,1.5314855527638191,0.6619047123155067,3.5434828528706834
R-HSA-8856825,Cargo recognition for clathrin-mediated endocytosis,10/1194,102/9872,0.09803921568627451,0.8105888921732848,-0.713232565898686,0.8042731465406201,0.9999999999999981,0.963097398669085,TACR1/PICALM/TFRC/ITSN2/IGF2R/SGIP1/KIAA0319/GRB2/ARRB1/CFTR,10,1.6015535192301376,0.8343285825648274,3.074296780140742
R-HSA-203927,MicroRNA (miRNA) biogenesis,2/1194,24/9872,0.08333333333333333,0.689000558347292,-0.5658015419367485,0.8053545058985965,0.9999999999999981,0.963097398669085,DICER1/AGO2,2,1.3613204913456172,0.321342176475829,5.767040917197709
R-HSA-210991,Basigin interactions,2/1194,24/9872,0.08333333333333333,0.689000558347292,-0.5658015419367485,0.8053545058985965,0.9999999999999981,0.963097398669085,ATP1B3/SLC7A11,2,1.3613204913456172,0.321342176475829,5.767040917197709
R-HSA-264876,Insulin processing,2/1194,24/9872,0.08333333333333333,0.689000558347292,-0.5658015419367485,0.8053545058985965,0.9999999999999981,0.963097398669085,KIF5C/CPE,2,1.3613204913456172,0.321342176475829,5.767040917197709
R-HSA-392451,G beta:gamma signalling through PI3Kgamma,2/1194,24/9872,0.08333333333333333,0.689000558347292,-0.5658015419367485,0.8053545058985965,0.9999999999999981,0.963097398669085,GNB3/GNG3,2,1.3613204913456172,0.321342176475829,5.767040917197709
R-HSA-418592,ADP signalling through P2Y purinoceptor 1,2/1194,24/9872,0.08333333333333333,0.689000558347292,-0.5658015419367485,0.8053545058985965,0.9999999999999981,0.963097398669085,GNB3/GNG3,2,1.3613204913456172,0.321342176475829,5.767040917197709
R-HSA-429947,Deadenylation of mRNA,2/1194,24/9872,0.08333333333333333,0.689000558347292,-0.5658015419367485,0.8053545058985965,0.9999999999999981,0.963097398669085,CNOT2/EIF4G1,2,1.3613204913456172,0.321342176475829,5.767040917197709
R-HSA-5674400,Constitutive Signaling by AKT1 E17K in Cancer,2/1194,24/9872,0.08333333333333333,0.689000558347292,-0.5658015419367485,0.8053545058985965,0.9999999999999981,0.963097398669085,CDKN1A/PRR5,2,1.3613204913456172,0.321342176475829,5.767040917197709
R-HSA-9634638,Estrogen-dependent nuclear events downstream of ESR-membrane signaling,2/1194,24/9872,0.08333333333333333,0.689000558347292,-0.5658015419367485,0.8053545058985965,0.9999999999999981,0.963097398669085,FOS/PTK2,2,1.3613204913456172,0.321342176475829,5.767040917197709
R-HSA-9934037,Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF),2/1194,24/9872,0.08333333333333333,0.689000558347292,-0.5658015419367485,0.8053545058985965,0.9999999999999981,0.963097398669085,SS18L1/ACTL6B,2,1.3613204913456172,0.321342176475829,5.767040917197709
R-HSA-157118,Signaling by NOTCH,17/1194,167/9872,0.10179640718562874,0.8416533766637578,-0.7654947012423892,0.810399432024087,0.9999999999999981,0.963097398669085,NEURL1B/HES5/KAT2B/HDAC4/HIF1A/TNRC6C/AGO2/CUL1/RUNX1/ST3GAL4/JUN/HES1/PLXND1/ARRB1/TLE1/STAT1/FABP7,17,1.6629304205659032,1.00621184116212,2.7482657930656798
R-HSA-5620924,Intraflagellar transport,4/1194,45/9872,0.08888888888888889,0.7349339289037782,-0.6610325363177809,0.8104085797536597,0.9999999999999981,0.963097398669085,DYNLRB2/IFT172/TUBB2A/TUBB4A,4,1.452075190768658,0.5213661122584459,4.044225948081223
R-HSA-2454202,Fc epsilon receptor (FCERI) signaling,11/1194,112/9872,0.09821428571428571,0.8120363723378798,-0.7420460150820755,0.8108089885068915,0.9999999999999981,0.963097398669085,PAK2/MAP2K4/FOS/CUL1/RASGRP1/JUN/NFKBIA/GRB2/UBE2D1/RELA/TRAF6,11,1.604413436228763,0.861314630614065,2.9886203982349397
R-HSA-5617472,Activation of anterior HOX genes in hindbrain development during early embryogenesis,5/1194,55/9872,0.09090909090909091,0.7516369727425004,-0.6850965972396366,0.8114025108696823,0.9999999999999981,0.963097398669085,PAX6/RARA/JUN/WDR5/KDM6A,5,1.4850768996497639,0.5933854817596459,3.716729622931162
R-HSA-5619507,Activation of HOX genes during differentiation,5/1194,55/9872,0.09090909090909091,0.7516369727425004,-0.6850965972396366,0.8114025108696823,0.9999999999999981,0.963097398669085,PAX6/RARA/JUN/WDR5/KDM6A,5,1.4850768996497639,0.5933854817596459,3.716729622931162
R-HSA-9687139,Aberrant regulation of mitotic cell cycle due to RB1 defects,3/1194,35/9872,0.08571428571428572,0.7086862885857861,-0.6403781854439052,0.8130057237271696,0.9999999999999981,0.963097398669085,CDKN1A/CDK2/UBE2D1,3,1.4002153625269202,0.430018121345453,4.5593498602384575
R-HSA-1358803,Downregulation of ERBB2:ERBB3 signaling,1/1194,13/9872,0.07692307692307693,0.6360005153975004,-0.4871121115731974,0.8130541040847532,0.9999999999999981,0.963097398669085,NRG1,1,1.2566035304728773,0.16424192077300007,9.61418635002034
R-HSA-1362409,Mitochondrial iron-sulfur cluster biogenesis,1/1194,13/9872,0.07692307692307693,0.6360005153975004,-0.4871121115731974,0.8130541040847532,0.9999999999999981,0.963097398669085,SLC25A37,1,1.2566035304728773,0.16424192077300007,9.61418635002034
R-HSA-171007,p38MAPK events,1/1194,13/9872,0.07692307692307693,0.6360005153975004,-0.4871121115731974,0.8130541040847532,0.9999999999999981,0.963097398669085,RALGDS,1,1.2566035304728773,0.16424192077300007,9.61418635002034
R-HSA-174430,Telomere C-strand synthesis initiation,1/1194,13/9872,0.07692307692307693,0.6360005153975004,-0.4871121115731974,0.8130541040847532,0.9999999999999981,0.963097398669085,STN1,1,1.2566035304728773,0.16424192077300007,9.61418635002034
R-HSA-179812,GRB2 events in EGFR signaling,1/1194,13/9872,0.07692307692307693,0.6360005153975004,-0.4871121115731974,0.8130541040847532,0.9999999999999981,0.963097398669085,GRB2,1,1.2566035304728773,0.16424192077300007,9.61418635002034
R-HSA-198323,AKT phosphorylates targets in the cytosol,1/1194,13/9872,0.07692307692307693,0.6360005153975004,-0.4871121115731974,0.8130541040847532,0.9999999999999981,0.963097398669085,CDKN1A,1,1.2566035304728773,0.16424192077300007,9.61418635002034
R-HSA-202670,ERKs are inactivated,1/1194,13/9872,0.07692307692307693,0.6360005153975004,-0.4871121115731974,0.8130541040847532,0.9999999999999981,0.963097398669085,DUSP3,1,1.2566035304728773,0.16424192077300007,9.61418635002034
R-HSA-209543,p75NTR recruits signalling complexes,1/1194,13/9872,0.07692307692307693,0.6360005153975004,-0.4871121115731974,0.8130541040847532,0.9999999999999981,0.963097398669085,TRAF6,1,1.2566035304728773,0.16424192077300007,9.61418635002034
R-HSA-2168880,Scavenging of heme from plasma,1/1194,13/9872,0.07692307692307693,0.6360005153975004,-0.4871121115731974,0.8130541040847532,0.9999999999999981,0.963097398669085,AMBP,1,1.2566035304728773,0.16424192077300007,9.61418635002034
R-HSA-2564830,Cytosolic iron-sulfur cluster assembly,1/1194,13/9872,0.07692307692307693,0.6360005153975004,-0.4871121115731974,0.8130541040847532,0.9999999999999981,0.963097398669085,CIAO3,1,1.2566035304728773,0.16424192077300007,9.61418635002034
R-HSA-3134975,Regulation of innate immune responses to cytosolic DNA,1/1194,13/9872,0.07692307692307693,0.6360005153975004,-0.4871121115731974,0.8130541040847532,0.9999999999999981,0.963097398669085,TRIM56,1,1.2566035304728773,0.16424192077300007,9.61418635002034
R-HSA-442720,CREB1 phosphorylation through the activation of Adenylate Cyclase,1/1194,13/9872,0.07692307692307693,0.6360005153975004,-0.4871121115731974,0.8130541040847532,0.9999999999999981,0.963097398669085,PRKAR2A,1,1.2566035304728773,0.16424192077300007,9.61418635002034
R-HSA-69166,Removal of the Flap Intermediate,1/1194,13/9872,0.07692307692307693,0.6360005153975004,-0.4871121115731974,0.8130541040847532,0.9999999999999981,0.963097398669085,RPA3,1,1.2566035304728773,0.16424192077300007,9.61418635002034
R-HSA-8847993,ERBB2 Activates PTK6 Signaling,1/1194,13/9872,0.07692307692307693,0.6360005153975004,-0.4871121115731974,0.8130541040847532,0.9999999999999981,0.963097398669085,NRG1,1,1.2566035304728773,0.16424192077300007,9.61418635002034
R-HSA-9013973,TICAM1-dependent activation of IRF3/IRF7,1/1194,13/9872,0.07692307692307693,0.6360005153975004,-0.4871121115731974,0.8130541040847532,0.9999999999999981,0.963097398669085,IKBKE,1,1.2566035304728773,0.16424192077300007,9.61418635002034
R-HSA-9027284,Erythropoietin activates RAS,1/1194,13/9872,0.07692307692307693,0.6360005153975004,-0.4871121115731974,0.8130541040847532,0.9999999999999981,0.963097398669085,GRB2,1,1.2566035304728773,0.16424192077300007,9.61418635002034
R-HSA-9710421,Defective pyroptosis,1/1194,13/9872,0.07692307692307693,0.6360005153975004,-0.4871121115731974,0.8130541040847532,0.9999999999999981,0.963097398669085,GSDME,1,1.2566035304728773,0.16424192077300007,9.61418635002034
R-HSA-9733458,Induction of Cell-Cell Fusion,1/1194,13/9872,0.07692307692307693,0.6360005153975004,-0.4871121115731974,0.8130541040847532,0.9999999999999981,0.963097398669085,ANO3,1,1.2566035304728773,0.16424192077300007,9.61418635002034
R-HSA-975110,TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling,1/1194,13/9872,0.07692307692307693,0.6360005153975004,-0.4871121115731974,0.8130541040847532,0.9999999999999981,0.963097398669085,TRAF6,1,1.2566035304728773,0.16424192077300007,9.61418635002034
R-HSA-1643713,Signaling by EGFR in Cancer,2/1194,25/9872,0.08,0.6614405360134004,-0.628674594394571,0.82346438027692,0.9999999999999981,0.963097398669085,GAB1/GRB2,2,1.3068676716917924,0.309173831820021,5.524086890728017
R-HSA-180024,DARPP-32 events,2/1194,25/9872,0.08,0.6614405360134004,-0.628674594394571,0.82346438027692,0.9999999999999981,0.963097398669085,PRKAR2A/PDE4D,2,1.3068676716917924,0.309173831820021,5.524086890728017
R-HSA-3238698,WNT ligand biogenesis and trafficking,2/1194,25/9872,0.08,0.6614405360134004,-0.628674594394571,0.82346438027692,0.9999999999999981,0.963097398669085,WNT2B/WNT6,2,1.3068676716917924,0.309173831820021,5.524086890728017
R-HSA-400685,Sema4D in semaphorin signaling,2/1194,25/9872,0.08,0.6614405360134004,-0.628674594394571,0.82346438027692,0.9999999999999981,0.963097398669085,LIMK2/RHOB,2,1.3068676716917924,0.309173831820021,5.524086890728017
R-HSA-5696397,Gap-filling DNA repair synthesis and ligation in GG-NER,2/1194,25/9872,0.08,0.6614405360134004,-0.628674594394571,0.82346438027692,0.9999999999999981,0.963097398669085,RPA3/POLE,2,1.3068676716917924,0.309173831820021,5.524086890728017
R-HSA-901042,Calnexin/calreticulin cycle,2/1194,25/9872,0.08,0.6614405360134004,-0.628674594394571,0.82346438027692,0.9999999999999981,0.963097398669085,EDEM1/EDEM2,2,1.3068676716917924,0.309173831820021,5.524086890728017
R-HSA-912446,Meiotic recombination,2/1194,25/9872,0.08,0.6614405360134004,-0.628674594394571,0.82346438027692,0.9999999999999981,0.963097398669085,RPA3/CDK2,2,1.3068676716917924,0.309173831820021,5.524086890728017
R-HSA-6784531,tRNA processing in the nucleus,5/1194,56/9872,0.08928571428571429,0.7382148839435272,-0.7286930139998369,0.8237296315318723,0.9999999999999981,0.963097398669085,NUP205/NUP58/NUP98/NUP188/NUP153,5,1.458557669298875,0.5831857762647452,3.6478778482841605
R-HSA-983189,Kinesins,5/1194,56/9872,0.08928571428571429,0.7382148839435272,-0.7286930139998369,0.8237296315318723,0.9999999999999981,0.963097398669085,KIF19/KIF26B/KIF21B/TUBB2A/TUBB4A,5,1.458557669298875,0.5831857762647452,3.6478778482841605
R-HSA-9609646,HCMV Infection,9/1194,95/9872,0.09473684210526316,0.7832848452790268,-0.7872654525122055,0.8270759920869301,0.9999999999999981,0.963097398669085,NUP205/CEBPD/NUP58/NUP98/NUP188/NUP153/DYNC1I1/TUBB2A/TUBB4A,9,1.5476064533192277,0.7792963442346341,3.0733953162677685
R-HSA-163125,Post-translational modification: synthesis of GPI-anchored proteins,7/1194,76/9872,0.09210526315789473,0.7615269329101648,-0.7740957119671475,0.8285169785626123,0.9999999999999981,0.963097398669085,PLAUR/PGAP1/OPCML/THY1/RAET1G/FOLR2/BST1,7,1.5046173851714713,0.6922288405831215,3.2704119548864616
R-HSA-195258,RHO GTPase Effectors,27/1194,261/9872,0.10344827586206896,0.8553110379483625,-0.8787073976974836,0.8350889292227557,0.9999999999999981,0.963097398669085,WIPF3/PAK2/CTNNA1/KDM4C/WIPF1/RHOQ/IQGAP1/RTKN/YWHAG/PRKCZ/LIMK2/PTK2/NUP98/PPP1CB/PAFAH1B1/DYNC1I1/NUF2/RHOB/ACTR3/AHCTF1/GRB2/TUBB2A/SKA1/PAK3/CFTR/TUBB4A/FLNA,27,1.689915092704904,1.1321973860705703,2.522363198932364
R-HSA-1500620,Meiosis,5/1194,57/9872,0.08771929824561403,0.7252637456287284,-0.7715803614734422,0.8353969641390595,0.9999999999999981,0.963097398669085,LMNA/RPA3/LMNB1/SYCP3/CDK2,5,1.432968938258544,0.5733308138042663,3.5815273286791185
R-HSA-8939902,Regulation of RUNX2 expression and activity,5/1194,57/9872,0.08771929824561403,0.7252637456287284,-0.7715803614734422,0.8353969641390595,0.9999999999999981,0.963097398669085,CBFB/WWP1/CUL1/BMP2/STAT1,5,1.432968938258544,0.5733308138042663,3.5815273286791185
R-HSA-162658,Golgi Cisternae Pericentriolar Stack Reorganization,1/1194,14/9872,0.07142857142857142,0.5905719071548217,-0.568617426941921,0.8356946761227698,0.9999999999999981,0.963097398669085,RAB1A,1,1.1668461354391002,0.1533044368628041,8.88121656262062
R-HSA-169893,Prolonged ERK activation events,1/1194,14/9872,0.07142857142857142,0.5905719071548217,-0.568617426941921,0.8356946761227698,0.9999999999999981,0.963097398669085,RAP1A,1,1.1668461354391002,0.1533044368628041,8.88121656262062
R-HSA-180336,SHC1 events in EGFR signaling,1/1194,14/9872,0.07142857142857142,0.5905719071548217,-0.568617426941921,0.8356946761227698,0.9999999999999981,0.963097398669085,GRB2,1,1.1668461354391002,0.1533044368628041,8.88121656262062
R-HSA-1834941,STING mediated induction of host immune responses,1/1194,14/9872,0.07142857142857142,0.5905719071548217,-0.568617426941921,0.8356946761227698,0.9999999999999981,0.963097398669085,IFI16,1,1.1668461354391002,0.1533044368628041,8.88121656262062
R-HSA-189451,Heme biosynthesis,1/1194,14/9872,0.07142857142857142,0.5905719071548217,-0.568617426941921,0.8356946761227698,0.9999999999999981,0.963097398669085,ALAS1,1,1.1668461354391002,0.1533044368628041,8.88121656262062
R-HSA-190242,FGFR1 ligand binding and activation,1/1194,14/9872,0.07142857142857142,0.5905719071548217,-0.568617426941921,0.8356946761227698,0.9999999999999981,0.963097398669085,FGF20,1,1.1668461354391002,0.1533044368628041,8.88121656262062
R-HSA-200425,Carnitine shuttle,1/1194,14/9872,0.07142857142857142,0.5905719071548217,-0.568617426941921,0.8356946761227698,0.9999999999999981,0.963097398669085,PPARD,1,1.1668461354391002,0.1533044368628041,8.88121656262062
R-HSA-2730905,Role of LAT2/NTAL/LAB on calcium mobilization,1/1194,14/9872,0.07142857142857142,0.5905719071548217,-0.568617426941921,0.8356946761227698,0.9999999999999981,0.963097398669085,GRB2,1,1.1668461354391002,0.1533044368628041,8.88121656262062
R-HSA-418359,Reduction of cytosolic Ca++ levels,1/1194,14/9872,0.07142857142857142,0.5905719071548217,-0.568617426941921,0.8356946761227698,0.9999999999999981,0.963097398669085,SLC8A1,1,1.1668461354391002,0.1533044368628041,8.88121656262062
R-HSA-435354,Zinc transporters,1/1194,14/9872,0.07142857142857142,0.5905719071548217,-0.568617426941921,0.8356946761227698,0.9999999999999981,0.963097398669085,SLC39A14,1,1.1668461354391002,0.1533044368628041,8.88121656262062
R-HSA-5358565,Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha),1/1194,14/9872,0.07142857142857142,0.5905719071548217,-0.568617426941921,0.8356946761227698,0.9999999999999981,0.963097398669085,RPA3,1,1.1668461354391002,0.1533044368628041,8.88121656262062
R-HSA-5358606,Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta),1/1194,14/9872,0.07142857142857142,0.5905719071548217,-0.568617426941921,0.8356946761227698,0.9999999999999981,0.963097398669085,RPA3,1,1.1668461354391002,0.1533044368628041,8.88121656262062
R-HSA-69183,Processive synthesis on the lagging strand,1/1194,14/9872,0.07142857142857142,0.5905719071548217,-0.568617426941921,0.8356946761227698,0.9999999999999981,0.963097398669085,RPA3,1,1.1668461354391002,0.1533044368628041,8.88121656262062
R-HSA-75892,Platelet Adhesion to exposed collagen,1/1194,14/9872,0.07142857142857142,0.5905719071548217,-0.568617426941921,0.8356946761227698,0.9999999999999981,0.963097398669085,ITGA2,1,1.1668461354391002,0.1533044368628041,8.88121656262062
R-HSA-9005891,Loss of function of MECP2 in Rett syndrome,1/1194,14/9872,0.07142857142857142,0.5905719071548217,-0.568617426941921,0.8356946761227698,0.9999999999999981,0.963097398669085,CAMK4,1,1.1668461354391002,0.1533044368628041,8.88121656262062
R-HSA-9005895,Pervasive developmental disorders,1/1194,14/9872,0.07142857142857142,0.5905719071548217,-0.568617426941921,0.8356946761227698,0.9999999999999981,0.963097398669085,CAMK4,1,1.1668461354391002,0.1533044368628041,8.88121656262062
R-HSA-937039,IRAK1 recruits IKK complex,1/1194,14/9872,0.07142857142857142,0.5905719071548217,-0.568617426941921,0.8356946761227698,0.9999999999999981,0.963097398669085,TRAF6,1,1.1668461354391002,0.1533044368628041,8.88121656262062
R-HSA-9675151,Disorders of Developmental Biology,1/1194,14/9872,0.07142857142857142,0.5905719071548217,-0.568617426941921,0.8356946761227698,0.9999999999999981,0.963097398669085,CAMK4,1,1.1668461354391002,0.1533044368628041,8.88121656262062
R-HSA-9697154,Disorders of Nervous System Development,1/1194,14/9872,0.07142857142857142,0.5905719071548217,-0.568617426941921,0.8356946761227698,0.9999999999999981,0.963097398669085,CAMK4,1,1.1668461354391002,0.1533044368628041,8.88121656262062
R-HSA-975144,IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation,1/1194,14/9872,0.07142857142857142,0.5905719071548217,-0.568617426941921,0.8356946761227698,0.9999999999999981,0.963097398669085,TRAF6,1,1.1668461354391002,0.1533044368628041,8.88121656262062
R-HSA-9828806,Maturation of hRSV A proteins,1/1194,14/9872,0.07142857142857142,0.5905719071548217,-0.568617426941921,0.8356946761227698,0.9999999999999981,0.963097398669085,PPP1CB,1,1.1668461354391002,0.1533044368628041,8.88121656262062
R-HSA-73854,RNA Polymerase I Promoter Clearance,4/1194,47/9872,0.0851063829787234,0.7036601446951067,-0.7553454724525717,0.8366566209406157,0.9999999999999981,0.963097398669085,KAT2B/GATAD2A/MBD2/CCNH,4,1.3902847571189278,0.5000670584494764,3.8652650143971106
R-HSA-3214847,HATs acetylate histones,7/1194,77/9872,0.09090909090909091,0.7516369727425004,-0.8115270560242356,0.8384966677632267,0.9999999999999981,0.963097398669085,KAT2B/YEATS2/MORF4L2/NCOA1/USP22/ELP3/WDR5,7,1.4850768996497639,0.6835278488725225,3.226574310777892
R-HSA-114508,Effects of PIP2 hydrolysis,2/1194,26/9872,0.07692307692307693,0.6360005153975004,-0.6893351804775905,0.8400452512215806,0.9999999999999981,0.963097398669085,MGLL/RASGRP1,2,1.2566035304728773,0.2978930265868635,5.3007364787589575
R-HSA-5357769,Caspase activation via extrinsic apoptotic signalling pathway,2/1194,26/9872,0.07692307692307693,0.6360005153975004,-0.6893351804775905,0.8400452512215806,0.9999999999999981,0.963097398669085,CD14/TLR4,2,1.2566035304728773,0.2978930265868635,5.3007364787589575
R-HSA-73933,Resolution of Abasic Sites (AP sites),3/1194,37/9872,0.08108108108108109,0.6703789216352031,-0.7450777119312482,0.841891779386289,0.9999999999999981,0.963097398669085,RPA3/POLE/POLB,3,1.3245280456335733,0.4077984148824049,4.302063175443668
R-HSA-9675126,Diseases of mitotic cell cycle,3/1194,37/9872,0.08108108108108109,0.6703789216352031,-0.7450777119312482,0.841891779386289,0.9999999999999981,0.963097398669085,CDKN1A/CDK2/UBE2D1,3,1.3245280456335733,0.4077984148824049,4.302063175443668
R-HSA-9678108,SARS-CoV-1 Infection,13/1194,135/9872,0.0962962962962963,0.796178422979093,-0.8844583231901115,0.8461944459451199,0.9999999999999981,0.963097398669085,PARP9/BCL2L1/RUNX1/ST3GAL4/IRAK2/YWHAG/NFKBIA/RELA/CASP1/TRAF6/SFTPD/RCAN3/IKBKE,13,1.5730814566660463,0.8876893164472706,2.7876704421885
R-HSA-68949,Orc1 removal from chromatin,5/1194,58/9872,0.08620689655172414,0.7127591982903021,-0.8137856298060516,0.8464247853041361,0.9999999999999981,0.963097398669085,CUL1/ORC4/CDK2/CCNA2/MCM7,5,1.4082625772540864,0.5638034057803588,3.5175443535133932
R-HSA-9843940,Regulation of endogenous retroelements by KRAB-ZFP proteins,4/1194,48/9872,0.08333333333333333,0.689000558347292,-0.801141017285268,0.8485978268830232,0.9999999999999981,0.963097398669085,ZNF708/GATAD2A/ZNF93/ZNF141,4,1.3613204913456172,0.49005704459479005,3.7815872674370175
R-HSA-9932298,Degradation of CRY and PER proteins,4/1194,48/9872,0.08333333333333333,0.689000558347292,-0.801141017285268,0.8485978268830232,0.9999999999999981,0.963097398669085,CRY1/PER1/CUL1/UBE2D1,4,1.3613204913456172,0.49005704459479005,3.7815872674370175
R-HSA-8853884,Transcriptional Regulation by VENTX,3/1194,38/9872,0.07894736842105263,0.6527373710658556,-0.7955320143480161,0.8548288722724293,0.9999999999999981,0.963097398669085,TNRC6C/UBE2D1/RELA,3,1.28967204443269,0.3975278415205168,4.183993694201043
R-HSA-1538133,G0 and Early G1,2/1194,27/9872,0.07407407407407407,0.6124449407531485,-0.7479634031820894,0.8552017098282529,0.9999999999999981,0.963097398669085,CDK2/CCNA2,2,1.2100626589738819,0.28740611614554185,5.094712869302501
R-HSA-1614635,Sulfur amino acid metabolism,2/1194,27/9872,0.07407407407407407,0.6124449407531485,-0.7479634031820894,0.8552017098282529,0.9999999999999981,0.963097398669085,SQOR/BHMT,2,1.2100626589738819,0.28740611614554185,5.094712869302501
R-HSA-420092,Glucagon-type ligand receptors,2/1194,27/9872,0.07407407407407407,0.6124449407531485,-0.7479634031820894,0.8552017098282529,0.9999999999999981,0.963097398669085,GNB3/GNG3,2,1.2100626589738819,0.28740611614554185,5.094712869302501
R-HSA-77387,Insulin receptor recycling,2/1194,27/9872,0.07407407407407407,0.6124449407531485,-0.7479634031820894,0.8552017098282529,0.9999999999999981,0.963097398669085,PTPRF/PTPN1,2,1.2100626589738819,0.28740611614554185,5.094712869302501
R-HSA-111447,Activation of BAD and translocation to mitochondria,1/1194,15/9872,0.06666666666666667,0.5512004466778336,-0.6452062768006168,0.8555953209502614,0.9999999999999981,0.963097398669085,YWHAG,1,1.0890563930764936,0.143731134116024,8.25182264507405
R-HSA-1614558,Degradation of cysteine and homocysteine,1/1194,15/9872,0.06666666666666667,0.5512004466778336,-0.6452062768006168,0.8555953209502614,0.9999999999999981,0.963097398669085,SQOR,1,1.0890563930764936,0.143731134116024,8.25182264507405
R-HSA-181431,Acetylcholine binding and downstream events,1/1194,15/9872,0.06666666666666667,0.5512004466778336,-0.6452062768006168,0.8555953209502614,0.9999999999999981,0.963097398669085,CHRNB2,1,1.0890563930764936,0.143731134116024,8.25182264507405
R-HSA-2022377,Metabolism of Angiotensinogen to Angiotensins,1/1194,15/9872,0.06666666666666667,0.5512004466778336,-0.6452062768006168,0.8555953209502614,0.9999999999999981,0.963097398669085,CPB2,1,1.0890563930764936,0.143731134116024,8.25182264507405
R-HSA-203615,eNOS activation,1/1194,15/9872,0.06666666666666667,0.5512004466778336,-0.6452062768006168,0.8555953209502614,0.9999999999999981,0.963097398669085,DDAH1,1,1.0890563930764936,0.143731134116024,8.25182264507405
R-HSA-209776,Metabolism of amine-derived hormones,1/1194,15/9872,0.06666666666666667,0.5512004466778336,-0.6452062768006168,0.8555953209502614,0.9999999999999981,0.963097398669085,DUOX2,1,1.0890563930764936,0.143731134116024,8.25182264507405
R-HSA-2691230,Signaling by NOTCH1 HD Domain Mutants in Cancer,1/1194,15/9872,0.06666666666666667,0.5512004466778336,-0.6452062768006168,0.8555953209502614,0.9999999999999981,0.963097398669085,NEURL1B,1,1.0890563930764936,0.143731134116024,8.25182264507405
R-HSA-2691232,Constitutive Signaling by NOTCH1 HD Domain Mutants,1/1194,15/9872,0.06666666666666667,0.5512004466778336,-0.6452062768006168,0.8555953209502614,0.9999999999999981,0.963097398669085,NEURL1B,1,1.0890563930764936,0.143731134116024,8.25182264507405
R-HSA-5083625,Defective GALNT3 causes HFTC,1/1194,15/9872,0.06666666666666667,0.5512004466778336,-0.6452062768006168,0.8555953209502614,0.9999999999999981,0.963097398669085,MUC15,1,1.0890563930764936,0.143731134116024,8.25182264507405
R-HSA-5083636,Defective GALNT12 causes CRCS1,1/1194,15/9872,0.06666666666666667,0.5512004466778336,-0.6452062768006168,0.8555953209502614,0.9999999999999981,0.963097398669085,MUC15,1,1.0890563930764936,0.143731134116024,8.25182264507405
R-HSA-5099900,WNT5A-dependent internalization of FZD4,1/1194,15/9872,0.06666666666666667,0.5512004466778336,-0.6452062768006168,0.8555953209502614,0.9999999999999981,0.963097398669085,PRKCG,1,1.0890563930764936,0.143731134116024,8.25182264507405
R-HSA-5358508,Mismatch Repair,1/1194,15/9872,0.06666666666666667,0.5512004466778336,-0.6452062768006168,0.8555953209502614,0.9999999999999981,0.963097398669085,RPA3,1,1.0890563930764936,0.143731134116024,8.25182264507405
R-HSA-5576893,Phase 2 - plateau phase,1/1194,15/9872,0.06666666666666667,0.5512004466778336,-0.6452062768006168,0.8555953209502614,0.9999999999999981,0.963097398669085,CACNG4,1,1.0890563930764936,0.143731134116024,8.25182264507405
R-HSA-622327,Postsynaptic nicotinic acetylcholine receptors,1/1194,15/9872,0.06666666666666667,0.5512004466778336,-0.6452062768006168,0.8555953209502614,0.9999999999999981,0.963097398669085,CHRNB2,1,1.0890563930764936,0.143731134116024,8.25182264507405
R-HSA-6785631,ERBB2 Regulates Cell Motility,1/1194,15/9872,0.06666666666666667,0.5512004466778336,-0.6452062768006168,0.8555953209502614,0.9999999999999981,0.963097398669085,NRG1,1,1.0890563930764936,0.143731134116024,8.25182264507405
R-HSA-8875360,InlB-mediated entry of Listeria monocytogenes into host cell,1/1194,15/9872,0.06666666666666667,0.5512004466778336,-0.6452062768006168,0.8555953209502614,0.9999999999999981,0.963097398669085,GRB2,1,1.0890563930764936,0.143731134116024,8.25182264507405
R-HSA-9018677,Biosynthesis of DHA-derived SPMs,1/1194,15/9872,0.06666666666666667,0.5512004466778336,-0.6452062768006168,0.8555953209502614,0.9999999999999981,0.963097398669085,LTC4S,1,1.0890563930764936,0.143731134116024,8.25182264507405
R-HSA-9694631,Maturation of nucleoprotein,1/1194,15/9872,0.06666666666666667,0.5512004466778336,-0.6452062768006168,0.8555953209502614,0.9999999999999981,0.963097398669085,PARP9,1,1.0890563930764936,0.143731134116024,8.25182264507405
R-HSA-9706369,Negative regulation of FLT3,1/1194,15/9872,0.06666666666666667,0.5512004466778336,-0.6452062768006168,0.8555953209502614,0.9999999999999981,0.963097398669085,PTPRJ,1,1.0890563930764936,0.143731134116024,8.25182264507405
R-HSA-9735871,SARS-CoV-1 targets host intracellular signalling and regulatory pathways,1/1194,15/9872,0.06666666666666667,0.5512004466778336,-0.6452062768006168,0.8555953209502614,0.9999999999999981,0.963097398669085,YWHAG,1,1.0890563930764936,0.143731134116024,8.25182264507405
R-HSA-9933947,Formation of the non-canonical BAF (ncBAF) complex,1/1194,15/9872,0.06666666666666667,0.5512004466778336,-0.6452062768006168,0.8555953209502614,0.9999999999999981,0.963097398669085,SS18L1,1,1.0890563930764936,0.143731134116024,8.25182264507405
R-HSA-8856688,Golgi-to-ER retrograde transport,12/1194,127/9872,0.09448818897637795,0.7812289795433862,-0.9203937221941915,0.8562575582076372,0.9999999999999981,0.963097398669085,KIF19/TMED10/COPA/ARFGAP3/KIF26B/RAB1A/PAFAH1B1/DYNC1I1/KIF21B/TUBB2A/TUBB4A/NSF,12,1.5435444941241643,0.8515248599515378,2.797956603964114
R-HSA-2132295,MHC class II antigen presentation,11/1194,118/9872,0.09322033898305085,0.7707463873037504,-0.9292631868026681,0.8597387073767243,0.9999999999999981,0.963097398669085,HLA-DMB/OSBPL1A/DNM3/SEC31A/SEC24D/DYNC1I1/SEC23A/TUBB2A/TUBB4A/SEC24A/DNM1,11,1.522833092013741,0.8186671206907601,2.8326783469396317
R-HSA-6811436,COPI-independent Golgi-to-ER retrograde traffic,4/1194,49/9872,0.08163265306122448,0.6749393224626533,-0.846083685074851,0.8597922212485768,0.9999999999999981,0.963097398669085,PAFAH1B1/DYNC1I1/TUBB2A/TUBB4A,4,1.333538440501829,0.4804399073594935,3.701450993256899
R-HSA-163841,"Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation",5/1194,60/9872,0.08333333333333333,0.689000558347292,-0.8962504385915252,0.8666481672954452,0.9999999999999981,0.963097398669085,PROS1/TPST1/STS/ARSG/TPST2,5,1.3613204913456167,0.5456680284828825,3.3961921597457225
R-HSA-6811442,Intra-Golgi and retrograde Golgi-to-ER traffic,19/1194,194/9872,0.0979381443298969,0.8097532335215596,-0.9926548219522576,0.8668514608937815,0.9999999999999981,0.963097398669085,KIF19/TMED10/PLIN3/COPA/GOSR2/STX6/RHOBTB3/ARFGAP3/VPS53/KIF26B/IGF2R/RAB1A/PAFAH1B1/DYNC1I1/KIF21B/TUBB2A/TMF1/TUBB4A/NSF,19,1.5999024331278386,0.9951849542017291,2.5720724421337224
R-HSA-8878171,Transcriptional regulation by RUNX1,15/1194,157/9872,0.09554140127388536,0.7899369458758763,-0.9841267021961145,0.8679430686730075,0.9999999999999981,0.963097398669085,PHC2/ELF2/CBFB/KAT2B/TNRC6C/AGO2/RUNX1/ACTL6B/PTPN11/SOCS4/CCNH/SOCS3/WDR5/LMO2/CTLA4,15,1.5607496079121725,0.915998328068779,2.659327275993777
R-HSA-164952,The role of Nef in HIV-1 replication and disease pathogenesis,2/1194,28/9872,0.07142857142857142,0.5905719071548217,-0.8047180967899851,0.869035434798896,0.9999999999999981,0.963097398669085,ELMO1/PAK2,2,1.1668461354391002,0.2776321765170776,4.904078197526262
R-HSA-1839126,FGFR2 mutant receptor activation,2/1194,28/9872,0.07142857142857142,0.5905719071548217,-0.8047180967899851,0.869035434798896,0.9999999999999981,0.963097398669085,FGF20/FGFR2,2,1.1668461354391002,0.2776321765170776,4.904078197526262
R-HSA-196071,Metabolism of steroid hormones,2/1194,28/9872,0.07142857142857142,0.5905719071548217,-0.8047180967899851,0.869035434798896,0.9999999999999981,0.963097398669085,HSD17B1/STS,2,1.1668461354391002,0.2776321765170776,4.904078197526262
R-HSA-350054,Notch-HLH transcription pathway,2/1194,28/9872,0.07142857142857142,0.5905719071548217,-0.8047180967899851,0.869035434798896,0.9999999999999981,0.963097398669085,KAT2B/HDAC4,2,1.1668461354391002,0.2776321765170776,4.904078197526262
R-HSA-73863,RNA Polymerase I Transcription Termination,2/1194,28/9872,0.07142857142857142,0.5905719071548217,-0.8047180967899851,0.869035434798896,0.9999999999999981,0.963097398669085,CAVIN1/CCNH,2,1.1668461354391002,0.2776321765170776,4.904078197526262
R-HSA-1227986,Signaling by ERBB2,4/1194,50/9872,0.08,0.6614405360134004,-0.890210909336129,0.8702721045777055,0.9999999999999981,0.963097398669085,ERBIN/GAB1/NRG1/GRB2,4,1.3068676716917924,0.47119296286165063,3.6246362868848547
R-HSA-187577,SCF(Skp2)-mediated degradation of p27/p21,4/1194,50/9872,0.08,0.6614405360134004,-0.890210909336129,0.8702721045777055,0.9999999999999981,0.963097398669085,CDKN1A/CUL1/CDK2/CCNA2,4,1.3068676716917924,0.47119296286165063,3.6246362868848547
R-HSA-110312,Translesion synthesis by REV1,1/1194,16/9872,0.0625,0.516750418760469,-0.7175531028077582,0.8730873760162436,0.9999999999999981,0.963097398669085,RPA3,1,1.0209903685092128,0.13528204172649036,7.7055410998018345
R-HSA-1362300,Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1,1/1194,16/9872,0.0625,0.516750418760469,-0.7175531028077582,0.8730873760162436,0.9999999999999981,0.963097398669085,CCNA2,1,1.0209903685092128,0.13528204172649036,7.7055410998018345
R-HSA-174437,Removal of the Flap Intermediate from the C-strand,1/1194,16/9872,0.0625,0.516750418760469,-0.7175531028077582,0.8730873760162436,0.9999999999999981,0.963097398669085,RPA3,1,1.0209903685092128,0.13528204172649036,7.7055410998018345
R-HSA-205043,NRIF signals cell death from the nucleus,1/1194,16/9872,0.0625,0.516750418760469,-0.7175531028077582,0.8730873760162436,0.9999999999999981,0.963097398669085,TRAF6,1,1.0209903685092128,0.13528204172649036,7.7055410998018345
R-HSA-422085,"Synthesis, secretion, and deacylation of Ghrelin",1/1194,16/9872,0.0625,0.516750418760469,-0.7175531028077582,0.8730873760162436,0.9999999999999981,0.963097398669085,IGF1,1,1.0209903685092128,0.13528204172649036,7.7055410998018345
R-HSA-427389,ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression,1/1194,16/9872,0.0625,0.516750418760469,-0.7175531028077582,0.8730873760162436,0.9999999999999981,0.963097398669085,GATAD2A,1,1.0209903685092128,0.13528204172649036,7.7055410998018345
R-HSA-4655427,SUMOylation of DNA methylation proteins,1/1194,16/9872,0.0625,0.516750418760469,-0.7175531028077582,0.8730873760162436,0.9999999999999981,0.963097398669085,PHC2,1,1.0209903685092128,0.13528204172649036,7.7055410998018345
R-HSA-5083632,Defective C1GALT1C1 causes TNPS,1/1194,16/9872,0.0625,0.516750418760469,-0.7175531028077582,0.8730873760162436,0.9999999999999981,0.963097398669085,MUC15,1,1.0209903685092128,0.13528204172649036,7.7055410998018345
R-HSA-5609975,Diseases associated with glycosylation precursor biosynthesis,1/1194,16/9872,0.0625,0.516750418760469,-0.7175531028077582,0.8730873760162436,0.9999999999999981,0.963097398669085,PMM2,1,1.0209903685092128,0.13528204172649036,7.7055410998018345
R-HSA-9614657,FOXO-mediated transcription of cell death genes,1/1194,16/9872,0.0625,0.516750418760469,-0.7175531028077582,0.8730873760162436,0.9999999999999981,0.963097398669085,BCL6,1,1.0209903685092128,0.13528204172649036,7.7055410998018345
R-HSA-69206,G1/S Transition,11/1194,120/9872,0.09166666666666666,0.7579006141820211,-0.9897155205582557,0.8736303314977055,0.9999999999999981,0.963097398669085,CDKN1A/CUL1/ORC4/RPA3/CCNH/CDK2/CCNA2/POLE/CABLES1/MCM7/CDC7,11,1.4974525404801786,0.8053747622320813,2.784249291318578
R-HSA-1236978,Cross-presentation of soluble exogenous antigens (endosomes),3/1194,40/9872,0.075,0.6201005025125628,-0.8929984318993915,0.8779492535977407,0.9999999999999981,0.963097398669085,MRC2/PSMB9/FCGR1A,3,1.2251884422110553,0.37846407746195215,3.966259437339756
R-HSA-5696400,Dual Incision in GG-NER,3/1194,40/9872,0.075,0.6201005025125628,-0.8929984318993915,0.8779492535977407,0.9999999999999981,0.963097398669085,CUL4A/RPA3/POLE,3,1.2251884422110553,0.37846407746195215,3.966259437339756
R-HSA-2173795,Downregulation of SMAD2/3:SMAD4 transcriptional activity,2/1194,29/9872,0.06896551724137931,0.5702073586322416,-0.8597400302873138,0.8816443670173864,0.9999999999999981,0.963097398669085,UBE2D1/STAT1,2,1.1266100618032693,0.2685009162977206,4.727172811391784
R-HSA-2424491,DAP12 signaling,2/1194,29/9872,0.06896551724137931,0.5702073586322416,-0.8597400302873138,0.8816443670173864,0.9999999999999981,0.963097398669085,GRB2/KLRD1,2,1.1266100618032693,0.2685009162977206,4.727172811391784
R-HSA-3214858,RMTs methylate histone arginines,2/1194,29/9872,0.06896551724137931,0.5702073586322416,-0.8597400302873138,0.8816443670173864,0.9999999999999981,0.963097398669085,ACTL6B/WDR5,2,1.1266100618032693,0.2685009162977206,4.727172811391784
R-HSA-8863795,Downregulation of ERBB2 signaling,2/1194,29/9872,0.06896551724137931,0.5702073586322416,-0.8597400302873138,0.8816443670173864,0.9999999999999981,0.963097398669085,ERBIN/NRG1,2,1.1266100618032693,0.2685009162977206,4.727172811391784
R-HSA-917977,Transferrin endocytosis and recycling,2/1194,29/9872,0.06896551724137931,0.5702073586322416,-0.8597400302873138,0.8816443670173864,0.9999999999999981,0.963097398669085,TFRC/TFR2,2,1.1266100618032693,0.2685009162977206,4.727172811391784
R-HSA-9668328,Sealing of the nuclear envelope (NE) by ESCRT-III,2/1194,29/9872,0.06896551724137931,0.5702073586322416,-0.8597400302873138,0.8816443670173864,0.9999999999999981,0.963097398669085,TUBB2A/TUBB4A,2,1.1266100618032693,0.2685009162977206,4.727172811391784
R-HSA-9683701,Translation of Structural Proteins,2/1194,29/9872,0.06896551724137931,0.5702073586322416,-0.8597400302873138,0.8816443670173864,0.9999999999999981,0.963097398669085,PARP9/ST3GAL4,2,1.1266100618032693,0.2685009162977206,4.727172811391784
R-HSA-9932444,ATP-dependent chromatin remodelers,2/1194,29/9872,0.06896551724137931,0.5702073586322416,-0.8597400302873138,0.8816443670173864,0.9999999999999981,0.963097398669085,SS18L1/ACTL6B,2,1.1266100618032693,0.2685009162977206,4.727172811391784
R-HSA-9932451,SWI/SNF chromatin remodelers,2/1194,29/9872,0.06896551724137931,0.5702073586322416,-0.8597400302873138,0.8816443670173864,0.9999999999999981,0.963097398669085,SS18L1/ACTL6B,2,1.1266100618032693,0.2685009162977206,4.727172811391784
R-HSA-388841,Regulation of T cell activation by CD28 family,6/1194,72/9872,0.08333333333333333,0.689000558347292,-0.982394078739967,0.8823275721919511,0.9999999999999981,0.963097398669085,PAK2/PTPN11/GRB2/PAK3/PRR5/CTLA4,6,1.361320491345617,0.5907088643993089,3.137236618316169
R-HSA-5693607,Processing of DNA double-strand break ends,5/1194,62/9872,0.08064516129032258,0.6667747338844762,-0.9762750286284436,0.8845792530270618,0.9999999999999981,0.963097398669085,RPA3/PPP4R2/BARD1/CDK2/CCNA2,5,1.3174069271086615,0.5286630483717171,3.282924760751515
R-HSA-74158,RNA Polymerase III Transcription,3/1194,41/9872,0.07317073170731707,0.6049761000122563,-0.9401331555228871,0.888235140315263,0.9999999999999981,0.963097398669085,BRF1/SNAPC3/NFIC,3,1.1953057972790784,0.36960171662400854,3.865663725968106
R-HSA-749476,RNA Polymerase III Abortive And Retractive Initiation,3/1194,41/9872,0.07317073170731707,0.6049761000122563,-0.9401331555228871,0.888235140315263,0.9999999999999981,0.963097398669085,BRF1/SNAPC3/NFIC,3,1.1953057972790784,0.36960171662400854,3.865663725968106
R-HSA-2142845,Hyaluronan metabolism,1/1194,17/9872,0.058823529411764705,0.48635333530397085,-0.786200897490607,0.88846213992012,0.9999999999999981,0.963097398669085,HAS2,1,0.9609321115380826,0.1277702980998629,7.22695756930404
R-HSA-379726,Mitochondrial tRNA aminoacylation,1/1194,17/9872,0.058823529411764705,0.48635333530397085,-0.786200897490607,0.88846213992012,0.9999999999999981,0.963097398669085,PPA2,1,0.9609321115380826,0.1277702980998629,7.22695756930404
R-HSA-389661,Glyoxylate metabolism and glycine degradation,1/1194,17/9872,0.058823529411764705,0.48635333530397085,-0.786200897490607,0.88846213992012,0.9999999999999981,0.963097398669085,GLDC,1,0.9609321115380826,0.1277702980998629,7.22695756930404
R-HSA-450513,"Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA",1/1194,17/9872,0.058823529411764705,0.48635333530397085,-0.786200897490607,0.88846213992012,0.9999999999999981,0.963097398669085,ZFP36,1,0.9609321115380826,0.1277702980998629,7.22695756930404
R-HSA-5655862,Translesion synthesis by POLK,1/1194,17/9872,0.058823529411764705,0.48635333530397085,-0.786200897490607,0.88846213992012,0.9999999999999981,0.963097398669085,RPA3,1,0.9609321115380826,0.1277702980998629,7.22695756930404
R-HSA-5656121,Translesion synthesis by POLI,1/1194,17/9872,0.058823529411764705,0.48635333530397085,-0.786200897490607,0.88846213992012,0.9999999999999981,0.963097398669085,RPA3,1,0.9609321115380826,0.1277702980998629,7.22695756930404
R-HSA-5676594,TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway,1/1194,17/9872,0.058823529411764705,0.48635333530397085,-0.786200897490607,0.88846213992012,0.9999999999999981,0.963097398669085,TNFRSF13C,1,0.9609321115380826,0.1277702980998629,7.22695756930404
R-HSA-9820965,"Respiratory syncytial virus (RSV) genome replication, transcription and translation",1/1194,17/9872,0.058823529411764705,0.48635333530397085,-0.786200897490607,0.88846213992012,0.9999999999999981,0.963097398669085,PPP1CB,1,0.9609321115380826,0.1277702980998629,7.22695756930404
R-HSA-15869,Metabolism of nucleotides,8/1194,93/9872,0.08602150537634409,0.711226382810108,-1.0378263201020512,0.8889306174275927,0.9999999999999981,0.963097398669085,NT5E/HPRT1/DPYD/ENTPD1/UCK2/SAMHD1/AK7/NT5C1B,8,1.4052340555825722,0.6809195832934342,2.900023438036555
R-HSA-69202,Cyclin E associated events during G1/S transition,6/1194,73/9872,0.0821917808219178,0.6795621945343153,-1.0192652464463257,0.8900887934159794,0.9999999999999981,0.963097398669085,CDKN1A/CUL1/CCNH/CDK2/CCNA2/CABLES1,6,1.3426722654367729,0.5828721095171642,3.0929062875670645
R-HSA-114452,Activation of BH3-only proteins,2/1194,30/9872,0.06666666666666667,0.5512004466778336,-0.9131545332738054,0.8931221260703848,0.9999999999999981,0.963097398669085,PMAIP1/YWHAG,2,1.0890563930764936,0.2599509866347433,4.562567131038785
R-HSA-6804758,Regulation of TP53 Activity through Acetylation,2/1194,30/9872,0.06666666666666667,0.5512004466778336,-0.9131545332738054,0.8931221260703848,0.9999999999999981,0.963097398669085,PIP4K2A/GATAD2A,2,1.0890563930764936,0.2599509866347433,4.562567131038785
R-HSA-8949613,Cristae formation,2/1194,30/9872,0.06666666666666667,0.5512004466778336,-0.9131545332738054,0.8931221260703848,0.9999999999999981,0.963097398669085,MICOS10/HSPA9,2,1.0890563930764936,0.2599509866347433,4.562567131038785
R-HSA-5663205,Infectious disease,99/1194,911/9872,0.10867178924259056,0.8984990815769296,-1.1926797297030634,0.8948381311938068,0.9999999999999981,0.963097398669085,ZDHHC11/DOCK1/ELMO1/WIPF3/ATP1A2/IFNAR2/MGAT4C/PGK1/PAK2/CX3CR1/IL1B/VEGFA/NT5E/TLR2/PARP9/GNB3/HMOX1/HSPA1A/GNAI1/HSPA1B/GATAD2A/WIPF1/MAP2K4/PRKAR2A/ANO3/MED28/NFE2L2/FGR/BCL2L1/NUP205/GJA1/CTDP1/NOD2/G3BP1/GPC5/RUNX1/CYSLTR1/SV2B/ENO1/ST3GAL4/PTGES3/JAK3/IRAK2/YWHAG/SEC24D/KPNA3/CEBPD/NUP58/JUN/MAP2K3/ZDHHC2/PTPN11/ENTPD1/MYO9B/MED15/GUCY2C/DPEP2/ATP1B3/PTK2/NUP98/NUP188/NUP153/NFKBIA/MYO10/PPP1CB/CCNH/ADCY3/DYNC1I1/CD14/FCGR2A/ITGA4/GEMIN8/ACTR3/SEC23A/EDEM2/GRB2/GNG3/MED29/GPC2/GNAZ/RELA/TUBB2A/CASP1/TUSC3/TLR4/FNTB/IL1A/RNF135/TUBB4A/TRAF6/SFTPD/ATP1A3/RCAN3/FCGR3A/SEC24A/FXYD1/STAT1/IKBKE/FCGR1A,99,1.7752456023255685,1.4311097893629972,2.2021349948133864
R-HSA-5620912,Anchoring of the basal body to the plasma membrane,8/1194,94/9872,0.0851063829787234,0.7036601446951067,-1.070784044590747,0.895563955805063,0.9999999999999981,0.963097398669085,RAB3IP/TTBK2/YWHAG/CEP70/PAFAH1B1/TUBB4A/HAUS2/AHI1,8,1.3902847571189278,0.6738801347925395,2.8683019517592636
R-HSA-2565942,Regulation of PLK1 Activity at G2/M Transition,7/1194,84/9872,0.08333333333333333,0.689000558347292,-1.0617571358352627,0.8959565729412617,0.9999999999999981,0.963097398669085,CUL1/YWHAG/PPP1CB/CEP70/PAFAH1B1/TUBB4A/HAUS2,7,1.361320491345617,0.628250939117429,2.94976635094386
R-HSA-2173782,Binding and Uptake of Ligands by Scavenger Receptors,3/1194,42/9872,0.07142857142857142,0.5905719071548217,-0.9862759454656511,0.897738497072186,0.9999999999999981,0.963097398669085,HSPH1/AMBP/COL4A2,3,1.1668461354391002,0.36114486307216787,3.7700381287635474
R-HSA-5696395,Formation of Incision Complex in GG-NER,3/1194,42/9872,0.07142857142857142,0.5905719071548217,-0.9862759454656511,0.897738497072186,0.9999999999999981,0.963097398669085,CUL4A/RPA3/CCNH,3,1.1668461354391002,0.36114486307216787,3.7700381287635474
R-HSA-6782315,tRNA modification in the nucleus and cytosol,3/1194,42/9872,0.07142857142857142,0.5905719071548217,-0.9862759454656511,0.897738497072186,0.9999999999999981,0.963097398669085,NSUN2/TRIT1/OSGEP,3,1.1668461354391002,0.36114486307216787,3.7700381287635474
R-HSA-6811438,Intra-Golgi traffic,3/1194,42/9872,0.07142857142857142,0.5905719071548217,-0.9862759454656511,0.897738497072186,0.9999999999999981,0.963097398669085,GOSR2/STX6/NSF,3,1.1668461354391002,0.36114486307216787,3.7700381287635474
R-HSA-3247509,Chromatin modifying enzymes,19/1194,201/9872,0.0945273631840796,0.7815528721551372,-1.1605973977615267,0.9013952482682079,0.9999999999999981,0.963097398669085,KDM3A/SETD7/DOT1L/KDM4C/KAT2B/GATAD2A/YEATS2/KDM7A/KDM4B/MORF4L2/ACTL6B/NCOA1/USP22/ELP3/AEBP2/WDR5/RELA/KDM6A/PADI1,19,1.5441844379442822,0.9612251643064051,2.480694083898537
R-HSA-1369062,ABC transporters in lipid homeostasis,1/1194,18/9872,0.05555555555555555,0.45933370556486136,-0.8515932024896751,0.9019757071383218,0.9999999999999981,0.963097398669085,ABCA9,1,0.9075469942304113,0.12104824320850299,6.804242051806974
R-HSA-1660514,Synthesis of PIPs at the Golgi membrane,1/1194,18/9872,0.05555555555555555,0.45933370556486136,-0.8515932024896751,0.9019757071383218,0.9999999999999981,0.963097398669085,TPTE2,1,0.9075469942304113,0.12104824320850299,6.804242051806974
R-HSA-174414,Processive synthesis on the C-strand of the telomere,1/1194,18/9872,0.05555555555555555,0.45933370556486136,-0.8515932024896751,0.9019757071383218,0.9999999999999981,0.963097398669085,RPA3,1,0.9075469942304113,0.12104824320850299,6.804242051806974
R-HSA-1912420,Pre-NOTCH Processing in Golgi,1/1194,18/9872,0.05555555555555555,0.45933370556486136,-0.8515932024896751,0.9019757071383218,0.9999999999999981,0.963097398669085,ST3GAL4,1,0.9075469942304113,0.12104824320850299,6.804242051806974
R-HSA-9933937,Formation of the canonical BAF (cBAF) complex,1/1194,18/9872,0.05555555555555555,0.45933370556486136,-0.8515932024896751,0.9019757071383218,0.9999999999999981,0.963097398669085,SS18L1,1,0.9075469942304113,0.12104824320850299,6.804242051806974
R-HSA-73887,Death Receptor Signaling,14/1194,154/9872,0.09090909090909091,0.7516369727425004,-1.1522103558402286,0.9033134309023492,0.9999999999999981,0.963097398669085,ARHGEF10/ARHGEF7/TNFRSF10D/ARHGEF3/PREX1/NFKBIA/ABR/SMPD3/NGEF/UBE2D1/RELA/CASP2/TRAF6/IKBKE,14,1.4850768996497639,0.8566125158369734,2.5746219639558556
R-HSA-2122948,Activated NOTCH1 Transmits Signal to the Nucleus,2/1194,31/9872,0.06451612903225806,0.5334197871075809,-0.9650736642967231,0.9035576223399022,0.9999999999999981,0.963097398669085,NEURL1B/ARRB1,2,1.0539255416869293,0.25192860349136803,4.409023159841975
R-HSA-983695,Antigen activates B Cell Receptor (BCR) leading to generation of second messengers,2/1194,31/9872,0.06451612903225806,0.5334197871075809,-0.9650736642967231,0.9035576223399022,0.9999999999999981,0.963097398669085,CD22/GRB2,2,1.0539255416869293,0.25192860349136803,4.409023159841975
R-HSA-69656,Cyclin A:Cdk2-associated events at S phase entry,6/1194,75/9872,0.08,0.6614405360134004,-1.0916714500481581,0.9043107992103755,0.9999999999999981,0.963097398669085,CDKN1A/CUL1/CCNH/CDK2/CCNA2/CABLES1,6,1.3068676716917924,0.5678063436102583,3.0078972003973057
R-HSA-5358351,Signaling by Hedgehog,12/1194,135/9872,0.08888888888888889,0.7349339289037782,-1.150221169922101,0.9048621413176684,0.9999999999999981,0.963097398669085,PRKAR2A/CUL1/GPC5/IFT172/ADCY3/GLI3/DHH/CDON/TUBB2A/ARRB1/TUBB4A/HHAT,12,1.4520751907686582,0.8022736221323242,2.6281835791156833
R-HSA-8854214,TBC/RABGAPs,3/1194,43/9872,0.06976744186046512,0.5768376767558724,-1.0314768125407971,0.906508026469359,0.9999999999999981,0.963097398669085,TBC1D14/RAB8B/RAB7B,3,1.1397101788009816,0.35306631111649955,3.6790236019826907
R-HSA-69239,Synthesis of DNA,9/1194,106/9872,0.08490566037735849,0.7020005688821466,-1.1441498924829228,0.9076376215097219,0.9999999999999981,0.963097398669085,CUL1/ORC4/RPA3/GINS3/CDK2/UBE2D1/CCNA2/POLE/MCM7,9,1.3870057836351568,0.7005700051304945,2.74602827661603
R-HSA-109581,Apoptosis,14/1194,156/9872,0.08974358974358974,0.7420006012970837,-1.2047866771955402,0.9126402516117128,0.9999999999999981,0.963097398669085,STAT3/PAK2/LMNA/ADD1/TJP2/BCL2L1/PMAIP1/YWHAG/PTK2/CASP7/CD14/LMNB1/TLR4/GSDME,14,1.4660374522183568,0.8458761574252284,2.54087527168169
R-HSA-2151201,Transcriptional activation of mitochondrial biogenesis,4/1194,55/9872,0.07272727272727272,0.6013095781940002,-1.0997669594683117,0.9130960768702847,0.9999999999999981,0.963097398669085,HELZ2/NCOA1/ALAS1/CAMK4,4,1.1880615197198112,0.4298287022210433,3.2838434644903627
R-HSA-5658442,Regulation of RAS by GAPs,4/1194,55/9872,0.07272727272727272,0.6013095781940002,-1.0997669594683117,0.9130960768702847,0.9999999999999981,0.963097398669085,RASA3/SPRED3/SPRED1/RASAL1,4,1.1880615197198112,0.4298287022210433,3.2838434644903627
R-HSA-110320,Translesion Synthesis by POLH,1/1194,19/9872,0.05263157894736842,0.4351582473772371,-0.9140969659521001,0.9138532193848047,0.9999999999999981,0.963097398669085,RPA3,1,0.8597813629551265,0.11499765965934519,6.428165532018309
R-HSA-166663,Initial triggering of complement,1/1194,19/9872,0.05263157894736842,0.4351582473772371,-0.9140969659521001,0.9138532193848047,0.9999999999999981,0.963097398669085,CFB,1,0.8597813629551265,0.11499765965934519,6.428165532018309
R-HSA-176412,Phosphorylation of the APC/C,1/1194,19/9872,0.05263157894736842,0.4351582473772371,-0.9140969659521001,0.9138532193848047,0.9999999999999981,0.963097398669085,UBE2D1,1,0.8597813629551265,0.11499765965934519,6.428165532018309
R-HSA-202131,Metabolism of nitric oxide: NOS3 activation and regulation,1/1194,19/9872,0.05263157894736842,0.4351582473772371,-0.9140969659521001,0.9138532193848047,0.9999999999999981,0.963097398669085,DDAH1,1,0.8597813629551265,0.11499765965934519,6.428165532018309
R-HSA-3000480,Scavenging by Class A Receptors,1/1194,19/9872,0.05263157894736842,0.4351582473772371,-0.9140969659521001,0.9138532193848047,0.9999999999999981,0.963097398669085,COL4A2,1,0.8597813629551265,0.11499765965934519,6.428165532018309
R-HSA-452723,Transcriptional regulation of pluripotent stem cells,1/1194,19/9872,0.05263157894736842,0.4351582473772371,-0.9140969659521001,0.9138532193848047,0.9999999999999981,0.963097398669085,STAT3,1,0.8597813629551265,0.11499765965934519,6.428165532018309
R-HSA-5620916,VxPx cargo-targeting to cilium,1/1194,19/9872,0.05263157894736842,0.4351582473772371,-0.9140969659521001,0.9138532193848047,0.9999999999999981,0.963097398669085,RAB3IP,1,0.8597813629551265,0.11499765965934519,6.428165532018309
R-HSA-6804760,Regulation of TP53 Activity through Methylation,1/1194,19/9872,0.05263157894736842,0.4351582473772371,-0.9140969659521001,0.9138532193848047,0.9999999999999981,0.963097398669085,L3MBTL1,1,0.8597813629551265,0.11499765965934519,6.428165532018309
R-HSA-69186,Lagging Strand Synthesis,1/1194,19/9872,0.05263157894736842,0.4351582473772371,-0.9140969659521001,0.9138532193848047,0.9999999999999981,0.963097398669085,RPA3,1,0.8597813629551265,0.11499765965934519,6.428165532018309
R-HSA-8851708,Signaling by FGFR2 IIIa TM,1/1194,19/9872,0.05263157894736842,0.4351582473772371,-0.9140969659521001,0.9138532193848047,0.9999999999999981,0.963097398669085,FGFR2,1,0.8597813629551265,0.11499765965934519,6.428165532018309
R-HSA-8964038,LDL clearance,1/1194,19/9872,0.05263157894736842,0.4351582473772371,-0.9140969659521001,0.9138532193848047,0.9999999999999981,0.963097398669085,NCEH1,1,0.8597813629551265,0.11499765965934519,6.428165532018309
R-HSA-9687136,Aberrant regulation of mitotic exit in cancer due to RB1 defects,1/1194,19/9872,0.05263157894736842,0.4351582473772371,-0.9140969659521001,0.9138532193848047,0.9999999999999981,0.963097398669085,UBE2D1,1,0.8597813629551265,0.11499765965934519,6.428165532018309
R-HSA-9912633,"Antigen processing: Ub, ATP-independent proteasomal degradation",1/1194,19/9872,0.05263157894736842,0.4351582473772371,-0.9140969659521001,0.9138532193848047,0.9999999999999981,0.963097398669085,PSMB9,1,0.8597813629551265,0.11499765965934519,6.428165532018309
R-HSA-380259,Loss of Nlp from mitotic centrosomes,5/1194,66/9872,0.07575757575757576,0.6263641439520836,-1.1296593116077505,0.9143087937450569,0.9999999999999981,0.963097398669085,YWHAG/CEP70/PAFAH1B1/TUBB4A/HAUS2,5,1.2375640830414698,0.4976463131894726,3.077617213354397
R-HSA-380284,Loss of proteins required for interphase microtubule organization from the centrosome,5/1194,66/9872,0.07575757575757576,0.6263641439520836,-1.1296593116077505,0.9143087937450569,0.9999999999999981,0.963097398669085,YWHAG/CEP70/PAFAH1B1/TUBB4A/HAUS2,5,1.2375640830414698,0.4976463131894726,3.077617213354397
R-HSA-3899300,SUMOylation of transcription cofactors,3/1194,44/9872,0.06818181818181818,0.5637277295568752,-1.0757820431604046,0.9145908807956795,0.9999999999999981,0.963097398669085,PHC2/NCOA1/UHRF2,3,1.113807674737323,0.345341235173396,3.592294837541982
R-HSA-73762,RNA Polymerase I Transcription Initiation,3/1194,44/9872,0.06818181818181818,0.5637277295568752,-1.0757820431604046,0.9145908807956795,0.9999999999999981,0.963097398669085,KAT2B/GATAD2A/CCNH,3,1.113807674737323,0.345341235173396,3.592294837541982
R-HSA-73884,Base Excision Repair,3/1194,44/9872,0.06818181818181818,0.5637277295568752,-1.0757820431604046,0.9145908807956795,0.9999999999999981,0.963097398669085,RPA3/POLE/POLB,3,1.113807674737323,0.345341235173396,3.592294837541982
R-HSA-453279,Mitotic G1 phase and G1/S transition,12/1194,138/9872,0.08695652173913043,0.7189571043623917,-1.2332167082146195,0.9191739920246669,0.9999999999999981,0.963097398669085,PPP2R2A/CDKN1A/CUL1/ORC4/RPA3/CCNH/CDK2/CCNA2/POLE/CABLES1/MCM7/CDC7,12,1.4205083387954265,0.7852423386330871,2.5697085362206904
R-HSA-4839726,Chromatin organization,20/1194,215/9872,0.09302325581395349,0.7691169023411633,-1.2695890593428454,0.9196246148788672,0.9999999999999981,0.963097398669085,KDM3A/SETD7/DOT1L/KDM4C/KAT2B/GATAD2A/YEATS2/KDM7A/KDM4B/SS18L1/MORF4L2/ACTL6B/NCOA1/USP22/ELP3/AEBP2/WDR5/RELA/KDM6A/PADI1,20,1.5196135717346422,0.957475181117151,2.411786177795008
R-HSA-69242,S Phase,13/1194,148/9872,0.08783783783783784,0.72624383177147,-1.2446441794212364,0.920096444091791,0.9999999999999981,0.963097398669085,CDKN1A/CUL1/PDS5A/ORC4/RPA3/CCNH/GINS3/CDK2/UBE2D1/CCNA2/POLE/CABLES1/MCM7,13,1.4349053827697043,0.811490569891647,2.5372487788445772
R-HSA-69002,DNA Replication Pre-Initiation,7/1194,88/9872,0.07954545454545454,0.6576823511496878,-1.1964245642711193,0.9202503890739,0.9999999999999981,0.963097398669085,ORC4/RPA3/CDK2/UBE2D1/POLE/MCM7/CDC7,7,1.2994422871935434,0.6005014033518641,2.811900602266171
R-HSA-113418,Formation of the Early Elongation Complex,2/1194,33/9872,0.06060606060606061,0.5010913151616669,-1.0648182113398479,0.9216326604081901,0.9999999999999981,0.963097398669085,CTDP1/CCNH,2,0.990051266433176,0.23728257716841597,4.130945987956874
R-HSA-167158,Formation of the HIV-1 Early Elongation Complex,2/1194,33/9872,0.06060606060606061,0.5010913151616669,-1.0648182113398479,0.9216326604081901,0.9999999999999981,0.963097398669085,CTDP1/CCNH,2,0.990051266433176,0.23728257716841597,4.130945987956874
R-HSA-174417,Telomere C-strand (Lagging Strand) Synthesis,2/1194,33/9872,0.06060606060606061,0.5010913151616669,-1.0648182113398479,0.9216326604081901,0.9999999999999981,0.963097398669085,RPA3/STN1,2,0.990051266433176,0.23728257716841597,4.130945987956874
R-HSA-390522,Striated Muscle Contraction,2/1194,33/9872,0.06060606060606061,0.5010913151616669,-1.0648182113398479,0.9216326604081901,0.9999999999999981,0.963097398669085,TPM4/MYBPC1,2,0.990051266433176,0.23728257716841597,4.130945987956874
R-HSA-5663084,Diseases of carbohydrate metabolism,2/1194,33/9872,0.06060606060606061,0.5010913151616669,-1.0648182113398479,0.9216326604081901,0.9999999999999981,0.963097398669085,GYS1/GBE1,2,0.990051266433176,0.23728257716841597,4.130945987956874
R-HSA-9615710,Late endosomal microautophagy,2/1194,33/9872,0.06060606060606061,0.5010913151616669,-1.0648182113398479,0.9216326604081901,0.9999999999999981,0.963097398669085,PLIN3/CFTR,2,0.990051266433176,0.23728257716841597,4.130945987956874
R-HSA-69052,Switching of origins to a post-replicative state,6/1194,78/9872,0.07692307692307693,0.6360005153975004,-1.1971289590024612,0.9226606838332203,0.9999999999999981,0.963097398669085,CUL1/ORC4/CDK2/UBE2D1/CCNA2/MCM7,6,1.2566035304728773,0.5466136157046033,2.8887908889013825
R-HSA-141405,Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components,1/1194,20/9872,0.05,0.41340033500837525,-0.9740192123020809,0.9242926039432685,0.9999999999999981,0.963097398669085,UBE2D1,1,0.8167922948073703,0.10952278835329159,6.091423190438155
R-HSA-141430,Inactivation of APC/C via direct inhibition of the APC/C complex,1/1194,20/9872,0.05,0.41340033500837525,-0.9740192123020809,0.9242926039432685,0.9999999999999981,0.963097398669085,UBE2D1,1,0.8167922948073703,0.10952278835329159,6.091423190438155
R-HSA-8876384,Listeria monocytogenes entry into host cells,1/1194,20/9872,0.05,0.41340033500837525,-0.9740192123020809,0.9242926039432685,0.9999999999999981,0.963097398669085,GRB2,1,0.8167922948073703,0.10952278835329159,6.091423190438155
R-HSA-9603798,Class I peroxisomal membrane protein import,1/1194,20/9872,0.05,0.41340033500837525,-0.9740192123020809,0.9242926039432685,0.9999999999999981,0.963097398669085,ALDH3A2,1,0.8167922948073703,0.10952278835329159,6.091423190438155
R-HSA-9854311,Maturation of TCA enzymes and regulation of TCA cycle,1/1194,20/9872,0.05,0.41340033500837525,-0.9740192123020809,0.9242926039432685,0.9999999999999981,0.963097398669085,SDHA,1,0.8167922948073703,0.10952278835329159,6.091423190438155
R-HSA-8939236,RUNX1 regulates transcription of genes involved in differentiation of HSCs,4/1194,57/9872,0.07017543859649122,0.5802109965029827,-1.178952343956372,0.9263533210594187,0.9999999999999981,0.963097398669085,CBFB/RUNX1/CCNH/LMO2,4,1.1463751506068354,0.4152474750684815,3.164801870769026
R-HSA-9711123,Cellular response to chemical stress,17/1194,189/9872,0.08994708994708994,0.7436831423431088,-1.3197024494429872,0.928829604790467,0.9999999999999981,0.963097398669085,STAT3/ERO1A/HMOX1/NFE2L2/CDKN1A/BCL2L1/HELZ2/CUL1/BACH1/NCOA1/GCLC/PDGFA/NDUFA4/RELA/CCL2/SLC7A11/EIF2AK3,17,1.4693618001825708,0.8914655061706128,2.4218818169533987
R-HSA-1222556,ROS and RNS production in phagocytes,2/1194,34/9872,0.058823529411764705,0.48635333530397085,-1.112816197287655,0.9294249940361133,0.9999999999999981,0.963097398669085,SLC11A1/HVCN1,2,0.9609321115380826,0.23057995886390814,4.004643454421108
R-HSA-532668,N-glycan trimming in the ER and Calnexin/Calreticulin cycle,2/1194,34/9872,0.058823529411764705,0.48635333530397085,-1.112816197287655,0.9294249940361133,0.9999999999999981,0.963097398669085,EDEM1/EDEM2,2,0.9609321115380826,0.23057995886390814,4.004643454421108
R-HSA-9709570,Impaired BRCA2 binding to RAD51,2/1194,34/9872,0.058823529411764705,0.48635333530397085,-1.112816197287655,0.9294249940361133,0.9999999999999981,0.963097398669085,RPA3/BARD1,2,0.9609321115380826,0.23057995886390814,4.004643454421108
R-HSA-1474165,Reproduction,7/1194,90/9872,0.07777777777777778,0.6430671877908058,-1.2617311223097107,0.930437100471784,0.9999999999999981,0.963097398669085,LMNA/HVCN1/RPA3/PDPN/LMNB1/SYCP3/CDK2,7,1.2705657919225757,0.5875261425754736,2.747686127679781
R-HSA-1280218,Adaptive Immune System,75/1194,718/9872,0.10445682451253482,0.8636497249478591,-1.4072968088962479,0.9309595935619537,0.9999999999999981,0.963097398669085,ZBTB16/PTPRJ/PAK2/SH3RF1/RNF130/LNX1/SIGLEC9/TLR2/MRC2/HECTD2/BTN1A1/TRIM9/FBXO7/RAP1A/HLA-DMB/WWP1/RBBP6/OSBPL1A/CD22/CUL1/DNM3/PIANP/UBR1/ENAH/SEC31A/SIGLEC5/RASGRP1/UBA7/SEC24D/RNF6/UBE2O/PTPN11/SELL/NCR3/TAP1/KLHL2/MADCAM1/NECTIN2/ZNRF1/RNF217/NFKBIA/KLHL3/SOCS3/DYNC1I1/CD14/ITGA4/SEC23A/SIGLEC7/GRB2/BTNL2/FBXL8/DTX3L/UBE2D1/RELA/TUBB2A/RAET1E/TLR4/KLRD1/SPSB1/RNF182/PAK3/TUBB4A/TRAF6/SFTPD/FCGR3A/PAG1/SEC24A/PSMB9/ITGB7/PRR5/FCGR1A/CTLA4/CD300LF/LILRB4/DNM1,75,1.7063905880376813,1.3357056374175196,2.1799480045418216
R-HSA-8951664,Neddylation,21/1194,228/9872,0.09210526315789473,0.7615269329101648,-1.3512978210202304,0.9314694713209353,0.9999999999999981,0.963097398669085,ZBTB16/FEM1C/HIF1A/CUL4A/NFE2L2/CDKN1A/FBXO7/DCUN1D4/CUL1/DCAF6/KLHL2/KLHL3/SOCS3/DCAF17/WDR5/CISH/FBXL8/UBE2D1/SPSB1/SPSB3/DCUN1D5,21,1.5046173851714713,0.9586445155993464,2.3615359384232826
R-HSA-8854518,AURKA Activation by TPX2,5/1194,69/9872,0.07246376811594203,0.5991309203019931,-1.2394257638008712,0.931964906139333,0.9999999999999981,0.963097398669085,YWHAG/CEP70/PAFAH1B1/TUBB4A/HAUS2,5,1.1837569489961886,0.4766716356868242,2.939718685542711
R-HSA-72662,"Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S",4/1194,58/9872,0.06896551724137931,0.5702073586322416,-1.217651090164253,0.9322739533375877,0.9999999999999981,0.963097398669085,EIF4EBP1/EIF3H/EIF2S1/EIF4G1,4,1.1266100618032693,0.4083216537331743,3.1084568250347613
R-HSA-1187000,Fertilization,1/1194,21/9872,0.047619047619047616,0.3937146047698811,-1.0316194245557107,0.9334678608344313,0.9999999999999981,0.963097398669085,HVCN1,1,0.7778974236260668,0.10454524079482234,5.788158285193233
R-HSA-211981,Xenobiotics,1/1194,21/9872,0.047619047619047616,0.3937146047698811,-1.0316194245557107,0.9334678608344313,0.9999999999999981,0.963097398669085,AHR,1,0.7778974236260668,0.10454524079482234,5.788158285193233
R-HSA-389948,Co-inhibition by PD-1,1/1194,21/9872,0.047619047619047616,0.3937146047698811,-1.0316194245557107,0.9334678608344313,0.9999999999999981,0.963097398669085,PTPN11,1,0.7778974236260668,0.10454524079482234,5.788158285193233
R-HSA-445144,Signal transduction by L1,1/1194,21/9872,0.047619047619047616,0.3937146047698811,-1.0316194245557107,0.9334678608344313,0.9999999999999981,0.963097398669085,ITGB3,1,0.7778974236260668,0.10454524079482234,5.788158285193233
R-HSA-73886,Chromosome Maintenance,7/1194,91/9872,0.07692307692307693,0.6360005153975004,-1.2939060748823699,0.9350893294315624,0.9999999999999981,0.963097398669085,MIS18BP1/ANKRD28/SHQ1/RPA3/CDK2/CCNA2/STN1,7,1.256603530472877,0.5812465602222812,2.7166654236939234
R-HSA-69306,DNA Replication,10/1194,122/9872,0.08196721311475409,0.6777054672268445,-1.3286281887561127,0.9356157697551586,0.9999999999999981,0.963097398669085,CUL1/ORC4/RPA3/GINS3/CDK2/UBE2D1/CCNA2/POLE/MCM7/CDC7,10,1.3390037619792954,0.7008756471130823,2.5581300791086363
R-HSA-3700989,Transcriptional Regulation by TP53,34/1194,351/9872,0.09686609686609686,0.8008895379079634,-1.4088970908328293,0.9357169779789674,0.9999999999999981,0.963097398669085,SESN3/PIP4K2A/SGK1/BCL2L14/CNOT2/BCL6/GATAD2A/L3MBTL1/BNIP3L/TNFRSF10D/TNRC6C/CDKN1A/FOS/DDIT4/NDRG1/CTDP1/AGO2/PMAIP1/GLS2/PLAGL1/YWHAG/BTG2/JUN/RPA3/CCNH/PRKAG3/NDUFA4/BARD1/CDK2/CCNA2/CASP1/RRAGD/CASP2/PRR5,34,1.5823896309658452,1.1074704478378128,2.260969535644823
R-HSA-1236975,Antigen processing-Cross presentation,7/1194,92/9872,0.07608695652173914,0.6290874663170928,-1.3257722111968946,0.9394655140715436,0.9999999999999981,0.963097398669085,TLR2/MRC2/TAP1/CD14/TLR4/PSMB9/FCGR1A,7,1.2429447964459979,0.575099808171166,2.686336780262624
R-HSA-9648025,EML4 and NUDC in mitotic spindle formation,9/1194,113/9872,0.07964601769911504,0.6585138079779428,-1.3541994307158522,0.9402482702822177,0.9999999999999981,0.963097398669085,NEK9/NUP98/PAFAH1B1/DYNC1I1/NUF2/AHCTF1/TUBB2A/SKA1/TUBB4A,9,1.3010850713745719,0.6582541184241963,2.5716851829294223
R-HSA-5620920,Cargo trafficking to the periciliary membrane,3/1194,48/9872,0.0625,0.516750418760469,-1.2448609523526022,0.9409351318764732,0.9999999999999981,0.963097398669085,RAB3IP/BBS2/BBS7,3,1.0209903685092128,0.3175490820346942,3.2827093245216417
R-HSA-113510,E2F mediated regulation of DNA replication,1/1194,22/9872,0.045454545454545456,0.3758184863712502,-1.0871188936226892,0.9415319532274564,0.9999999999999981,0.963097398669085,ORC4,1,0.7425384498248819,0.10000023361297937,5.513620614149998
R-HSA-2979096,NOTCH2 Activation and Transmission of Signal to the Nucleus,1/1194,22/9872,0.045454545454545456,0.3758184863712502,-1.0871188936226892,0.9415319532274564,0.9999999999999981,0.963097398669085,NEURL1B,1,0.7425384498248819,0.10000023361297937,5.513620614149998
R-HSA-912631,Regulation of signaling by CBL,1/1194,22/9872,0.045454545454545456,0.3758184863712502,-1.0871188936226892,0.9415319532274564,0.9999999999999981,0.963097398669085,GRB2,1,0.7425384498248819,0.10000023361297937,5.513620614149998
R-HSA-195721,Signaling by WNT,23/1194,251/9872,0.09163346613545817,0.7576261119675403,-1.4427314514825547,0.942820645827584,0.9999999999999981,0.963097398669085,PRICKLE1/SOX6/WIF1/GNAO1/GNB3/FZD5/SOX4/KREMEN2/TNKS/PIP5K1B/TNRC6C/AGO2/CUL1/PRKCG/PLCB1/RNF43/ROR2/GNG3/RSPO2/WNT2B/TLE1/SOX3/WNT6,23,1.4969101817186863,0.9727977532619325,2.3033976842766575
R-HSA-5685938,HDR through Single Strand Annealing (SSA),2/1194,36/9872,0.05555555555555555,0.45933370556486136,-1.2054361264474178,0.9428638181748723,0.9999999999999981,0.963097398669085,RPA3/BARD1,2,0.9075469942304113,0.21824972162437414,3.773849242997934
R-HSA-76046,RNA Polymerase III Transcription Initiation,2/1194,36/9872,0.05555555555555555,0.45933370556486136,-1.2054361264474178,0.9428638181748723,0.9999999999999981,0.963097398669085,BRF1/SNAPC3,2,0.9075469942304113,0.21824972162437414,3.773849242997934
R-HSA-9845323,Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs),2/1194,36/9872,0.05555555555555555,0.45933370556486136,-1.2054361264474178,0.9428638181748723,0.9999999999999981,0.963097398669085,GATAD2A/SS18L1,2,0.9075469942304113,0.21824972162437414,3.773849242997934
R-HSA-1592230,Mitochondrial biogenesis,7/1194,93/9872,0.07526881720430108,0.6223230849588445,-1.3573367495927096,0.9435788196123303,0.9999999999999981,0.963097398669085,MICOS10/HELZ2/NCOA1/PRKAG3/HSPA9/ALAS1/CAMK4,7,1.2295797986347505,0.5690817154937444,2.6566773102153776
R-HSA-983169,Class I MHC mediated antigen processing & presentation,35/1194,364/9872,0.09615384615384616,0.7950006442468754,-1.478194281889108,0.9442618083747798,0.9999999999999981,0.963097398669085,ZBTB16/SH3RF1/RNF130/LNX1/TLR2/MRC2/HECTD2/TRIM9/FBXO7/WWP1/RBBP6/CUL1/UBR1/SEC31A/UBA7/SEC24D/RNF6/UBE2O/TAP1/KLHL2/ZNRF1/RNF217/KLHL3/SOCS3/CD14/SEC23A/FBXL8/DTX3L/UBE2D1/TLR4/SPSB1/RNF182/SEC24A/PSMB9/FCGR1A,35,1.5707544130910964,1.1049563105577944,2.2329112949268097
R-HSA-69275,G2/M Transition,16/1194,185/9872,0.08648648648648649,0.7150708497442166,-1.4511122678034682,0.9467071215560066,0.9999999999999981,0.963097398669085,PPP2R2A/MIS18BP1/CDKN1A/CUL1/YWHAG/PPME1/PPP1CB/CCNH/CEP70/PAFAH1B1/CDK2/TUBB2A/CCNA2/TUBB4A/PHLDA1/HAUS2,16,1.4128299153424781,0.8449424445528809,2.3623956667757486
R-HSA-1234174,Cellular response to hypoxia,4/1194,61/9872,0.06557377049180328,0.5421643737814758,-1.3304261733616614,0.9475382420218568,0.9999999999999981,0.963097398669085,VEGFA/HIF1A/EGLN1/UBE2D1,4,1.0712030095834364,0.3888642971356785,2.95083888182269
R-HSA-69473,G2/M DNA damage checkpoint,4/1194,61/9872,0.06557377049180328,0.5421643737814758,-1.3304261733616614,0.9475382420218568,0.9999999999999981,0.963097398669085,YWHAG/RPA3/BARD1/CCNA2,4,1.0712030095834364,0.3888642971356785,2.95083888182269
R-HSA-167242,Abortive elongation of HIV-1 transcript in the absence of Tat,1/1194,23/9872,0.043478260869565216,0.35947855218119584,-1.1407078819037524,0.9486193489479048,0.9999999999999981,0.963097398669085,CTDP1,1,0.7102541693977131,0.0958337613032548,5.263917207115844
R-HSA-174048,APC/C:Cdc20 mediated degradation of Cyclin B,1/1194,23/9872,0.043478260869565216,0.35947855218119584,-1.1407078819037524,0.9486193489479048,0.9999999999999981,0.963097398669085,UBE2D1,1,0.7102541693977131,0.0958337613032548,5.263917207115844
R-HSA-379724,tRNA Aminoacylation,1/1194,23/9872,0.043478260869565216,0.35947855218119584,-1.1407078819037524,0.9486193489479048,0.9999999999999981,0.963097398669085,PPA2,1,0.7102541693977131,0.0958337613032548,5.263917207115844
R-HSA-73980,RNA Polymerase III Transcription Termination,1/1194,23/9872,0.043478260869565216,0.35947855218119584,-1.1407078819037524,0.9486193489479048,0.9999999999999981,0.963097398669085,NFIC,1,0.7102541693977131,0.0958337613032548,5.263917207115844
R-HSA-9733709,Cardiogenesis,1/1194,23/9872,0.043478260869565216,0.35947855218119584,-1.1407078819037524,0.9486193489479048,0.9999999999999981,0.963097398669085,WDR5,1,0.7102541693977131,0.0958337613032548,5.263917207115844
R-HSA-9833109,Evasion by RSV of host interferon responses,1/1194,23/9872,0.043478260869565216,0.35947855218119584,-1.1407078819037524,0.9486193489479048,0.9999999999999981,0.963097398669085,IFNAR2,1,0.7102541693977131,0.0958337613032548,5.263917207115844
R-HSA-8964043,Plasma lipoprotein clearance,2/1194,37/9872,0.05405405405405406,0.4469192810901354,-1.2501873927570468,0.9486336489627913,0.9999999999999981,0.963097398669085,NCEH1/CUBN,2,0.8830186970890488,0.21256614042580615,3.6681383867013135
R-HSA-9013407,RHOH GTPase cycle,2/1194,37/9872,0.05405405405405406,0.4469192810901354,-1.2501873927570468,0.9486336489627913,0.9999999999999981,0.963097398669085,PAK2/TFRC,2,0.8830186970890488,0.21256614042580615,3.6681383867013135
R-HSA-9772572,Early SARS-CoV-2 Infection Events,2/1194,37/9872,0.05405405405405406,0.4469192810901354,-1.2501873927570468,0.9486336489627913,0.9999999999999981,0.963097398669085,GPC5/GPC2,2,0.8830186970890488,0.21256614042580615,3.6681383867013135
R-HSA-72306,tRNA processing,8/1194,105/9872,0.0761904761904762,0.6299433676318099,-1.4140187374409348,0.948967495444823,0.9999999999999981,0.963097398669085,NSUN2/NUP205/TRIT1/NUP58/NUP98/NUP188/NUP153/OSGEP,8,1.244635877801707,0.6050727262671403,2.560218633333819
R-HSA-6807070,PTEN Regulation,10/1194,126/9872,0.07936507936507936,0.6561910079498019,-1.4406623833912606,0.949759617662457,0.9999999999999981,0.963097398669085,PHC2/GATAD2A/TNKS/TNRC6C/AGO2/FRK/JUN/EGR1/PPARG/RRAGD,10,1.2964957060434448,0.6791501071416648,2.47500677407457
R-HSA-5607764,CLEC7A (Dectin-1) signaling,6/1194,84/9872,0.07142857142857142,0.5905719071548217,-1.3977941467664539,0.9503265113273333,0.9999999999999981,0.963097398669085,IL1B/CUL1/NFKBIA/UBE2D1/RELA/TRAF6,6,1.1668461354391002,0.5086448186322465,2.6767792650485207
R-HSA-159236,Transport of Mature mRNA derived from an Intron-Containing Transcript,5/1194,73/9872,0.0684931506849315,0.5663018287785961,-1.3795297116421055,0.9504302437831675,0.9999999999999981,0.963097398669085,NUP205/NUP58/NUP98/NUP188/NUP153,5,1.118893554530644,0.4513095111107391,2.7739782910602817
R-HSA-6807505,RNA polymerase II transcribes snRNA genes,5/1194,73/9872,0.0684931506849315,0.5663018287785961,-1.3795297116421055,0.9504302437831675,0.9999999999999981,0.963097398669085,ELL2/INTS10/INTS6/SNAPC3/INTS9,5,1.118893554530644,0.4513095111107391,2.7739782910602817
R-HSA-2173793,Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer,3/1194,50/9872,0.06,0.4960804020100502,-1.3250101423148677,0.9510752495274513,0.9999999999999981,0.963097398669085,JUNB/UBE2D1/STAT1,3,0.9801507537688443,0.30526546097873963,3.147082205217254
R-HSA-1834949,Cytosolic sensors of pathogen-associated DNA,4/1194,62/9872,0.06451612903225806,0.5334197871075809,-1.3669750076547122,0.9518802412628771,0.9999999999999981,0.963097398669085,TRIM56/NFKBIA/RELA/IFI16,4,1.0539255416869293,0.3827841468640273,2.901789576501588
R-HSA-6782210,Gap-filling DNA repair synthesis and ligation in TC-NER,4/1194,62/9872,0.06451612903225806,0.5334197871075809,-1.3669750076547122,0.9518802412628771,0.9999999999999981,0.963097398669085,CUL4A/RPA3/CCNH/POLE,4,1.0539255416869293,0.3827841468640273,2.901789576501588
R-HSA-6796648,TP53 Regulates Transcription of DNA Repair Genes,4/1194,62/9872,0.06451612903225806,0.5334197871075809,-1.3669750076547122,0.9518802412628771,0.9999999999999981,0.963097398669085,FOS/CTDP1/JUN/CCNH,4,1.0539255416869293,0.3827841468640273,2.901789576501588
R-HSA-453274,Mitotic G2-G2/M phases,16/1194,187/9872,0.0855614973262032,0.7074230331694121,-1.4982491515355403,0.9520452006175562,0.9999999999999981,0.963097398669085,PPP2R2A/MIS18BP1/CDKN1A/CUL1/YWHAG/PPME1/PPP1CB/CCNH/CEP70/PAFAH1B1/CDK2/TUBB2A/CCNA2/TUBB4A/PHLDA1/HAUS2,16,1.3977194349644837,0.836086245481586,2.336624516232951
R-HSA-2172127,DAP12 interactions,2/1194,38/9872,0.05263157894736842,0.4351582473772371,-1.2939765463132111,0.9538450254455892,0.9999999999999981,0.963097398669085,GRB2/KLRD1,2,0.8597813629551265,0.20717100721379492,3.5681826430573644
R-HSA-174143,APC/C-mediated degradation of cell cycle proteins,5/1194,74/9872,0.06756756756756757,0.5586491013626692,-1.4135268877818155,0.95427224990078,0.9999999999999981,0.963097398669085,CUL1/CDC14A/CDK2/UBE2D1/CCNA2,5,1.103773371361311,0.44538516094798164,2.735420400475818
R-HSA-453276,Regulation of mitotic cell cycle,5/1194,74/9872,0.06756756756756757,0.5586491013626692,-1.4135268877818155,0.95427224990078,0.9999999999999981,0.963097398669085,CUL1/CDC14A/CDK2/UBE2D1/CCNA2,5,1.103773371361311,0.44538516094798164,2.735420400475818
R-HSA-5668599,RHO GTPases Activate NADPH Oxidases,1/1194,24/9872,0.041666666666666664,0.344500279173646,-1.192551185338856,0.95484825516744,0.9999999999999981,0.963097398669085,PRKCZ,1,0.6806602456728086,0.09200044549042011,5.035827463331261
R-HSA-9615017,"FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes",1/1194,24/9872,0.041666666666666664,0.344500279173646,-1.192551185338856,0.95484825516744,0.9999999999999981,0.963097398669085,PCK1,1,0.6806602456728086,0.09200044549042011,5.035827463331261
R-HSA-9709603,Impaired BRCA2 binding to PALB2,1/1194,24/9872,0.041666666666666664,0.344500279173646,-1.192551185338856,0.95484825516744,0.9999999999999981,0.963097398669085,BARD1,1,0.6806602456728086,0.09200044549042011,5.035827463331261
R-HSA-9865881,Complex III assembly,1/1194,24/9872,0.041666666666666664,0.344500279173646,-1.192551185338856,0.95484825516744,0.9999999999999981,0.963097398669085,HSPA9,1,0.6806602456728086,0.09200044549042011,5.035827463331261
R-HSA-1169091,Activation of NF-kappaB in B cells,3/1194,51/9872,0.058823529411764705,0.48635333530397085,-1.3640950136666457,0.9555130673348049,0.9999999999999981,0.963097398669085,CUL1/NFKBIA/RELA,3,0.9609321115380827,0.29947323235530904,3.0833824970690022
R-HSA-9639288,Amino acids regulate mTORC1,3/1194,51/9872,0.058823529411764705,0.48635333530397085,-1.3640950136666457,0.9555130673348049,0.9999999999999981,0.963097398669085,FNIP2/FNIP1/RRAGD,3,0.9609321115380827,0.29947323235530904,3.0833824970690022
R-HSA-6782135,Dual incision in TC-NER,4/1194,63/9872,0.06349206349206349,0.5249528063598414,-1.4030320139468315,0.9558895331897779,0.9999999999999981,0.963097398669085,CUL4A/RPA3/CCNH/POLE,4,1.0371965648347559,0.3768912026761024,2.8543428619890947
R-HSA-9663891,Selective autophagy,6/1194,86/9872,0.06976744186046512,0.5768376767558724,-1.461929834789518,0.9573416770062806,0.9999999999999981,0.963097398669085,PLIN3/PRKAG3/DYNC1I1/TUBB2A/CFTR/TUBB4A,6,1.1397101788009816,0.4971342864951052,2.6128539651134175
R-HSA-450531,Regulation of mRNA stability by proteins that bind AU-rich elements,5/1194,75/9872,0.06666666666666667,0.5512004466778336,-1.4471362087682391,0.9578409249500947,0.9999999999999981,0.963097398669085,ZFP36/HSPA1A/HSPA1B/HSPB1/EIF4G1,5,1.0890563930764936,0.43961434024827,2.697918877330002
R-HSA-5693616,Presynaptic phase of homologous DNA pairing and strand exchange,2/1194,39/9872,0.05128205128205128,0.4240003435983335,-1.3368553694916452,0.9585484954570906,0.9999999999999981,0.963097398669085,RPA3/BARD1,2,0.8377356869819181,0.20204291116775036,3.4735248922461888
R-HSA-9830369,Kidney development,2/1194,39/9872,0.05128205128205128,0.4240003435983335,-1.3368553694916452,0.9585484954570906,0.9999999999999981,0.963097398669085,ID4/PCDH19,2,0.8377356869819181,0.20204291116775036,3.4735248922461888
R-HSA-5358346,Hedgehog ligand biogenesis,3/1194,52/9872,0.057692307692307696,0.47700038654812527,-1.4025560060182964,0.9595718766574988,0.9999999999999981,0.963097398669085,GPC5/DHH/HHAT,3,0.942452647854658,0.29389670230987486,3.02220809715568
R-HSA-212165,Epigenetic regulation of gene expression,22/1194,249/9872,0.08835341365461848,0.7305066160790565,-1.597590446457027,0.9598304642837732,0.9999999999999981,0.963097398669085,ZNF708/ELOVL5/ACSL1/KAT2B/PHF19/GATAD2A/YEATS2/MGLL/SS18L1/MBD2/ZNF93/UHRF1/NCOA1/AEBP2/CEBPA/CCNH/WDR5/PPARG/ZNF141/KDM6A/PHLDA1/LPL,22,1.4433277498604133,0.9297028534447803,2.2407105515470542
R-HSA-1632852,Macroautophagy,11/1194,140/9872,0.07857142857142857,0.6496290978703039,-1.5486879368876205,0.960213953876923,0.9999999999999981,0.963097398669085,PLIN3/AMBRA1/ATG16L2/ATG4B/PRKAG3/DYNC1I1/WDR45B/TUBB2A/RRAGD/CFTR/TUBB4A,11,1.2835307489830103,0.6928787101561377,2.3776905819687264
R-HSA-179409,APC-Cdc20 mediated degradation of Nek2A,1/1194,25/9872,0.04,0.3307202680067002,-1.242792504137615,0.9603225832878783,0.9999999999999981,0.963097398669085,UBE2D1,1,0.6534338358458962,0.08846187919280499,4.826664114806749
R-HSA-5357786,TNFR1-induced proapoptotic signaling,1/1194,25/9872,0.04,0.3307202680067002,-1.242792504137615,0.9603225832878783,0.9999999999999981,0.963097398669085,IKBKE,1,0.6534338358458962,0.08846187919280499,4.826664114806749
R-HSA-5621480,Dectin-2 family,1/1194,25/9872,0.04,0.3307202680067002,-1.242792504137615,0.9603225832878783,0.9999999999999981,0.963097398669085,MUC15,1,0.6534338358458962,0.08846187919280499,4.826664114806749
R-HSA-6803529,FGFR2 alternative splicing,1/1194,25/9872,0.04,0.3307202680067002,-1.242792504137615,0.9603225832878783,0.9999999999999981,0.963097398669085,HNRNPF,1,0.6534338358458962,0.08846187919280499,4.826664114806749
R-HSA-9013507,NOTCH3 Activation and Transmission of Signal to the Nucleus,1/1194,25/9872,0.04,0.3307202680067002,-1.242792504137615,0.9603225832878783,0.9999999999999981,0.963097398669085,NEURL1B,1,0.6534338358458962,0.08846187919280499,4.826664114806749
R-HSA-9701192,Defective homologous recombination repair (HRR) due to BRCA1 loss of function,1/1194,25/9872,0.04,0.3307202680067002,-1.242792504137615,0.9603225832878783,0.9999999999999981,0.963097398669085,BARD1,1,0.6534338358458962,0.08846187919280499,4.826664114806749
R-HSA-9701193,Defective homologous recombination repair (HRR) due to PALB2 loss of function,1/1194,25/9872,0.04,0.3307202680067002,-1.242792504137615,0.9603225832878783,0.9999999999999981,0.963097398669085,BARD1,1,0.6534338358458962,0.08846187919280499,4.826664114806749
R-HSA-9704331,Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function,1/1194,25/9872,0.04,0.3307202680067002,-1.242792504137615,0.9603225832878783,0.9999999999999981,0.963097398669085,BARD1,1,0.6534338358458962,0.08846187919280499,4.826664114806749
R-HSA-9704646,Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function,1/1194,25/9872,0.04,0.3307202680067002,-1.242792504137615,0.9603225832878783,0.9999999999999981,0.963097398669085,BARD1,1,0.6534338358458962,0.08846187919280499,4.826664114806749
R-HSA-9675136,Diseases of DNA Double-Strand Break Repair,2/1194,40/9872,0.05,0.41340033500837525,-1.3788714764160799,0.9627905608181091,0.9999999999999981,0.963097398669085,RPA3/BARD1,2,0.8167922948073703,0.1971625089176544,3.383755139448583
R-HSA-9701190,Defective homologous recombination repair (HRR) due to BRCA2 loss of function,2/1194,40/9872,0.05,0.41340033500837525,-1.3788714764160799,0.9627905608181091,0.9999999999999981,0.963097398669085,RPA3/BARD1,2,0.8167922948073703,0.1971625089176544,3.383755139448583
R-HSA-5619084,ABC transporter disorders,4/1194,65/9872,0.06153846153846154,0.5088004123180002,-1.4737353492722356,0.9629986597387479,0.9999999999999981,0.963097398669085,ABCD4/ABCC2/ABCB6/CFTR,4,1.0052828243783019,0.3656333817961208,2.763953203686222
R-HSA-1234176,Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha,3/1194,53/9872,0.05660377358490566,0.4680003792547644,-1.440418013581124,0.9632810827951103,0.9999999999999981,0.963097398669085,HIF1A/EGLN1/UBE2D1,3,0.924670522423438,0.2885240433261207,2.9634118709212864
R-HSA-69563,p53-Dependent G1 DNA Damage Response,3/1194,53/9872,0.05660377358490566,0.4680003792547644,-1.440418013581124,0.9632810827951103,0.9999999999999981,0.963097398669085,CDKN1A/CDK2/CCNA2,3,0.924670522423438,0.2885240433261207,2.9634118709212864
R-HSA-69580,p53-Dependent G1/S DNA damage checkpoint,3/1194,53/9872,0.05660377358490566,0.4680003792547644,-1.440418013581124,0.9632810827951103,0.9999999999999981,0.963097398669085,CDKN1A/CDK2/CCNA2,3,0.924670522423438,0.2885240433261207,2.9634118709212864
R-HSA-5610787,Hedgehog 'off' state,7/1194,99/9872,0.0707070707070707,0.584606534355278,-1.5407643631035963,0.9634316559215479,0.9999999999999981,0.963097398669085,PRKAR2A/CUL1/IFT172/ADCY3/GLI3/TUBB2A/TUBB4A,7,1.1550598108387053,0.535462138834314,2.4916106478026276
R-HSA-3858494,Beta-catenin independent WNT signaling,10/1194,131/9872,0.07633587786259542,0.6311455496311071,-1.576383281866669,0.9635448878148392,0.9999999999999981,0.963097398669085,PRICKLE1/GNAO1/GNB3/FZD5/TNRC6C/AGO2/PRKCG/PLCB1/ROR2/GNG3,10,1.2470111371104888,0.6538168554006056,2.3783981144456647
R-HSA-5621481,C-type lectin receptors (CLRs),9/1194,121/9872,0.0743801652892562,0.6149757049711367,-1.580626132092298,0.9647797901362294,0.9999999999999981,0.963097398669085,PAK2/IL1B/MUC15/CUL1/NFKBIA/UBE2D1/RELA/PAK3/TRAF6,9,1.2150629178952612,0.6157492039535055,2.3976935495244684
R-HSA-174411,Polymerase switching on the C-strand of the telomere,1/1194,26/9872,0.038461538461538464,0.3180002576987502,-1.2915579151390748,0.9651336765705302,0.9999999999999981,0.963097398669085,STN1,1,0.6283017652364387,0.08518533814702661,4.634167296699334
R-HSA-380320,Recruitment of NuMA to mitotic centrosomes,6/1194,89/9872,0.06741573033707865,0.557393710123652,-1.555784621903111,0.9661898194158778,0.9999999999999981,0.963097398669085,YWHAG/CEP70/PAFAH1B1/TUBB2A/TUBB4A/HAUS2,6,1.1012929817627464,0.48081329302913994,2.5224889770391097
R-HSA-9824585,Regulation of MITF-M-dependent genes involved in pigmentation,2/1194,41/9872,0.04878048780487805,0.40331740000817096,-1.4200687492410557,0.9666139157156909,0.9999999999999981,0.963097398669085,SS18L1/SOX10,2,0.7968705315193856,0.1925122809315428,3.2985045989341035
R-HSA-1236974,ER-Phagosome pathway,5/1194,78/9872,0.0641025641025641,0.5300004294979169,-1.5457442121963343,0.9670718887965448,0.9999999999999981,0.963097398669085,TLR2/TAP1/CD14/TLR4/PSMB9,5,1.0471696087273976,0.42316560527135005,2.59133581695311
R-HSA-202424,Downstream TCR signaling,5/1194,78/9872,0.0641025641025641,0.5300004294979169,-1.5457442121963343,0.9670718887965448,0.9999999999999981,0.963097398669085,CUL1/NFKBIA/UBE2D1/RELA/TRAF6,5,1.0471696087273976,0.42316560527135005,2.59133581695311
R-HSA-380270,Recruitment of mitotic centrosome proteins and complexes,5/1194,78/9872,0.0641025641025641,0.5300004294979169,-1.5457442121963343,0.9670718887965448,0.9999999999999981,0.963097398669085,YWHAG/CEP70/PAFAH1B1/TUBB4A/HAUS2,5,1.0471696087273976,0.42316560527135005,2.59133581695311
R-HSA-380287,Centrosome maturation,5/1194,78/9872,0.0641025641025641,0.5300004294979169,-1.5457442121963343,0.9670718887965448,0.9999999999999981,0.963097398669085,YWHAG/CEP70/PAFAH1B1/TUBB4A/HAUS2,5,1.0471696087273976,0.42316560527135005,2.59133581695311
R-HSA-2500257,Resolution of Sister Chromatid Cohesion,9/1194,122/9872,0.07377049180327869,0.6099349205041601,-1.6080057443367624,0.9671025882196775,0.9999999999999981,0.963097398669085,PDS5A/NUP98/PAFAH1B1/DYNC1I1/NUF2/AHCTF1/TUBB2A/SKA1/TUBB4A,9,1.2051033857813658,0.6108190143360442,2.3775850723971366
R-HSA-1168372,Downstream signaling events of B Cell Receptor (BCR),4/1194,67/9872,0.05970149253731343,0.4936123403085077,-1.5426579175750765,0.9690314472209576,0.9999999999999981,0.963097398669085,CUL1/RASGRP1/NFKBIA/RELA,4,0.9752743818595465,0.3550285983457453,2.6791084558918588
R-HSA-176408,Regulation of APC/C activators between G1/S and early anaphase,4/1194,67/9872,0.05970149253731343,0.4936123403085077,-1.5426579175750765,0.9690314472209576,0.9999999999999981,0.963097398669085,CUL1/CDK2/UBE2D1/CCNA2,4,0.9752743818595465,0.3550285983457453,2.6791084558918588
R-HSA-167160,RNA Pol II CTD phosphorylation and interaction with CE during HIV infection,1/1194,27/9872,0.037037037037037035,0.30622247037657424,-1.3389586582015858,0.9693618291375409,0.9999999999999981,0.963097398669085,CCNH,1,0.6050313294869409,0.08214276768124851,4.456422884132987
R-HSA-389357,CD28 dependent PI3K/Akt signaling,1/1194,27/9872,0.037037037037037035,0.30622247037657424,-1.3389586582015858,0.9693618291375409,0.9999999999999981,0.963097398669085,PRR5,1,0.6050313294869409,0.08214276768124851,4.456422884132987
R-HSA-5693554,Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA),1/1194,27/9872,0.037037037037037035,0.30622247037657424,-1.3389586582015858,0.9693618291375409,0.9999999999999981,0.963097398669085,BARD1,1,0.6050313294869409,0.08214276768124851,4.456422884132987
R-HSA-76066,RNA Polymerase III Transcription Initiation From Type 2 Promoter,1/1194,27/9872,0.037037037037037035,0.30622247037657424,-1.3389586582015858,0.9693618291375409,0.9999999999999981,0.963097398669085,BRF1,1,0.6050313294869409,0.08214276768124851,4.456422884132987
R-HSA-77075,RNA Pol II CTD phosphorylation and interaction with CE,1/1194,27/9872,0.037037037037037035,0.30622247037657424,-1.3389586582015858,0.9693618291375409,0.9999999999999981,0.963097398669085,CCNH,1,0.6050313294869409,0.08214276768124851,4.456422884132987
R-HSA-8978934,Metabolism of cofactors,1/1194,27/9872,0.037037037037037035,0.30622247037657424,-1.3389586582015858,0.9693618291375409,0.9999999999999981,0.963097398669085,GCH1,1,0.6050313294869409,0.08214276768124851,4.456422884132987
R-HSA-69615,G1/S DNA Damage Checkpoints,3/1194,55/9872,0.05454545454545454,0.45098218364550025,-1.5144373216969866,0.9697588937589494,0.9999999999999981,0.963097398669085,CDKN1A/CDK2/CCNA2,3,0.8910461397898584,0.2783471992981869,2.85242037727081
R-HSA-5693579,Homologous DNA Pairing and Strand Exchange,2/1194,42/9872,0.047619047619047616,0.3937146047698811,-1.4604877189722218,0.9700576866478661,0.9999999999999981,0.963097398669085,RPA3/BARD1,2,0.7778974236260668,0.1880763215496002,3.217440646958245
R-HSA-9762114,GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2,2/1194,42/9872,0.047619047619047616,0.3937146047698811,-1.4604877189722218,0.9700576866478661,0.9999999999999981,0.963097398669085,NFE2L2/CUL1,2,0.7778974236260668,0.1880763215496002,3.217440646958245
R-HSA-6799198,Complex I biogenesis,4/1194,68/9872,0.058823529411764705,0.48635333530397085,-1.5764862743987584,0.9716911100337584,0.9999999999999981,0.963097398669085,NDUFB9/LYRM2/HSPA9/NDUFB6,4,0.9609321115380826,0.34995359289883016,2.6386084947325728
R-HSA-390918,Peroxisomal lipid metabolism,1/1194,28/9872,0.03571428571428571,0.29528595357741083,-1.3850933927799567,0.9730776215204536,0.9999999999999981,0.963097398669085,ALDH3A2,1,0.5834230677195501,0.07930997879135802,4.291798852231952
R-HSA-5250924,B-WICH complex positively regulates rRNA expression,1/1194,28/9872,0.03571428571428571,0.29528595357741083,-1.3850933927799567,0.9730776215204536,0.9999999999999981,0.963097398669085,KAT2B,1,0.5834230677195501,0.07930997879135802,4.291798852231952
R-HSA-606279,Deposition of new CENPA-containing nucleosomes at the centromere,1/1194,28/9872,0.03571428571428571,0.29528595357741083,-1.3850933927799567,0.9730776215204536,0.9999999999999981,0.963097398669085,MIS18BP1,1,0.5834230677195501,0.07930997879135802,4.291798852231952
R-HSA-73772,RNA Polymerase I Promoter Escape,1/1194,28/9872,0.03571428571428571,0.29528595357741083,-1.3850933927799567,0.9730776215204536,0.9999999999999981,0.963097398669085,CCNH,1,0.5834230677195501,0.07930997879135802,4.291798852231952
R-HSA-76061,RNA Polymerase III Transcription Initiation From Type 1 Promoter,1/1194,28/9872,0.03571428571428571,0.29528595357741083,-1.3850933927799567,0.9730776215204536,0.9999999999999981,0.963097398669085,BRF1,1,0.5834230677195501,0.07930997879135802,4.291798852231952
R-HSA-76071,RNA Polymerase III Transcription Initiation From Type 3 Promoter,1/1194,28/9872,0.03571428571428571,0.29528595357741083,-1.3850933927799567,0.9730776215204536,0.9999999999999981,0.963097398669085,SNAPC3,1,0.5834230677195501,0.07930997879135802,4.291798852231952
R-HSA-774815,Nucleosome assembly,1/1194,28/9872,0.03571428571428571,0.29528595357741083,-1.3850933927799567,0.9730776215204536,0.9999999999999981,0.963097398669085,MIS18BP1,1,0.5834230677195501,0.07930997879135802,4.291798852231952
R-HSA-167169,HIV Transcription Elongation,2/1194,43/9872,0.046511627906976744,0.38455845117058163,-1.5001658990455726,0.9731576700712079,0.9999999999999981,0.963097398669085,CTDP1/CCNH,2,0.7598067858673211,0.18384015736630177,3.140262498251377
R-HSA-167200,Formation of HIV-1 elongation complex containing HIV-1 Tat,2/1194,43/9872,0.046511627906976744,0.38455845117058163,-1.5001658990455726,0.9731576700712079,0.9999999999999981,0.963097398669085,CTDP1/CCNH,2,0.7598067858673211,0.18384015736630177,3.140262498251377
R-HSA-167246,Tat-mediated elongation of the HIV-1 transcript,2/1194,43/9872,0.046511627906976744,0.38455845117058163,-1.5001658990455726,0.9731576700712079,0.9999999999999981,0.963097398669085,CTDP1/CCNH,2,0.7598067858673211,0.18384015736630177,3.140262498251377
R-HSA-427413,NoRC negatively regulates rRNA expression,2/1194,43/9872,0.046511627906976744,0.38455845117058163,-1.5001658990455726,0.9731576700712079,0.9999999999999981,0.963097398669085,MBD2/CCNH,2,0.7598067858673211,0.18384015736630177,3.140262498251377
R-HSA-5250913,Positive epigenetic regulation of rRNA expression,2/1194,43/9872,0.046511627906976744,0.38455845117058163,-1.5001658990455726,0.9731576700712079,0.9999999999999981,0.963097398669085,KAT2B/GATAD2A,2,0.7598067858673211,0.18384015736630177,3.140262498251377
R-HSA-5675221,Negative regulation of MAPK pathway,2/1194,43/9872,0.046511627906976744,0.38455845117058163,-1.5001658990455726,0.9731576700712079,0.9999999999999981,0.963097398669085,DUSP1/MARK3,2,0.7598067858673211,0.18384015736630177,3.140262498251377
R-HSA-5693565,Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks,2/1194,43/9872,0.046511627906976744,0.38455845117058163,-1.5001658990455726,0.9731576700712079,0.9999999999999981,0.963097398669085,KDM4B/BARD1,2,0.7598067858673211,0.18384015736630177,3.140262498251377
R-HSA-9842860,Regulation of endogenous retroelements,5/1194,81/9872,0.06172839506172839,0.510370783960957,-1.6412291607680194,0.9744047084651414,0.9999999999999981,0.963097398669085,ZNF708/GATAD2A/SS18L1/ZNF93/ZNF141,5,1.0083855491449014,0.40790342129313895,2.4928484603062775
R-HSA-112382,Formation of RNA Pol II elongation complex,3/1194,57/9872,0.05263157894736842,0.4351582473772371,-1.5863243264393019,0.9751450975583519,0.9999999999999981,0.963097398669085,CTDP1/CCNH/IWS1,3,0.8597813629551265,0.26886376901826786,2.749436991024063
R-HSA-72649,Translation initiation complex formation,3/1194,57/9872,0.05263157894736842,0.4351582473772371,-1.5863243264393019,0.9751450975583519,0.9999999999999981,0.963097398669085,EIF3H/EIF2S1/EIF4G1,3,0.8597813629551265,0.26886376901826786,2.749436991024063
R-HSA-72702,Ribosomal scanning and start codon recognition,3/1194,57/9872,0.05263157894736842,0.4351582473772371,-1.5863243264393019,0.9751450975583519,0.9999999999999981,0.963097398669085,EIF3H/EIF2S1/EIF4G1,3,0.8597813629551265,0.26886376901826786,2.749436991024063
R-HSA-75893,TNF signaling,3/1194,57/9872,0.05263157894736842,0.4351582473772371,-1.5863243264393019,0.9751450975583519,0.9999999999999981,0.963097398669085,SMPD3/UBE2D1/IKBKE,3,0.8597813629551265,0.26886376901826786,2.749436991024063
R-HSA-75955,RNA Polymerase II Transcription Elongation,3/1194,57/9872,0.05263157894736842,0.4351582473772371,-1.5863243264393019,0.9751450975583519,0.9999999999999981,0.963097398669085,CTDP1/CCNH/IWS1,3,0.8597813629551265,0.26886376901826786,2.749436991024063
R-HSA-9793380,Formation of paraxial mesoderm,3/1194,57/9872,0.05263157894736842,0.4351582473772371,-1.5863243264393019,0.9751450975583519,0.9999999999999981,0.963097398669085,KAT2B/DLL3/EPHA4,3,0.8597813629551265,0.26886376901826786,2.749436991024063
R-HSA-141424,Amplification of signal from the kinetochores,6/1194,93/9872,0.06451612903225806,0.5334197871075809,-1.676847179083368,0.9753792131279351,0.9999999999999981,0.963097398669085,NUP98/PAFAH1B1/DYNC1I1/NUF2/AHCTF1/SKA1,6,1.053925541686929,0.4606491642026389,2.411290703941157
R-HSA-141444,Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal,6/1194,93/9872,0.06451612903225806,0.5334197871075809,-1.676847179083368,0.9753792131279351,0.9999999999999981,0.963097398669085,NUP98/PAFAH1B1/DYNC1I1/NUF2/AHCTF1/SKA1,6,1.053925541686929,0.4606491642026389,2.411290703941157
R-HSA-5693606,DNA Double Strand Break Response,2/1194,44/9872,0.045454545454545456,0.3758184863712502,-1.539138078504188,0.9759465647986141,0.9999999999999981,0.963097398669085,KDM4B/BARD1,2,0.7425384498248819,0.17979058959447186,3.066697487960692
R-HSA-9824272,Somitogenesis,2/1194,44/9872,0.045454545454545456,0.3758184863712502,-1.539138078504188,0.9759465647986141,0.9999999999999981,0.963097398669085,DLL3/EPHA4,2,0.7425384498248819,0.17979058959447186,3.066697487960692
R-HSA-418360,Platelet calcium homeostasis,1/1194,29/9872,0.034482758620689655,0.2851036793161208,-1.4300500409711172,0.9763430948955631,0.9999999999999981,0.963097398669085,SLC8A1,1,0.5633050309016346,0.07666600471676771,4.138895185830542
R-HSA-499943,Interconversion of nucleotide di- and triphosphates,1/1194,29/9872,0.034482758620689655,0.2851036793161208,-1.4300500409711172,0.9763430948955631,0.9999999999999981,0.963097398669085,AK7,1,0.5633050309016346,0.07666600471676771,4.138895185830542
R-HSA-5601884,PIWI-interacting RNA (piRNA) biogenesis,1/1194,29/9872,0.034482758620689655,0.2851036793161208,-1.4300500409711172,0.9763430948955631,0.9999999999999981,0.963097398669085,MYBL1,1,0.5633050309016346,0.07666600471676771,4.138895185830542
R-HSA-5669034,TNFs bind their physiological receptors,1/1194,29/9872,0.034482758620689655,0.2851036793161208,-1.4300500409711172,0.9763430948955631,0.9999999999999981,0.963097398669085,EDA,1,0.5633050309016346,0.07666600471676771,4.138895185830542
R-HSA-72086,mRNA Capping,1/1194,29/9872,0.034482758620689655,0.2851036793161208,-1.4300500409711172,0.9763430948955631,0.9999999999999981,0.963097398669085,CCNH,1,0.5633050309016346,0.07666600471676771,4.138895185830542
R-HSA-75067,Processing of Capped Intronless Pre-mRNA,1/1194,29/9872,0.034482758620689655,0.2851036793161208,-1.4300500409711172,0.9763430948955631,0.9999999999999981,0.963097398669085,ZNF473,1,0.5633050309016346,0.07666600471676771,4.138895185830542
R-HSA-72202,Transport of Mature Transcript to Cytoplasm,5/1194,82/9872,0.06097560975609756,0.5041467500102136,-1.6724057838132373,0.9764901291910784,0.9999999999999981,0.963097398669085,NUP205/NUP58/NUP98/NUP188/NUP153,5,0.9960881643992319,0.4030577766419773,2.4616610539623993
R-HSA-167152,Formation of HIV elongation complex in the absence of HIV Tat,2/1194,45/9872,0.044444444444444446,0.3674669644518891,-1.5774365804870174,0.9784541969414682,0.9999999999999981,0.963097398669085,CTDP1/CCNH,2,0.726037595384329,0.17591555679696957,2.9964978624365712
R-HSA-983705,Signaling by the B Cell Receptor (BCR),6/1194,95/9872,0.06315789473684211,0.5221898968526846,-1.735750264228155,0.9790514029962725,0.9999999999999981,0.963097398669085,CD22/CUL1/RASGRP1/NFKBIA/GRB2/RELA,6,1.0317376355461518,0.45118834013329606,2.3592864751067824
R-HSA-201722,Formation of the beta-catenin:TCF transactivating complex,1/1194,30/9872,0.03333333333333333,0.2756002233389168,-1.473907304639755,0.9792127834757417,0.9999999999999981,0.963097398669085,TLE1,1,0.5445281965382468,0.07419258184888566,3.996504090248868
R-HSA-2871809,FCERI mediated Ca+2 mobilization,1/1194,30/9872,0.03333333333333333,0.2756002233389168,-1.473907304639755,0.9792127834757417,0.9999999999999981,0.963097398669085,GRB2,1,0.5445281965382468,0.07419258184888566,3.996504090248868
R-HSA-4641262,Disassembly of the destruction complex and recruitment of AXIN to the membrane,1/1194,30/9872,0.03333333333333333,0.2756002233389168,-1.473907304639755,0.9792127834757417,0.9999999999999981,0.963097398669085,FZD5,1,0.5445281965382468,0.07419258184888566,3.996504090248868
R-HSA-8866652,Synthesis of active ubiquitin: roles of E1 and E2 enzymes,1/1194,30/9872,0.03333333333333333,0.2756002233389168,-1.473907304639755,0.9792127834757417,0.9999999999999981,0.963097398669085,UBE2D1,1,0.5445281965382468,0.07419258184888566,3.996504090248868
R-HSA-69017,CDK-mediated phosphorylation and removal of Cdc6,3/1194,59/9872,0.05084745762711865,0.4204071203475002,-1.656231591808799,0.9796115447523748,0.9999999999999981,0.963097398669085,CDK2/UBE2D1/CCNA2,3,0.830636232007495,0.26000522157755884,2.653625745426797
R-HSA-5632684,Hedgehog 'on' state,4/1194,72/9872,0.05555555555555555,0.45933370556486136,-1.707872410975227,0.980333541104538,0.9999999999999981,0.963097398669085,GLI3/DHH/CDON/ARRB1,4,0.9075469942304113,0.33102599981144615,2.488147599299765
R-HSA-9013694,Signaling by NOTCH4,4/1194,72/9872,0.05555555555555555,0.45933370556486136,-1.707872410975227,0.980333541104538,0.9999999999999981,0.963097398669085,HES5/KAT2B/CUL1/HES1,4,0.9075469942304113,0.33102599981144615,2.488147599299765
R-HSA-5250941,Negative epigenetic regulation of rRNA expression,2/1194,46/9872,0.043478260869565216,0.35947855218119584,-1.6150914908259062,0.9807077357998766,0.9999999999999981,0.963097398669085,MBD2/CCNH,2,0.7102541693977131,0.17220401498100293,2.9294379994710695
R-HSA-5387390,Hh mutants abrogate ligand secretion,2/1194,46/9872,0.043478260869565216,0.35947855218119584,-1.6150914908259062,0.9807077357998766,0.9999999999999981,0.963097398669085,DHH/HHAT,2,0.7102541693977131,0.17220401498100293,2.9294379994710695
R-HSA-5610785,GLI3 is processed to GLI3R by the proteasome,2/1194,46/9872,0.043478260869565216,0.35947855218119584,-1.6150914908259062,0.9807077357998766,0.9999999999999981,0.963097398669085,CUL1/GLI3,2,0.7102541693977131,0.17220401498100293,2.9294379994710695
R-HSA-167238,Pausing and recovery of Tat-mediated HIV elongation,1/1194,31/9872,0.03225806451612903,0.26670989355379043,-1.5167359233550468,0.9817346221802696,0.9999999999999981,0.963097398669085,CTDP1,1,0.5269627708434647,0.07187372782584145,3.8635781147722987
R-HSA-167243,Tat-mediated HIV elongation arrest and recovery,1/1194,31/9872,0.03225806451612903,0.26670989355379043,-1.5167359233550468,0.9817346221802696,0.9999999999999981,0.963097398669085,CTDP1,1,0.5269627708434647,0.07187372782584145,3.8635781147722987
R-HSA-9837999,Mitochondrial protein degradation,6/1194,97/9872,0.061855670103092786,0.5114230948557219,-1.793631963691829,0.9822091247212656,0.9999999999999981,0.963097398669085,PDK1/HSPD1/ACADSB/HSPA9/ALAS1/NDUFB6,6,1.010464694607056,0.4421083326116214,2.30947671358251
R-HSA-5607761,Dectin-1 mediated noncanonical NF-kB signaling,2/1194,47/9872,0.0425531914893617,0.35183007234755337,-1.6521308607931355,0.9827318995992318,0.9999999999999981,0.963097398669085,CUL1/RELA,2,0.6951423785594639,0.16864583254621482,2.8653119924376966
R-HSA-69618,Mitotic Spindle Checkpoint,7/1194,109/9872,0.06422018348623854,0.5309729073502067,-1.82638550011083,0.9829428242293053,0.9999999999999981,0.963097398669085,NUP98/PAFAH1B1/DYNC1I1/NUF2/AHCTF1/UBE2D1/SKA1,7,1.049091020853503,0.4874662306687182,2.2577809513607243
R-HSA-201681,TCF dependent signaling in response to WNT,11/1194,153/9872,0.0718954248366013,0.5944318542604088,-1.8753039913787641,0.9829589267876251,0.9999999999999981,0.963097398669085,SOX6/WIF1/FZD5/SOX4/KREMEN2/TNKS/PIP5K1B/RNF43/RSPO2/TLE1/SOX3,11,1.1744725807687677,0.6352084707500836,2.1715482498978753
R-HSA-68882,Mitotic Anaphase,17/1194,216/9872,0.0787037037037037,0.6507227495502202,-1.9251805396944082,0.9833839808460638,0.9999999999999981,0.963097398669085,LMNA/PPP2R2A/NUP205/LBR/PDS5A/NUP58/NUP98/NUP188/PAFAH1B1/DYNC1I1/NUF2/LMNB1/AHCTF1/UBE2D1/TUBB2A/SKA1/TUBB4A,17,1.2856915751597493,0.7820229067769985,2.113752438850397
R-HSA-5693567,HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA),6/1194,98/9872,0.061224489795918366,0.5062044918469901,-1.8222036909168353,0.9836158804550192,0.9999999999999981,0.963097398669085,RPA3/PPP4R2/BARD1/CDK2/CCNA2/POLE,6,1.0001538303763717,0.43770402093726546,2.2853518281018914
R-HSA-69481,G2/M Checkpoints,8/1194,121/9872,0.06611570247933884,0.5466450710854549,-1.8611413799263175,0.9838772640921336,0.9999999999999981,0.963097398669085,ORC4/YWHAG/RPA3/BARD1/CDK2/CCNA2/MCM7/CDC7,8,1.0800559270180101,0.526831168849831,2.2142213188210973
R-HSA-3214815,HDACs deacetylate histones,1/1194,32/9872,0.03125,0.2583752093802345,-1.5585997244797571,0.98395074463904,0.9999999999999981,0.963097398669085,GATAD2A,1,0.5104951842546064,0.06969539623386364,3.7392044127660964
R-HSA-2555396,Mitotic Metaphase and Anaphase,17/1194,217/9872,0.07834101382488479,0.6477240272020625,-1.9462994825702222,0.9843297219133947,0.9999999999999981,0.963097398669085,LMNA/PPP2R2A/NUP205/LBR/PDS5A/NUP58/NUP98/NUP188/PAFAH1B1/DYNC1I1/NUF2/LMNB1/AHCTF1/UBE2D1/TUBB2A/SKA1/TUBB4A,17,1.2797667291912713,0.7784832847044872,2.1038382112040286
R-HSA-5357905,Regulation of TNFR1 signaling,2/1194,48/9872,0.041666666666666664,0.344500279173646,-1.6885808874199366,0.9845491503697865,0.9999999999999981,0.963097398669085,UBE2D1/IKBKE,2,0.6806602456728086,0.1652316979835505,2.8039315439673773
R-HSA-9033241,Peroxisomal protein import,3/1194,62/9872,0.04838709677419355,0.4000648403306857,-1.7576749866809809,0.9849038800562413,0.9999999999999981,0.963097398669085,AGPS/UBE2D1/DHRS4,3,0.790444156265197,0.24776032047058924,2.521799951610763
R-HSA-9612973,Autophagy,11/1194,155/9872,0.07096774193548387,0.586761765818339,-1.9234157202695414,0.9851315903068638,0.9999999999999981,0.963097398669085,PLIN3/AMBRA1/ATG16L2/ATG4B/PRKAG3/DYNC1I1/WDR45B/TUBB2A/RRAGD/CFTR/TUBB4A,11,1.1593180958556224,0.6271775457476932,2.142963274898541
R-HSA-167287,HIV elongation arrest and recovery,1/1194,33/9872,0.030303030303030304,0.25054565758083347,-1.5995565052836354,0.985898184771254,0.9999999999999981,0.963097398669085,CTDP1,1,0.495025633216588,0.06764519216840734,3.6225838036118554
R-HSA-167290,Pausing and recovery of HIV elongation,1/1194,33/9872,0.030303030303030304,0.25054565758083347,-1.5995565052836354,0.985898184771254,0.9999999999999981,0.963097398669085,CTDP1,1,0.495025633216588,0.06764519216840734,3.6225838036118554
R-HSA-3299685,Detoxification of Reactive Oxygen Species,1/1194,33/9872,0.030303030303030304,0.25054565758083347,-1.5995565052836354,0.985898184771254,0.9999999999999981,0.963097398669085,ERO1A,1,0.495025633216588,0.06764519216840734,3.6225838036118554
R-HSA-71403,Citric acid cycle (TCA cycle),1/1194,33/9872,0.030303030303030304,0.25054565758083347,-1.5995565052836354,0.985898184771254,0.9999999999999981,0.963097398669085,SDHA,1,0.495025633216588,0.06764519216840734,3.6225838036118554
R-HSA-8852276,The role of GTSE1 in G2/M progression after G2 checkpoint,3/1194,63/9872,0.047619047619047616,0.3937146047698811,-1.7906385523047854,0.9863545973995645,0.9999999999999981,0.963097398669085,CDKN1A/TUBB2A/TUBB4A,3,0.7778974236260668,0.24393101121912517,2.480719440549051
R-HSA-6781827,Transcription-Coupled Nucleotide Excision Repair (TC-NER),4/1194,76/9872,0.05263157894736842,0.4351582473772371,-1.833505074518859,0.9864405923829873,0.9999999999999981,0.963097398669085,CUL4A/RPA3/CCNH/POLE,4,0.8597813629551265,0.3140407815511651,2.353910815129394
R-HSA-6804756,Regulation of TP53 Activity through Phosphorylation,5/1194,89/9872,0.056179775280898875,0.4644947584363766,-1.8823293722417496,0.987202005492417,0.9999999999999981,0.963097398669085,RPA3/PRKAG3/BARD1/CDK2/CCNA2,5,0.9177441514689552,0.37211442725328836,2.2634283055684175
R-HSA-5693571,Nonhomologous End-Joining (NHEJ),1/1194,34/9872,0.029411764705882353,0.24317666765198542,-1.6396587783169916,0.9876094935814098,0.9999999999999981,0.963097398669085,BARD1,1,0.4804660557690413,0.06571213650087948,3.5130136233383586
R-HSA-8953750,Transcriptional Regulation by E2F6,1/1194,34/9872,0.029411764705882353,0.24317666765198542,-1.6396587783169916,0.9876094935814098,0.9999999999999981,0.963097398669085,CDC7,1,0.4804660557690413,0.06571213650087948,3.5130136233383586
R-HSA-72695,"Formation of the ternary complex, and subsequently, the 43S complex",2/1194,50/9872,0.04,0.3307202680067002,-1.7598093752936061,0.9876425704199248,0.9999999999999981,0.963097398669085,EIF3H/EIF2S1,2,0.6534338358458962,0.15880194846261025,2.6887313534998127
R-HSA-9675135,Diseases of DNA repair,2/1194,50/9872,0.04,0.3307202680067002,-1.7598093752936061,0.9876425704199248,0.9999999999999981,0.963097398669085,RPA3/BARD1,2,0.6534338358458962,0.15880194846261025,2.6887313534998127
R-HSA-983168,Antigen processing: Ubiquitination & Proteasome degradation,24/1194,292/9872,0.0821917808219178,0.6795621945343153,-2.0616993614950228,0.987707557504087,0.9999999999999981,0.963097398669085,ZBTB16/SH3RF1/RNF130/LNX1/HECTD2/TRIM9/FBXO7/WWP1/RBBP6/CUL1/UBR1/UBA7/RNF6/UBE2O/KLHL2/ZNRF1/RNF217/KLHL3/SOCS3/FBXL8/DTX3L/UBE2D1/SPSB1/RNF182,24,1.3426722654367729,0.8819495384153185,2.044072516452948
R-HSA-5689880,Ub-specific processing proteases,10/1194,147/9872,0.06802721088435375,0.5624494353855446,-1.9825083602676512,0.9878488743292617,0.9999999999999981,0.963097398669085,HIF1A/TNKS/USP22/NFKBIA/TGFBR1/CCNA2/ARRB1/CFTR/TRAF6/POLB,10,1.111282033751524,0.5840978216986247,2.114282424384927
R-HSA-5663220,RHO GTPases Activate Formins,9/1194,136/9872,0.0661764705882353,0.5471475022169672,-1.9724629554611972,0.9879065176078661,0.9999999999999981,0.963097398669085,NUP98/PAFAH1B1/DYNC1I1/NUF2/RHOB/AHCTF1/TUBB2A/SKA1/TUBB4A,9,1.0810486254803429,0.5492513544438427,2.1277437391780287
R-HSA-382556,ABC-family proteins mediated transport,5/1194,90/9872,0.05555555555555555,0.45933370556486136,-1.9112154084418134,0.9882877949299274,0.9999999999999981,0.963097398669085,ABCA9/ABCC2/ABCB6/CFTR/EIF2S1,5,0.9075469942304112,0.36807760103654064,2.237684511138964
R-HSA-4086400,PCP/CE pathway,4/1194,78/9872,0.05128205128205128,0.4240003435983335,-1.8943594653902074,0.988770640710547,0.9999999999999981,0.963097398669085,PRICKLE1/FZD5/PRKCG/ROR2,4,0.8377356869819181,0.30618546511340367,2.292078368197969
R-HSA-4608870,Asymmetric localization of PCP proteins,2/1194,51/9872,0.0392156862745098,0.3242355568693139,-1.794632323434442,0.9889539787091133,0.9999999999999981,0.963097398669085,PRICKLE1/FZD5,2,0.6406214076920551,0.15577112523207892,2.6346075845694346
R-HSA-6781823,Formation of TC-NER Pre-Incision Complex,2/1194,51/9872,0.0392156862745098,0.3242355568693139,-1.794632323434442,0.9889539787091133,0.9999999999999981,0.963097398669085,CUL4A/CCNH,2,0.6406214076920551,0.15577112523207892,2.6346075845694346
R-HSA-9907900,Proteasome assembly,2/1194,51/9872,0.0392156862745098,0.3242355568693139,-1.794632323434442,0.9889539787091133,0.9999999999999981,0.963097398669085,PSMD5/PSMB9,2,0.6406214076920551,0.15577112523207892,2.6346075845694346
R-HSA-432720,Lysosome Vesicle Biogenesis,1/1194,35/9872,0.02857142857142857,0.23622876286192865,-1.6789544047148488,0.9891132814106227,0.9999999999999981,0.963097398669085,ARRB1,1,0.4667384541756401,0.06388646939320007,3.4098735878720032
R-HSA-5693568,Resolution of D-loop Structures through Holliday Junction Intermediates,1/1194,35/9872,0.02857142857142857,0.23622876286192865,-1.6789544047148488,0.9891132814106227,0.9999999999999981,0.963097398669085,BARD1,1,0.4667384541756401,0.06388646939320007,3.4098735878720032
R-HSA-5693538,Homology Directed Repair,6/1194,103/9872,0.05825242718446602,0.48163145826218473,-1.9615758751619239,0.9892173017794835,0.9999999999999981,0.963097398669085,RPA3/PPP4R2/BARD1/CDK2/CCNA2/POLE,6,0.9516026735619847,0.4169363607658872,2.171908553782357
R-HSA-5688426,Deubiquitination,17/1194,224/9872,0.07589285714285714,0.6274826513519981,-2.0918222661094026,0.9896924041008177,0.9999999999999981,0.963097398669085,KAT2B/HIF1A/TNKS/NOD2/USP22/NFKBIA/TNIP2/YOD1/BARD1/TGFBR1/UBE2D1/CCNA2/ARRB1/CFTR/RNF135/TRAF6/POLB,17,1.239774018904044,0.7545756986831926,2.0369588109341015
R-HSA-9824446,Viral Infection Pathways,69/1194,725/9872,0.09517241379310344,0.7868861549124935,-2.2111298373811756,0.9900959186051581,0.9999999999999981,0.963097398669085,ZDHHC11/ELMO1/ATP1A2/IFNAR2/MGAT4C/PAK2/CX3CR1/VEGFA/TLR2/PARP9/HSPA1A/HSPA1B/GATAD2A/ANO3/MED28/NFE2L2/BCL2L1/NUP205/GJA1/CTDP1/NOD2/G3BP1/GPC5/RUNX1/CYSLTR1/ST3GAL4/PTGES3/JAK3/IRAK2/YWHAG/SEC24D/KPNA3/CEBPD/NUP58/ZDHHC2/PTPN11/MED15/ATP1B3/NUP98/NUP188/NUP153/NFKBIA/PPP1CB/CCNH/DYNC1I1/CD14/ITGA4/GEMIN8/SEC23A/EDEM2/GRB2/MED29/GPC2/RELA/TUBB2A/CASP1/TUSC3/TLR4/FNTB/RNF135/TUBB4A/TRAF6/SFTPD/ATP1A3/RCAN3/SEC24A/FXYD1/STAT1/IKBKE,69,1.5547218852885116,1.2062879013495449,2.003800367964269
R-HSA-429914,Deadenylation-dependent mRNA decay,2/1194,52/9872,0.038461538461538464,0.3180002576987502,-1.8289551465520677,0.9901292627911777,0.9999999999999981,0.963097398669085,CNOT2/EIF4G1,2,0.6283017652364387,0.15285381324785943,2.5826186459548675
R-HSA-162909,Host Interactions of HIV factors,7/1194,116/9872,0.0603448275862069,0.4989314388032115,-2.0135534833334687,0.9902580515972279,0.9999999999999981,0.963097398669085,ELMO1/PAK2/NUP205/NUP58/NUP98/NUP188/NUP153,7,0.9857838040778605,0.4586866898845442,2.118591469542797
R-HSA-2173796,SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription,1/1194,36/9872,0.027777777777777776,0.22966685278243068,-1.7174871350657013,0.9904346946459299,0.9999999999999981,0.963097398669085,JUNB,1,0.45377349711520565,0.06215948564418523,3.3126140692804396
R-HSA-5693537,Resolution of D-Loop Structures,1/1194,36/9872,0.027777777777777776,0.22966685278243068,-1.7174871350657013,0.9904346946459299,0.9999999999999981,0.963097398669085,BARD1,1,0.45377349711520565,0.06215948564418523,3.3126140692804396
R-HSA-9758941,Gastrulation,6/1194,105/9872,0.05714285714285714,0.4724575257238573,-2.0157859045753446,0.990905312081055,0.9999999999999981,0.963097398669085,KAT2B/PAX6/DLL3/ZNF521/TEAD4/EPHA4,6,0.9334769083512803,0.4091708499392849,2.129621742493056
R-HSA-5617833,Cilium Assembly,13/1194,184/9872,0.07065217391304347,0.5841526472944432,-2.1120232948092212,0.9910553532446871,0.9999999999999981,0.963097398669085,DYNLRB2/RAB3IP/TTBK2/YWHAG/IFT172/BBS2/CEP70/PAFAH1B1/TUBB2A/TUBB4A/HAUS2/AHI1/BBS7,13,1.1541630252712838,0.6556465158885406,2.0317232786604436
R-HSA-211733,Regulation of activated PAK-2p34 by proteasome mediated degradation,1/1194,37/9872,0.02702702702702703,0.2234596405450677,-1.7552970735828455,0.9915958348037948,0.9999999999999981,0.963097398669085,PAK2,1,0.4415093485445244,0.060523396010758346,3.220746317962073
R-HSA-5685942,HDR through Homologous Recombination (HRR),3/1194,68/9872,0.04411764705882353,0.36476500147797813,-1.949665645702819,0.9918151533318762,0.9999999999999981,0.963097398669085,RPA3/BARD1/POLE,3,0.720699083653562,0.2264325654082927,2.29387132651398
R-HSA-5696394,DNA Damage Recognition in GG-NER,1/1194,38/9872,0.02631578947368421,0.21757912368861854,-1.7924210782784062,0.9926161269486111,0.9999999999999981,0.963097398669085,CUL4A,1,0.42989068147756326,0.05897120984682601,3.133834264232761
R-HSA-5696399,Global Genome Nucleotide Excision Repair (GG-NER),4/1194,83/9872,0.04819277108433735,0.39845815422493996,-2.0413084928971035,0.993040752847494,0.9999999999999981,0.963097398669085,CUL4A/RPA3/CCNH/POLE,4,0.7872696817420436,0.2881652753050329,2.15082664326625
R-HSA-169911,Regulation of Apoptosis,1/1194,39/9872,0.02564102564102564,0.21200017179916675,-1.8288931074538224,0.9935126435668091,0.9999999999999981,0.963097398669085,PAK2,1,0.41886784349095907,0.057496635332931506,3.051487609576285
R-HSA-6783310,Fanconi Anemia Pathway,1/1194,39/9872,0.02564102564102564,0.21200017179916675,-1.8288931074538224,0.9935126435668091,0.9999999999999981,0.963097398669085,RPA3,1,0.41886784349095907,0.057496635332931506,3.051487609576285
R-HSA-8948751,Regulation of PTEN stability and activity,2/1194,56/9872,0.03571428571428571,0.29528595357741083,-1.9616096217820105,0.9937242339291925,0.9999999999999981,0.963097398669085,TNKS/FRK,2,0.5834230677195501,0.14220103879020513,2.3936708117123575
R-HSA-5633007,Regulation of TP53 Activity,10/1194,156/9872,0.0641025641025641,0.5300004294979169,-2.1947695369653397,0.9937271198219173,0.9999999999999981,0.963097398669085,PIP4K2A/SGK1/GATAD2A/L3MBTL1/RPA3/PRKAG3/BARD1/CDK2/CCNA2/PRR5,10,1.0471696087273976,0.5510459190915306,1.9899688055944902
R-HSA-68867,Assembly of the pre-replicative complex,3/1194,72/9872,0.041666666666666664,0.344500279173646,-2.070611577092857,0.9945976384408127,0.9999999999999981,0.963097398669085,ORC4/UBE2D1/MCM7,3,0.6806602456728085,0.21414320758623287,2.163497853896689
R-HSA-174184,Cdc20:Phospho-APC/C mediated degradation of Cyclin A,2/1194,59/9872,0.03389830508474576,0.2802714135650001,-2.056680239233155,0.9955440789089365,0.9999999999999981,0.963097398669085,UBE2D1/CCNA2,2,0.5537574880049967,0.1351374047746453,2.26915231969245
R-HSA-174113,SCF-beta-TrCP mediated degradation of Emi1,1/1194,42/9872,0.023809523809523808,0.19685730238494056,-1.9346994924787924,0.9956007185434654,0.9999999999999981,0.963097398669085,CUL1,1,0.3889487118130334,0.05348444026068941,2.828506752312567
R-HSA-4641257,Degradation of AXIN,1/1194,42/9872,0.023809523809523808,0.19685730238494056,-1.9346994924787924,0.9956007185434654,0.9999999999999981,0.963097398669085,TNKS,1,0.3889487118130334,0.05348444026068941,2.828506752312567
R-HSA-8854050,FBXL7 down-regulates AURKA during mitotic entry and in early mitosis,1/1194,42/9872,0.023809523809523808,0.19685730238494056,-1.9346994924787924,0.9956007185434654,0.9999999999999981,0.963097398669085,CUL1,1,0.3889487118130334,0.05348444026068941,2.828506752312567
R-HSA-8866654,E3 ubiquitin ligases ubiquitinate target proteins,1/1194,42/9872,0.023809523809523808,0.19685730238494056,-1.9346994924787924,0.9956007185434654,0.9999999999999981,0.963097398669085,UBE2D1,1,0.3889487118130334,0.05348444026068941,2.828506752312567
R-HSA-9609507,Protein localization,10/1194,161/9872,0.062111801242236024,0.5135407888302798,-2.3083428241740913,0.9957074065808216,0.9999999999999981,0.963097398669085,ALDH3A2/HMOX1/SGTA/HSPD1/HSPA9/AGPS/UBE2D1/DHRS4/VAPA/GET1,10,1.0146488134253044,0.5342509394118187,1.9270199425738317
R-HSA-179419,APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint,2/1194,60/9872,0.03333333333333333,0.2756002233389168,-2.087603804360224,0.996026740462624,0.9999999999999981,0.963097398669085,UBE2D1/CCNA2,2,0.5445281965382468,0.1329362528443409,2.2304747612556013
R-HSA-68877,Mitotic Prometaphase,13/1194,196/9872,0.0663265306122449,0.5483881995009059,-2.3687449623442154,0.9961062615377525,0.9999999999999981,0.963097398669085,PDS5A/YWHAG/NEK9/NUP98/CEP70/PAFAH1B1/DYNC1I1/NUF2/AHCTF1/TUBB2A/SKA1/TUBB4A/HAUS2,13,1.083499982907736,0.6162016182274203,1.9051754786657977
R-HSA-9604323,Negative regulation of NOTCH4 signaling,1/1194,44/9872,0.022727272727272728,0.1879092431856251,-2.002494113847971,0.9966045771204661,0.9999999999999981,0.963097398669085,CUL1,1,0.37126922491244096,0.051106862449828754,2.6971101484150397
R-HSA-376176,Signaling by ROBO receptors,13/1194,198/9872,0.06565656565656566,0.5428489247584726,-2.4102506887992785,0.9966246221284591,0.9999999999999981,0.963097398669085,PAK2/CXCL12/NCK2/PRKAR2A/ROBO1/ENAH/MYO9B/LHX2/NELL2/NTN1/MSI1/PAK3/EIF4G1,13,1.0725555386359407,0.6100843734155725,1.8856004736168337
R-HSA-176409,APC/C:Cdc20 mediated degradation of mitotic proteins,2/1194,62/9872,0.03225806451612903,0.26670989355379043,-2.1483749657072497,0.9968430890646309,0.9999999999999981,0.963097398669085,UBE2D1/CCNA2,2,0.5269627708434647,0.12874226445704953,2.1569432775331023
R-HSA-69278,"Cell Cycle, Mitotic",40/1194,478/9872,0.08368200836820083,0.6918834058717577,-2.561395696010157,0.997009840649031,0.9999999999999981,0.963097398669085,LMNA/PPP2R2A/MIS18BP1/CDKN1A/NUP205/LBR/CUL1/PDS5A/ORC4/YWHAG/NEK9/NUP58/RAB1A/PPME1/NUP98/RPA3/NUP188/NUP153/PPP1CB/CCNH/CEP70/PAFAH1B1/DYNC1I1/CDC14A/NUF2/LMNB1/GINS3/AHCTF1/CDK2/UBE2D1/TUBB2A/CCNA2/SKA1/POLE/TUBB4A/CABLES1/PHLDA1/HAUS2/MCM7/CDC7,40,1.3670163929830461,0.9848874098606695,1.897408576832904
R-HSA-167161,HIV Transcription Initiation,1/1194,45/9872,0.022222222222222223,0.18373348222594454,-2.0356386025716353,0.9970170857608979,0.9999999999999981,0.963097398669085,CCNH,1,0.3630187976921645,0.04999560961396866,2.6358844005583424
R-HSA-167162,RNA Polymerase II HIV Promoter Escape,1/1194,45/9872,0.022222222222222223,0.18373348222594454,-2.0356386025716353,0.9970170857608979,0.9999999999999981,0.963097398669085,CCNH,1,0.3630187976921645,0.04999560961396866,2.6358844005583424
R-HSA-73776,RNA Polymerase II Promoter Escape,1/1194,45/9872,0.022222222222222223,0.18373348222594454,-2.0356386025716353,0.9970170857608979,0.9999999999999981,0.963097398669085,CCNH,1,0.3630187976921645,0.04999560961396866,2.6358844005583424
R-HSA-73779,RNA Polymerase II Transcription Pre-Initiation And Promoter Opening,1/1194,45/9872,0.022222222222222223,0.18373348222594454,-2.0356386025716353,0.9970170857608979,0.9999999999999981,0.963097398669085,CCNH,1,0.3630187976921645,0.04999560961396866,2.6358844005583424
R-HSA-75953,RNA Polymerase II Transcription Initiation,1/1194,45/9872,0.022222222222222223,0.18373348222594454,-2.0356386025716353,0.9970170857608979,0.9999999999999981,0.963097398669085,CCNH,1,0.3630187976921645,0.04999560961396866,2.6358844005583424
R-HSA-76042,RNA Polymerase II Transcription Initiation And Promoter Clearance,1/1194,45/9872,0.022222222222222223,0.18373348222594454,-2.0356386025716353,0.9970170857608979,0.9999999999999981,0.963097398669085,CCNH,1,0.3630187976921645,0.04999560961396866,2.6358844005583424
R-HSA-8941858,Regulation of RUNX3 expression and activity,1/1194,45/9872,0.022222222222222223,0.18373348222594454,-2.0356386025716353,0.9970170857608979,0.9999999999999981,0.963097398669085,CBFB,1,0.3630187976921645,0.04999560961396866,2.6358844005583424
R-HSA-9864848,Complex IV assembly,1/1194,45/9872,0.022222222222222223,0.18373348222594454,-2.0356386025716353,0.9970170857608979,0.9999999999999981,0.963097398669085,NDUFA4,1,0.3630187976921645,0.04999560961396866,2.6358844005583424
R-HSA-674695,RNA Polymerase II Pre-transcription Events,3/1194,78/9872,0.038461538461538464,0.3180002576987502,-2.2429747185840805,0.9971309457301082,0.9999999999999981,0.963097398669085,CTDP1/CCNH/IWS1,3,0.6283017652364387,0.19802201357992685,1.99353143149354
R-HSA-176814,Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins,2/1194,63/9872,0.031746031746031744,0.2624764031799207,-2.178245090662739,0.9971869740372561,0.9999999999999981,0.963097398669085,UBE2D1/CCNA2,2,0.5185982824173779,0.12674295891186954,2.1219654396207073
R-HSA-1852241,Organelle biogenesis and maintenance,20/1194,277/9872,0.07220216606498195,0.5969679927918776,-2.523654216412983,0.9972985784767208,0.9999999999999981,0.963097398669085,MICOS10/DYNLRB2/RAB3IP/HELZ2/TTBK2/YWHAG/NCOA1/IFT172/BBS2/PRKAG3/CEP70/PAFAH1B1/HSPA9/ALAS1/TUBB2A/CAMK4/TUBB4A/HAUS2/AHI1/BBS7,20,1.1794834582055886,0.7464061526592747,1.8638394434774601
R-HSA-351202,Metabolism of polyamines,1/1194,46/9872,0.021739130434782608,0.17973927609059792,-2.0683087505596567,0.9973795157600317,0.9999999999999981,0.963097398669085,AZIN2,1,0.35512708469885657,0.04893164844820002,2.5773757943229088
R-HSA-5610780,Degradation of GLI1 by the proteasome,1/1194,46/9872,0.021739130434782608,0.17973927609059792,-2.0683087505596567,0.9973795157600317,0.9999999999999981,0.963097398669085,CUL1,1,0.35512708469885657,0.04893164844820002,2.5773757943229088
R-HSA-5610783,Degradation of GLI2 by the proteasome,1/1194,46/9872,0.021739130434782608,0.17973927609059792,-2.0683087505596567,0.9973795157600317,0.9999999999999981,0.963097398669085,CUL1,1,0.35512708469885657,0.04893164844820002,2.5773757943229088
R-HSA-5676590,NIK-->noncanonical NF-kB signaling,1/1194,46/9872,0.021739130434782608,0.17973927609059792,-2.0683087505596567,0.9973795157600317,0.9999999999999981,0.963097398669085,CUL1,1,0.35512708469885657,0.04893164844820002,2.5773757943229088
R-HSA-162599,Late Phase of HIV Life Cycle,7/1194,132/9872,0.05303030303030303,0.43845490076645854,-2.4091566780813016,0.9974735582678584,0.9999999999999981,0.963097398669085,NUP205/CTDP1/NUP58/NUP98/NUP188/NUP153/CCNH,7,0.866294858129029,0.40414898892381856,1.8569062444500044
R-HSA-1268020,Mitochondrial protein import,2/1194,64/9872,0.03125,0.2583752093802345,-2.207785687466567,0.9974939422576428,0.9999999999999981,0.963097398669085,HSPD1/HSPA9,2,0.5104951842546064,0.12480479608479605,2.0881035130259065
R-HSA-5693532,DNA Double-Strand Break Repair,7/1194,133/9872,0.05263157894736842,0.4351582473772371,-2.432586800782575,0.9976845729661878,0.9999999999999981,0.963097398669085,KDM4B/RPA3/PPP4R2/BARD1/CDK2/CCNA2/POLE,7,0.8597813629551264,0.4011678433305784,1.8426800761192232
R-HSA-5678895,Defective CFTR causes cystic fibrosis,1/1194,48/9872,0.020833333333333332,0.172250139586823,-2.132300822487271,0.9979777037265765,0.9999999999999981,0.963097398669085,CFTR,1,0.3403301228364043,0.046934019734335045,2.4678174417076275
R-HSA-9754678,SARS-CoV-2 modulates host translation machinery,1/1194,48/9872,0.020833333333333332,0.172250139586823,-2.132300822487271,0.9979777037265765,0.9999999999999981,0.963097398669085,GEMIN8,1,0.3403301228364043,0.046934019734335045,2.4678174417076275
R-HSA-69620,Cell Cycle Checkpoints,16/1194,241/9872,0.06639004149377593,0.548913307894938,-2.629697303873493,0.998317638426073,0.9999999999999981,0.963097398669085,CDKN1A/ORC4/YWHAG/NUP98/RPA3/PAFAH1B1/DYNC1I1/NUF2/BARD1/AHCTF1/CDK2/UBE2D1/CCNA2/SKA1/MCM7/CDC7,16,1.0845374868811555,0.6516724186191237,1.8049276397839182
R-HSA-2467813,Separation of Sister Chromatids,10/1194,173/9872,0.057803468208092484,0.477919462437428,-2.5696264382513414,0.9983272299372741,0.9999999999999981,0.963097398669085,PDS5A/NUP98/PAFAH1B1/DYNC1I1/NUF2/AHCTF1/UBE2D1/TUBB2A/SKA1/TUBB4A,10,0.9442685489102545,0.4978355863020064,1.7910392848456846
R-HSA-167172,Transcription of the HIV genome,2/1194,68/9872,0.029411764705882353,0.24317666765198542,-2.3228450170068795,0.9984246860090684,0.9999999999999981,0.963097398669085,CTDP1/CCNH,2,0.4804660557690413,0.11761071261748643,1.9628112576535564
R-HSA-72165,mRNA Splicing - Minor Pathway,1/1194,50/9872,0.02,0.1653601340033501,-2.194608608272345,0.9984394289416431,0.9999999999999981,0.963097398669085,SNRNP48,1,0.3267169179229481,0.045093084106503104,2.3671910354358823
R-HSA-195253,Degradation of beta-catenin by the destruction complex,2/1194,70/9872,0.02857142857142857,0.23622876286192865,-2.378635447355777,0.9987524733711295,0.9999999999999981,0.963097398669085,CUL1/TLE1,2,0.4667384541756401,0.11431595549013032,1.905637613509464
R-HSA-168255,Influenza Infection,8/1194,153/9872,0.05228758169934641,0.4323140758257518,-2.624919364690594,0.9988098599389887,0.9999999999999981,0.963097398669085,HSPA1A/HSPA1B/NUP205/KPNA3/NUP58/NUP98/NUP188/NUP153,8,0.8541618769227401,0.41858191832608505,1.7430101015969086
R-HSA-5689603,UCH proteinases,2/1194,71/9872,0.028169014084507043,0.232901597187817,-2.4061238320884057,0.9988901305398057,0.9999999999999981,0.963097398669085,BARD1/TGFBR1,2,0.46016467313091275,0.11273684160398004,1.8782815216831845
R-HSA-174084,Autodegradation of Cdh1 by Cdh1:APC/C,1/1194,53/9872,0.018867924528301886,0.1560001264182548,-2.2851757293818045,0.9989422188875229,0.9999999999999981,0.963097398669085,UBE2D1,1,0.3082235074744793,0.042587394701863984,2.23074764786474
R-HSA-381753,Olfactory Signaling Pathway,3/1194,88/9872,0.03409090909090909,0.2818638647784376,-2.5099369417716186,0.9990227908206264,0.9999999999999981,0.963097398669085,LHX2/ADCY3/GNAL,3,0.5569038373686614,0.17594586199944884,1.76271201011202
R-HSA-5668541,TNFR2 non-canonical NF-kB pathway,3/1194,88/9872,0.03409090909090909,0.2818638647784376,-2.5099369417716186,0.9990227908206264,0.9999999999999981,0.963097398669085,TNFRSF13C/CUL1/EDA,3,0.5569038373686614,0.17594586199944884,1.76271201011202
R-HSA-174154,APC/C:Cdc20 mediated degradation of Securin,1/1194,54/9872,0.018518518518518517,0.15311123518828712,-2.314646394662462,0.9990708461049889,0.9999999999999981,0.963097398669085,UBE2D1,1,0.30251566474347047,0.041812916174188405,2.1886951638086787
R-HSA-162587,HIV Life Cycle,7/1194,144/9872,0.04861111111111111,0.4019169923692537,-2.681660809906032,0.9991302020285865,0.9999999999999981,0.963097398669085,NUP205/CTDP1/NUP58/NUP98/NUP188/NUP153/CCNH,7,0.7941036199516098,0.37106020638676257,1.6994561754837292
R-HSA-5696398,Nucleotide Excision Repair,4/1194,107/9872,0.037383177570093455,0.30908436262308425,-2.665346668592849,0.9993763177371479,0.9999999999999981,0.963097398669085,CUL4A/RPA3/CCNH/POLE,4,0.6106858278933609,0.22469053472006903,1.6597814449746349
R-HSA-68886,M Phase,23/1194,332/9872,0.06927710843373494,0.5727835966983511,-2.9370794210636624,0.9993863548647797,0.9999999999999981,0.963097398669085,LMNA/PPP2R2A/NUP205/LBR/PDS5A/YWHAG/NEK9/NUP58/RAB1A/NUP98/NUP188/NUP153/CEP70/PAFAH1B1/DYNC1I1/NUF2/LMNB1/AHCTF1/UBE2D1/TUBB2A/SKA1/TUBB4A/HAUS2,23,1.1317001675041876,0.7386677615975894,1.7338583538003776
R-HSA-6790901,rRNA modification in the nucleus and cytosol,1/1194,58/9872,0.017241379310344827,0.1425518396580604,-2.4292474712388574,0.9994469125845787,0.9999999999999981,0.963097398669085,NAT10,1,0.2816525154508173,0.03897756955404465,2.035225396744655
R-HSA-174178,APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1,1/1194,60/9872,0.016666666666666666,0.1378001116694584,-2.48472159294979,0.9995733123518529,0.9999999999999981,0.963097398669085,UBE2D1,1,0.2722640982691234,0.03769935740357482,1.9662865446950502
R-HSA-8852135,Protein ubiquitination,1/1194,62/9872,0.016129032258064516,0.13335494677689522,-2.5390749447335184,0.9996708439526882,0.9999999999999981,0.963097398669085,UBE2D1,1,0.26348138542173233,0.036502312414744324,1.901864179862581
R-HSA-72613,Eukaryotic Translation Initiation,4/1194,117/9872,0.03418803418803419,0.2826668957322224,-2.8951634278069696,0.9997817154358428,0.9999999999999981,0.963097398669085,EIF4EBP1/EIF3H/EIF2S1/EIF4G1,4,0.5584904579879454,0.20580202399491979,1.5155904961910605
R-HSA-72737,Cap-dependent Translation Initiation,4/1194,117/9872,0.03418803418803419,0.2826668957322224,-2.8951634278069696,0.9997817154358428,0.9999999999999981,0.963097398669085,EIF4EBP1/EIF3H/EIF2S1/EIF4G1,4,0.5584904579879454,0.20580202399491979,1.5155904961910605
R-HSA-168273,Influenza Viral RNA Transcription and Replication,5/1194,132/9872,0.03787878787878788,0.3131820719760418,-2.9466057137411275,0.9997914744707908,0.9999999999999981,0.963097398669085,NUP205/NUP58/NUP98/NUP188/NUP153,5,0.6187820415207349,0.25286554491211444,1.514208727178096
R-HSA-73856,RNA Polymerase II Transcription Termination,1/1194,67/9872,0.014925373134328358,0.12340308507712693,-2.6704623334453177,0.9998280018074999,0.9999999999999981,0.963097398669085,ZNF473,1,0.24381859546488663,0.03381780367021316,1.7578760606157162
R-HSA-156827,L13a-mediated translational silencing of Ceruloplasmin expression,3/1194,109/9872,0.027522935779816515,0.22755981743580286,-3.0078721917063946,0.9999052200772711,0.9999999999999981,0.963097398669085,EIF3H/EIF2S1/EIF4G1,3,0.44961043750864416,0.14256824334831064,1.4179142617535085
R-HSA-611105,Respiratory electron transport,6/1194,154/9872,0.03896103896103896,0.32213013117535727,-3.144786449885028,0.9999057081990558,0.9999999999999981,0.963097398669085,SDHA/NDUFB9/LYRM2/HSPA9/NDUFA4/NDUFB6,6,0.6364615284213274,0.2809644441244323,1.4417599295269214
R-HSA-72706,GTP hydrolysis and joining of the 60S ribosomal subunit,3/1194,110/9872,0.02727272727272727,0.22549109182275012,-3.0298859038891806,0.9999153549241632,0.9999999999999981,0.963097398669085,EIF3H/EIF2S1/EIF4G1,3,0.4455230698949292,0.14129187548856062,1.4048281624280112
R-HSA-71291,Metabolism of amino acids and derivatives,20/1194,329/9872,0.060790273556231005,0.5026143890679333,-3.4034676011437766,0.9999254243296104,0.9999999999999981,0.963097398669085,SHMT1/BCAT1/AZIN2/NNMT/NAALAD2/QDPR/GLUL/SLC6A8/GLS2/DUOX2/GLDC/ACADSB/CRYM/DMGDH/SQOR/KYAT3/ACMSD/BHMT/ASPA/SLC45A2,20,0.9930605407992341,0.6299442041006624,1.5654866435359434
R-HSA-927802,Nonsense-Mediated Decay (NMD),3/1194,113/9872,0.02654867256637168,0.2195046026593143,-3.0951366334801307,0.9999397651815769,0.9999999999999981,0.963097398669085,PPP2R2A/SMG9/EIF4G1,3,0.43369502379152397,0.1375963063890879,1.366979816519604
R-HSA-975957,Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC),3/1194,113/9872,0.02654867256637168,0.2195046026593143,-3.0951366334801307,0.9999397651815769,0.9999999999999981,0.963097398669085,PPP2R2A/SMG9/EIF4G1,3,0.43369502379152397,0.1375963063890879,1.366979816519604
R-HSA-1428517,Aerobic respiration and respiratory electron transport,13/1194,250/9872,0.052,0.42993634840871015,-3.386363659562217,0.9999424801468468,0.9999999999999981,0.963097398669085,PDK1/MKLN1/SDHA/NDUFB9/LDHA/LYRM2/HSPA9/NDUFA4/LDHC/D2HGDH/PDK3/PDHX/NDUFB6,13,0.849463986599665,0.4849235165008665,1.4880471661524513
R-HSA-9633012,Response of EIF2AK4 (GCN2) to amino acid deficiency,2/1194,98/9872,0.02040816326530612,0.16873483061566333,-3.0675338976825675,0.9999553445046085,0.9999999999999981,0.963097398669085,ATF3/EIF2S1,2,0.3333846101254572,0.08211148686771381,1.3535901310320249
R-HSA-1640170,Cell Cycle,45/1194,606/9872,0.07425742574257425,0.6139608935767948,-3.6382654501136655,0.9999569040126141,0.9999999999999981,0.963097398669085,LMNA/PPP2R2A/MIS18BP1/CDKN1A/NUP205/LBR/CUL1/PDS5A/ANKRD28/ORC4/SHQ1/YWHAG/NEK9/NUP58/RAB1A/PPME1/NUP98/RPA3/NUP188/NUP153/PPP1CB/CCNH/CEP70/PAFAH1B1/DYNC1I1/CDC14A/NUF2/LMNB1/BARD1/GINS3/AHCTF1/SYCP3/CDK2/UBE2D1/TUBB2A/CCNA2/SKA1/POLE/TUBB4A/CABLES1/PHLDA1/STN1/HAUS2/MCM7/CDC7,45,1.2130578635753022,0.8911209743130952,1.651301476229042
R-HSA-9711097,Cellular response to starvation,5/1194,149/9872,0.03355704697986577,0.2774498892673659,-3.296354263366005,0.9999639847692334,0.9999999999999981,0.963097398669085,FNIP2/FNIP1/ATF3/RRAGD/EIF2S1,5,0.5481827481928658,0.22443153231869956,1.3389576870577962
R-HSA-9752946,Expression and translocation of olfactory receptors,1/1194,82/9872,0.012195121951219513,0.10082935000204274,-3.0327081565416116,0.999975511161115,0.9999999999999981,0.963097398669085,LHX2,1,0.1992176328798464,0.027705121706028398,1.4325028300313718
R-HSA-5368286,Mitochondrial translation initiation,1/1194,83/9872,0.012048192771084338,0.09961453855623499,-3.0554224984266876,0.9999784978489218,0.9999999999999981,0.963097398669085,MRPS22,1,0.1968174204355109,0.027375241161530964,1.4150413053282598
R-HSA-5389840,Mitochondrial translation elongation,1/1194,83/9872,0.012048192771084338,0.09961453855623499,-3.0554224984266876,0.9999784978489218,0.9999999999999981,0.963097398669085,MRPS22,1,0.1968174204355109,0.027375241161530964,1.4150413053282598
R-HSA-5419276,Mitochondrial translation termination,1/1194,83/9872,0.012048192771084338,0.09961453855623499,-3.0554224984266876,0.9999784978489218,0.9999999999999981,0.963097398669085,MRPS22,1,0.1968174204355109,0.027375241161530964,1.4150413053282598
R-HSA-162906,HIV Infection,9/1194,213/9872,0.04225352112676056,0.34935239578172556,-3.5607580937239964,0.9999835297998452,0.9999999999999981,0.963097398669085,ELMO1/PAK2/NUP205/CTDP1/NUP58/NUP98/NUP188/NUP153/CCNH,9,0.6902470096963691,0.3533650068871819,1.3482968746446693
R-HSA-5368287,Mitochondrial translation,1/1194,89/9872,0.011235955056179775,0.09289895168727531,-3.188508373596303,0.9999901500338186,0.9999999999999981,0.963097398669085,MRPS22,1,0.18354883029379104,0.025549922614015834,1.3186017668694467
R-HSA-156842,Eukaryotic Translation Elongation,1/1194,91/9872,0.01098901098901099,0.0908572164853572,-3.2317226267769974,0.9999924077645859,0.9999999999999981,0.963097398669085,EEF1A2,1,0.1795147900675539,0.024994397930992254,1.2893113065563893
R-HSA-975956,Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),1/1194,93/9872,0.010752688172043012,0.0889032978512635,-3.2743993265366593,0.99999414832901945,0.9999999999999981,0.963097398669085,EIF4G1,1,0.17565425694782152,0.024462515757497423,1.2612937397673358
R-HSA-9010553,Regulation of expression of SLITs and ROBOs,4/1194,153/9872,0.026143790849673203,0.2161570379128759,-3.624406529106367,0.9999957248550054,0.9999999999999981,0.963097398669085,ROBO1/LHX2/MSI1/EIF4G1,4,0.4270809384613701,0.15798933554353245,1.1544964561660966
R-HSA-73894,DNA Repair,13/1194,283/9872,0.045936395759717315,0.3798024279228889,-3.926535575636295,0.9999967496737976,0.9999999999999981,0.963097398669085,USP43/CUL4A/KDM4B/ALKBH5/UBA7/RPA3/PPP4R2/CCNH/BARD1/CDK2/CCNA2/POLE/POLB,13,0.750409882155181,0.42906378485033964,1.3124272220564386
R-HSA-72689,Formation of a pool of free 40S subunits,1/1194,99/9872,0.010101010101010102,0.08351521919361116,-3.399396491231824,0.9999973216808142,0.9999999999999981,0.963097398669085,EIF3H,1,0.16500854440552934,0.02299453735581883,1.184099480042005
R-HSA-72203,Processing of Capped Intron-Containing Pre-mRNA,12/1194,278/9872,0.04316546762589928,0.35689237554679876,-4.034401492365546,0.9999984352859396,0.9999999999999981,0.963097398669085,HNRNPF/TRA2B/NUP205/RBM5/NUP58/HNRNPU/NUP98/NUP188/NUP153/NKAP/TCERG1/SNRNP48,12,0.7051444271718303,0.39448066415176425,1.2604639678364447
R-HSA-72172,mRNA Splicing,7/1194,209/9872,0.03349282296650718,0.2769188846946054,-3.9190164728916344,0.9999984741214203,0.9999999999999981,0.963097398669085,HNRNPF/TRA2B/RBM5/HNRNPU/NKAP/TCERG1/SNRNP48,7,0.5471335946078077,0.25706152638530233,1.1645273198127897
R-HSA-2408522,Selenoamino acid metabolism,1/1194,105/9872,0.009523809523809525,0.07874292095397624,-3.520203822411369,0.9999987747572602,0.9999999999999981,0.963097398669085,NNMT,1,0.15557948472521338,0.021692765882023544,1.1158086616986538
R-HSA-72163,mRNA Splicing - Major Pathway,6/1194,201/9872,0.029850746268656716,0.24680617015425385,-4.001676778967861,0.9999992744782735,0.9999999999999981,0.963097398669085,HNRNPF/TRA2B/RBM5/HNRNPU/NKAP/TCERG1,6,0.48763719092977326,0.21603714818769287,1.100690469082143
R-HSA-1799339,SRP-dependent cotranslational protein targeting to membrane,1/1194,110/9872,0.00909090909090909,0.07516369727425003,-3.6179680407141968,0.999999361709518,0.9999999999999981,0.963097398669085,SRPRB,1,0.1485076899649764,0.02071547314257774,1.0646406107617967
R-HSA-72766,Translation,8/1194,265/9872,0.03018867924528302,0.24960020226920768,-4.592981185328355,0.9999999792077228,0.9999999999999981,0.963097398669085,SRPRB/PPA2/EEF1A2/EIF4EBP1/EIF3H/MRPS22/EIF2S1/EIF4G1,8,0.4931576119591669,0.24348590240063037,0.9988439898795497
R-HSA-8868773,rRNA processing in the nucleus and cytosol,1/1194,188/9872,0.005319148936170213,0.04397875904344417,-4.9089882464562065,0.9999999999767263,0.9999999999999981,0.963097398669085,NAT10,1,0.08689279731993299,0.012165459853478163,0.620638949700226
R-HSA-72312,rRNA processing,1/1194,198/9872,0.005050505050505051,0.04175760959680558,-5.052168761247535,0.999999999993761,0.9999999999999981,0.963097398669085,NAT10,1,0.08250427220276467,0.011554074948504115,0.5891388935978098
R-HSA-8953854,Metabolism of RNA,28/1194,706/9872,0.039660056657223795,0.32790961417094916,-6.87405532910812,0.9999999999999981,0.9999999999999981,0.963097398669085,NSUN2/ZFP36/CNOT2/HNRNPF/HSPA1A/HSPA1B/PPP2R2A/TRA2B/NUP205/RBM5/SMG9/TRIT1/IGF2BP2/ZNF473/NUP58/HNRNPU/NUP98/NUP188/NUP153/CCNH/NKAP/GEMIN8/HSPB1/TCERG1/SNRNP48/NAT10/OSGEP/EIF4G1,28,0.6478805737848828,0.44209906713560926,0.9494461062933556
